Form 10-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark One)
|
|
|
þ |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2008
or
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 000-51251
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
20-1538254
(I.R.S. Employer
Identification No.) |
|
|
|
103 Powell Court, Suite 200
Brentwood, Tennessee
(Address Of Principal Executive Offices)
|
|
37027
(Zip Code) |
(615) 372-8500
(Registrants Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of Each Class
|
|
Name of Exchange on Which Registered |
|
|
|
Common Stock, par value $.01 per share
|
|
NASDAQ Global Select Market |
Preferred Stock Purchase Rights
|
|
NASDAQ Global Select Market |
Securities registered pursuant to Section 12(g) of the Act: NONE
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act.
Yes þ No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or Section 15(d) of the Act.
Yes o No þ
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Act). Yes o No þ
The aggregate market value of the shares of registrants Common Stock held by non-affiliates
as of June 30, 2008, was approximately $950 million.
As
of February 17, 2009, the number of outstanding shares of the registrants Common Stock was
52,094,515.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement for our 2009 annual meeting of stockholders are
incorporated by reference into Part III of this report.
PART I
Overview of Our Company
LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates
general acute care hospitals in non-urban communities in the United States. Unless the context
otherwise requires, LifePoint and its subsidiaries are referred to herein as LifePoint, the
Company, we, our or us. At December 31, 2008, our subsidiaries owned or leased 48
hospitals, having a total of 5,686 licensed beds, and serving communities in 17 states. Two of
these hospitals were held for sale and classified as discontinued operations in our consolidated
financial statements, and seven were owned by third parties and leased by our subsidiaries. We
generated $2,336.5 million, $2,568.4 million and $2,700.8 million in revenues from continuing
operations during the years ended December 31, 2006, 2007 and 2008, respectively.
We
seek to fulfill our mission of Making Communities
Healthier® by striving to (1) improve the
quality and types of healthcare services available in our communities; (2) provide physicians with
a positive environment in which to practice medicine, with access to necessary equipment and
resources; (3) develop and provide a positive work environment for employees; (4) expand each
hospitals role as a community asset; and (5) improve each hospitals financial performance. We
expect our hospitals to be the place where patients want to come for care, where physicians want to
practice medicine and where employees want to work.
Operations
Our hospitals typically provide the range of medical and surgical services commonly available
in hospitals in non-urban markets. These services include general surgery, internal medicine,
obstetrics, psychiatric care, emergency room care, radiology, oncology, diagnostic care, coronary
care, rehabilitation services, pediatric services, and, in some of our hospitals, specialized
services such as open-heart surgery, skilled nursing and neuro-surgery. In many markets, we also
provide outpatient services such as one-day surgery, laboratory, x-ray, respiratory therapy,
imaging, sports medicine and lithotripsy. Like most hospitals located in non-urban markets, our
hospitals do not engage in extensive medical research and medical education programs. However, two
of our hospitals have an affiliation with medical schools, including the clinical rotation of
medical students, and one of our hospitals owns and operates a school of health professions with a
nursing program and a radiologic technology program.
The range of services that can be offered at any of our hospitals depends significantly on the
efforts, abilities and experience of the physicians on the medical staffs of our hospitals, most of
whom have no long-term contractual relationship with us. Our hospitals are staffed by licensed
physicians who have been admitted to the medical staffs of individual hospitals. Under state laws
and other licensing standards, hospital medical staffs are generally self-governing organizations
subject to ultimate oversight by the hospitals local governing board. Each of our hospitals has a
local board of trustees. These boards generally include members of the hospitals medical staff as
well as community leaders. These boards establish policies concerning medical, professional and
ethical practices, monitor these practices, and are responsible for reviewing these practices in
order to determine that they conform to established standards. The Company maintains quality
assurance programs to support and monitor quality of care standards and to meet accreditation and
regulatory requirements. The Company also monitors patient care evaluations and other quality of
care assessment activities on a regular basis.
Nurses, therapists, lab technicians, facility maintenance workers and the administrative
staffs of hospitals are the majority of our employees. We are subject to federal minimum wage
and hour laws and various state labor laws, and maintain a number of different employee benefit
plans.
1
Members of the medical staffs of our hospitals are free to serve on the medical staffs of
hospitals not owned by us. Members of our medical staffs are free to terminate their affiliation
with our hospitals or admit their patients to competing hospitals at any time. Although we own some
physician practices and, where permitted by law, employ some physicians, the majority of the
physicians who practice at our hospitals are not our employees. It is essential to our ongoing
business that we attract and retain skilled employees and an appropriate number of quality
physicians and other healthcare professionals in all specialties on our medical staffs.
In our markets, physician recruitment and retention are affected by a shortage of physicians
in certain sought-after specialties, the difficulties that physicians are experiencing in obtaining
affordable malpractice insurance or finding insurers willing to provide such insurance, and the
challenges that can be associated with practicing medicine in small groups or independently. In
order for our hospitals to be successful, we must recruit and retain a sufficient number of
active, engaged and successful physicians.
Although we believe we will continue to successfully attract and retain key employees,
qualified physicians and other health care professionals, the loss of some or all of our key
employees or the inability to attract or retain sufficient numbers of qualified physicians and
other health care professionals could have a material adverse effect on our business, financial
condition, results of operations or cash flows.
Each
of our acute care
hospitals is accredited by the Joint Commission (formerly, the Joint Commission on Accreditation of
Healthcare Organizations). With such accreditation, our hospitals are deemed to meet the Medicare
Conditions of Participation and are, therefore, eligible to participate in government-sponsored
provider programs, such as the Medicare and Medicaid programs. Bluegrass Community Hospital is
designated by the Centers for Medicare and Medicaid Services
(CMS) as a critical access hospital,
and we have not sought accreditation. Bluegrass Community Hospital
also participates in the Medicare
program by otherwise meeting the Medicare Conditions of
Paiticipation.
We seek to operate our hospitals in a manner that positions them to compete effectively and to
further our mission of making communities healthier. The operating strategies of our hospitals,
however, are determined largely by local hospital leadership and are tailored to each of their
respective communities. Generally, our overall operating strategy is to strive to: (1) expand the
breadth of services offered at our hospitals by adding equipment and seeking to attract
specialty physicians in an effort to attract community patients that might otherwise leave their
community for healthcare; (2) recruit, attract and retain physicians interested in practicing in
the rural communities where our hospitals are located; (3) responsibly manage and control the cost
of supplies, improve employee productivity by adjusting staffing levels to patient volumes, and
reduce or control the cost of contract labor and fees paid to physicians or physician groups for
call coverage; (4) recruit, retain and develop hospital executives interested in working and living
in the rural communities where our hospitals are located; and (5) negotiate favorable,
facility-specific contracts with managed care and other private-pay payors. In appropriate
circumstances, we may also selectively acquire hospitals or other healthcare facilities where our
operating strategies can improve performance.
In connection with our efforts to responsibly manage purchasing costs, we participate along
with other healthcare companies in a group purchasing organization, HealthTrust Purchasing Group,
which makes certain national supply and equipment contracts available to our facilities. We own
approximately a 5.0% equity interest in this group purchasing organization at December 31, 2008.
Availability of Information
Our website is www.lifepointhospitals.com. We make available free of charge on this
website under Investor Information SEC Filings our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or
furnished as soon as reasonably practicable after we electronically file such materials with, or
furnish them to, the United States Securities and Exchange Commission (SEC).
2
Sources of Revenue
Our hospitals receive payment for patient services from the federal government primarily under
the Medicare program, state governments under their respective Medicaid programs, health
maintenance organizations (HMOs), preferred provider organizations (PPOs) and other private
insurers, as well as directly from patients (self-pay). The approximate percentages of total
revenues from continuing operations from these sources during the years specified below were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Medicare |
|
|
34.8 |
% |
|
|
32.6 |
% |
|
|
31.2 |
% |
Medicaid |
|
|
10.1 |
|
|
|
9.7 |
|
|
|
9.5 |
|
HMOs, PPOs and other private insurers |
|
|
39.2 |
|
|
|
42.7 |
|
|
|
44.5 |
|
Self-pay |
|
|
12.0 |
|
|
|
11.7 |
|
|
|
12.0 |
|
Other |
|
|
3.9 |
|
|
|
3.3 |
|
|
|
2.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Certain changes have been made to our historical sources of revenues table above.
Specifically, we previously classified uninsured discounts as revenue deductions for HMOs, PPOs and
other private insurers. We changed the classification of uninsured discounts to revenue deductions
for self-pay revenues effective in our June 30, 2008 quarterly report on Form 10-Q for all periods
previously reported. This change had no impact on our historical results of operations. Generally,
these reclassifications reduced self-pay as a percentage of total revenues and increased HMOs,
PPOs, and other private insurers as a percentage of total revenues. We have determined that it is
more appropriate to apply uninsured discounts as revenue deductions against self-pay revenues
rather than against HMOs, PPOs and other private insurers revenues.
Patients generally are not responsible for any difference between customary hospital charges
and amounts reimbursed for the services under Medicare, Medicaid, private insurance plans, HMOs or
PPOs, but are responsible for services not covered by these plans, exclusions, deductibles or
co-payment features of their coverage. The amount of exclusions, deductibles and co-payments
generally has been increasing each year as employers have been shifting a higher percentage of
healthcare costs to employees. In some states, the Medicaid program budgets have been either cut or
funds diverted to other programs, which have resulted in limiting the enrollment of participants.
This has resulted in higher bad debt expense at many of our hospitals during the past few years.
Medicare
Medicare provides hospital and medical insurance benefits to persons age 65 and over, some
disabled persons and persons with end-stage renal disease. All of our hospitals are currently
certified as providers of Medicare services. Amounts received under the Medicare program generally
are often significantly less than the hospitals customary charges for the services provided.
With the passage of the Medicare Prescription Drug, Improvement and Modernization Act of 2003
(MMA), which was signed into law on December 8, 2003, Congress passed sweeping changes to the
Medicare program. This legislation offers a prescription drug benefit for Medicare beneficiaries
and also provides a number of benefits to hospitals, particularly rural hospitals. The Deficit
Reduction Act of 2005 (the DRA), which was signed into law on February 6, 2006, includes measures
related to specialty hospitals, quality reporting and pay-for-performance, the inpatient
rehabilitation 75% Rule and Medicaid cuts. The Medicare, Medicaid and SCHIP Extension Act of 2007
(the Extension Act) was signed into law on December 29, 2007, and affects physician payments and
rehabilitation services. Additionally, CMS has continued to implement changes to various Medicare
payment methodologies. The major hospital provisions of MMA, DRA and the Extension Act are
discussed in the subsections below.
3
Inpatient Acute Care Diagnosis Related Group Payments
Payments from Medicare for inpatient hospital services are generally made under the
prospective payment system, commonly known as PPS. Under PPS, our hospitals are paid a
prospectively determined amount for each hospital discharge based on the patients diagnosis.
Specifically, each diagnosis is assigned a diagnosis related group, commonly known as a DRG. Each
DRG is assigned a payment rate that is prospectively set using national average resources used per
case for treating a patient with a particular diagnosis. DRG payments do not consider the actual
resources incurred by an individual hospital in providing a particular inpatient service. This DRG
assignment also affects the prospectively determined capital rate paid with each DRG. DRG and
capital payments are adjusted by a predetermined geographic adjustment factor assigned to the
geographic area in which the hospital is located.
The following tables list our historical Medicare DRG and capital payments for the years
presented (in millions):
|
|
|
|
|
|
|
|
|
|
|
Medicare |
|
Medicare |
|
|
DRG |
|
Capital |
|
|
Payments |
|
Payments |
2006 |
|
$ |
443.3 |
|
|
$ |
39.2 |
|
2007 |
|
|
456.5 |
|
|
|
40.5 |
|
2008 |
|
|
453.7 |
|
|
|
39.6 |
|
The DRG rates are adjusted by an update factor each federal fiscal year (FFY), which begins
on October 1. The index used to adjust the DRG rates, known as the hospital market basket index,
gives consideration to the inflation experienced by hospitals in purchasing goods and services. The
DRG rates that became effective on October 1, 2006, October 1, 2007 and October 1, 2008 represented
increases of 3.4%, 3.3% and 3.6%, respectively over the previous years rates. Generally, however,
the percentage increases in the DRG payments have been lower than the projected increase in the
cost of goods and services purchased by hospitals.
The hospital inpatient prospective payment system final rule for FFY 2008 created 745 new
severity-adjusted diagnosis-related groups (Medicare Severity DRGs or MS-DRGs) to replace
Medicares previous 538 DRGs. The rule phased in the new MS-DRGs over a two year period, so that in
FY 2008 only half of the relative weight for each MS-DRG was based on the new MS-DRG relative
weight and half was based on the old DRG relative weight. For FFY 2009, the relative weights are
based entirely on the new MS-DRG relative weight. To offset the effect of the coding and discharge
classification changes that CMS believes will occur as hospitals implement the MS-DRG system, it
implemented a rule reducing Medicare payments to hospitals by 1.2% in FFY 2008 and 1.8% in both FFY
2009 and 2010. Subsequently, on September 29, 2007, President Bush signed Public Law No: 110-90,
effectively decreasing these reductions for FFY 2008 and 2009 to 0.6% and 0.9%. CMS plans to
conduct a look-back beginning in FFY 2010 and make appropriate changes to the reduction
percentages based on actual claims data. CMS anticipates that the conversion to MS-DRGs will result
in an increase in payments to hospitals that serve more severely ill patients and a decrease to
hospitals that serve patients who are less severely ill. Although difficult to predict, the full
implementation of the MS-DRG system and the other provisions of the final rule, including wage
index changes, may result in our Medicare acute inpatient hospital reimbursement increasing in a
range between 3.0% to 3.5% in FFY 2009.
In order to receive the full 3.6% market basket update for FFY 2009, hospitals were required
to report certain patient care quality measures. Hospitals that did not submit this data received
a 2% reduction in their payment rate, resulting in a net 1.6% update for 2009. Reductions to a
non-participating hospitals rate apply only to the fiscal year involved. If the hospital
subsequently joins the program, the prior reduction will not be taken into account in computing the
update for that fiscal year. MMA and DRA restrict the application of these provisions to hospitals
paid under the inpatient PPS. The provisions do not apply to hospitals and hospital units excluded
from the inpatient PPS. For FFY 2009, our hospitals reported all quality measures required by CMS
and received the full market basket update.
4
MMA also made a permanent 1.6% increase in the base DRG payment rate for rural hospitals and
urban hospitals in smaller metropolitan areas. In addition, MMA provided for payment relief to the
wage index component of the base DRG rate. MMA lowered the percentage of the DRG subject to a wage
adjustment from 71.1% to 62.0% for hospitals in areas with a wage index below the national average
and from 71.1% to 69.7% for hospitals in areas with a wage index greater than the national average.
A majority of our hospitals have benefited from the MMA provisions adjusting the DRG payment rates.
Several provisions will continue to affect the FFY 2009 standardized amounts, including a full
market basket adjusted rate for hospitals reporting of quality data as part of the CMS Hospital
Quality Initiative and the reduction of the labor share.
These changes are reflected in the following tables:
FFY 2009 Standard Rate for Hospitals with a Wage Index Greater than the National
Average
(69.7% Labor Share and 30.3% Nonlabor Share)
|
|
|
|
|
|
|
|
|
|
|
Labor-Related |
|
Nonlabor-Related |
Full update (3.6%) |
|
$ |
3,574.50 |
|
|
$ |
1,553.91 |
|
Reduced update (1.6%) |
|
$ |
3,505.49 |
|
|
$ |
1,523.91 |
|
FFY 2009 Standard Rate for Hospitals with a Wage Index Less than or Equal to the
National Average
(62.0% Labor Share and 38.0% Percent Nonlabor Share)
|
|
|
|
|
|
|
|
|
|
|
Labor-Related |
|
Nonlabor-Related |
Full update (3.6%) |
|
$ |
3,179.61 |
|
|
$ |
1,948.80 |
|
Reduced update (1.6%) |
|
$ |
3,118.23 |
|
|
$ |
1,911.17 |
|
Capital Standard
Federal Payment Rate
$424.17
Outlier Payments
In addition to DRG and capital payments, hospitals may qualify for payments for cases
involving extraordinarily high costs when compared to average cases in the same DRG. To qualify as
a cost outlier, a hospitals cost for the case must exceed the payment rate for the DRG plus a
specified amount called the fixed-loss threshold. The outlier payment is equal to 80% of the
difference between the hospitals cost for the stay and the threshold amount. The threshold is
adjusted every year based on CMSs projections of total outlier payments to make outlier
reimbursement equal 5.1% of total payments. We anticipate outlier payments to increase slightly in
2009 as a result of a decrease in the outlier threshold from $22,185 to $20,045.
Disproportionate Share Payments
The Disproportionate Share Hospital (DSH) adjustment provides additional payments to
hospitals that treat a high percentage of low-income patients. The adjustment is based on the
hospitals DSH patient percentage, which is the sum of the number of patient days for patients who
were entitled to both Medicare Part A and Supplemental Security Income benefits, divided by the
total number of Medicare Part A patient days plus the days for patients who were eligible for
Medicaid divided by the total number of hospital inpatient days. Hospitals whose DSH patient
percentage exceeds 15% are eligible for a DSH payment adjustment. Effective April 1, 2004, MMA
raised the cap on the DSH payment adjustment percentage from 5.25% to 12.0% for rural and small
urban hospitals and specified that payments to all hospitals be based on the same conversion
factor, regardless of geographic location. Most of our hospitals have benefited from these
provisions. Medicare DSH payments received in the aggregate by our hospitals for 2006, 2007 and
2008, were approximately $48.5 million, $53.7 million and $55.3 million, respectively.
5
Wage Index and Geographic Reclassification
Under PPS, the prospective payment rates are adjusted for the area differences in wage levels
by a factor (wage index) reflecting the relative wage level in the geographic area compared to
the national average wage level. Effective October 1, 2004 for inpatient PPS and January 1, 2005
for outpatient PPS, CMS implemented a number of changes to the wage index calculation. These
changes include adopting new standards for defining labor market geographic areas based on
standards for defining Core-Based Statistical Areas issued by the Office of Management and Budget.
Hospitals that have been adversely affected by this new definition received a blended (50/50) wage
index based on the old and new wage geographic definitions for one year. Further, CMS has applied
an occupational mix adjustment factor to the wage index amounts. However, because of a court order
issued on April 3, 2006, the final rates for FFY 2007 fully (i.e., at 100%) adjusted the wage
indices for occupational mix.
The Medicare Geographic Classification Review Board issues decisions concerning the geographic
reclassification of hospitals as rural or urban for prospective payment purposes. Hospitals seeking
reclassification, except for sole community hospitals and rural referral centers, must prove close
proximity to the area in which they seek reclassification. In addition to close proximity, a
hospital seeking reclassification for purposes of using another areas wage index must prove that
the hospitals incurred wage costs are comparable to hospital wage costs in the other area.
Inpatient Rehabilitation and the 75% Rule
Rehabilitation hospitals and rehabilitation units in acute care hospitals meeting certain
criteria established by CMS are eligible to be paid as an Inpatient Rehabilitation Facility (IRF)
under the IRF prospective payment system (IRF-PPS). Payments under the IRF-PPS are made on a per
discharge basis. A patient classification system is used to assign patients in IRFs into case-mix
groups (CMGs). The IRF-PPS uses federal prospective payment rates across distinct CMGs.
Prior to July 1, 2004, a rehabilitation hospital or unit was eligible for classification as an
IRF if it could show that, during its most recent 12-month cost reporting period, it served an
inpatient population of whom at least 75 percent required intensive rehabilitation services for the
treatment of one or more of ten specific conditions. This became known as the 75 percent rule.
On May 7, 2004, CMS released a final rule entitled Medicare Program; Changes to the Criteria
for Being Classified as an Inpatient Rehabilitation Facility (IRF Rule) that revised the medical
condition criteria rehabilitation hospitals and units must meet. The IRF Rule also replaced the 75
percent rule compliance threshold with a three-year transition compliance threshold of 50%, 60%
and 65% for years one, two and three, respectively, that commenced with cost reporting periods
beginning on or after July 1, 2004. The three-year transition period was later delayed by one year.
At the end of the three-year transition period, the 75% compliance threshold would be restored.
However, the Medicare, Medicaid and SCHIP Extension Act of 2007 (MMSEA), enacted on December 29,
2007 permanently froze the compliance threshold at 60% effective for cost reporting periods
starting July 1, 2006, and allows co-morbid conditions to count toward this threshold.
On July 31, 2008, CMS published its Medicare inpatient rehabilitation facility prospective
payment system final rule for FFY 2009. The final rule increased the high-cost outlier threshold
from $7,362 to $10,250 for FFY 2009. As required by the MMSEA, the rule includes a 0% market basket
update for inpatient rehabilitation facility PPS payments for FY 2009.
At December 31, 2008, 14 of our hospitals in continuing operations operated inpatient
rehabilitation units. Under this program, our hospitals received an aggregate of approximately
$27.4 million, $25.4 million and $25.9 million during 2006, 2007 and 2008, respectively.
6
Inpatient Psychiatric
As of December 31, 2008, we operated 14 inpatient psychiatric units. Effective for reporting
periods after January 1, 2005, CMS replaced the cost-based system with a PPS for inpatient hospital
services furnished in psychiatric hospitals and psychiatric units of general, acute care hospitals
and critical access hospitals (IPF PPS). IPF PPS is a per diem prospective payment system with
adjustments to account for certain patient and facility characteristics. IPF PPS contains an
outlier policy for extraordinarily costly cases and an adjustment to a facilitys base payment if
it maintains a full-service emergency department. The three-year transition to the IPF PPS is now
complete and all inpatient psychiatric facilities payments will now be based entirely on the IPF
PPS payment rate. CMS has established the IPF PPS payment rate in a manner intended to be budget
neutral and has adopted a July 1 update cycle. In May 2008, CMS released its final IPF PPS
regulation for July 1, 2008 through June 30, 2009 (Rate Year 2009). The rule provides a 3.2%
market basket update in Rate Year 2009, but this increase is partially offset by a 0.5% reduction
resulting from the transition to full PPS rates in Rate Year 2009, and a 0.1% reduction associated
with the sunset of a stop-loss provision. Under this program, our hospitals received an aggregate
of approximately $14.6 million, $15.0 million and $17.9 million for 2006, 2007 and 2008,
respectively.
Outpatient Payments
The Balanced Budget Refinement Act of 1999 (BBRA) established a PPS for outpatient hospital
services that commenced on August 1, 2000. Outpatient services are assigned ambulatory payment
classifications (APCs), with associated specific relative weights, which are multiplied by an APC
conversion factor. The APC conversion factors are $61.468, $63.694, and $66.059 for 2007, 2008, and
2009 respectively. Prior to August 1, 2000, outpatient services were paid at the lower of customary
charges or on a reasonable cost basis.
BBRA eliminated the anticipated average reduction of 5.7% for various Medicare outpatient
payments under the Balanced Budget Act of 1997. Under BBRA, outpatient payment reductions for
non-urban hospitals with 100 beds or less were postponed until December 31, 2003. Fifteen of our
hospitals qualified for this hold harmless relief. Payment reductions under Medicare outpatient
PPS for non-urban hospitals with greater than 100 beds and urban hospitals were mitigated through a
corridor reimbursement approach, pursuant to which a percentage of such reductions were reimbursed
through December 31, 2003. Substantially all of our remaining hospitals qualified for relief under
this provision. MMA extended the hold harmless provision for non-urban hospitals with 100 beds or
less and expanded the provision to include sole community hospitals for cost reporting periods
beginning in 2004 until December 31, 2005. DRA extended these payments for three years but at a
reduced amount. Payments for 2006 were 95% and for 2007 and 2008 will be 90% and 85%, respectively,
of the hold harmless amount. On July 15, 2008, Congress enacted the Medicare Improvement for
Patients and Providers Act (MIPPA), which included a provision extending hold harmless payments
through 2009 at the 85% rate for both small rural hospitals and sole community hospitals.
On October 30, 2008, CMS issued its final hospital outpatient prospective payment system rule
for calendar year 2009. Among other provisions, the rule includes a 3.6% market basket update for
hospitals that reported seven hospital outpatient quality measures. The annual payment update
factor is reduced by 2.0 percentage points for hospitals that do not report those measures. CMS
also added an additional four quality measures relating to imaging efficiency in order for
hospitals to receive the full payment update in 2010. For FY 2009, our hospitals reported all
quality measures required by CMS and received the full market basket update.
The following table lists our historical Medicare outpatient payments for the years presented
(in millions):
|
|
|
|
|
|
|
Medicare |
|
|
Outpatient Payments |
2006 |
|
$ |
171.6 |
|
2007 |
|
|
185.0 |
|
2008 |
|
|
190.5 |
|
7
Home Health Payments
As of December 31, 2008, we operated 12 home health agencies. Home health payments are
reimbursed based on a PPS. For a two-year period beginning April 1, 2001, the Benefits Improvement
and Protection Act of 2000 increased Medicare payments 10.0% for home health services furnished in
specific rural areas. This provision expired on March 31, 2003. Home health PPS rates for 2003,
which became effective October 1, 2002, were effectively decreased by 4.9%. The market basket rate
increase for calendar year 2005 was 3.1%, which was reduced 0.8% as mandated by MMA, and resulted
in a net increase of the 60-day episode of care rate of 2.3%. MMA included several changes to home
health services, including a 5% additional payment for those home health services furnished in
rural areas for one year, effective April 1, 2004. DRA froze 2006 Medicare payments but reinstated
the 5% rural payment add-on for 2006 only. Home health agencies are required to submit data on
certain quality measures and those agencies that do not submit quality data receive a 2% decrease
in the market basket update. The home health market basket rate increases for FFY 2007 and 2008
were 3.3% and 3.0% respectively. The final rule for FFY 2008 created a 2.75% annual reduction in
the national standardized 60-day episode payment rate through 2010 and a 2.71% reduction for 2011.
On October 30, 2008, CMS issued the final Home Health Prospective Payment System rule for 2009,
which included a rate increase of 2.9%.
Medicare Bad Debt Reimbursement
Under Medicare, the costs attributable to the deductible and coinsurance amounts which remain
unpaid by the Medicare beneficiary can be added to the Medicare share of allowable costs as cost
reports are filed. Hospitals generally receive interim pass-through payments during the cost report
year which were determined by the fiscal intermediary from the prior cost report filing.
Bad debts must meet the following criteria to be allowable:
|
|
|
the debt must be related to covered services and derived from deductible and
coinsurance amounts; |
|
|
|
|
the provider must be able to establish that reasonable collection efforts were made; |
|
|
|
|
the debt was actually uncollectible when claimed as worthless; and |
|
|
|
|
sound business judgment established that there was no likelihood of recovery at any
time in the future. |
The amounts uncollectible from specific beneficiaries are to be charged off as bad debts in
the accounting period in which the accounts are deemed to be worthless. In some cases, an amount
previously written off as a bad debt and allocated to the program may be recovered in a subsequent
accounting period. In these cases, the recoveries must be used to reduce the cost of beneficiary
services for the period in which the collection is made. In determining reasonable costs for
hospitals, the amount of bad debts otherwise treated as allowable costs is reduced by 30%. Under
this program, our hospitals received an aggregate of approximately $16.2 million, $15.6 million and
$16.4 million for 2006, 2007 and 2008, respectively.
Recovery Audit Contractors
In 2005, CMS began using recovery audit contractors (RACs) to detect Medicare overpayments
not identified through existing claims review mechanisms. The RAC program relies on private
auditing firms to examine Medicare claims filed by healthcare providers. Fees to the RACs are paid
on a contingency basis. The RAC program began as a demonstration project in five states (New York,
California, Florida, Massachusetts, and South Carolina), but was made permanent by the Tax Relief
and Health Care Act of 2006. The permanent RAC program is set to begin in 23 states on March 1,
2009. We currently have facilities in nine of those states, specifically Arizona, Colorado,
Florida, Indiana, Nevada, New Mexico, Texas, Utah, and Wyoming. CMS plans to have RACs in place in
all 50 states by 2010.
8
RACs perform post-discharge audits of medical records to identify Medicare overpayments
resulting from incorrect payment amounts, non-covered services, medically unnecessary services,
incorrectly coded services, and duplicate services. CMS has given RACs the authority to look back
at claims up to three years old, provided that the claim was paid on or after October 1, 2007.
Claims identified as overpayments will be subject to a RAC program appeals process. Although we
believe the claims for reimbursement submitted to the Medicare program are accurate, we cannot
predict whether we will be subject to RAC audits in the future, or if audited, what the result of
such audits might be.
Medicaid
Medicaid programs are funded by both the federal government and state governments to provide
healthcare benefits to certain low-income individuals and groups. These programs and the
reimbursement methodologies are administered by the states and vary from state to state and from
year to year. Amounts received under the Medicaid program are often significantly less than the
hospitals customary charges for the services provided. Most state Medicaid payments are made under
a PPS, fee schedule, cost reimbursement programs, or some combination of these three methods.
Estimated revenues under various state Medicaid programs, excluding state-funded managed care
programs, constituted approximately 10.1%, 9.7% and 9.5% of total revenues at our hospitals for
2006, 2007 and 2008, respectively. These payments are typically based on fixed rates determined by
the individual states. We also receive disproportionate share payments under various state Medicaid
programs. For 2006, 2007 and 2008, our revenue attributable to disproportionate share payments and
other supplemental payments was approximately $17.6 million $19.4 million and $19.8 million,
respectively.
The increase in revenue from disproportionate share payments and other supplemental payments
is primarily attributable to additional funding provided by certain states, which was made
available in part by additional annual state provider taxes on certain of our hospitals and changes
in classification of state programs. However, there are proposed changes to the Medicaid system
that could materially reduce the amount of Medicaid payments we receive in the future.
Many states in which we operate are facing budgetary challenges that also pose a threat to
Medicaid funding levels to hospitals and other providers. We expect these challenges to continue
and, perhaps, to intensify. States have adopted, or may be considering, legislation designed to
reduce coverage and program eligibility, enroll Medicaid recipients in managed care programs and/or
impose additional taxes on hospitals to help finance or expand the states Medicaid systems. Such
budget cuts, federal or state legislation, or other changes in the administration or interpretation
of government health programs could have a material adverse effect on our financial position and
results of operations.
Congress has recently made an effort to address the financial challenges Medicaid is facing by
increasing the amount of Medicaid funding available to states. On
February 17, 2009,
the American Recovery and Reinvestment Act of 2009,
(ARRA) was enacted. Among other provisions, the ARRA provides $86.6
billion over 27 months to help states maintain and expand
Medicaid enrollment. Under ARRA, each
state will receive a 6.2% increase in federal Medicaid funding. At this point it is unclear how
much of an impact ARRA will have on Medicaid payments in the states in which we operate.
9
Annual Cost Reports
Hospitals participating in the Medicare and some Medicaid programs, whether paid on a
reasonable cost basis or under a PPS, are required to meet certain financial reporting
requirements. Federal and, where applicable, state
regulations require submission of annual cost reports identifying medical costs and expenses
associated with the services provided by each hospital to Medicare beneficiaries and Medicaid
recipients.
Annual cost reports required under the Medicare and some Medicaid programs are subject to
routine governmental audits. These audits may result in adjustments to the amounts ultimately
determined to be payable to us under these reimbursement programs. Finalization of these audits
often takes several years. Providers may appeal any final determination made in connection with an
audit.
HMOs, PPOs and Other Private Insurers
In addition to government programs, our hospitals are reimbursed by differing types of private
payors including HMOs, PPOs, other private insurance companies and employers. To attract additional
volume, most of our hospitals offer discounts from established charges to certain large group
purchasers of healthcare services. These discount programs often limit our ability to increase
charges in response to increasing costs. Generally, patients covered by HMOs, PPOs and other
private insurers will be responsible for certain co-payments and deductibles.
Self-Pay and Charity/Indigent Care
Self-pay revenues are derived from patients who do not have any form of healthcare coverage.
The revenues associated with self-pay patients are generally reported at our gross charges. We
evaluate these patients, after the patients medical condition is determined to be stable, for
qualifications of Medicaid or other governmental assistance programs, as well as our local
hospitals policy for charity/indigent care. A significant portion of self-pay patients are
admitted through the emergency department and often require high-acuity treatment. High-acuity
treatment is more costly to provide and, therefore, results in higher billings. Over the past few
years, we have seen an increase in the amount of self-pay revenues at our hospitals, which are the
least collectible of all accounts.
We provide care to certain patients that qualify under the local charity/indigent care policy
at each of our hospitals. We discount a charity/indigent care patients charges against our
revenues and do not report such discounts in our provision for doubtful accounts as it is our
policy not to pursue collection of amounts related to these patients.
The following table lists our self-pay revenues and charity/indigent care write-offs from
continuing operations for the years presented (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Self-Pay |
|
Charity/Indigent Care |
|
Combined |
|
|
Revenues |
|
Write-Offs |
|
Total |
2006 |
|
$ |
279.7 |
|
|
$ |
40.5 |
|
|
$ |
320.2 |
|
2007 |
|
|
300.0 |
|
|
|
50.5 |
|
|
|
350.5 |
|
2008 |
|
|
324.5 |
|
|
|
53.7 |
|
|
|
378.2 |
|
Competition for Patients
Our hospitals and other healthcare businesses operate in extremely competitive environments.
Competition among healthcare providers occurs primarily at the local level. A hospitals position
within the geographic area in which it operates is affected by a number of competitive factors,
including, but not limited to:
|
|
|
the scope, breadth and quality of services a hospital offers to its patients and
physicians; |
|
|
|
|
whether new, competitive services require the receipt of a certificate of need or
other similar authorization; |
|
|
|
|
the number, quality and specialties of the physicians who admit and refer patients to
the hospital; |
|
|
|
|
nurses and other health care professionals employed by the hospital or on the
hospitals staff; |
|
|
|
|
the hospitals reputation; |
10
|
|
|
its managed care contracting relationships; |
|
|
|
|
its location and the location and number of competitive facilities and other
health care alternatives; |
|
|
|
|
the physical condition of its buildings and improvements; |
|
|
|
|
the quality, age and state-of-the-art of its medical equipment; |
|
|
|
|
its parking or proximity to public transportation; |
|
|
|
|
the length of time it has been a part of the community; |
|
|
|
|
the relative convenience of the manner in which care is provided (for example,
whether services are available on an outpatient basis and whether services can be
obtained quickly); |
|
|
|
|
the choices made by the physicians on the medical staffs of our hospitals; and |
|
|
|
|
the charges for its services. |
Accordingly, each hospital develops its own strategies to address these competitive factors
locally. In addition, tax-exempt competitors may have certain financial advantages not available to
our facilities, such as endowments, charitable contributions, tax-exempt financing, and exemptions
from sales, property and income taxes. In certain states, some not-for-profit hospitals are
permitted by law to directly employ physicians while for-profit hospitals are prohibited from doing
so.
We also face increasing competition from other specialized care providers, including
outpatient surgery, oncology, physical therapy and diagnostic centers, as well as competing services rendered in physician
offices. To the extent that other providers are successful in developing specialized outpatient
facilities, our market share for those specialized services will likely decrease. Some of our
hospitals have developed specialized outpatient facilities where necessary to compete with these
other providers. Physician competition also has increased as physicians, in some cases, have become
equity owners in surgery centers and outpatient diagnostic centers, to which they refer patients.
Competition for Professionals
Our hospitals must also compete for professional talent. A significant factor in our future
success will be the ability of our hospitals to attract and retain physicians, as it is physicians
who decide whether a patient is admitted to the hospital and the procedures to be performed. We
seek to attract physicians by striving to employ excellent nurses, equip our hospitals with technologically advanced
equipment and an attractive, up-to-date physical plant, properly maintaining the equipment and
physical plant, and otherwise create an environment within which physicians prefer to practice.
While physicians may terminate their association with our hospitals at any time, we believe that by
striving to maintain and improve the quality of care at our hospitals and by maintaining ethical
and professional standards, our hospitals will be better positioned to attract and retain qualified
physicians with a variety of specialties.
We also recruit physicians to the communities in which our hospitals are located. The types,
amount and duration of assistance we can provide to recruited physicians are limited by the federal
Stark physician self-referral law, federal and state anti-kickback statutes, and related
regulations. For example, the Stark law requires, among other things,
that recruitment assistance can only be
provided to physicians who meet certain geographic and practice requirements, that the amount of
assistance cannot be changed during the term, and that the recruitment payments cannot generally
benefit physicians currently in practice in the community beyond
recruitment costs actually incurred. In addition to these legal requirements, there is competition from other
communities and facilities for these physicians, and this competition continues after the physician
begins practicing in one of our communities.
11
We compete with other healthcare providers in recruiting and retaining qualified management
and staff personnel responsible for the day-to-day operations of each of our hospitals, including
nurses and other non-physician healthcare professionals. In some markets, the scarce availability
of nurses and other medical support personnel presents a significant operating issue. This shortage
may require us to enhance wages and benefits to recruit and retain nurses and other medical support
personnel, recruit personnel from foreign countries, and hire more expensive temporary personnel.
We also depend on the available labor pool of semi-skilled and unskilled employees in each of the
markets in which we operate.
Employees
At December 31, 2008, we had approximately 21,000 employees, including approximately 5,300
part-time employees. Nurses, therapists, lab technicians, facility maintenance staff and the
administrative staff of hospitals constitute the majority of our employees. Approximately 225 of
our employees are subject to collective bargaining agreements. We consider our employee relations
to be generally good. While some of our hospitals experience union organizing activity from time to
time, we do not currently expect these efforts to materially affect our future operations.
Government Regulation
Overview. All participants in the healthcare industry are required to comply with extensive
government regulations at the federal, state and local levels. Under these laws and regulations,
hospitals must meet requirements for licensure and qualify to participate in government programs,
including the Medicare and Medicaid programs. These requirements relate to the adequacy of medical
care, equipment, personnel, operating policies and procedures, maintenance of adequate records,
rate-setting, compliance with building codes and environmental protection laws. If we fail to
comply with applicable laws and regulations, we may be subject to criminal penalties and civil
sanctions, and our hospitals may lose their licenses and ability to participate in government
programs. In addition, government regulations frequently change. When regulations change, we may be
required to make changes in our facilities, equipment, personnel and services so that our hospitals
remain licensed and qualified to participate in these programs. We believe that our hospitals are
in substantial compliance with current federal, state and local regulations and standards.
Acute care hospitals are subject to periodic inspection by federal, state and local
authorities to determine their compliance with applicable regulations and requirements necessary
for licensing, certification and accreditation. All of our hospitals are currently licensed under
appropriate state laws and are qualified to participate in the Medicare and Medicaid programs. In
addition, as of December 31, 2008, all of our acute care hospitals were accredited by The Joint
Commission. The Joint Commission accreditation and deemed status with CMS indicates that a
hospital satisfies the applicable health and administrative standards to participate in Medicare
and Medicaid.
Utilization Review. Federal law contains numerous provisions designed to ensure that services
rendered by hospitals to Medicare and Medicaid patients meet professionally recognized standards,
are medically necessary and that claims for reimbursement are properly filed. These provisions
include a requirement that a sampling of admissions of Medicare and Medicaid patients must be
reviewed by quality improvement organizations, which review the appropriateness of Medicare and
Medicaid patient admissions and discharges, the quality of care provided, the validity of DRG
classifications and the appropriateness of cases of extraordinary length of stay or cost. Quality
improvement organizations may deny payment for services provided, or assess fines and also have the
authority to recommend to the Department of Health and Human Services (DHHS) that a provider
which is in substantial noncompliance with the standards of the quality improvement organization be
excluded from participation in the Medicare program. Utilization review is also a requirement of
most non-governmental managed care organizations.
12
Fraud and Abuse Laws. Participation in the Medicare and/or Medicaid programs is heavily
regulated by federal statutes and regulations. If a hospital fails to comply substantially with the
numerous federal laws governing a facilitys activities, the hospitals participation in the
Medicare and/or Medicaid programs may be terminated and/or civil or criminal penalties may be
imposed. For example, a hospital may lose its ability to participate in the Medicare and/or
Medicaid programs if it performs any of the following acts:
|
|
|
making claims to Medicare and/or Medicaid for services not provided or misrepresenting
actual services provided in order to obtain higher payments; |
|
|
|
|
paying money to induce the referral of patients or purchase of items or services where
such items or services are reimbursable under a federal or state health program; or |
|
|
|
|
failing to provide appropriate emergency medical screening services to any individual
who comes to a hospitals campus or otherwise failing to properly treat and transfer
emergency patients. |
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) broadened the scope
of the fraud and abuse laws by adding several criminal statutes that are not related to receipt of
payments from a federal healthcare program. HIPAA created civil penalties for proscribed conduct,
including upcoding and billing for medically unnecessary goods or services. HIPAA established new
enforcement mechanisms to combat fraud and abuse. These new mechanisms include a bounty system,
where a portion of the payments recovered is returned to the government agencies, as well as a
whistleblower program. HIPAA also expanded the categories of persons that may be excluded from
participation in federal and state healthcare programs.
The anti-kickback provision of the Social Security Act prohibits the payment, receipt, offer
or solicitation of anything of value, whether in cash or in kind, with the intent of generating
referrals or orders for services or items covered by a federal or state healthcare program.
Violations of the anti-kickback statute may be punished by criminal and civil fines, exclusion from
federal and state healthcare programs, imprisonment and damages up to three times the total dollar
amount involved.
The Office of Inspector General (OIG) of DHHS is responsible for identifying fraud and abuse
activities in government programs. In order to fulfill its duties, the OIG performs audits,
investigations and inspections. In addition, it provides guidance to healthcare providers by
identifying types of activities that could violate the anti-kickback statute. The OIG has
identified the following hospital/physician incentive arrangements as potential violations:
|
|
|
payment of any incentive by a hospital each time a physician refers a patient to the
hospital; |
|
|
|
|
use of free or significantly discounted office space or equipment; |
|
|
|
|
provision of free or significantly discounted billing, nursing or other staff services; |
|
|
|
|
free training (other than compliance training) for a physicians office staff,
including management and laboratory technique training; |
|
|
|
|
guarantees which provide that if a physicians income fails to reach a predetermined
level, the hospital will pay any portion of the remainder; |
|
|
|
|
low-interest or interest-free loans, or loans which may be forgiven if a physician
refers patients to the hospital; |
|
|
|
|
payment of the costs for a physicians travel and expenses for conferences; |
|
|
|
|
payment of services which require few, if any, substantive duties by the physician or
which are in excess of the fair market value of the services rendered; or |
|
|
|
|
purchasing goods or services from physicians at prices in excess of their fair market
value. |
13
We have a variety of financial relationships with physicians who refer patients to our
hospitals, including employment contracts, leases, joint ventures, independent contractor
agreements and professional service agreements. Physicians may also own shares of our common stock.
We provide financial incentives to recruit physicians to relocate to communities served by our
hospitals. These incentives for relocation include minimum revenue guarantees and, in some cases,
loans. The OIG is authorized to publish regulations outlining activities and business relationships
that would be deemed not to violate the anti-kickback statute. These regulations are known as safe
harbor regulations. Failure to comply with the safe harbor regulations does not make conduct
illegal, but instead the safe harbors delineate standards that, if complied with, protect conduct
that might otherwise be deemed in violation of the anti-kickback statute. We seek to structure each
of our arrangements with physicians to fit as closely as possible within an applicable safe harbor.
However, not all of our business arrangements fit wholly within safe harbors, so we cannot
guarantee that these arrangements will not be scrutinized by government authorities or, if
scrutinized, that they will be determined to be in compliance with the anti-kickback statute or
other applicable laws. The failure of a particular activity to comply with the safe harbor
regulations does not mean that the activity violates the anti-kickback statute. We intend for all
of our business arrangements to be in full compliance with the anti-kickback statute. If we violate
the anti-kickback statute, we would be subject to criminal and civil penalties and/or possible
exclusion from participating in Medicare, Medicaid or other governmental healthcare programs.
The Social Security Act also includes a provision commonly known as the Stark law. This law
prohibits physicians from referring Medicare and Medicaid patients to selected types of healthcare
entities in which they or any of their immediate family members have ownership or a compensation
relationship. These types of referrals are commonly known as self referrals. A violation of the
Stark law may result in a denial of payment, require refunds to patients and the Medicare program,
civil monetary penalties of up to $15,000 for each violation, civil monetary penalties of up to
$100,000 for circumvention schemes, civil monetary penalties of up to $10,000 for each day that an
entity fails to report required information, exclusion from participation in the Medicare and
Medicaid programs and other federal programs, and additionally could result in penalties for false
claims. There are ownership and compensation arrangement exceptions to the self-referral
prohibition. One exception allows a physician to make a referral to a hospital if the physician
owns an interest in the entire hospital, as opposed to an ownership interest in a department of the
hospital. Another exception allows a physician to refer patients to a healthcare entity in which
the physician has an ownership interest if the entity is located in a rural area, as defined in the
statute. There are also exceptions for many of the customary financial arrangements between
physicians and facilities, including employment contracts, leases and recruitment agreements. We
intend for our financial arrangements with physicians to comply with the exceptions included in the
Stark law and regulations. CMS issued proposed and final rules in 2007 modifying Stark law
exceptions, including addressing equipment lease terms and under arrangements services
agreements. While some changes have been implemented, other proposals remain in proposed form or
have been delayed. Further, the Stark law and related regulations have been subject to little
judicial interpretation to date. We anticipate that there will be further changes in the future
that will require us to continue to modify our activities.
In addition to issuing new regulations, or applying new interpretations to existing rules or
regulations, CMS also seems to be significantly intensifying its scrutiny of the conduct of
hospitals. CMS originally indicated its intent to require a group of 500 hospitals to submit a
Disclosure of Financial Relationships Report (DFRR) to CMS in 2007. If issued, the DFRR is
expected to require detailed information concerning each selected hospitals ownership, investment,
and compensation arrangements with physicians, including copies of contracts and an indication as
to whether such contracts comply with the strict requirements of the Stark law. CMS has indicated
it will distribute the DFRR to selected hospitals once the DFRR is approved by the Office of
Management and Budget (OMB). Although final OMB approval is still pending, the deadline for
public comment was January 20, 2009; therefore, the DFRR could be distributed at any time. If the
DFRR is distributed, we expect that a number of our facilities may be included among those required
to respond.
Another example of intensifying scrutiny is the use by CMS of RACs, which are paid on a
contingency basis, to detect Medicare overpayments not identified through existing claims review
mechanisms. RACs are scheduled to begin audits in several states in 2009 and plan to be
operational in every state by 2010.
14
Corporate Practice of Medicine and Fee-Splitting. Some states have laws that prohibit
unlicensed persons or business entities, including corporations or business organizations that own
hospitals, from employing physicians. Some states also have adopted laws that prohibit direct or
indirect payments or fee-splitting arrangements between physicians and unlicensed persons or
business entities. Possible sanctions for violations of these restrictions include loss of a
physicians license, civil and criminal penalties and rescission of business arrangements. These
laws vary from state to state, are often vague and have seldom been interpreted by the courts or
regulatory agencies. We attempt to structure our arrangements with healthcare providers to comply
with the relevant state laws and the few available regulatory interpretations.
Emergency Medical Treatment and Active Labor Act. All of our facilities are subject to the
Emergency Medical Treatment and Active Labor Act (EMTALA). This federal law requires any hospital
that participates in the Medicare program to conduct an appropriate medical screening examination
of every person who presents to the hospitals emergency department for treatment and, if the
patient is suffering from an emergency medical condition, to either stabilize that condition or
make an appropriate transfer of the patient to a facility that can handle the condition. The
obligation to screen and stabilize emergency medical conditions exists regardless of a patients
ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen
or appropriately stabilize or transfer a patient or if the hospital delays appropriate treatment in
order to first inquire about the patients ability to pay. Penalties for violations of EMTALA
include civil monetary penalties and exclusion from participation in the Medicare program. In
addition, an injured patient, the patients family or a medical facility that suffers a financial
loss as a direct result of another hospitals violation of the law can bring a civil suit against
that other hospital.
During 2003, CMS published a final rule clarifying a hospitals duties under EMTALA. In the
final rule, CMS clarified when a patient is considered to be on a hospitals property for purposes
of treating the person pursuant to EMTALA. CMS stated that off-campus facilities such as specialty
clinics, surgery centers and other facilities that lack emergency departments should not be subject
to EMTALA, but that these locations must have a plan explaining how the location should proceed in
an emergency situation such as transferring the patient to the closest hospital with an emergency
department. CMS further clarified that hospital-owned ambulances could transport a patient to the
closest emergency department instead of to the hospital that owns the ambulance.
CMSs rules did not specify on-call physician requirements for an emergency department, but
provided a subjective standard stating that on-call hospital schedules should meet the hospitals
and communitys needs. Although we believe that our hospitals comply with EMTALA, we cannot predict
whether CMS will implement new requirements in the future and whether our hospitals will comply
with any new requirements.
Federal False Claims Act. The federal False Claims Act prohibits providers from knowingly
submitting false claims for payment to the federal government. This law has been used not only by
the federal government, but also by individuals who bring an action on behalf of the government
under the laws qui tam or whistleblower provisions. When a private party brings a qui tam
action under the federal False Claims Act, the defendant will generally not be aware of the lawsuit
until the government makes a determination whether it will intervene and take a lead in the
litigation.
Civil liability under the federal False Claims Act can be up to three times the actual damages
sustained by the government plus civil penalties for each separate false claim. There are many
potential bases for liability under the federal False Claims Act, including claims submitted
pursuant to a referral found to violate the anti-kickback statute. Although liability under the
federal False Claims Act arises when an entity knowingly submits a false claim for reimbursement to
the federal government, the federal False Claims Act defines the term knowingly broadly. Although
simple negligence generally will not give rise to liability under the federal False Claims Act,
submitting a claim with reckless disregard to its truth or falsity can constitute knowingly
submitting a false claim.
15
Healthcare Reform. The healthcare industry continues to attract much legislative interest and
public attention. MMA introduced changes to the Medicare program. Many of MMAs changes went into
effect January 1, 2006. MMA establishes a voluntary prescription drug benefit, provides federal
subsidies to plan sponsors that provide prescription drug benefits to Medicare-eligible retirees,
substantially adjusts Medicare+Choice and provides favorable payment adjustments for rural
hospitals. MMA also provides favorable tax treatment for individual health savings accounts. In
addition, MMA authorizes MedPAC to study the effects of home health and rural hospital
reimbursement in current and anticipated reimbursement methodologies. Medicare payment
methodologies have been, and can be expected to continue to be, subject to significant revisions
based on cost containment and policy considerations. For example, the adoption of severity-adjusted
diagnosis groups known as MS-DRGs is intended to result in higher payments to hospitals treating
more severe patients, and lower payments to hospitals treating less severe patients.
On January 20, 2009, a new President took office and the incoming administration has signaled
a desire to enact substantial healthcare reform. During his campaign, President Obama consistently
advocated fundamental changes to the U.S. healthcare system intended to provide coverage and access
to substantially all Americans. Given the strain on federal finances caused by current economic
conditions, it remains to be seen whether such major reform will be undertaken or could come
quickly enough to affect our facilities in 2009.
In recent years, Medicaid enrollment has grown as more people became eligible for the program.
At the same time, healthcare costs have been rising, forcing states to address Medicaid
cost-containment. Healthcare costs, demographics, erosion of employer-sponsored health coverage and
potential changes in federal Medicaid policies continue to put pressure on state Medicaid programs.
Policymakers in many states are evaluating the Medicaid programs in their states and considering
reforms. Also, the number of persons without health insurance has risen. The federal government has
recently taken steps to address some of these challenges by expanding health insurance coverage for
children through the State Childrens Health Insurance Program (SCHIP) program and increasing federal funding of the Medicaid program as part
of the ARRA. We anticipate that the federal and state governments will continue to introduce
legislative proposals to modify the cost and efficiency of the healthcare delivery system to
provide coverage for more or all persons.
Conversion Legislation. Many states have adopted legislation regarding the sale or other
disposition of hospitals operated by not-for-profit entities. In states that do not have such
legislation, the attorneys general have demonstrated an interest in these transactions under their
general obligations to protect charitable assets. These legislative and administrative efforts
primarily focus on the appropriate valuation of the assets divested and the use of the proceeds of
the sale by the not-for-profit seller. These reviews and, in some instances, approval processes can
add additional time to the closing of a not-for-profit hospital acquisition. Future actions by
state legislators or attorneys general may seriously delay or even prevent our ability to acquire
certain hospitals.
Certificates of Need. The construction of new facilities, the acquisition or expansion of
existing facilities and the addition of new services and expensive equipment at our facilities may
be subject to state laws that require prior approval by state regulatory agencies. These
certificate of need laws generally require that a state agency determine the public need and give
approval prior to the construction or acquisition of facilities or the addition of new services. We
operate hospitals in ten states that have adopted certificate of need
laws Alabama, Florida, Georgia,
Kentucky, Louisiana, Mississippi, Nevada, Tennessee, Virginia and West Virginia. If we fail to obtain
necessary state approval, we will not be able to expand our facilities, complete acquisitions or
add new services at our facilities in these states. Violation of these state laws may result in the
imposition of civil sanctions or the revocation of hospital licenses. All other states in which we
operate do not require a certificate of need prior to the initiation of new healthcare services. In
these other states, our facilities are subject to competition from other providers who may choose
to enter the market by developing new facilities or services.
HIPAA Transaction, Privacy and Security Requirements. Federal regulations issued pursuant to
HIPAA contain, among other measures, provisions that require us to implement very significant and
potentially expensive new computer systems, employee training programs and business procedures. The
federal regulations are intended to protect the privacy of healthcare information and encourage
electronic commerce in the healthcare industry.
16
Among other things, HIPAA requires healthcare facilities to use standard data formats and code
sets established by DHHS when electronically transmitting information in connection with several
transactions, including health claims and equivalent encounter information, healthcare payment and
remittance advice and health claim status. We have implemented or upgraded computer systems
utilizing a third party vendor, as appropriate, at our facilities and at our corporate headquarters
to comply with the new transaction and code set regulations and have tested these systems with
several of our payors.
HIPAA also requires DHHS to issue regulations establishing standard unique health identifiers
for individuals, employers, health plans and healthcare providers to be used in connection with the
standard electronic transactions. DHHS published on January 23, 2004, the final rule establishing
the standard for the unique health identifier for healthcare providers. Our facilities have
obtained and fully implemented the use of the National Provider Identifiers required for standard
transactions instead of other numerical identifiers. We have not experienced any significant
payment delays during the transition to the new identifier. Our facilities have fully implemented
use of the Employer Identification Number as the standard unique health identifier for employers.
The
Health Information Technology for Economic and Clinical Health Act
(HITECH Act) was enacted into law on February 17,
2009 as part of the ARRA. The HITECH Act contains a
number of provisions that significantly expand the reach of HIPAA. For example, the law imposes
varying civil monetary penalties and creates a private cause of action for HIPAA violations,
extends HIPAAs security provisions to business associates, and creates new security breach
notification requirements. We may incur significant costs in implementing the policies and systems
required to comply with these new requirements.
HIPAA regulations also require our facilities to establish and maintain reasonable and
appropriate administrative, technical and physical safeguards to ensure the integrity,
confidentiality and the availability of electronic protected health information (ePHI). The
security standards were designed to protect ePHI against reasonably anticipated threats or hazards
to the security or integrity of the information and to protect the ePHI against unauthorized use or
disclosure. We believe that the business procedures advisable for compliance with the security
standards include comprehensive security risk assessments and the documentation and implementation
of mitigating controls, processes and remediation for systems, devices and applications that have
been identified as having the highest levels of vulnerability. This is an ongoing process as we
continuously update, upgrade and implement new systems and technologies.
DHHS has also established standards for the privacy of individually identifiable health
information. These privacy standards apply to all health plans, all healthcare clearinghouses and
healthcare providers, such as our facilities, that transmit health information in an electronic
form in connection with standard transactions, and apply to individually identifiable information
held or disclosed by a covered entity in any form. These standards impose extensive administrative
requirements on our facilities and require compliance with rules governing the use and disclosure
of this health information, and they require our facilities to impose these rules, by contract, on
any business associate to whom we disclose such information in order for them to perform functions
on our facilities behalf. In addition, our facilities will continue to remain subject to any state
laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary by
state and could impose additional penalties. Compliance with these standards requires significant
commitment and action by us.
Patient Safety and Quality Improvement Act of 2005. On July 29, 2005, the President signed
the Patient Safety and Quality Improvement Act of 2005, which has the goal of reducing medical
errors and increasing patient safety. This legislation establishes a confidential reporting
structure in which providers can voluntarily report Patient Safety Work Product (PSWP) to
Patient Safety Organizations (PSOs). Under the system, PSWP is made privileged, confidential
and legally protected from disclosure. PSWP does not include medical, discharge or billing records
or any other original patient or provider records but does include information gathered
specifically in connection with the reporting of medical errors and improving patient safety. This
legislation does not preempt state or federal mandatory disclosure laws concerning information that
does not constitute PSWP. PSOs will be certified by the Secretary of the DHHS for three-year
periods after the Secretary develops applicable certification criteria. PSOs will analyze PSWP,
provide feedback to providers and may report non-identifiable PSWP to a database. In addition, PSOs
are expected to generate patient safety improvement strategies. We will monitor the progress of
these voluntary reporting programs and we anticipate that we will participate in some form when the
details are available.
17
State Hospital Rate-Setting Activity. We currently operate two hospitals in West Virginia.
The West Virginia Health Care Authority requires that requests for increases in hospital charges be
submitted annually. Requests for rate increases are reviewed by the West Virginia Health Care
Authority and are either approved at the amount requested, approved for lower amounts than
requested, or are rejected. As a result, in West Virginia, our ability to increase our rates to
compensate for increased costs per admission is limited and the operating margins for our hospitals
located in West Virginia may be adversely affected if we are not able to increase our rates as our
expenses increase. We can provide no assurance that other states in which we operate hospitals will
not enact similar rate-setting laws in the future.
Medical Malpractice Tort Law Reform. Medical malpractice tort law has historically been
maintained at the state level. All states have laws governing medical liability lawsuits. Over half
of the states have limits on damages awards. Almost all states have eliminated joint and several
liability in malpractice lawsuits, and many states have established limits on attorney fees.
Recently, many states had bills introduced in their legislative sessions to address medical
malpractice tort reform. Proposed solutions include enacting limits on non-economic damages,
malpractice insurance reform, and gathering lawsuit claims data from malpractice insurance
companies and the courts for the purpose of assessing the connection between malpractice
settlements and premium rates. Reform legislation has also been proposed, but not adopted, at the
federal level that could preempt additional state legislation in this area.
Environmental Regulation. Our healthcare operations generate medical waste that must be
disposed of in compliance with federal, state and local environmental laws, rules and regulations.
Our operations, as well as our purchases and sales of healthcare facilities, are also subject to
compliance with various other environmental laws, rules and regulations. Such compliance costs are
not significant and we do not anticipate that such compliance costs will be significant in the
future.
Regulatory Compliance Program
It is our policy to conduct our business with integrity and in compliance with the law. We
have in place and continue to enhance a company-wide compliance program that focuses on all areas
of regulatory compliance including billing, reimbursement, cost reporting practices and contractual
arrangements with referral sources.
This regulatory compliance program is intended to help ensure that high standards of conduct
are maintained in the operation of our business and that policies and procedures are implemented so
that employees act in full compliance with all applicable laws, regulations and company policies.
Under the regulatory compliance program, every employee, certain contractors involved in patient
care, and coding and billing, receive initial and periodic legal compliance and ethics training. In
addition, we regularly monitor our ongoing compliance efforts and develop and implement policies
and procedures designed to foster compliance with the law. The program also includes a mechanism
for employees to report, without fear of retaliation, any suspected legal or ethical violations to
their supervisors, designated compliance officers in our hospitals, our compliance hotline or
directly to our corporate compliance office. We believe our compliance program is consistent with
standard industry practices.
Risk Management and Insurance
We retain a substantial portion of our professional and general liability risks through a self
insurance reserve (SIR) insurance program administered in-house by our risk and insurance
department with assistance from our insurance brokers. As of December 31, 2008, our SIR for
professional and general liability risks is $15.0 million per claim. We maintain professional and
general liability insurance with unrelated commercial insurance carriers to provide for losses in
excess of the SIR.
Our workers compensation program has a $2.0 million deductible for each loss in all states
except for West Virginia and Wyoming. Workers compensation in West Virginia and Wyoming operate
under state specific programs.
18
We also maintain directors and officers, property and other types of insurance coverage with
unrelated commercial carriers. Our directors and officers liability insurance coverage for
current officers and directors is a program that protects us as well as the individual director or
officer. The limits provided by the directors and officers policy are based on numerous factors,
including the commercial insurance market. We maintain property insurance through an unrelated
commercial insurance company. We maintain large property insurance deductibles with respect to our
facilities in coastal regions because of the high wind exposure and the related cost of such
coverage. We have four locations that are considered a high exposure to named-storm risk and carry
a deductible of 3% of their respective property values.
We operate a captive insurance company under the name Point of Life Indemnity, Ltd. This
captive insurance company which was approved by the Cayman Islands Monetary Authority and which
operates as our wholly-owned subsidiary, issues malpractice insurance policies to our employed
physicians and certain voluntary attending physicians.
Item 1A. Risk Factors.
There are several factors, some beyond our control that could cause results to differ
significantly from our expectations. Some of these factors are described below. Other factors, such
as market, operational, liquidity, interest rate and other risks, are described elsewhere in this
report (see, for example, Part II, Item 7. Managements Discussion and Analysis of Financial
Condition and Results of Operations).
Any factor described in this report
could by itself, or together with one or more factors, adversely affect our business, results of
operations and/or financial condition. There may be factors not described in this report that could
also cause results to differ from our expectations.
If we do not effectively attract, recruit and retain qualified physicians, nurses, medical
technicians and other healthcare professionals, our ability to deliver healthcare services
efficiently will be adversely affected.
As a general matter, only physicians on our medical staffs may direct hospital admissions and
the services ordered once a patient is admitted to a hospital. As a result, our success depends
significantly on the efforts, abilities and experience of the physicians on the medical staffs of
our hospitals most of whom have no long-term contractual relationship with us, having an
appropriate number of physicians on our hospitals medical staffs, the admissions practices of
these physicians and the maintenance of good relations with these physicians.
The primary method we use to add or expand medical services is the recruitment of new
physicians into our communities. The success of our recruiting efforts will depend on several
factors. In general, there is a shortage of specialty care physicians. We face intense competition
in the recruitment and retention of specialists because of the difficulty in convincing these
individuals of the benefits of practicing or remaining in practice in non-urban communities. If the
growth rate slows more significantly in the non-urban communities where our hospitals operate, then
we could experience difficulty attracting and retaining physicians to practice in our communities.
We also employed more physicians during 2008 than in prior years. We believe that physician
employment by acute care hospitals has become more common in recent periods and that our experience
in employing physicians is consistent with industry trends. Employed physicians could present more
direct risks to us than those presented by independent members of our hospitals medical staffs.
For example, it is more likely that we could be found liable if an employed physician commits
malpractice. In light of the competition for a limited number of physicians, some are able to
command significant (although fair market value) salaries. The combined costs of these salaries is
significant and , if this trend continues, could have an adverse effect on our results of
operations.
19
Further, our ability to recruit physicians is closely regulated. For example, the types,
amount, and duration of assistance we can provide to recruited physicians are limited by the
federal Stark physician self-referral law, federal and state anti-kickback statutes, and related
regulations. The Stark law requires, among other things, that assistance can only be provided to
physicians who meet certain geographic and practice requirements, that the amount of assistance
cannot be changed during the term, and that the recruitment payments cannot generally benefit
physicians currently in practice in the community beyond costs actually incurred by them in the
recruitment. In addition to these legal requirements, there is competition from other communities
and facilities for these physicians, and this competition continues after the physician is
practicing in one of our communities.
We also compete with other healthcare providers in recruiting and retaining qualified
management and staff personnel responsible for the day-to-day operations of each of our hospitals,
including nurses and other non-physician healthcare professionals. In some markets, the scarce
availability of nurses and other medical support personnel presents a significant operating issue.
This shortage may require us to enhance wages and benefits to recruit and retain nurses and other
medical support personnel, recruit personnel from foreign countries, and hire more expensive
temporary personnel. We also depend on the available labor pool of semi-skilled and unskilled
employees in each of the markets in which we operate. Because a significant percentage of our
revenue consists of fixed, prospective payments, our ability to pass along increased labor costs is
constrained. Our failure to recruit and retain qualified management, nurses and other medical
support personnel, or to control our labor costs could have a material adverse effect on our
financial condition or results of operations.
The loss of certain physicians can have a disproportionate impact on certain of our hospitals.
Generally, the top ten attending physicians within each of our facilities represent a large
share of our inpatient revenues and admissions. The loss of one or more of these physicians even if temporary - could cause a material reduction in our revenues, which could take significant time
to replace given the difficulty and cost associated with recruiting and retaining physicians. We
may not be able to recruit all of the physicians we have targeted. In addition, we may incur
increased malpractice expense if the quality of such physicians does not meet our expectations.
We believe physician attrition is one of the reasons for our recent volume declines. If we are
unable to reverse this trend
we expect these volume declines to continue.
The
failure of certain employers, or the closure of certain manufacturing
and other facilities, can have a disproportionate impact on our
hospitals.
The
economies in the non-urban communities in which our
hospitals operate are often dependant on a small number of large
employers, especially manufacturing or other facilities. These
employers often provide income and health insurance for a
disproportionately large number of
community residents who may depend on our hospitals for
care. The failure of one or more large employers, or the closure or
substantial reduction in the number of individuals employed at
manufacturing or other facilities located in or near many of the
non-urban communities in which our hospitals operate, could cause
affected employees to move elsewhere for
employment or lose insurance coverage that was otherwise
available to them. The occurrence of these
events may cause a material reduction in our revenues and results of
operations or impede our business strategies
intended to generate organic growth and improve
operating results at our hospitals.
We may continue to see the growth of uninsured and patient due accounts; deterioration in
the collectability of these accounts could adversely affect our results of operations and cash
flows.
The primary collection risks associated with our accounts receivable relate to the uninsured
patient accounts and patient accounts for which the primary insurance carrier has paid the amounts
covered by the applicable agreement, but patient responsibility amounts (deductibles and
co-payments) remain outstanding. The provision for doubtful accounts relates primarily to amounts
due directly from patients. This risk has increased, and will likely continue to increase, as more
individuals enroll in high deductible insurance plans or those with
high co-payments or who have no insurance coverage. These trends will likely be exacerbated if general economic conditions remain
challenging. These trends will also
likely be exacerbated as unemployment levels in the communities in which we operate rise.
As unemployment rates increase, our business strategies that intend to
generate organic growth, and to improve admissions and adjusted
admissions at our hospitals could become more difficult to accomplish.
The amount of our provision for doubtful accounts is based on our assessments of historical
collection trends, business and economic conditions, trends in federal and state governmental and
private employer health coverage and other collection indicators. A continuation in trends that
results in increasing the proportion of accounts receivable being comprised of uninsured accounts
and deterioration in the collectability of these accounts could adversely affect our collections of
accounts receivable, cash flows and results of operations.
20
The current economic recession, along with difficult and volatile conditions in the capital
and credit markets, could materially adversely affect our financial position, results of operations
or cash flows, and we are unsure whether these conditions will improve in the near future.
The United States economy is currently in a period of recession and global credit markets
remain volatile. Declining consumer confidence and increased unemployment have increased concerns
of prolonged economic weakness. While certain healthcare spending is considered non-discretionary
and may not be significantly impacted by economic downturns, other types of healthcare spending may
be adversely impacted by such conditions. When patients are experiencing personal
financial difficulties or have concerns about general economic conditions, they may choose to defer
or forego elective surgeries and other non-emergent procedures, which are generally more profitable
lines of business for hospitals.
Moreover, a greater number of uninsured patients may seek care in our
emergency rooms.
We are unable to determine the specific impact of the current
economic conditions on our business at this time, but we believe that further deterioration or a
prolonged period of recession will have an adverse impact on our operations and could impact not
only the healthcare decisions of our patients, but also the solvency of managed care providers and
other counterparties to transactions with us.
Our revenues will decline if federal or state programs reduce our Medicare or Medicaid
payments or if managed care companies reduce reimbursement amounts. In addition, the financial
condition of payors and healthcare cost containment initiatives may limit our revenues and
profitability.
In 2008, we derived 40.7% of our revenues from the Medicare and Medicaid programs. The
Medicare and Medicaid programs are subject to statutory and regulatory changes, administrative
rulings, interpretations and determinations concerning patient eligibility requirements, funding
levels and the method of calculating payments or reimbursements, among other things; requirements
for utilization review; and federal and state funding restrictions, all of which could materially
increase or decrease payments from these government programs in the future, as well as affect the
timing of payments to our facilities.
We are unable to predict the effect of future government health care funding policy changes on
our operations. If the rates paid by governmental payers are reduced, if the scope of services
covered by governmental payers is limited or if we, or one or more of our subsidiaries hospitals,
are excluded from participation in the Medicare or Medicaid program or any other government health
care program, there could be a material adverse effect on our business, financial condition,
results of operations or cash flows.
During the past several years, healthcare payors, such as federal and state governments,
insurance companies and employers, have undertaken initiatives to revise payment methodologies and
monitor healthcare costs. As part of their efforts to contain healthcare costs, payors increasingly
are demanding discounted fee structures or the assumption by healthcare providers of all or a
portion of the financial risk relating to paying for care provided, often in exchange for exclusive
or preferred participation in their benefit plans. We expect efforts to impose greater discounts
and more stringent cost controls by government and other payors to continue, thereby reducing the
payments we receive for our services. In addition, these payors have instituted policies and
procedures to substantially reduce or limit the use of inpatient services.
All of our hospitals are certified as providers of Medicaid services. Medicaid programs are
jointly funded by federal and state governments and are administered by states under an approved
plan that provides hospital and other healthcare benefits to qualifying individuals who are unable
to afford care. A number of states, however, are experiencing budget problems and have adopted or
are considering legislation designed to reduce their Medicaid expenditures or to provide universal
coverage and additional care, including enrolling Medicaid recipients in managed care programs and
imposing additional taxes on hospitals to help finance or expand states Medicaid systems.
The ARRA includes increased
federal funding for Medicaid. However, we are unable to predict at this time how this will impact
states ability to provide Medicaid coverage in the future. It is possible that, despite Congress
actions, budgetary pressures will force states to resort to some of the cost saving measures
mentioned above. These efforts could have a material adverse effect on our business, financial
condition, results of operations or cash flows.
21
For example, one of our hospitals, Memorial Medical Center of Las Cruces, New Mexico (MMC),
received approximately $33.0 million during 2008 under the New Mexico Sole Community Provider
Program (the SCPP). While the funds made available to MMC (and other New Mexico hospitals that
participate in the SCPP) are not tied directly to the cost of actual services provided, MMC is
required to provide an annual report of its costs to Dona Ana County (the county primarily served
by MMC). Once desired funding levels were established by Dona Ana County for 2008, the county
submitted funds to the New Mexico Human Services Department (the NMHSD), which in turn were
combined with funds sent by other New Mexico counties and then used by the NMHSD to request
matching funds from the federal government. Once the federal matching dollars were made available
to the state, the resulting sole community provider payment was made under the SCPP directly to MMC
(and other hospitals participating in the SCPP) by the NMHSD. The payments made by the NMHSD to
hospitals pursuant to the SCPP are based on formulas established with respect to each participating
hospital. The SCPP was created in 1993 and has resulted in significant payments to MMC in prior
years. Like many other states, there is a general concern in New Mexico that the SCPP cannot be
sustained at current funding levels due to budget concerns and other factors. It seems likely, as a
result, that the SCPP will soon be reconstituted. We are not able to predict what changes may be
made to the SCPP, but any change in the SCPP is likely to reduce payments made to MMC.
We are subject to increasingly stringent governmental regulation, and may be subjected to
allegations that we have failed to comply with governmental regulations which could result in
sanctions and even greater scrutiny that reduce our revenues and profitability.
All participants in the healthcare industry are required to comply with many laws and
regulations at the federal state and local government levels. These laws and regulations require
that hospitals meet various requirements, including those relating to hospitals relationships with
physicians and other referral sources, the adequacy and quality of medical care, equipment,
personnel, operating policies and procedures, billing and cost reports, payment for services and
supplies, maintenance of adequate records, privacy, compliance with building codes and
environmental protection, among other matters.
The hospital industry has seen a number of ongoing investigations related to referrals,
physician recruiting practices, cost reporting and billing practices, laboratory and home
healthcare services and physician ownership and joint ventures involving hospitals. Federal and
state government agencies have announced heightened and coordinated civil and criminal enforcement
efforts. In addition, the OIG (which is responsible for investigating fraud and abuse activities in
government programs) and the U.S. Department of Justice periodically establish enforcement
initiatives that focus on specific billing practices or other suspected areas of abuse. In January
2005, the OIG issued Supplemental Compliance Program Guidance for Hospitals that focuses on
hospital compliance risk areas. Some of the risk areas highlighted by the OIG include correct
outpatient procedure coding, revising admission and discharge policies to reflect current CMS
rules, submitting appropriate claims for supplemental payments such as pass-through costs and
outlier payments and a general discussion of the fraud and abuse risks related to financial
relationships with referral sources.
Hospitals continue to be one of the primary focal areas of OIG investigations. The OIG
reported savings and expected recoveries for federal health care programs of more than $20.4
billion for FY 2008, which includes one of the largest civil fraud recoveries ever against an
individual hospital. It is likely that the introduction of RACs in
2009 signals additional government scrutiny of hospitals. The claims review strategies used by the
RACs include review of high dollar claims, including inpatient hospital claims. During the three
year RAC demonstration program, a large majority of the total amounts recovered by RACs came from
hospitals.
In public statements, governmental authorities have taken positions on issues for which little
official interpretation was previously available. Some of these positions appear to be inconsistent
with common practices within the industry but have not previously been challenged. Moreover, some
government investigations that have in the past been conducted under the civil provisions of
federal law are now being conducted as criminal investigations under the Medicare fraud and abuse
laws.
22
In a series of notices in 2007, CMS indicated its intent to require a group of 500 hospitals
to submit a Disclosure of Financial Relationships Report to CMS. Although final OMB approval of the
DFRR is still pending, the deadline for public comment was January 20, 2009; therefore, it could be
distributed at any time. If the DFRR is distributed, we expect that a number of our facilities may
be included among those required to respond. CMS intends to use this data to monitor compliance
with the Stark law, and CMS has indicated that it may share the information with other government
agencies. Many of these agencies have not previously analyzed this information and have the
authority to bring enforcement actions against us. Once a hospital receives this request, the
hospital will have a limited amount of time to compile a significant amount of information relating
to its financial relationships with physicians, including any ownership by physicians. The hospital
may be subject to substantial penalties if it is unable to assemble and report this information
within the required timeframe or if CMS or any other government agency determines that the
submission is inaccurate or incomplete. The hospital may be the subject of investigations or
enforcement actions if a government agency determines that any of the information indicates a
potential violation of law. Any such investigation or enforcement action could materially adversely
affect the results of our operations.
These activities reflect the general trend of increasing governmental scrutiny of the
financial relationships between hospitals and referring physicians under the fraud and abuse laws.
The laws and regulations with which we must comply are complex and subject to change. In the
future, different interpretations or enforcement of these laws and regulations could subject our
practices to allegations of impropriety or illegality or could require us to make changes in our
facilities, equipment, personnel, services, capital expenditure programs and operating expenses. If
we fail to comply with applicable laws and regulations, we could suffer civil or criminal
penalties, including the loss of our licenses to operate our hospitals and our ability to
participate in the Medicare, Medicaid and other federal and state healthcare programs.
Finally, we are subject to various federal, state and local statutes and ordinances regulating
the discharge of materials into the environment. Our healthcare operations generate medical waste,
such as pharmaceuticals, biological materials and disposable medical instruments that must be
disposed of in compliance with federal, state and local environmental laws, rules and regulations.
Our operations are also subject to various other environmental laws, rules and regulations.
Environmental regulations also may apply when we renovate or refurbish hospitals, particularly
older facilities.
Other hospitals and outpatient facilities provide services similar to those which we offer. In
addition, physicians provide services in their offices that could be provided in our hospitals.
These factors increase the level of competition we face and may therefore adversely affect our
revenues, profitability and market share.
Competition among hospitals and other healthcare service providers, including outpatient
facilities, has intensified in recent years. We compete with other hospitals, including larger
tertiary care centers located in larger metropolitan areas, and with physicians who provide
services in their offices which could otherwise be provided in our hospitals. Although the
hospitals with which we compete may be a significant distance away from our facilities, patients in
our markets may migrate on their own to, may be referred by local physicians to, or may be
encouraged by their health plan to travel to these hospitals. Furthermore, some of the hospitals
with which we compete may offer more or different services than those available at our hospitals,
may have more advanced equipment or a medical staff that is thought to be better qualified. Also,
some of the hospitals that compete with our facilities are owned by tax-supported governmental
agencies or not-for-profit entities supported by endowments and charitable contributions. These
hospitals, in most instances, are also exempt from paying sales, property and income taxes.
We also face very significant and increasing competitions from services offered by physicians
(including physicians on our medical staffs) in their offices and from other specialized care
providers, including outpatient surgery, oncology, physical therapy and diagnostic centers
(including many in which physicians may have and ownership interest). Some of our hospitals have
and will seek to develop outpatient facilities where necessary to compete effectively. However, to
the extent that other providers are successful in developing outpatient facilities or physicians
are able to offer additional, advanced services in their offices, our market share for these
services will likely decrease in the future.
23
In 2005, CMS began making public performance data relating to ten quality measures that
hospitals submit in connection with their Medicare reimbursement. Since that time, CMS has on
several occasions increased the number of quality measures hospitals are required to report. If
these measures become a primary factor in where patients choose to receive care, and if competing
hospitals have better results than our hospitals on the measures, we would expect that our patient
volumes would decline. In the future, other trends toward clinical transparency may have an
unanticipated impact on our competitive position and patient volume.
Our revenues are especially concentrated in a small number of states which will make us
particularly sensitive to regulatory and economic changes in those states.
Our revenues are particularly sensitive to regulatory and economic changes in Kentucky,
Virginia, New Mexico, West Virginia, Tennessee, Alabama, Louisiana, Arizona and Texas. The
following table contains our revenues and revenues as a percentage of our total revenues by state
for each of these states for the years presented (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue Concentration by State |
|
|
Amount |
|
% of Total Revenues |
|
|
2006 |
|
2007 |
|
2008 |
|
2006 |
|
2007 |
|
2008 |
Kentucky |
|
$ |
404.0 |
|
|
$ |
435.4 |
|
|
$ |
465.0 |
|
|
|
17.3 |
% |
|
|
17.0 |
% |
|
|
17.2 |
% |
Virginia |
|
|
341.9 |
|
|
|
369.7 |
|
|
|
381.6 |
|
|
|
14.6 |
|
|
|
14.4 |
|
|
|
14.1 |
|
New Mexico |
|
|
210.9 |
|
|
|
225.0 |
|
|
|
245.7 |
|
|
|
9.0 |
|
|
|
8.8 |
|
|
|
9.1 |
|
West Virginia |
|
|
151.7 |
|
|
|
229.7 |
|
|
|
243.4 |
|
|
|
6.5 |
|
|
|
8.9 |
|
|
|
9.0 |
|
Tennessee |
|
|
199.6 |
|
|
|
209.8 |
|
|
|
223.2 |
|
|
|
8.5 |
|
|
|
8.2 |
|
|
|
8.3 |
|
Alabama |
|
|
186.5 |
|
|
|
191.0 |
|
|
|
203.2 |
|
|
|
8.0 |
|
|
|
7.4 |
|
|
|
7.5 |
|
Louisiana |
|
|
170.5 |
|
|
|
189.4 |
|
|
|
194.6 |
|
|
|
7.3 |
|
|
|
7.4 |
|
|
|
7.2 |
|
Arizona |
|
|
133.0 |
|
|
|
167.1 |
|
|
|
173.8 |
|
|
|
5.7 |
|
|
|
6.5 |
|
|
|
6.4 |
|
Texas |
|
|
136.3 |
|
|
|
135.3 |
|
|
|
142.3 |
|
|
|
5.8 |
|
|
|
5.3 |
|
|
|
5.3 |
|
Accordingly, any change in the current demographic, economic, competitive or regulatory
conditions in the above-mentioned states could have an adverse effect on our business, financial
condition, results of operations and/or prospects. Medicaid changes in these states could also have
a material adverse effect on our business, financial condition, results of operations or cash
flows.
If our access to licensed information systems is interrupted or restricted, or if we are not
able to integrate changes to our existing information systems or information systems of acquired
hospitals, our operations could suffer.
Our business depends significantly on effective information systems to process clinical and
financial information. Information systems require an ongoing commitment of significant resources
to maintain and enhance existing systems and develop new systems in order to keep pace with
continuing changes in information processing technology. We rely heavily on HCA-Information
Technology and Services, Inc., (HCA-IT), for information systems. HCA-IT provides us with
financial, clinical, patient accounting and network information services. We do not control
HCA-ITs systems, and if these systems fail or are interrupted, if our access to these systems is
limited in the future or if HCA-IT develops systems more appropriate for the urban healthcare
market and not suited for our hospitals, our operations could suffer. Our contract with HCA-IT, as
amended, expires on December 31, 2017 (including a wind-down period) unless extended by the
parties.
HCAs primary business is to own and operate hospitals, not to provide information systems. In
addition, HCA was taken private in a leveraged buyout in November 2006. The additional debt
incurred by HCA in this transaction could impact its ability to provide information systems and
related support to us. During late 2008, HCA announced layoffs which included over 100 employees of
HCA-IT. At this time, it remains uncertain whether these staffing reductions will impact the
performance of HCA-IT under our agreements.
System conversions are costly, time consuming and disruptive for physicians and employees.
Should we decide or be required to convert away from systems provided by HCA-IT, such
implementation would be very costly and could have a material adverse effect on our business,
financial condition, results of operations or cash flows.
24
In addition, as new information systems are developed in the future, we will need to integrate
them into our existing systems. Evolving industry and regulatory standards, such as HIPAA
regulations, may require changes to our information systems in the future. We may not be able to
integrate new systems or changes required to our existing systems or systems of acquired hospitals
in the future effectively or on a cost-efficient basis.
An element of our long-term business strategy is growth through the acquisition of additional
acute care hospitals. Our acquisition activity requires transitions from, and the integration of,
various information systems that are used by the hospitals we acquire. If we experience
difficulties with the integration of the information systems of acquired hospitals, we could
suffer, among other things, operational disruptions and increases in administrative expenses.
We have substantial indebtedness and we may incur significant amounts of additional
indebtedness in the future which could affect our ability to finance operations and capital
expenditures, pursue desirable business opportunities or successfully operate our business in the
future.
As of December 31, 2008, our consolidated debt was approximately $1,516.7 million. We also
have the ability to incur significant amounts of additional indebtedness, subject to the conditions
imposed by the terms of our credit agreements an the agreements or indentures governing any
additional indebtedness that we incur in the future. Our credit facility contains an uncommitted
accordion feature that permits us to borrow at a later
date additional aggregate principal
amounts of up to $650.0 million under the term A and the term B loan components and up to $411.6
million under the revolving loan component, subject to the receipt of commitments and the
satisfaction of other conditions. Our ability to repay or refinance our indebtedness will depend
upon our future ability to monetize our interests in our hospital assets and our operating
performance, which may be affected by general economic, financial, competitive, regulatory,
business and other factors beyond our control.
Although we believe that our future operating cash flow, together with available financing
arrangements, will be sufficient to fund our operating requirements, our leverage and debt service
obligations could have important consequences, including the following:
|
|
|
Under our credit facility, we are required to satisfy and maintain specified
financial ratios and tests. Failure to comply with these obligations may cause an event
of default which, if not cured or waived, could required us to repay substantial
indebtedness immediately. Moreover, if debt repayment is accelerated, we will be subject
to higher interest rates on our debt obligations as a result of these covenants and our
credit ratings may be adversely impacted. |
|
|
|
|
We may be vulnerable in the event of downturns and adverse changes in the general
economy or our industry. Specific examples of industry changes that could have an
adverse impact on our cash flow include the implementation by the government of further
limitations on reimbursement under Medicare and Medicaid. |
|
|
|
|
We may have difficulty obtaining additional financing at favorable interest rates
to meet our requirements for working capital, capital expenditures, acquisitions,
general corporate or other purposes. |
|
|
|
|
We will be required to dedicate a substantial portion of our cash flow to the
payment of principal and interest on indebtedness, which will reduce the amount of funds
available for operations, capital expenditures and future acquisitions. |
|
|
|
|
Any borrowings we incur at variable interest rates expose us to increases in
interest rates generally. |
|
|
|
|
A breach of any of the restrictions or covenants in our debt agreements could
cause a cross-default under other debt agreements. We may be required to pay our
indebtedness immediately if we default on any of the numerous financial or other
restrictive covenants contained in the debt agreements. It is not certain whether we
will have, or will be able to obtain, sufficient funds to make these accelerated
payments. If any senior debt is accelerated, our assets may not be sufficient to repay
such indebtedness and our other indebtedness. |
25
|
|
|
In the event of a default, we may be forced to pursue one or more alternative
strategies, such as restructuring or refinancing our indebtedness, selling assets,
reducing or delaying capital expenditures or seeking additional equity capital. There
can be no assurances that any of these strategies could be effected on satisfactory
terms, if at all, or that sufficient funds could be obtained to make these accelerated
payments. |
We may be subject to liabilities because of malpractice and related legal claims brought
against our hospitals. If we become subject to these claims, we could be required to pay
significant damages, which may not be covered by insurance.
We may be subject to medical malpractice lawsuits and other legal actions arising out of the
operations of our owned and leased hospitals. These actions may involve large claims and
significant defense costs. In an effort to resolve one or more of these matters, we may choose to
negotiate a settlement. Amounts we pay to settle any of these matters may be material. To mitigate
a portion of this risk, we maintain professional malpractice liability and general liability
insurance coverage for these potential claims in amounts above our SIR level that we believe to be
appropriate for our operations. However, some of these claims could exceed the scope of the
coverage in effect, or coverage of particular claims could be denied.
We maintain professional and general liability insurance with unrelated commercial insurance
carriers to provide for losses in excess of our SIR amount. As a result, one or more successful
claims against us that are within our SIR amounts could have an adverse effect on our results of
operations, cash flows, financial condition or liquidity. In addition, we operate a wholly-owned
captive insurance company under the name Point of Life Indemnity, Ltd., which, issues malpractice
insurance policies to our employed physicians and certain voluntary attending physicians.
Additionally, we experienced unfavorable claims development results recently, which are
reflected in our professional and general liability costs. Insurance coverage in the future may not
continue to be available at a cost allowing us to maintain adequate levels of insurance with
acceptable SIR level amounts. One or more of our insurance carriers may become insolvent and unable
to fulfill its obligation to defend, pay or reimburse us when that obligation becomes due. In
addition, physicians using our hospitals may be unable to obtain insurance on acceptable terms.
Our revenues and volume trends may be adversely affected by certain factors over which we have
no control.
Our revenues and volume trends are dependent on many factors, including physicians clinical
decisions and availability, payor programs shifting to a more outpatient-based environment, whether
or not certain services are offered, seasonal and severe weather conditions, including the effects
of extreme low temperatures, hurricanes and tornados, earthquakes, current local economic and
demographic changes, the intensity and timing of yearly flu outbreaks. In addition, technological
developments and pharmaceutical improvements may reduce the demand for healthcare services or the profitability
of the services we offer.
If our fair value declines, a material non-cash charge to earnings from impairment of our
goodwill could result.
At December 31, 2008, we had approximately $1,516.5 million of goodwill on our consolidated
balance sheet. We expect to recover the carrying value of this goodwill through our future cash
flows. We evaluate annually, based on our fair value, whether the carrying value of our goodwill is
impaired. If the carrying value of our goodwill is impaired, we may incur a material non-cash
charge to earnings.
26
We may have difficulty acquiring hospitals on favorable terms and, because of regulatory
scrutiny, acquiring not-for-profit entities.
One element of our business strategy is expansion through the acquisition of acute care
hospitals in non-urban markets. We face significant competition to acquire other attractive
non-urban hospitals, and we may not find suitable acquisitions on favorable terms. Our primary
competitors for acquisitions have included for-profit and tax-exempt hospitals and hospital
systems, and privately capitalized start-up companies. Buyers with a strategic desire for any
particular hospital for example, a hospital located near existing hospitals or those who will
realize economic synergies have demonstrated an ability and willingness to pay premium prices
for hospitals. Strategic buyers, as a result, can present a competitive barrier to our acquisition
efforts.
Even if we are able to identify an attractive candidate, we may not be able to obtain
financing, if necessary, for any acquisitions or joint ventures that we might make or may be
required to borrow at higher rates and on less favorable terms. We may incur or assume additional
indebtedness as a result of acquisitions. Our failure to acquire non-urban hospitals consistent
with our growth plans could prevent us from increasing our revenues.
The cost of an acquisition could result in a dilutive effect on our results of operations,
depending on various factors, including the amount paid for the acquisition, the acquired
hospitals results of operations, allocation of purchase price, effects of subsequent legislation
and limitations on rate increases. In the past, we have occasionally experienced temporary delays
in improving the operating margins or effectively integrating the operations of our acquired
hospitals. In the future, if we are unable to improve the operating margins of acquired hospitals,
operate them profitably or effectively integrate their operations, we may be unable to achieve our
growth strategy.
In recent years, the legislatures and attorneys general of several states have become more
interested in sales of hospitals by tax-exempt entities. This heightened scrutiny may increase the
cost and difficulty, or prevent the completion, of transactions with tax-exempt organizations in
the future.
We may encounter numerous business risks in acquiring additional hospitals and may have
difficulty operating and integrating those hospitals. As a result, we may be unable to achieve our
growth strategy.
We may be unable to timely and effectively integrate any hospitals that we acquire with our
ongoing operations. We may experience delays in implementing operating procedures and systems in
newly acquired hospitals. Integrating an acquired hospital could be expensive and time consuming
and could disrupt our ongoing business, negatively affect cash flow and distract management and
other key personnel. In addition, acquisition activity requires transitions from, and the
integration of, operations and, usually, information systems that are used by acquired hospitals.
We will rely heavily on HCA-IT for information systems integration as part of a contractual
arrangement for information technology services. We may not be successful in causing HCA-IT to
convert our newly acquired hospitals information systems in a timely manner.
In addition, businesses we have acquired, or businesses we may acquire may have unknown or
contingent liabilities for past activities of acquired businesses, including liabilities for
failure to comply with healthcare laws and regulations, medical and general professional
liabilities, workers compensation liabilities, previous tax liabilities and unacceptable business
practices. Although we have historically obtained, and we intend to continue to obtain, contractual
indemnification from sellers covering these matters, any indemnification obtained from sellers may
be insufficient to cover material claims or liabilities for past activities of acquired businesses.
If we do not continually enhance our hospitals with the most recent technological advances in
diagnostic and surgical equipment, our ability to maintain and expand our markets may be adversely
affected.
Technological advances, including with respect to computer-assisted tomography scanner (CTs),
magnetic resonance imaging (MRIs) and positron emission tomography scanner (PETs) equipment
continue to evolve. In addition, the manufacturers of such equipment often provide incentives to
try to increase their sales, including providing favorable financing to higher credit risk
organizations. In an effort to compete, we must continually assess our equipment needs and upgrade
our equipment as a result of technological improvements. We believe that the direction of the
patient flow correlates directly to the level and intensity of such diagnostic equipment.
27
We may be subjected to actions brought by the government under anti-fraud and abuse provisions
or by individuals on the governments behalf under the False Claims Acts qui tam or
whistleblower provisions.
We are subject to the anti-kickback statute, which prohibits some business practices and
relationships related to items or services reimbursable under Medicare, Medicaid and other federal
healthcare programs. For example, the anti-kickback statute prohibits healthcare service providers
from paying or receiving remuneration to induce or arrange for the referral of patients or purchase
of items or services covered by a federal or state healthcare program. If regulatory authorities
determine that any of our hospitals arrangements violate the anti-kickback statute, we could be
subject to liabilities under the Social Security Act, including:
|
|
|
criminal penalties; |
|
|
|
|
civil monetary penalties; and/or |
|
|
|
|
exclusion from participation in Medicare, Medicaid or other federal healthcare
programs, any of which could impair our ability to operate one or more of our hospitals
profitably. |
Whistleblower provisions allow private individuals to bring actions on behalf of the
government alleging that the defendant has defrauded the federal government. Defendants found to be
liable under the False Claims Act may be required to pay three times the actual damages sustained
by the government, plus mandatory civil penalties ranging between $5,500 and $11,000 for each
separate false claim.
There are many potential bases for liability under the False Claims Act. Liability often
arises when an entity knowingly submits a false claim for reimbursement to the federal government.
The False Claims Act defines the term knowingly broadly. Although simple negligence will not give
rise to liability under the False Claims Act, submitting a claim with reckless disregard for its
truth or falsity constitutes a knowing submission under the False Claims Act and, therefore, will
give rise to liability.
In some cases, whistleblowers or the federal government have taken the position that providers
who allegedly have violated other statutes, such as the anti-kickback statute and the Stark law,
have thereby submitted false claims under the False Claims Act. In addition, a number of states
have adopted their own false claims provisions as well as their own whistleblower provisions
whereby a private party may file a civil lawsuit in state court. We are required to provide
information to our employees and certain contractors about state and federal false claims laws and
whistleblower provisions and protections.
Although we intend and will endeavor to conduct our business in compliance with all applicable
federal and state fraud and abuse laws, many of these laws are broadly worded and may be
interpreted or applied in ways that cannot be predicted. Therefore, we cannot assure you that our
arrangements or business practices will not be subject to government scrutiny or be found to be in
compliance with applicable fraud and abuse laws.
Certificate of need laws and regulations regarding licenses, ownership and operation may
impair our future expansion in some states.
Some states require prior approval for the purchase, construction and expansion of healthcare
facilities, based on the states determination of need for additional or expanded healthcare
facilities or services. Ten states in which we operate hospitals,
including the recently acquired Rockdale Medical Center in Georgia, require a certificate
of need for capital expenditures exceeding a prescribed amount, changes in bed capacity or
services, and for certain other planned activities. We may not be able to obtain certificates of
need required for expansion activities in the future. In addition, all of the states in which we
operate facilities require hospitals and most healthcare providers to maintain one or more
licenses. If we fail to obtain any required certificate of need or license, our ability to operate
or expand operations in those states could be impaired.
28
In states without certificate of need laws, competing providers of healthcare services are
able to expand and construct facilities without the need for significant regulatory approval.
In
the nine states in which we operate that do not require certificates of need for the
purchase, construction and expansion of healthcare facilities or services, competing healthcare
providers face low barriers to entry and expansion. If competing providers of healthcare services
are able to purchase, construct or expand healthcare facilities without the need for regulatory
approval, we may face decreased market share and revenues in those markets.
Different interpretations of accounting principles could have a material adverse effect on our
results of operations or financial condition.
Generally accepted accounting principles are complex, continually evolving and may be subject
to varied interpretation by us, our independent registered public accounting firm and the SEC. Such
varied interpretations could result from differing views related to specific facts and
circumstances. Differences in interpretation of generally accepted accounting principles could have
a material adverse effect on our results of operations or financial condition.
Our stock price has been and may continue to be volatile; any significant decline may result
in litigation.
The trading price of our common stock has been and may continue to be subject to wide
fluctuations. This may result in stockholder lawsuits, which could divert managements time away
from operations and could result in higher legal fees and proxy costs.
Our stock price may fluctuate in response to the results or our operations and to a number of
events and factors, including:
|
|
|
actual or anticipated quarterly variations in operating results, particularly if they
differ from investors expectations; |
|
|
|
|
changes in financial estimates and recommendations by securities analysts; |
|
|
|
|
changes in government regulations including those relating to reimbursement and
operational policies and procedures; |
|
|
|
|
the operating and stock price performance of other companies that investors may deem
comparable; |
|
|
|
|
changes in overall economic factors in our markets; |
|
|
|
|
news reports relating to trends or events in our markets; and |
|
|
|
|
issues associated with integration of the hospitals that we acquire. |
Broad market and industry fluctuations may adversely affect the price of our common stock,
regardless of our operating performance.
As a result of the above factors, we could be subjected to potential stockholder lawsuits.
Such lawsuits are time consuming and expensive. Among other things, such lawsuits divert
managements time and attention from operations. Such lawsuits also force us to incur substantial
legal fees and proxy costs in defending our position.
|
|
|
Item 1B. |
|
Unresolved Staff Comments. |
We
have no material unresolved written comments from the staff of
the SEC regarding our periodic or current reports filed under the
Securities Exchange Act of 1934 (the Exchange Act) that
were issued more than 180 days prior to the end of our 2008 fiscal
year.
29
The following table presents certain information with respect to our hospitals as of December
31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition/Opening/ |
|
Licensed |
|
Operational |
Hospital |
|
City |
|
Lease Date |
|
Beds |
|
Status |
Alabama |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andalusia Regional Hospital |
|
Andalusia |
|
HCA Spin-Off(a) |
|
|
100 |
|
|
Own |
Lakeland Community Hospital |
|
Haleyville |
|
December 1, 2002 |
|
|
50 |
|
|
Own |
Northwest Medical Center |
|
Winfield |
|
December 1, 2002 |
|
|
71 |
|
|
Own |
Russellville Hospital |
|
Russellville |
|
October 3, 2002 |
|
|
100 |
|
|
Own |
Vaughan Regional Medical Center |
|
Selma |
|
April 15, 2005 |
|
|
175 |
|
|
Own |
Arizona |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Havasu Regional Medical Center |
|
Lake Havasu City |
|
April 15, 2005 |
|
|
181 |
|
|
Own |
Valley View Medical Center |
|
Ft. Mohave |
|
November 8, 2005 |
|
|
66 |
|
|
Own |
Colorado |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Colorado Plains Medical Center |
|
Fort Morgan |
|
April 15, 2005 |
|
|
50 |
|
|
Lease |
Florida |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Putnam Community Medical Center |
|
Palatka |
|
June 16, 2000 |
|
|
141 |
|
|
Own |
Indiana |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Starke Memorial Hospital (Starke) (b) |
|
Knox |
|
April 15, 2005 |
|
|
53 |
|
|
Lease |
Kansas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Western Plains Medical Complex |
|
Dodge City |
|
HCA Spin-Off(a) |
|
|
99 |
|
|
Own |
Kentucky |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bluegrass Community Hospital |
|
Versailles |
|
January 2, 2001 |
|
|
25 |
|
|
Own |
Bourbon Community Hospital |
|
Paris |
|
HCA Spin-Off(a) |
|
|
58 |
|
|
Own |
Georgetown Community Hospital |
|
Georgetown |
|
HCA Spin-Off(a) |
|
|
75 |
|
|
Own |
Jackson Purchase Medical Center |
|
Mayfield |
|
HCA Spin-Off(a) |
|
|
107 |
|
|
Own |
Lake Cumberland Regional Hospital |
|
Somerset |
|
HCA Spin-Off(a) |
|
|
259 |
|
|
Own |
Logan Memorial Hospital |
|
Russellville |
|
HCA Spin-Off(a) |
|
|
92 |
|
|
Own |
Meadowview Regional Medical Center |
|
Maysville |
|
HCA Spin-Off(a) |
|
|
101 |
|
|
Own |
Spring View Hospital |
|
Lebanon |
|
October 1, 2003 |
|
|
75 |
|
|
Own |
Louisiana |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acadian Medical Center |
|
Eunice |
|
April 15, 2005 |
|
|
52 |
|
|
Own |
Doctors Hospital of Opelousas
(Opelousas) (b) |
|
Opelousas |
|
April 15, 2005 |
|
|
171 |
|
|
Own |
Minden Medical Center |
|
Minden |
|
April 15, 2005 |
|
|
159 |
|
|
Own |
River Parishes Hospital |
|
LaPlace |
|
July 1, 2004 |
|
|
106 |
|
|
Own |
Teche Regional Medical Center |
|
Morgan City |
|
April 15, 2005 |
|
|
149 |
|
|
Lease |
Ville Platte Medical Center |
|
Ville Platte |
|
December 1, 2001 |
|
|
95 |
|
|
Own |
Mississippi |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bolivar Medical Center |
|
Cleveland |
|
April 15, 2005 |
|
|
200 |
|
|
Lease |
Nevada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Northeastern Nevada Regional Hospital |
|
Elko |
|
April 15, 2005 |
|
|
75 |
|
|
Own |
New Mexico |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Los Alamos Medical Center |
|
Los Alamos |
|
April 15, 2005 |
|
|
47 |
|
|
Own |
Memorial Medical Center of Las Cruces |
|
Las Cruces |
|
April 15, 2005 |
|
|
286 |
|
|
Lease |
Tennessee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Athens Regional Medical Center |
|
Athens |
|
October 1, 2001 |
|
|
118 |
|
|
Own |
Crockett Hospital |
|
Lawrenceburg |
|
HCA Spin-Off(a) |
|
|
107 |
|
|
Own |
Emerald-Hodgson Hospital |
|
Sewanee |
|
HCA Spin-Off(a) |
|
|
41 |
|
|
Own |
Hillside Hospital |
|
Pulaski |
|
HCA Spin-Off(a) |
|
|
95 |
|
|
Own |
Livingston Regional Hospital |
|
Livingston |
|
HCA Spin-Off(a) |
|
|
114 |
|
|
Own |
Southern Tennessee Medical Center |
|
Winchester |
|
HCA Spin-Off(a) |
|
|
157 |
|
|
Own |
Texas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ennis Regional Medical Center |
|
Ennis |
|
April 15, 2005 |
|
|
60 |
|
|
Lease |
Palestine Regional Medical Center |
|
Palestine |
|
April 15, 2005 |
|
|
150 |
|
|
Own |
Parkview Regional Hospital |
|
Mexia |
|
April 15, 2005 |
|
|
59 |
|
|
Lease |
Utah |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ashley Regional Medical Center |
|
Vernal |
|
HCA Spin-Off(a) |
|
|
39 |
|
|
Own |
Castleview Hospital |
|
Price |
|
HCA Spin-Off(a) |
|
|
84 |
|
|
Own |
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition/Opening/ |
|
Licensed |
|
Operational |
Hospital |
|
City |
|
Lease Date |
|
Beds |
|
Status |
Virginia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinch Valley Medical Center |
|
Richlands |
|
July 1, 2006 |
|
|
175 |
|
|
Own |
Danville Regional Medical Center |
|
Danville |
|
July 1, 2005 |
|
|
350 |
|
|
Own |
Memorial Hospital of Martinsville and
Henry County |
|
Martinsville |
|
April 15, 2005 |
|
|
220 |
|
|
Own |
Wythe County Community Hospital |
|
Wytheville |
|
June 1, 2005 |
|
|
100 |
|
|
Lease |
West Virginia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Logan Regional Medical Center |
|
Logan |
|
December 1, 2002 |
|
|
140 |
|
|
Own |
Raleigh General Hospital |
|
Beckley |
|
July 1, 2006 |
|
|
300 |
|
|
Own |
Wyoming |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lander Regional Hospital |
|
Lander |
|
July 1, 2000 |
|
|
89 |
|
|
Own |
Riverton Memorial Hospital |
|
Riverton |
|
HCA Spin-Off(a) |
|
|
70 |
|
|
Own |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
We were formerly a division of HCA and were spun-off as an independent publicly-traded
company on May 11, 1999. |
|
(b) |
|
Held-for-sale hospital. |
We operate medical office buildings in conjunction with many of our hospitals. We own the
majority of these medical office buildings. These office buildings are primarily occupied by
physicians who practice at our hospitals. Our corporate headquarters are located in approximately
130,000 square feet of leased space in Brentwood, Tennessee. Our corporate headquarters, hospitals
and other facilities are suitable for their respective uses and are generally adequate for our
present needs.
|
|
|
Item 3. |
|
Legal Proceedings. |
We are, from time to time, subject to claims and suits arising in the ordinary course of
business, including claims for damages for personal injuries, medical malpractice, breach of
contracts, wrongful restriction of or interference with physicians staff privileges and employment
related claims. In certain of these actions, plaintiffs request payment for damages, including
punitive damages that may not be covered by insurance. We are currently not a party to any pending
or threatened proceeding, which, in managements opinion, would have a material adverse effect on
our business, financial condition or results of operations.
|
|
|
Item 4. |
|
Submission of Matters to a Vote of Security Holders. |
We had no matters submitted to a vote of the stockholders during the quarter ended December
31, 2008.
31
PART II
|
|
|
Item 5. |
|
Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases
of Equity Securities. |
Market Information for Common Stock
Our common stock is listed on the NASDAQ Global Select Market under the symbol LPNT. The
high and low sales prices per share of our common stock were as follows for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
High |
|
Low |
2007 |
|
|
|
|
|
|
|
|
First Quarter |
|
$ |
38.49 |
|
|
$ |
32.74 |
|
Second Quarter |
|
|
40.80 |
|
|
|
35.91 |
|
Third Quarter |
|
|
40.49 |
|
|
|
27.38 |
|
Fourth Quarter |
|
|
32.50 |
|
|
|
28.10 |
|
2008 |
|
|
|
|
|
|
|
|
First Quarter |
|
$ |
30.75 |
|
|
$ |
23.76 |
|
Second Quarter |
|
|
33.25 |
|
|
|
27.28 |
|
Third Quarter |
|
|
35.94 |
|
|
|
27.85 |
|
Fourth Quarter |
|
|
31.79 |
|
|
|
16.92 |
|
2009 |
|
|
|
|
|
|
|
|
First Quarter (through February 17, 2009) |
|
$ |
25.06 |
|
|
$ |
21.20 |
|
On February 17, 2009, the last reported sales price for our common stock on the NASDAQ Global
Select Market was $23.60 per share.
Stockholders
As of February 17, 2009, there were 52,094,515 shares of our common stock held by 10,463
holders of record.
Dividends
We have never declared or paid cash dividends on our common stock. We intend to retain future
earnings to finance the growth and development of our business and, accordingly, do not currently
intend to declare or pay any cash dividends on our common stock. Our board of directors will
evaluate our future earnings, results of operations, financial condition and capital requirements
in determining whether to declare or pay cash dividends. Delaware law prohibits us from paying any
dividends unless we have capital surplus or net profits available for this purpose. In addition,
our credit facilities impose restrictions on our ability to pay dividends.
Recent Sales of Unregistered Securities
None.
32
Recent Purchases of Equity Securities by the Issuer and Affiliated Purchasers
In November 2007, our Board of Directors authorized the repurchase of up to $150.0 million of
outstanding shares of our common stock either in the open market or through privately negotiated
transactions, subject to market conditions, regulatory constraints and other factors. Our stock
repurchase program expired on November 26, 2008. We repurchased approximately 1.4 million shares
for an aggregate purchase price, including commissions, of approximately $41.2 million with a
weighted average purchase price of $30.35 per share during the year ended December 31, 2007. We
repurchased approximately 3.8 million shares for an aggregate purchase price, including
commissions, of approximately $103.7 million with a weighted average purchase price of $26.57 per
share during the year ended December 31, 2008. As of December 31, 2008, we had repurchased in the
aggregate, approximately 5.2 million shares at an aggregate purchase price, including commissions,
of approximately $144.9 million with an average purchase price of $27.56 per share. We have
designated these shares as treasury stock.
We redeem shares from employees upon vesting of our 1998 Long-Term Incentive Plan (LTIP) and
Management Stock Purchase Plan (MSPP) stock awards for minimum statutory tax withholding
purposes. We redeemed approximately 0.1 million shares upon vesting of certain LTIP and MSPP shares
for an aggregate price of approximately $2.4 million during the year ended December 31, 2008. There
were no redemptions during the years end December 31, 2006 and 2007 because there were no LTIP or
MSPP shares that vested during these years. We have designated these shares as treasury stock.
The
following table summarizes our share repurchase activity by month
during the years ended
December 31, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Approximate |
|
|
|
|
|
|
|
|
|
|
Total Number |
|
Dollar Value |
|
|
|
|
|
|
|
|
|
|
of Shares |
|
of Shares that |
|
|
|
|
|
|
|
|
|
|
Purchased as |
|
May Yet Be |
|
|
|
|
|
|
Weighted |
|
Part of a |
|
Purchased |
|
|
Total Number |
|
Average |
|
Publicly |
|
Under the |
|
|
of Shares |
|
Price Paid |
|
Announced |
|
Program |
Period |
|
Purchased |
|
per Share |
|
Program |
|
(In millions) |
December 1, 2007 to December 31, 2007 |
|
|
1,356,487 |
|
|
$ |
30.35 |
|
|
|
1,356,487 |
|
|
$ |
108.8 |
|
January 1, 2008 to January 31, 2008 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
108.8 |
|
February 1, 2008 to February 29, 2008 |
|
|
1,865,280 |
|
|
$ |
25.12 |
|
|
|
1,865,280 |
|
|
$ |
62.0 |
|
March 1, 2008 to March 31, 2008 |
|
|
1,132,500 |
|
|
$ |
25.20 |
|
|
|
1,132,500 |
|
|
$ |
33.4 |
|
April 1, 2008 to April 30, 2008 |
|
|
77,532 |
|
|
$ |
28.37 |
|
|
|
|
|
|
$ |
33.4 |
|
May 1, 2008 to May 31, 2008 |
|
|
548,039 |
|
|
$ |
31.37 |
|
|
|
548,039 |
|
|
$ |
16.2 |
|
June 1, 2008 to June 30, 2008 |
|
|
359,424 |
|
|
$ |
31.08 |
|
|
|
359,424 |
|
|
$ |
5.1 |
|
July 1, 2008 to July 31, 2008 |
|
|
1,727 |
|
|
$ |
28.76 |
|
|
|
|
|
|
$ |
5.1 |
|
August 1, 2008 to August 31, 2008 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
5.1 |
|
September 1, 2008 to September 30, 2008 |
|
|
556 |
|
|
$ |
33.28 |
|
|
|
|
|
|
$ |
5.1 |
|
October 1, 2008 to October 31, 2008 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
5.1 |
|
November 1, 2008 to November 30, 2008 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
December 1, 2008 to December 31, 2008 |
|
|
4,611 |
|
|
$ |
21.22 |
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
5,346,156 |
|
|
$ |
27.56 |
|
|
|
5,261,730 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
Equity Compensation Plan Information
The following table provides aggregate information as of December 31, 2008, with respect to
shares of common stock that may be issued under our existing equity compensation plans, including
our LTIP, our Outside Directors Stock and Incentive Compensation Plan (the ODSICP) and our MSPP:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities |
|
|
|
Number of Securities |
|
|
|
|
|
|
Available for Future |
|
|
|
to be Issued Upon |
|
|
Weighted-Average |
|
|
Issuance Under Equity |
|
|
|
Exercise of Outstanding |
|
|
Exercise Price of |
|
|
Compensation Plans |
|
|
|
Options, Warrants and |
|
|
Outstanding Options, |
|
|
(Excluding Securities |
|
|
|
Rights |
|
|
Warrants and Rights |
|
|
Reflected in Column (a)) |
|
Plan Category |
|
(a) |
|
|
(b) |
|
|
(c) |
|
Equity Compensation
Plans Approved by
Security Holders |
|
|
4,807,142 |
(1) |
|
$ |
30.13 |
(2) |
|
|
3,776,437 |
(3) |
Equity Compensation
Plans not Approved
by Security Holders |
|
None |
|
None |
|
None |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
4,807,142 |
|
|
$ |
30.13 |
|
|
|
3,776,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Includes the following: |
|
|
|
4,665,973 shares of common stock to be issued upon exercise of outstanding stock
options granted under the LTIP; |
|
|
|
|
131,587 shares of common stock to be issued upon exercise of outstanding stock options
granted under the ODSICP; |
|
|
|
|
9,582 shares of common stock to be issued upon the vesting of deferred stock units
outstanding under the ODSICP |
|
|
|
(2) |
|
Upon vesting, deferred stock units and restricted stock units are settled for shares of
common stock on a one-for-one basis. Accordingly, the deferred stock units and restricted
stock units have been excluded for purposes of computing the weighted-average exercise price. |
|
(3) |
|
Includes the following: |
|
|
|
3,591,770 shares of common stock available for issuance under the LTIP; |
|
|
|
|
97,893 shares of common stock available for issuance under the MSPP; and |
|
|
|
|
86,774 shares of common stock available for issuance under the ODSCIP. |
34
|
|
|
Item 6. |
|
Selected Financial Data. |
The table below contains our selected financial data for, or as of the end of, each of the
five years ended December 31, 2008. The selected financial data is derived from our audited
consolidated financial statements. In April 2005, we completed a merger with Province Healthcare
Company (Province) (the Province Business Combination). The results of operations of Province
are included in our results of operations beginning April 16, 2005. The timing of this and other
acquisitions and divestitures completed during the years presented affects the comparability of the
selected financial data. The selected financial data excludes the operations as well as assets and
liabilities of our discontinued operations in our consolidated financial statements. Additionally,
we have recognized certain transaction and debt retirement costs during certain of the periods
presented that affected the comparability of the selected financial data. You should read this
table in conjunction with the consolidated financial statements and related notes included
elsewhere in this report and in Part II, Item 7. Managements Discussion and Analysis of Financial
Condition and Results of Operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2004 |
|
|
2005 |
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
(In millions, except per share amounts) |
|
Statement of Operations Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
982.8 |
|
|
$ |
1,762.7 |
|
|
$ |
2,336.5 |
|
|
$ |
2,568.4 |
|
|
$ |
2,700.8 |
|
Income from continuing operations |
|
|
85.9 |
|
|
|
77.2 |
|
|
|
144.2 |
|
|
|
127.7 |
|
|
|
138.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
2.32 |
|
|
$ |
1.54 |
|
|
$ |
2.59 |
|
|
$ |
2.27 |
|
|
$ |
2.63 |
|
Diluted |
|
$ |
2.18 |
|
|
$ |
1.51 |
|
|
$ |
2.56 |
|
|
$ |
2.23 |
|
|
$ |
2.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
37.0 |
|
|
|
50.1 |
|
|
|
55.6 |
|
|
|
56.2 |
|
|
|
52.5 |
|
Diluted |
|
|
42.8 |
|
|
|
53.2 |
|
|
|
56.3 |
|
|
|
57.2 |
|
|
|
53.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data (as of end of year): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Working capital |
|
$ |
159.9 |
|
|
$ |
275.5 |
|
|
$ |
377.9 |
|
|
$ |
373.6 |
|
|
$ |
376.2 |
|
Property and equipment, net |
|
|
495.5 |
|
|
|
1,221.9 |
|
|
|
1,305.4 |
|
|
|
1,383.0 |
|
|
|
1,416.0 |
|
Total assets |
|
|
890.4 |
|
|
|
3,224.6 |
|
|
|
3,638.3 |
|
|
|
3,635.9 |
|
|
|
3,680.3 |
|
Long-term debt, including amounts due within one year |
|
|
221.0 |
|
|
|
1,514.1 |
|
|
|
1,668.6 |
|
|
|
1,517.2 |
|
|
|
1,516.7 |
|
Stockholders equity |
|
|
509.5 |
|
|
|
1,287.8 |
|
|
|
1,450.0 |
|
|
|
1,544.2 |
|
|
|
1,578.6 |
|
35
|
|
|
Item 7. |
|
Managements Discussion and Analysis of Financial Condition and Results of Operations. |
We recommend that you read this discussion together with our consolidated financial statements
and related notes included elsewhere in this report. Unless otherwise indicated, all relevant
financial and statistical information included herein relates to our continuing operations.
We
make forward-looking statements in this report, other reports and in statements we
file with the SEC and/or release to the public. In addition, our senior management makes
forward-looking statements orally to analysts, investors, the media and others. Broadly speaking,
forward-looking statements include projections of our revenues;
net income; earnings per
share; capital expenditures; cash flows; debt repayments; interest
rates; operating statistics and
data or other financial items; descriptions of plans or objectives of our management for future
operations; services or growth plans including acquisitions, divestitures, business strategies and
initiatives; interpretations of Medicare and Medicaid laws and regulations and their effect on
our business; and descriptions of assumptions underlying or relating to any of the foregoing.
In this
report, for example, we make forward-looking statements discussing our expectations
about: future financial performance and condition; future liquidity and capital resources; repurchases of our
common stock; future cash flows; existing and future debt and equity
structure; compliance with debt covenants; our
strategic goals; future acquisitions and
dispositions; our business strategy and operating philosophy, including the manner in which
potential acquisitions or divestitures are evaluated; supply and
information technology costs; changes in interest rates; our compliance with
new and existing laws and regulations; the performance of
counterparties to our agreements, our plans as to the
payment of dividends; industry and
general economic trends; taxes and tax rates; the efforts of insurers and other payors, healthcare providers and
others to contain healthcare costs; reimbursement changes; patient volumes and related
revenues; future capital expenditures; expected
changes in certain expenses; the
impact of changes in our critical accounting estimates; claims and legal actions relating to
professional liabilities and other matters; the impact and applicability of new accounting
standards; staffing issues relating to nurses and other
clinical personnel; and physician
recruiting and retention.
Forward-looking statements discuss matters that are not historical facts. Because they discuss
future events or conditions, forward-looking statements often include words such as can, could,
may, should, believe, will, would, expect, project, estimate, anticipate, plan,
intend, target, continue or similar expressions. Do not unduly rely on forward-looking
statements, which give our expectations about the future and are not guarantees. Forward-looking
statements speak only as of the date they are made. We do not undertake any obligation to update
our forward-looking statements to reflect events or circumstances after the date of this document
or to reflect the occurrence of unanticipated events.
There are several factors, some beyond our control that could cause results to differ
significantly from our expectations. Some of these factors are described in Part I, Item 1A. Risk
Factors. Other factors, such as market, operational, liquidity, interest rate and other risks, are
described elsewhere in this section and Part II, Item 7A. Quantitative and Qualitative Disclosures
about Market Risk. Any factor described in this report could by itself, or together with one or
more factors, adversely affect our business, results of operations and/or financial condition.
There may be factors not described in this report that could also cause results to differ from our
expectations.
Overview
We operate general acute care hospitals in non-urban communities in the United States. At
December 31, 2008, we owned or leased through subsidiaries 48 hospitals, having a total of 5,686
licensed beds, and serving communities in 17 states. Two of these hospitals were held for sale and
classified as discontinued operations in our consolidated financial statements, and seven were
owned by third parties and leased by our subsidiaries. Effective February 1, 2009, we acquired
Rockdale Medical Center (RMC), a 138-bed acute care hospital located in Conyers, Georgia
(approximately 25 miles outside of Atlanta, Georgia). The financial results of RMC are not
included in our financial statements or results of operations for the periods described in this
report.
36
We generate revenues primarily through hospital services offered at our facilities. We
generated $2,336.5 million, $2,568.4 million and $2,700.8 million in revenues from continuing
operations during 2006, 2007 and 2008, respectively. In 2008, we derived 40.7% of our revenues from
the Medicare and Medicaid programs. Payments made to our hospitals pursuant to the Medicare and
Medicaid programs for services rendered rarely exceed our costs for such services. As a result,
we rely largely on payments made by private or commercial payors, together with certain limited
services provided to Medicare recipients, to generate an operating profit.
Our hospitals typically provide the range of medical and surgical services commonly available
in hospitals in non-urban markets, although the services provided at any specific hospital depend
on factors such as community need for the service, whether physicians necessary to operate the
service line safely are members of the medical staff of that hospital, whether the service might be
economically viable, and any contractual or CON obligations that might exist.
Competitive and Regulatory Environment
The environment in which our hospitals operate is extremely competitive. We face competition
from other acute care hospitals, including larger tertiary hospitals
located in larger markets and/or affiliated with universities; specialty hospitals that focus on
one or a small number of very lucrative service lines but that are not required to operate
emergency departments; stand-alone centers at which surgeries or diagnostic tests can be performed;
and physicians on the medical staffs of our hospitals. In many cases, our competitors focus on the
service lines that offer the highest margins. By doing so, our competitors can potentially draw the
best-paying business out of our hospitals. This, in turn, can reduce the overall operating profit
of our hospitals as we are often obligated to offer service lines that operate at a loss or that
have much lower profit margins. We continue to see growth in this general shift of lower acuity
procedures to outpatient settings. We have also seen the shift of increasingly complex procedures
from the inpatient to the outpatient setting.
The competition from physicians on the medical staffs of our hospitals can be especially
challenging. Within their offices, physicians may provide a vast range of services that would
otherwise be provided by acute care hospitals. Physicians also have a high level of influence with
respect to where their patients receive healthcare services and have the sole authority to order
tests. As a result of declining reimbursements to physicians, and as a result of these unique
competitive advantages, we believe that physicians often provide high margin services in their
offices to patients whose insurance plans pay reimbursement rates much higher than those set by
Medicare or Medicaid. This trend has likely offset to some extent our
efforts to improve equivalent admission
rates at many of our hospitals.
Our hospitals also face extreme competition in their efforts to recruit and retain physicians
on their medical staffs. It is widely recognized that the U.S. has a shortage of physicians in
certain practice areas, including specialists such as cardiologists and orthopedists, in various
areas of the country.
The environment in which our hospitals operate is very highly regulated and the penalties for
noncompliance are severe. We are required to comply with extensive, extremely complicated and
overlapping government regulations at the federal, state and local levels. These regulate every
aspect of how our hospitals conduct their operations, from what service lines must be offered in
order to be licensed as an acute care hospital, to whether our hospitals may employ physicians to
how (and whether) our hospitals may receive payments pursuant to the Medicare and Medicaid
programs. The failure to comply with these laws and regulations can result in severe penalties
including criminal penalties and civil sanctions, and the loss of our ability to receive
reimbursements through the Medicare and Medicaid programs.
Not only are our hospitals heavily regulated, the rules, regulations and laws to which they
are subject often change, with little or no notice, and they are often interpreted and applied
differently by various regulatory agencies with authority to enforce such requirements. Each change
or conflicting interpretation may require our hospitals to make changes in their facilities,
equipment, personnel or services, and may also require that standard operating policies and
procedures be re-written and re-implemented. The cost of complying with such laws is a very
significant component of our overall expenses. Further, this expense has grown in recent periods
due to the requirements of new regulations and the severity of the penalties associated with
non-compliance and management believes compliance expenses will continue to grow in the foreseeable
future.
37
The hospital industry is also enduring a period where the costs of providing care are rising
faster than reimbursement rates. This places a premium on efficient operation, the ability to
reduce or control costs and the need to leverage the benefits of our organization across all of our
hospitals.
The regulatory, enforcement and reimbursement environment could change substantially during
2009. Although President Obama has said that healthcare reform is among his administrations
highest priorities, the details and timing of any such reform are unknown.
Business Strategy
We seek to fulfill our mission of Making Communities Healthier® by striving to improve the
quality and types of healthcare services available in our communities, provide physicians with
a positive environment in which to practice medicine, with access to necessary equipment and
resources, develop and provide a positive work environment
for employees, expand each
hospitals role as a community asset, and improve each hospitals financial performance. We
expect our hospitals to be the place where patients want to come for care, where physicians want to
practice medicine and where employees want to work.
In many
of our markets, a portion of patients who require the services available
at acute care hospitals leave our markets to receive such care. This
fact presents an
opportunity for growth, and we are working with the hospitals in communities where this phenomenon
exists to implement new, or better implement existing strategies.
We believe that growth opportunities remain in our existing markets. Growth at our
hospitals is dependent in part on how successful our hospitals are in their efforts to recruit
physicians to their respective medical staffs, whether such physicians are active members of such
medical staffs over a long period of time and whether and to what extent members of our hospitals
medical staffs admit patients to our hospitals. During 2008, we refined our recruiting process in
an effort to better identify and focus on those physicians most likely to desire to practice in our
communities, to better tailor our communications to the physicians who want to practice in
non-urban communities. During 2009, we will continue to strive to improve our recruiting and retention efforts including
centralizing at our corporate office many of the recruiting functions
and efforts that have in the past been performed by vendors on a
contract basis.
The quality of healthcare services provided at our hospitals, and the perceived quality of
such services, is an increasingly important factor to patients when deciding where to seek care and
to physicians when deciding where to practice. Because in virtually every case the core measure
scores ascribed to our hospitals are determined based on the practice behaviors of the physicians
on our medical staffs, we have implemented new strategies to work with medical staff members to
improve these scores. Management believes that our efforts in this regard during 2008 were, on
average, successful. The core measure scores at some of our largest hospitals continue to be below
our company average and our expectations. We will continue to work with our medical staff members
to seek to improve our the core measure scores of our hospitals.
We also believe that growth can also be achieved as we add new service lines in our existing
markets, invest in new technologies desired by physicians and patients, and demonstrate the quality
of the care provided in our facilities. For the past two years, we have undertaken redesigned
operating reviews of our hospitals to pinpoint new service lines or technologies that could reduce
the outmigration of patients leaving our markets to receive health care services. Where needed
service lines have been identified, we have focused on recruiting the physicians necessary to
correctly operate such service lines. Physicians affiliated with our hospitals also seem to be
interested in admitting patients to hospitals with active hospitalist programs. As a result, our
hospitals have responded by introducing or strengthening hospitalists programs where appropriate.
Our hospitals have taken other steps, such as structured efforts to solicit input from medical
staff members and to promptly respond to legitimate unmet physicians needs, to limit or offset the
impact of outmigration and to grow.
38
While responsibly managing our operating expenses, we have also made significant, targeted
investments at our hospitals to add new technologies, modernize facilities and expand the services
available. These investments should assist in our efforts to attract and retain physicians, to
offset outmigration of patients and to make our hospitals more desirable to our employees and
potential patients.
We also continue to strive to improve our operating performance by improving on our revenue
cycle processes, making an even higher level of purchases through our group purchasing
organization, operating more efficiently and effectively, and working to appropriately standardize
our policies, procedures and practices across all of our affiliated hospitals. We also believe that
being positioned as the sole acute care hospital in virtually all of our communities has allowed
us, and will continue to allow us, in many cases to negotiate preferred reimbursement rates with
commercial insurance payors.
Additional Growth
Effective February 1, 2009, we acquired RMC, a 138-bed acute care hospital located in Conyers,
Georgia (approximately 25 miles outside of Atlanta, Georgia). During 2008, RMC generated net
revenues of approximately $120 million, which are not included in our financial results. We believe
that, through group purchasing efforts and the implementation of other initiatives, RMCs operating
performance will improve during 2009 and subsequent years.
The acquisition of RMC is consistent with our stated goal of seeking to acquire one to three
complimentary hospitals a year. Our intention is to acquire well-positioned hospitals in growing
areas of the U.S. that we believe are fairly priced and that could benefit from our management and
strategic initiatives. We believe that this growth by strategic acquisition can supplement the
growth we believe we can generate organically in our existing markets.
Revenue Sources
Our hospitals generate revenues by providing healthcare services to our patients. Depending
upon the patients medical insurance coverage, we are paid for these services by governmental
Medicare and Medicaid programs, commercial insurance, including managed care organizations, and
directly by the patient. The amounts we are paid for providing healthcare services to our patients
vary depending upon the payor. Governmental payors generally pay significantly less than the
hospitals customary charges for the services provided.
Revenues from governmental payors, such as Medicare and Medicaid, are controlled by complex
rules and regulations that stipulate the amount a hospital is paid for providing healthcare
services. Our compliance with these rules and regulations requires an extensive effort to ensure we
remain eligible to participate in these governmental programs. In addition, these rules and
regulations are subject to frequent changes as a result of legislative and administrative action on
both the federal and the state levels. For these reasons, revenues from governmental programs
change frequently and require us to monitor regularly the environment in which these governmental
programs operate.
Revenues from HMOs, PPOs and other private insurers are subject to contracts and other
arrangements that require us to discount the amounts we customarily charge for healthcare services.
These discounted arrangements often limit our ability to increase charges in response to increasing
costs. We actively negotiate with these payors to seek to maintain or increase the pricing of our
healthcare services. Insured patients are generally not responsible for any difference between
customary hospital charges and the amounts received from commercial insurance payors. However,
insured patients are responsible for payments not covered by insurance, such as exclusions,
deductibles and co-payments.
Self-pay revenues are primarily generated through the treatment of uninsured patients. Our
hospitals experienced an increase in self-pay revenues during recent years.
39
Results of Operations
The following definitions apply throughout the remaining portion of Managements Discussion
and Analysis of Financial Condition and Results of Operations:
Admissions. Represents the total number of patients admitted (in the facility for a period in
excess of 23 hours) to our hospitals and used by management and investors as a general measure of
inpatient volume.
bps. Basis point change.
Continuing operations. Continuing operations information excludes the operations of hospitals that
are held for sale and disposed of.
Emergency room visits. Represents the total number of hospital-based emergency room visits.
Equivalent admissions. Management and investors use equivalent admissions as a general measure of
combined inpatient and outpatient volume. We compute equivalent admissions by multiplying
admissions (inpatient volume) by the outpatient factor (the sum of gross inpatient revenue and
gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue). The
equivalent admissions computation equates outpatient revenue to the volume measure (admissions)
used to measure inpatient volume resulting in a general measure of combined inpatient and
outpatient volume.
Net revenue days outstanding. We compute net revenue days outstanding by dividing our accounts
receivable net of allowance for doubtful accounts, by our revenue per day. Our revenue per day is
calculated by dividing our quarterly revenues, including revenues for held for sale / disposed of
hospitals, by the number of calendar days in the quarter.
ESOP. Employee stock ownership plan. The ESOP is a defined contribution retirement plan that
covered substantially all of our employees through December 31, 2008.
Medicare case mix index. Refers to the acuity or severity of illness of an average Medicare
patient at our hospitals.
N/A. Not applicable.
N/M. Not meaningful.
Outpatient surgeries. Outpatient surgeries are those surgeries that do not require admission to
our hospitals.
40
Operating Results Summary
The following tables present summaries of results of operations for the three months ended
December 31, 2007 and 2008 and for the years ended December 31, 2006, 2007 and 2008 (dollars in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
2007 |
|
|
2008 |
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
|
Amount |
|
|
Revenues |
|
|
Amount |
|
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
643.4 |
|
|
|
100.0 |
% |
|
$ |
674.9 |
|
|
|
100.0 |
% |
|
Salaries and benefits |
|
|
253.6 |
|
|
|
39.4 |
|
|
|
267.9 |
|
|
|
39.7 |
|
Supplies |
|
|
88.8 |
|
|
|
13.8 |
|
|
|
93.3 |
|
|
|
13.8 |
|
Other operating expenses |
|
|
117.9 |
|
|
|
18.3 |
|
|
|
127.6 |
|
|
|
19.0 |
|
Provision for doubtful accounts |
|
|
79.1 |
|
|
|
12.3 |
|
|
|
78.5 |
|
|
|
11.6 |
|
Depreciation and amortization |
|
|
32.2 |
|
|
|
5.0 |
|
|
|
34.3 |
|
|
|
5.1 |
|
Interest expense, net |
|
|
21.8 |
|
|
|
3.4 |
|
|
|
21.8 |
|
|
|
3.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
593.4 |
|
|
|
92.2 |
|
|
|
623.4 |
|
|
|
92.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before minority
interests and income taxes |
|
|
50.0 |
|
|
|
7.8 |
|
|
|
51.5 |
|
|
|
7.6 |
|
Minority interests in earnings of consolidated entities |
|
|
0.2 |
|
|
|
|
|
|
|
0.6 |
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes |
|
|
49.8 |
|
|
|
7.8 |
|
|
|
50.9 |
|
|
|
7.5 |
|
Provision for income taxes |
|
|
18.1 |
|
|
|
2.9 |
|
|
|
17.7 |
|
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
31.7 |
|
|
|
4.9 |
% |
|
$ |
33.2 |
|
|
|
4.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Amount |
|
|
Revenues |
|
|
Amount |
|
|
Revenues |
|
|
Amount |
|
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
2,336.5 |
|
|
|
100.0 |
% |
|
$ |
2,568.4 |
|
|
|
100.0 |
% |
|
$ |
2,700.8 |
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
918.0 |
|
|
|
39.3 |
|
|
|
1,006.1 |
|
|
|
39.2 |
|
|
|
1,065.4 |
|
|
|
39.4 |
|
Supplies |
|
|
326.1 |
|
|
|
14.0 |
|
|
|
352.2 |
|
|
|
13.7 |
|
|
|
372.6 |
|
|
|
13.8 |
|
Other operating expenses |
|
|
397.4 |
|
|
|
17.0 |
|
|
|
464.0 |
|
|
|
18.0 |
|
|
|
499.8 |
|
|
|
18.5 |
|
Provision for doubtful accounts |
|
|
250.0 |
|
|
|
10.7 |
|
|
|
307.0 |
|
|
|
12.0 |
|
|
|
313.2 |
|
|
|
11.6 |
|
Depreciation and amortization |
|
|
105.4 |
|
|
|
4.5 |
|
|
|
129.4 |
|
|
|
5.0 |
|
|
|
132.1 |
|
|
|
4.9 |
|
Interest expense, net |
|
|
100.8 |
|
|
|
4.3 |
|
|
|
94.5 |
|
|
|
3.7 |
|
|
|
88.0 |
|
|
|
3.3 |
|
Impairment loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,097.7 |
|
|
|
89.8 |
|
|
|
2,353.2 |
|
|
|
91.6 |
|
|
|
2,472.3 |
|
|
|
91.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before minority interests and
income taxes |
|
|
238.8 |
|
|
|
10.2 |
|
|
|
215.2 |
|
|
|
8.4 |
|
|
|
228.5 |
|
|
|
8.5 |
|
Minority interests in earnings of
consolidated entities |
|
|
1.4 |
|
|
|
|
|
|
|
1.7 |
|
|
|
0.1 |
|
|
|
2.2 |
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
237.4 |
|
|
|
10.2 |
|
|
|
213.5 |
|
|
|
8.3 |
|
|
|
226.3 |
|
|
|
8.4 |
|
Provision for income taxes |
|
|
93.2 |
|
|
|
4.0 |
|
|
|
85.8 |
|
|
|
3.3 |
|
|
|
88.1 |
|
|
|
3.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
144.2 |
|
|
|
6.2 |
% |
|
$ |
127.7 |
|
|
|
5.0 |
% |
|
$ |
138.2 |
|
|
|
5.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
For the Three Months Ended December 31, 2007 and 2008
Revenues
The 4.9% increase in our revenues for the three months ended December 31, 2008, compared to
the same period last year, was primarily the result of an increase in our revenues per equivalent
admission. Revenues per equivalent admission increased 5.7% to $7,390 during the three months
ended December 31, 2008, compared to $6,992 during the same period last year. This increase is
largely a result of changes in the acuity of our patients;
service mix changes related to volume growth in higher reimbursement
outpatient diagnostic services, including CTs, MRIs and cardiac
catheterization; the impact of favorable commercial pricing,
inclusive of improvements in third party payor contracting; and benefits associated with
Medicares hospital market basket updates.
Revenues during the three months ended December 31, 2008, were negatively impacted by declines
in equivalent admissions. Equivalent admissions of 91,321 for the three months ended December 31,
2008, declined 0.7% as compared to the same period last year, as a result of fewer admissions and
overall declines in our inpatient surgeries and emergency room visits. During the year ended
December 31, 2008, we experienced a shift from inpatient admissions to outpatient observations for
a portion of our patient population, which contributed to our decline in equivalent
admissions. Although we experienced equivalent admission declines, our volume improved in certain
aspects of our business, such as in outpatient diagnostic services, including CT imaging and
laboratory services.
The following table shows the key drivers of our revenues for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
% |
|
|
December 31, |
|
Increase |
|
Increase |
|
|
2007 |
|
2008 |
|
(Decrease) |
|
(Decrease) |
Admissions |
|
|
46,756 |
|
|
|
45,674 |
|
|
|
(1,082 |
) |
|
|
(2.3 |
)% |
Equivalent admissions |
|
|
92,011 |
|
|
|
91,321 |
|
|
|
(690 |
) |
|
|
(0.7 |
) |
Revenues per equivalent admission |
|
$ |
6,992 |
|
|
$ |
7,390 |
|
|
$ |
398 |
|
|
|
5.7 |
|
Medicare case mix index |
|
|
1.28 |
|
|
|
1.28 |
|
|
|
|
|
|
|
|
|
Average length of stay (days) |
|
|
4.3 |
|
|
|
4.4 |
|
|
|
0.1 |
|
|
|
2.3 |
|
Inpatient surgeries |
|
|
13,982 |
|
|
|
13,312 |
|
|
|
(670 |
) |
|
|
(4.8 |
) |
Outpatient surgeries |
|
|
35,525 |
|
|
|
36,059 |
|
|
|
534 |
|
|
|
1.5 |
|
Emergency room visits |
|
|
215,128 |
|
|
|
210,159 |
|
|
|
(4,969 |
) |
|
|
(2.3 |
) |
Outpatient factor |
|
|
1.97 |
|
|
|
2.00 |
|
|
|
0.03 |
|
|
|
1.5 |
|
The following table shows the sources of our revenues by payor for the periods presented,
expressed as a percentage of total revenues, including adjustments to estimated reimbursement
amounts:
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Ended |
|
|
December 31, |
|
|
2007 |
|
2008 |
Medicare |
|
|
32.2 |
% |
|
|
30.7 |
% |
Medicaid |
|
|
9.5 |
|
|
|
9.0 |
|
HMOs, PPOs and other private insurers |
|
|
43.5 |
|
|
|
45.4 |
|
Self-Pay |
|
|
11.4 |
|
|
|
12.1 |
|
Other |
|
|
3.4 |
|
|
|
2.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
The table above is inclusive of certain changes we have made to our historical practices
regarding sources of revenues. Specifically, we previously classified uninsured discounts as
revenue deductions for HMOs, PPOs and other private insurers. We changed the classification of
uninsured discounts to revenue deductions for self-pay revenues effective in our June 30, 2008
quarterly report on Form 10-Q for all periods previously reported. This change had no impact on our
historical results of operations. Generally, these reclassifications reduced self-pay as a
percentage of total revenues and increased HMOs, PPOs, and other private insurers as a percentage
of total revenues. We have determined that it is more appropriate to apply uninsured discounts as
revenue deductions against self-pay revenues rather than against HMOs, PPOs and other private
insurers revenues.
42
Expenses
Salaries and Benefits
The following table summarizes our salaries and benefits expenses for the periods presented
(dollars in millions, except for salaries and benefits per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Increase |
|
|
% Increase |
|
|
|
2007 |
|
|
Revenues |
|
|
2008 |
|
|
Revenues |
|
|
(Decrease) |
|
|
(Decrease) |
|
Salaries and benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, wages, benefits and contract labor |
|
$ |
247.3 |
|
|
|
38.4 |
% |
|
$ |
262.0 |
|
|
|
38.8 |
% |
|
$ |
14.7 |
|
|
|
5.9 |
% |
Stock-based compensation |
|
|
6.3 |
|
|
|
1.0 |
|
|
|
5.9 |
|
|
|
0.9 |
|
|
|
(0.4 |
) |
|
|
(6.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
253.6 |
|
|
|
39.4 |
% |
|
$ |
267.9 |
|
|
|
39.7 |
% |
|
$ |
14.3 |
|
|
|
5.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Man-hours per equivalent admission |
|
|
91.9 |
|
|
|
N/A |
|
|
|
94.0 |
|
|
|
N/A |
|
|
|
2.1 |
|
|
|
2.3 |
% |
Salaries and benefits per equivalent admission |
|
$ |
2,612 |
|
|
|
N/A |
|
|
$ |
2,754 |
|
|
|
N/A |
|
|
$ |
142 |
|
|
|
5.4 |
% |
For the three months ended December 31, 2008, our salaries and benefits expense of $267.9
million increased to 39.7% as a percentage of revenues as compared to 39.4% in the same period last
year. This increase was a result of annual compensation increases for our employees, plus the
impact of an increasing number of employed physicians within our hospitals. Additionally, we
experienced an overall increase in our benefit costs, most notably within our medical benefit
component. These increases were partially offset by improvements in our contract labor costs as
well as a slight decline in our stock-based compensation expense during the period. Our
stock-based compensation expense decline for the three months ended December 31, 2008, was due to
the absence of a forfeiture rate methodology change that was recorded in the same period last year.
As we continue to employ an increasing number of medical professionals including physicians, we
expect that salaries and benefits as a percentage of revenues will also increase.
Supplies
The following table summarizes our supplies expense for the periods presented (dollars in
millions, except for supplies per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2007 |
|
Revenues |
|
2008 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Supplies |
|
$ |
88.8 |
|
|
|
13.8 |
% |
|
$ |
93.3 |
|
|
|
13.8 |
% |
|
$ |
4.5 |
|
|
|
5.2 |
% |
Supplies per equivalent admission |
|
$ |
966 |
|
|
|
N/A |
|
|
$ |
1,022 |
|
|
|
N/A |
|
|
$ |
56 |
|
|
|
5.8 |
% |
For the three months ended December 31, 2008, supplies expense of $93.3 million increased
5.2%, as compared to $88.8 million in the same period last year. Similarly, our supplies per
equivalent admission increased 5.8% to $1,022, as compared to $966 in the same period last year.
Supplies per equivalent admission increased as a result of a higher utilization of more expensive
supplies in areas such as orthopedics, cardiac devices and spine and
bone.
In addition, our pharmacy and laboratory supply expenses increased
over the 2007 period as we experienced an increased utilization of
more expensive drugs and
blood products. Additionally, our other general supplies costs
incurred price increases
resulting in an increase in our overall supply costs.
43
Other Operating Expenses
The following table summarizes our other operating expenses for the periods presented (dollars
in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Increase |
|
|
% Increase |
|
|
|
2007 |
|
|
Revenues |
|
|
2008 |
|
|
Revenues |
|
|
(Decrease) |
|
|
(Decrease) |
|
Professional fees |
|
$ |
15.7 |
|
|
|
2.4 |
% |
|
$ |
17.6 |
|
|
|
2.6 |
% |
|
$ |
1.9 |
|
|
|
12.4 |
% |
Utilities |
|
|
11.7 |
|
|
|
1.8 |
|
|
|
12.9 |
|
|
|
1.9 |
|
|
|
1.2 |
|
|
|
10.8 |
|
Repairs and maintenance |
|
|
14.1 |
|
|
|
2.2 |
|
|
|
14.7 |
|
|
|
2.2 |
|
|
|
0.6 |
|
|
|
3.8 |
|
Rents and leases |
|
|
6.4 |
|
|
|
1.0 |
|
|
|
6.1 |
|
|
|
0.9 |
|
|
|
(0.3 |
) |
|
|
(4.7 |
) |
Insurance |
|
|
7.4 |
|
|
|
1.2 |
|
|
|
10.7 |
|
|
|
1.6 |
|
|
|
3.3 |
|
|
|
44.8 |
|
Physician recruiting |
|
|
4.7 |
|
|
|
0.7 |
|
|
|
5.8 |
|
|
|
0.9 |
|
|
|
1.1 |
|
|
|
23.1 |
|
Contract services |
|
|
34.7 |
|
|
|
5.4 |
|
|
|
34.9 |
|
|
|
5.2 |
|
|
|
0.2 |
|
|
|
0.9 |
|
Non-income taxes |
|
|
8.2 |
|
|
|
1.3 |
|
|
|
10.0 |
|
|
|
1.5 |
|
|
|
1.8 |
|
|
|
19.1 |
|
Other |
|
|
15.0 |
|
|
|
2.3 |
|
|
|
14.9 |
|
|
|
2.2 |
|
|
|
(0.1 |
) |
|
|
(0.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
117.9 |
|
|
|
18.3 |
% |
|
$ |
127.6 |
|
|
|
19.0 |
% |
|
$ |
9.7 |
|
|
|
8.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the three months ended December 31, 2008, our other operating expenses of $127.6 million
increased by $9.7 million or 8.2%, as compared to $117.9 million in the same period last year. The
$9.7 million increase in other operating expenses for the three months ended December 31, 2008, was
primarily the result of increases in professional fees, utilities,
insurance, physician recruiting
and non-income taxes.
Our expense for professional fees paid to hospital-based physicians increased $1.9 million or
12.4% to $17.6 million during the three months ended December 31, 2008. As a shortage of
physicians continues to become more acute, we have experienced increasing professional fees in
areas such as anesthesiology and emergency room physician coverage. Also, an increasing number of
physicians are demanding that our hospitals retain hospitalists and that they be paid for call
coverage in excess of what they are obligated to provide in order to maintain active staff status
at our hospitals. We expect these trends to continue and that professional fees as a percentage of
revenue will climb in future periods.
Our utilities expense increased for the three months ended December 31, 2008 as compared to
the same period last year as a result of higher energy costs experienced nationally. We anticipate
a moderation in the overall level of increase in our utility costs during 2009.
The increase in our insurance expense during the three months ended December 31, 2008, as
compared to the same period last year, was the result of a change in our professional and general
liability claims accrual, as we reduced the discount factor from 5.0% to 4.0% during the three
months ended December 31, 2008. As a result of the decrease in the discount factor, our
professional and general liability claims expense increased by approximately $2.4 million for the
three months ended December 31, 2008.
Physician recruiting expense increased 23.1% to $5.8 million in the three months ended
December 31, 2008, as compared to the same period last year. The increase is primarily the result
of an increase in the amortization expense associated with a greater number of physician minimum
revenue guarantees outstanding and an increase in recruiting fees paid. To
attract and retain qualified physicians, hospitals in small communities are
increasingly required to guarantee that these physicians will meet or exceed negotiated minimum
income levels. We expect to experience an increasing number of physician minimum revenue guarantee
arrangements and, accordingly, we anticipate higher recruiting fees and increases to the
amortization expense associated with the physician minimum revenue
guarantee intangible asset during 2009.
Non-income taxes increased during the three months ended December 31, 2008, as compared to the
same period last year, as a result of the absence of certain sale, use and property tax credits
recorded in the 2007 period.
44
Provision for Doubtful Accounts
The following table summarizes our provision for doubtful accounts and related key indicators
for the periods presented (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2007 |
|
Revenues |
|
2008 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Provision for doubtful accounts |
|
$ |
79.1 |
|
|
|
12.3 |
% |
|
$ |
78.5 |
|
|
|
11.6 |
% |
|
$ |
(0.6 |
) |
|
|
(0.8 |
)% |
Related Key Indicators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charity care write-offs |
|
$ |
11.0 |
|
|
|
0.7 |
% |
|
$ |
13.7 |
|
|
|
0.8 |
% |
|
$ |
2.7 |
|
|
|
23.5 |
% |
Self-pay revenues, net of
charity care write-offs and
uninsured discounts |
|
$ |
73.2 |
|
|
|
11.4 |
% |
|
$ |
81.6 |
|
|
|
12.1 |
% |
|
$ |
8.4 |
|
|
|
11.5 |
% |
Net revenue days outstanding
(at end of period) |
|
|
42.4 |
|
|
|
N/A |
|
|
|
42.4 |
|
|
|
N/A |
|
|
|
|
|
|
|
|
% |
Our provision for doubtful accounts of $78.5 million, or 11.6% of revenues, for the three
months ended December 31, 2008, decreased slightly from $79.1 million, or 12.3% of revenues, as
recognized in same period last year. The 70 bps improvement as a percentage of revenues is due to
our strategic efforts leading to improved cash collections. Specifically, we experienced an
increase in both up-front cash collections and collections related to insured receivables for the
three months ended December 31, 2008, as compared to the same period last year. The decrease in our
provision for doubtful accounts was partially offset by an increase in our charity care write-offs
that were primarily attributable to an increase in our self-pay revenues. We do not report charity
care in our revenues or in our provision for doubtful accounts as it is our policy not to pursue
collections of amounts related to these patients. Overall, net revenue days outstanding remained
unchanged at 42.4 days as of December 31, 2008 as compared to December 31, 2007. The provision and
allowance for doubtful accounts are critical accounting estimates and are further discussed in
Critical Accounting Estimates.
Depreciation and Amortization
Our depreciation and amortization expense increased $2.1 million for the three months ended
December 31, 2008 to $34.3 million, or 5.1% of revenues, as compared to $32.2 million, or 5.0% of
revenues, in the same period last year. The increase in our depreciation and amortization expense
is largely a result of capital improvement projects completed during 2008, normal replacement costs
of facilities and equipment and the amortization of separately identifiable intangible assets such
as non-compete agreements.
Interest Expense
Our interest expense of $21.8 million or 3.2% of revenues, for the three months ended December
31, 2008 was comparable to $21.8 million, or 3.4% of revenues, for the same period last year. As a
result of a recently issued accounting pronouncement, FSP APB 14-1, Accounting for Convertible
Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement)
(FSP APB 14-1), we must compute and recognize additional interest expense on our convertible debt
instruments beginning in 2009. FSP APB 14-1 requires retrospective application for all periods
presented. We estimate that the impact of this new accounting standard will increase our interest
expense by $21.1 million during 2009. For a further discussion of our debt and corresponding
interest rates, see Liquidity and Capital Resources Debt.
Minority Interests in Earnings of Consolidated Entities
Minority interests in earnings of consolidated entities were $0.6 million for the three months
ended December 31, 2008. Minority interests in earnings of consolidated entities represents the
allocable portion of income or loss of our less than 100% owned entities that we control to which
the minority interest holders are entitled based upon their portion of certain of the subsidiaries
that they own.
45
Provision for Income Taxes
The provision for income taxes was $17.7 million, or 2.6% of revenues for the three months
ended December 31, 2008, as compared to $18.1 million, or 2.9% of revenue for the same period last
year. The decline in the tax provision was primarily the result of reductions in our long-term
income tax liability as certain statutes of limitation lapses occurred during for the three months
ended December 31, 2008. This reduction was partially offset by significant increases in our
deferred tax valuation allowance during the same period.
For the Years Ended December 31, 2007 and 2008
Revenues
The 5.2% increase in our revenues for 2008 as compared to 2007, was primarily the result of an
increase in our revenues per equivalent admission. Revenues per equivalent admission increased
5.8% to $7,192, as compared to $6,795 in 2007. This increase is largely a result of changes in the
acuity of our patients; service mix changes related to volume growth in higher reimbursement
outpatient diagnostic services, including CTs; MRIs and cardiac
catheterization; the impact of favorable commercial pricing, inclusive of improvements in third
party payor contracting and benefits associated with Medicares hospital market basket
updates. Additionally, we experienced favorable adjustments to our estimated reimbursement
settlements that increased revenues by $7.1 million and $8.0 million for the years ended December
31, 2008 and 2007, respectively.
Revenues during 2008 were negatively impacted by declines in our equivalent admissions.
Equivalent admissions of 375,539 for 2008 declined 0.6%, as compared to 377,994 for 2007, as a
result of fewer admissions and overall declines in our inpatient surgeries. Although many of our
hospitals experienced widespread flu outbreaks in February and March of 2008, the resulting
increase in our emergency room visits did not fully offset our total decline in equivalent
admissions for the year. During 2008, our volumes were negatively impacted by the temporary
closure of three of our hospitals in Louisiana, as a result of Hurricane Gustav, as well as the
permanent closure of certain unprofitable service lines at a few of our hospitals. Additionally,
during 2008 we experienced a shift from inpatient admissions to outpatient observations for a
portion of our patient population, which further contributed to the decline in equivalent
admissions. Although we experienced equivalent admission declines, our volume improved in certain
aspects of our business, such as in outpatient diagnostic services, including CT imaging and
laboratory services.
The following table shows the key drivers of our revenues for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended |
|
|
|
|
|
|
December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase |
|
% Increase |
|
|
2007 |
|
2008 |
|
(Decrease) |
|
(Decrease) |
Admissions |
|
|
191,778 |
|
|
|
188,713 |
|
|
|
(3,065 |
) |
|
|
(1.6 |
)% |
Equivalent admissions |
|
|
377,994 |
|
|
|
375,539 |
|
|
|
(2,455 |
) |
|
|
(0.6 |
) |
Revenues per equivalent admission |
|
$ |
6,795 |
|
|
$ |
7,192 |
|
|
$ |
397 |
|
|
|
5.8 |
|
Medicare case mix index |
|
|
1.24 |
|
|
|
1.27 |
|
|
|
0.03 |
|
|
|
2.4 |
|
Average length of stay (days) |
|
|
4.3 |
|
|
|
4.3 |
|
|
|
|
|
|
|
|
|
Inpatient surgeries |
|
|
56,732 |
|
|
|
54,775 |
|
|
|
(1,957 |
) |
|
|
(3.4 |
) |
Outpatient surgeries |
|
|
144,438 |
|
|
|
145,041 |
|
|
|
603 |
|
|
|
0.4 |
|
Emergency room visits |
|
|
868,960 |
|
|
|
873,862 |
|
|
|
4,902 |
|
|
|
0.6 |
|
Outpatient factor |
|
|
1.97 |
|
|
|
1.99 |
|
|
|
0.02 |
|
|
|
1.0 |
|
46
The following table shows the sources of our revenues by payor for the periods presented,
expressed as a percentage of total revenues, including adjustments to estimated reimbursement
amounts:
|
|
|
|
|
|
|
|
|
|
|
Years Ended |
|
|
December 31, |
|
|
2007 |
|
2008 |
Medicare |
|
|
32.6 |
% |
|
|
31.2 |
% |
Medicaid |
|
|
9.7 |
|
|
|
9.5 |
|
HMOs, PPOs and other private insurers |
|
|
42.7 |
|
|
|
44.5 |
|
Self-Pay |
|
|
11.7 |
|
|
|
12.0 |
|
Other |
|
|
3.3 |
|
|
|
2.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
The table above is inclusive of certain changes we have made to our historical practices
regarding sources of revenues. Specifically, we previously classified uninsured discounts as
revenue deductions for HMOs, PPOs and other private insurers. We changed the classification of
uninsured discounts to revenue deductions for self-pay revenues effective in our June 30, 2008
quarterly report on Form 10-Q for all periods previously reported. This change had no impact on our
historical results of operations. Generally, these reclassifications reduced self-pay as a
percentage of total revenues and increased HMOs, PPOs, and other private insurers as a percentage
of total revenues. We have determined that it is more appropriate to apply uninsured discounts as
revenue deductions against self-pay revenues rather than against HMOs, PPOs and other private
insurers revenues.
Expenses
Salaries and Benefits
The following table summarizes our salaries and benefits expenses for the periods presented
(dollars in millions, except for salaries and benefits per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Increase |
|
|
% Increase |
|
|
|
2007 |
|
|
Revenues |
|
|
2008 |
|
|
Revenues |
|
|
(Decrease) |
|
|
(Decrease) |
|
Salaries and benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, wages, benefits and contract labor |
|
$ |
987.4 |
|
|
|
38.5 |
% |
|
$ |
1,041.9 |
|
|
|
38.5 |
% |
|
$ |
54.5 |
|
|
|
5.5 |
% |
Stock-based compensation |
|
|
18.7 |
|
|
|
0.7 |
|
|
|
23.5 |
|
|
|
0.9 |
|
|
|
4.8 |
|
|
|
25.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,006.1 |
|
|
|
39.2 |
% |
|
$ |
1,065.4 |
|
|
|
39.4 |
% |
|
$ |
59.3 |
|
|
|
5.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Man-hours per equivalent admission |
|
|
89.5 |
|
|
|
N/A |
|
|
|
90.9 |
|
|
|
N/A |
|
|
|
1.4 |
|
|
|
1.6 |
% |
Salaries and benefits per equivalent
admission |
|
$ |
2,529 |
|
|
|
N/A |
|
|
$ |
2,662 |
|
|
|
N/A |
|
|
$ |
133 |
|
|
|
5.3 |
% |
Our salaries and benefits expense of $1,065.4 million or 39.4% of revenues during 2008,
increased $59.3 million from $1,006.1 million or 39.2% percent of revenues, in 2007. This increase
was a result of annual compensation increases for our employees, plus the impact of an increasing
number of employed physicians within our hospitals. Additionally, we experienced an overall
increase in our benefit costs, most notably within our medical benefit component. These increases
were partially offset by improvements in our contract labor costs during 2008. Our stock-based
compensation increased in 2008, as compared to 2007, as a result of an increase in the number of
outstanding unvested stock options and nonvested stock during 2008. As we continue to employ an
increasing number of medical professionals including physicians, we expect that salaries and
benefits as a percentage of revenues will also increase.
47
Supplies
The following table summarizes our supplies expense for the periods presented (dollars in
millions, except for supplies per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2007 |
|
Revenues |
|
2008 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Supplies |
|
$ |
352.2 |
|
|
|
13.7 |
% |
|
$ |
372.6 |
|
|
|
13.8 |
% |
|
$ |
20.4 |
|
|
|
5.8 |
% |
Supplies per equivalent admission |
|
$ |
932 |
|
|
|
N/A |
|
|
$ |
992 |
|
|
|
N/A |
|
|
$ |
60 |
|
|
|
6.4 |
% |
During 2008, our supplies expense of $372.6 million increased 5.8%, as compared to $352.2
million in 2007. Similarly, our supplies per equivalent admission increased 6.4% to $992, as
compared to $932 in 2007. Our supplies per equivalent admission increased as a result of higher
utilization of more expensive supplies in areas such as orthopedics,
cardiac devices and spine and bone.
In addition, our pharmacy and laboratory
supply expenses increased over 2007 as we experienced increased
utilization of more
expensive drugs. We continue to experience overall price increases in supply costs, particularly
those related to pharmaceutical products, orthopedic implants, blood
products and other surgical-related supplies.
Other Operating Expenses
The following table summarizes our other operating expenses for the periods presented (dollars
in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Increase |
|
|
% Increase |
|
|
|
2007 |
|
|
Revenues |
|
|
2008 |
|
|
Revenues |
|
|
(Decrease) |
|
|
(Decrease) |
|
Professional fees |
|
$ |
59.7 |
|
|
|
2.3 |
% |
|
$ |
65.4 |
|
|
|
2.4 |
% |
|
$ |
5.7 |
|
|
|
9.5 |
% |
Utilities |
|
|
47.0 |
|
|
|
1.8 |
|
|
|
51.5 |
|
|
|
1.9 |
|
|
|
4.5 |
|
|
|
9.6 |
|
Repairs and maintenance |
|
|
53.7 |
|
|
|
2.1 |
|
|
|
56.8 |
|
|
|
2.1 |
|
|
|
3.1 |
|
|
|
5.7 |
|
Rents and leases |
|
|
25.8 |
|
|
|
1.0 |
|
|
|
25.6 |
|
|
|
1.0 |
|
|
|
(0.2 |
) |
|
|
(0.6 |
) |
Insurance |
|
|
33.2 |
|
|
|
1.3 |
|
|
|
42.3 |
|
|
|
1.6 |
|
|
|
9.1 |
|
|
|
27.7 |
|
Physician recruiting |
|
|
14.4 |
|
|
|
0.6 |
|
|
|
22.0 |
|
|
|
0.8 |
|
|
|
7.6 |
|
|
|
52.7 |
|
Contract services |
|
|
135.0 |
|
|
|
5.3 |
|
|
|
136.3 |
|
|
|
5.0 |
|
|
|
1.3 |
|
|
|
1.0 |
|
Non-income taxes |
|
|
36.5 |
|
|
|
1.4 |
|
|
|
39.1 |
|
|
|
1.5 |
|
|
|
2.6 |
|
|
|
7.0 |
|
Other |
|
|
58.7 |
|
|
|
2.2 |
|
|
|
60.8 |
|
|
|
2.2 |
|
|
|
2.1 |
|
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
464.0 |
|
|
|
18.0 |
% |
|
$ |
499.8 |
|
|
|
18.5 |
% |
|
$ |
35.8 |
|
|
|
7.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During 2008, our other operating expenses of $499.8 million increased by $35.8 million or
7.7%, as compared to $464.0 million during 2007. With the exception of rents and leases, each
component of our other operating expenses experienced increases in 2008. As the most significant
increases occurred in professional fees, utilities, insurance and physician recruiting,
explanations for these changes are as follows.
Our expense for professional fees paid to hospital-based physicians increased $5.7 million or
9.5%, to $65.4 million during 2008. As a shortage of physicians continues to become more acute, we
have experienced increasing professional fees in areas such as anesthesiology and emergency room
physician coverage. Also, an increasing number of physicians are demanding that our hospitals
retain hospitalists and that they be paid for call coverage in excess of what they are obligated to
provide in order to maintain active staff status at our hospitals. We expect these trends to
continue and that professional fees as a percentage of revenue will climb in future periods.
Our utilities expense increased during 2008 as compared to 2007, as a result of higher energy
costs experienced nationally. We anticipate a moderation in the overall level of increase in our
utility costs during 2009.
48
Our insurance expense increased $9.1 million, or 27.7%, to $42.3 million, during 2008 as
compared to 2007. This increase in insurance expense during 2008 was the result of an increase in
our reserves for professional and
general liability claims as a result of higher anticipated settlements for certain claims and
an increase in our professional and general liability claims accrual, as we reduced the discount
factor from 5.0% to 4.0%. As a result of the decrease in the discount factor, our professional and
general liability claims expense increased by approximately $2.4 million for 2008.
Physician recruiting expense increased 52.7% to $22.0 million during 2008 as compared to 2007.
The increase is primarily the result of an increase in the amortization expense associated with a
greater number of physician minimum revenue guarantees outstanding and an increase in recruiting
fees paid. To attract and retain qualified physicians, hospitals
in small communities are increasingly required to guarantee that these physicians will meet or
exceed negotiated minimum income levels. We expect to experience an increasing number of physician
minimum revenue guarantee arrangements and, accordingly, we anticipate higher recruiting fees and
increases to the amortization expense associated with the physician minimum revenue guarantee
intangible asset.
Provision for Doubtful Accounts
The following table summarizes our provision for doubtful accounts and related key indicators
for the periods presented (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2007 |
|
Revenues |
|
2008 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Provision for doubtful accounts |
|
$ |
307.0 |
|
|
|
12.0 |
% |
|
$ |
313.2 |
|
|
|
11.6 |
% |
|
$ |
6.2 |
|
|
|
2.0 |
% |
Related Key Indicators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charity care write-offs |
|
$ |
50.5 |
|
|
|
0.8 |
% |
|
$ |
53.7 |
|
|
|
0.8 |
% |
|
$ |
3.2 |
|
|
|
6.1 |
% |
Self-pay revenues, net of
charity care write-offs and
uninsured discounts |
|
$ |
300.0 |
|
|
|
11.7 |
% |
|
$ |
324.5 |
|
|
|
12.0 |
% |
|
$ |
24.5 |
|
|
|
8.2 |
% |
Net revenue days outstanding
(at end of period) |
|
|
42.4 |
|
|
|
N/A |
|
|
|
42.4 |
|
|
|
N/A |
|
|
|
|
|
|
|
|
% |
Our provision for doubtful accounts of $313.2 million or 11.6% of revenues, for 2008,
increased $6.2 million from $307.0 million or 12.0% of revenues, in 2007. The 40 bps reduction as
a percentage of revenues is due to our strategic efforts leading to improved cash collections.
Specifically, we experienced an increase in both up-front cash collections and collections related
to insured receivables during 2008 as compared to 2007. In addition, the decrease in our provision
for doubtful accounts as a percentage of revenues was reduced by the impact of a self-pay discount
program at our Tennessee hospitals that became effective July 1, 2007. The decrease in the
provision for doubtful accounts as a percentage of revenue was partially offset by an increase in
charity care write-offs that were primarily attributable to an increase in our self-pay revenues.
We do not report charity care in revenues or in our provision for doubtful accounts as it is our
policy not to pursue collections of amounts related to these patients. Overall, net revenue days
outstanding remained unchanged at 42.4 days as of December 31, 2008 as compared to December 31,
2007. The provision and allowance for doubtful accounts are critical accounting estimates and are
further discussed in Critical Accounting Estimates.
Depreciation and Amortization
Our depreciation and amortization expense increased $2.7 million during 2008 to $132.1
million, or 4.9% of revenues, as compared to $129.4 million or 5.0% of revenues during 2007. The
increase in our depreciation and amortization expense is largely due to capital improvement
projects completed during 2008, normal replacement costs of facilities and equipment, and the
amortization of separately identifiable intangible assets such as non-compete agreements.
Additionally, during 2007, we revised purchase price allocations for certain of our acquisitions
that occurred in 2006. As a result of the purchase price allocation changes, we recognized an
increase in our depreciation and amortization expense of $3.2 million during 2007. Excluding this
$3.2 million adjustment, our depreciation and amortization expense increased $5.9 million during
2008 and depreciation and amortization expense as a percentage of
revenues was consistent at 4.9%
in both years.
49
Interest Expense
Our interest expense of $88.0 million decreased during 2008 by $6.5 million, as compared to
$94.5 million recognized in 2007. The decrease is primarily the result of decreases in our
outstanding debt balances and lower interest rates under our 31/2% Notes as compared to our Senior
Secured Credit Facilities. In May 2007, we issued a total of $575.0 million of our 31/2% Notes. The
net proceeds of approximately $561.7 million were used to repay a portion of the outstanding
borrowings under our Senior Secured Credit Facilities. Our weighted-average monthly
interest-bearing debt balance, excluding capital leases, decreased from $1,577.1 million during
2007 to $1,513.7 million during 2008. This decrease was partially offset by an increase in
interest expense related to our interest rate swap. The increase in our interest rate swap interest
expense during 2008, as compared to 2007, was the result of an increase in the spread between our
payment rate, which is based on an annual fixed rate of 5.585% and our receipt rate, which is based
on the prevailing three-month LIBOR floating rate. For further discussion of our interest rate
swap, see Liquidity and Capital Resources Interest Rate Swap.
As a result of a recently issued accounting pronouncement, FSP APB 14-1, we must compute and
recognize additional interest expense on our convertible debt instruments beginning in 2009. FSP
APB 14-1 requires retrospective application for all periods presented. We estimate that the impact
of this new accounting standard will increase our interest expense by $21.1 million during 2009.
For a further discussion of our debt and corresponding interest rates, see Liquidity and Capital
Resources Debt.
Impairment of Long-Lived Assets
We incurred a $1.2 million pre-tax impairment loss in continuing operations during 2008. This
impairment charge relates to the impairment of certain operating assets for which the existing
carrying amount exceeded their current estimated fair value.
Minority Interests in Earnings of Consolidated Entities
Minority interests in earnings of consolidated entities were $2.2 million for 2008. Minority
interests in earnings of consolidated represents the allocable portion of income or loss of our
less than 100% owned entities that we control to which the minority interest holders are entitled
based upon their portion of certain of the subsidiaries that they own.
Provision for Income Taxes
The provision for income taxes was $88.1 million or 3.3% of revenues during 2008, as compared
to $85.8 million or 3.3% of revenues during 2007. The effective tax rate declined in 2008 to 38.9%
as compared to 40.2% in 2007 as a result of the reductions in our long-term income tax liability
from statutes of limitation lapses. This reduction, however, was partially offset by significant
increases in our deferred tax valuation allowance during 2008.
For the Years Ended December 31, 2006 and 2007
Revenues
The 9.9% increase in our revenues for 2007as compared to 2006 was primarily the result of an
increase in revenues per equivalent admission plus the impact of increased equivalent admissions.
Revenues per equivalent admission increased by 4.3% to $6,795 during 2007 as compared to $6,513 in
2006. This increase is largely due to the impact of favorable commercial pricing, inclusive of
improvements in third party payor contracting, as well as benefits associated with Medicares
hospital market basket updates. Additionally, we experienced favorable adjustments to our
estimated reimbursement settlements that increased revenues by $8.0 million during 2007 and $12.6
million during 2006. Equivalent admissions of 377,994 for 2007 increased 5.4%, as compared to
358,724 for 2006. We experienced year over year increases in both inpatient and outpatient
surgeries as well as emergency room visits, which contributed to the increase in equivalent
admissions. In addition, our equivalent admissions benefited from the full year impact of our July
1, 2006 acquisition of two hospitals from HCA.
50
The following table shows the key drivers of our revenues for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended |
|
|
|
|
|
|
|
|
December 31, |
|
|
|
|
|
% Increase |
|
|
2006 |
|
2007 |
|
Increase |
|
(Decrease) |
Admissions |
|
|
184,339 |
|
|
|
191,778 |
|
|
|
7,439 |
|
|
|
4.0 |
% |
Equivalent admissions |
|
|
358,724 |
|
|
|
377,994 |
|
|
|
19,270 |
|
|
|
5.4 |
|
Revenues per equivalent admission |
|
$ |
6,513 |
|
|
$ |
6,795 |
|
|
$ |
282 |
|
|
|
4.3 |
|
Medicare case mix index |
|
|
1.23 |
|
|
|
1.24 |
|
|
|
0.01 |
|
|
|
0.1 |
|
Average length of stay (days) |
|
|
4.2 |
|
|
|
4.3 |
|
|
|
0.1 |
|
|
|
2.4 |
|
Inpatient surgeries |
|
|
54,893 |
|
|
|
56,732 |
|
|
|
1,839 |
|
|
|
3.4 |
|
Outpatient surgeries |
|
|
138,013 |
|
|
|
144,438 |
|
|
|
6,425 |
|
|
|
4.7 |
|
Emergency room visits |
|
|
812,115 |
|
|
|
868,960 |
|
|
|
56,845 |
|
|
|
7.0 |
|
Outpatient factor |
|
|
1.95 |
|
|
|
1.97 |
|
|
|
0.02 |
|
|
|
0.1 |
|
The following table shows the sources of our revenues by payor for the periods presented,
expressed as percentages of total revenues, including adjustments to estimated reimbursement
amounts:
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
Medicare |
|
|
34.8 |
% |
|
|
32.6 |
% |
Medicaid |
|
|
10.1 |
|
|
|
9.7 |
|
HMOs, PPOs and other private insurers |
|
|
39.2 |
|
|
|
42.7 |
|
Self-Pay |
|
|
12.0 |
|
|
|
11.7 |
|
Other |
|
|
3.9 |
|
|
|
3.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
Expenses
Salaries and Benefits
The following table summarizes our salaries and benefits expenses for the periods presented
(dollars in millions, except for salaries and benefits per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% Increase |
|
|
|
2006 |
|
|
Revenues |
|
|
2007 |
|
|
Revenues |
|
|
Increase |
|
|
(Decrease) |
|
Salaries and benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, wages, benefits and contract labor |
|
$ |
904.9 |
|
|
|
38.7 |
% |
|
$ |
987.4 |
|
|
|
38.5 |
% |
|
$ |
82.5 |
|
|
|
9.1 |
% |
Stock-based compensation |
|
|
13.1 |
|
|
|
0.6 |
|
|
|
18.7 |
|
|
|
0.7 |
|
|
|
5.6 |
|
|
|
42.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
918.0 |
|
|
|
39.3 |
% |
|
$ |
1,006.1 |
|
|
|
39.2 |
% |
|
$ |
88.1 |
|
|
|
9.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Man-hours per equivalent admission |
|
|
89.9 |
|
|
|
N/A |
|
|
|
89.5 |
|
|
|
N/A |
|
|
|
(0.4 |
) |
|
|
(0.4 |
) |
Salaries and benefits per equivalent
admission |
|
$ |
2,438 |
|
|
|
N/A |
|
|
$ |
2,529 |
|
|
|
N/A |
|
|
$ |
91 |
|
|
|
3.7 |
|
51
Our salaries and benefits expense of $1,006.1 million during 2007, or 39.2% of revenues,
increased $88.1 million from $918.0 million or 39.3% percent of revenues during 2006. This
increase in 2007 as compared to 2006 is primarily the result of our annual compensation increases
for our employees, the impact of our July 1, 2006 acquisition of two hospitals from HCA and an
increase in the number of our employed physicians and other nursing and clinical personnel.
Furthermore, our salaries and benefits increased during 2007 as compared to 2006 as a result of an
increase in our ESOP expense. During 2007 and 2006, our ESOP expense had two components, common
stock and cash. Shares of our common stock were allocated ratably to employee accounts, based on
employee salaries and wages at a rate of 23,306 shares per month. The ESOP expense amount for the
common stock component was determined using the average market price of our common stock released
to participants in the ESOP. The cash component was determined using the average market price of
our common stock released to participant in the ESOP as well as a discretionary component, both of
which were impacted by the amount of forfeitures in the ESOP. We made $5.1 million of discretionary
cash contributions to the ESOP during 2007 and $3.9 million of discretionary cash contributions to
the ESOP during 2006.
The increase in our stock-based compensation expense is the result of an increase in the
number of outstanding unvested stock options and nonvested stock and a change in our forfeiture
rate methodology. We changed from a static forfeiture rate methodology to a dynamic forfeiture rate
methodology during 2007. The dynamic forfeiture rate methodology incorporates the lapse of time
into the resulting stock-based compensation expense calculation and results in a forfeiture rate
that diminishes as the granted awards approach their vest dates. Accordingly, the dynamic
forfeiture rate methodology results in a more consistent stock-based compensation expense
calculation over the vesting period of the award. This change in methodology resulted in a higher
stock-based compensation expense during 2007 as compared to 2006.
Supplies
The following table summarizes our supplies expense for the periods presented (dollars in
millions, except for supplies per equivalent admission):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2006 |
|
Revenues |
|
2007 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Supplies |
|
$ |
326.1 |
|
|
|
14.0 |
% |
|
$ |
352.2 |
|
|
|
13.7 |
% |
|
$ |
26.1 |
|
|
|
8.0 |
% |
Supplies per equivalent admission |
|
$ |
909 |
|
|
|
N/A |
|
|
$ |
932 |
|
|
|
N/A |
|
|
$ |
23 |
|
|
|
2.5 |
% |
During 2007, our supplies expense of $352.2 million increased 8.0% or $26.1 million, as
compared to $326.1 million in 2006. A large portion of the $26.1 million increase during 2007 is
due to the full year impact of our July 1, 2006 acquisition of two hospitals from HCA. Our
supplies per equivalent admission increased 2.5% to $932 during 2007, as compared to $909 in 2006.
This modest increase in supplies per equivalent admission was largely due to overall pricing
increases, particularly those related to pharmaceutical products, orthopedic implants, implantable
cardiac devices, blood costs and other surgical-related supplies. Furthermore, supplies as a
percentage of revenues decreased as a result of our continuing efforts to effectively manage supply
costs and increased synergies based on our participation in a group purchasing organization.
52
Other Operating Expenses
The following table summarizes our other operating expenses for the periods presented (dollars
in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
|
% of |
|
|
Increase |
|
|
% Increase |
|
|
|
2006 |
|
|
Revenues |
|
|
2007 |
|
|
Revenues |
|
|
(Decrease) |
|
|
(Decrease) |
|
Other operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Professional fees |
|
$ |
42.4 |
|
|
|
1.8 |
% |
|
$ |
59.7 |
|
|
|
2.3 |
% |
|
$ |
17.3 |
|
|
|
40.8 |
% |
Utilities |
|
|
44.7 |
|
|
|
1.9 |
|
|
|
47.0 |
|
|
|
1.8 |
|
|
|
2.3 |
|
|
|
5.1 |
|
Repairs and maintenance |
|
|
48.4 |
|
|
|
2.1 |
|
|
|
53.7 |
|
|
|
2.0 |
|
|
|
5.3 |
|
|
|
11.1 |
|
Rents and leases |
|
|
23.0 |
|
|
|
1.0 |
|
|
|
25.8 |
|
|
|
1.0 |
|
|
|
2.8 |
|
|
|
12.0 |
|
Insurance |
|
|
25.3 |
|
|
|
1.1 |
|
|
|
33.2 |
|
|
|
1.3 |
|
|
|
7.9 |
|
|
|
31.0 |
|
Physician recruiting |
|
|
16.5 |
|
|
|
0.7 |
|
|
|
14.4 |
|
|
|
0.6 |
|
|
|
(2.1 |
) |
|
|
(12.5 |
) |
Contract services |
|
|
117.1 |
|
|
|
5.0 |
|
|
|
135.0 |
|
|
|
5.3 |
|
|
|
17.9 |
|
|
|
15.2 |
|
Non-income taxes |
|
|
32.7 |
|
|
|
1.4 |
|
|
|
36.5 |
|
|
|
1.4 |
|
|
|
3.8 |
|
|
|
11.8 |
|
Other |
|
|
47.3 |
|
|
|
2.0 |
|
|
|
58.7 |
|
|
|
2.3 |
|
|
|
11.4 |
|
|
|
24.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
397.4 |
|
|
|
17.0 |
% |
|
$ |
464.0 |
|
|
|
18.0 |
% |
|
$ |
66.6 |
|
|
|
16.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During 2007, our other operating expenses of $464.0 million increased by $66.6 million or
16.8%, as compared to $397.4 million during 2006. A portion of this increase is the result of our
July 1, 2006 acquisition of two hospitals from HCA. With the exception of physician recruiting,
each component of our other operating expenses experienced increases in 2007 as compared to 2006.
As the most significant changes occurred in professional fees, repairs and maintenance, insurance,
contract services and other, explanations for these components are as follows.
Our expense for professional fees paid to hospital-based physicians increased $17.3 million or
40.8%, to $59.7 million during 2007. As the shortage of physicians continues to become more acute,
we have experienced increasing professional fees in areas such as anesthesiology and emergency room
physician coverage. Also, an increasing number of physicians are demanding that our hospitals
retain hospitalists and that they be paid for call coverage in excess of what they are obligated to
provide in order to maintain active staff status at our hospitals.
Repairs and maintenance expense increased during 2007 as compared to 2006 as a result of
increasing levels of property and equipment that require on-going maintenance and repair services.
Insurance, inclusive of our professional and general liability claims expense, increased
during 2007 as compared to 2006, primarily as a result of an increase in our professional and
general liability claims liability from increased estimated settlements plus an overall increase in
the volume of potential claims.
Contract services increased $17.9 million to $135.0 million during 2007 as a result of
increased accounts receivable collection fees and fees related to our conversion of the clinical
and patient accounting information system applications at certain hospitals.
Other expenses increased during 2007 as compared to 2006, largely as a result of increased
legal and accounting fees, recruitment expenses and other miscellaneous expenses.
53
Provision for Doubtful Accounts
The following table summarizes our provision for doubtful accounts and related key indicators
for the periods presented (dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
|
|
|
|
|
|
|
% of |
|
|
|
|
|
% of |
|
Increase |
|
% Increase |
|
|
2006 |
|
Revenues |
|
2007 |
|
Revenues |
|
(Decrease) |
|
(Decrease) |
Provision for doubtful accounts |
|
$ |
250.0 |
|
|
|
10.7 |
% |
|
$ |
307.0 |
|
|
|
12.0 |
% |
|
$ |
57.0 |
|
|
|
22.8 |
% |
Related Key Indicators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charity care write-offs |
|
$ |
40.5 |
|
|
|
0.8 |
% |
|
$ |
50.5 |
|
|
|
0.8 |
% |
|
$ |
10.0 |
|
|
|
24.9 |
% |
Self-pay revenues, net of
charity care write-offs and
uninsured discounts |
|
$ |
279.7 |
|
|
|
12.0 |
% |
|
$ |
300.0 |
|
|
|
11.7 |
% |
|
$ |
20.3 |
|
|
|
7.3 |
% |
Net revenue days outstanding
(at end of period) |
|
|
43.0 |
|
|
|
N/A |
|
|
|
42.4 |
|
|
|
N/A |
|
|
|
(0.6 |
) |
|
|
(1.4 |
)% |
Our provision for doubtful accounts of $307.0 million or 12.0% of revenues during 2007,
increased $57.0 million from $250.0 million or 10.7% of revenues in 2006. The provision for
doubtful accounts relates principally to self-pay amounts due from patients. The increase in our
provision for doubtful accounts and charity care write-offs during 2007 as compared to 2006 was
partially a result of our July 1, 2006 acquisition of two hospitals from HCA. As a percentage of
revenues, our provision for doubtful accounts increased during 2007 as compared to 2006 primarily
as a result of an increase in self-pay revenues and increased co-payments and deductibles. We do
not report charity care in our revenues or in our provision for doubtful accounts as it is our
policy not to pursue collections of amounts related to these patients. Overall, net revenue days
outstanding improved to 42.4 days as of December 31, 2007 from 43.0 days as of December 31, 2006.
The provision and allowance for doubtful accounts are critical accounting estimates and are further
discussed in Critical Accounting Estimates.
Depreciation and Amortization
Our depreciation and amortization expense increased $24.0 million during 2007 to $129.4
million or 5.0% of revenues, as compared to $105.4 million or 4.5% of revenues during 2006. Our
depreciation and amortization expense increased in 2007 as compared
to 2006, partially as a result
of our July 1, 2006 acquisition of two hospitals from HCA and an increase in depreciable fixed
assets from capital projects that we completed during 2007. Additionally, during 2007 and 2006, we
revised purchase price allocations for certain 2006 and 2005 acquisitions, respectively. As a
result of the purchase price allocation changes, we recognized an increase in depreciation and
amortization expense of $3.2 million during 2007 and a decrease in depreciation and amortization
expense of $13.5 million during 2006. After normalization for these adjustments, depreciation and
amortization expense as a percentage of revenues for both 2007 and 2006 are comparable.
Interest Expense
Our interest expense decreased $6.3 million to $94.5 million during 2007, as compared to
$100.8 million during 2006. This decrease is primarily the result of decreases in our outstanding
debt balances and lower interest rates under our 31/2% Notes as compared to
our Senior Secured Credit Facilities. In May 2007, we issued a total of $575.0 million of our
31/2% Notes. The net proceeds of approximately $561.7 million were used to
repay a portion of the outstanding borrowings under our Senior Secured Credit Facilities. Our
weighted-average monthly interest-bearing debt balance decreased from $1,642.7 million during 2006
to $1,577.1 million during 2007. For a further discussion of our long-term debt, see Liquidity and
Capital ResourcesDebt.
Minority Interests in Earnings of Consolidated Entities
Minority interests in earnings of consolidated entities were $1.7 million during 2007.
Minority interests in earnings of consolidated represents the allocable portion of income or loss
of our less than 100% owned entities that we control to which the minority interest holders are
entitled based upon their portion of certain of the subsidiaries that they own.
54
Provision for Income Taxes
Our provision for income taxes was $85.8 million or 3.3% of revenues during 2007, as compared
to $93.2 million or 4.0% of revenues during 2006. Our provision for income taxes decreased during
2007 as compared to 2006, primarily as a result of lower income from continuing operations. The
decrease in income from continuing operations plus increases in our deferred tax valuation
allowance for 2007 resulted in a higher effective tax rate as compared to 2006.
Discontinued Operations
A summary of our operating results of our discontinued operations for the years ended December
31, 2006, 2007 and 2008 were as follows (in millions, except for per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Revenues |
|
$ |
212.0 |
|
|
$ |
120.6 |
|
|
$ |
53.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations |
|
$ |
(2.9 |
) |
|
$ |
(8.6 |
) |
|
$ |
(6.3 |
) |
Impairment charge |
|
|
|
|
|
|
(16.5 |
) |
|
|
(17.1 |
) |
Gain (loss) on sale of hospitals |
|
|
4.2 |
|
|
|
(0.6 |
) |
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations |
|
$ |
1.3 |
|
|
$ |
(25.7 |
) |
|
$ |
(23.7 |
) |
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share from
discontinued operations |
|
$ |
0.03 |
|
|
$ |
(0.44 |
) |
|
$ |
(0.44 |
) |
|
|
|
|
|
|
|
|
|
|
From time to time, we evaluate our facilities and may sell assets which we believe may no
longer fit with our long-term strategy for various reasons. Please refer to Note 3 to our
consolidated financial statements included in this report for a discussion of facilities that we
have sold or identified for disposal in recent years. Our results of operations, net of income
taxes, of our previously sold facilities and those identified for disposal are reflected as
discontinued operations.
For the Year Ended December 31, 2008
In September 2008, we committed to sell Opelousas and Starke. We are actively engaged in
negotiations with respect to both facilities and currently anticipate selling both hospitals by no
later than September 30, 2009. In connection with the identification of Opelousas and Starke for
disposal, we recognized combined impairment charges of $19.4 million, net of income taxes, or $0.36
loss per diluted share during 2008. The impairment charges include the impairment of property and
equipment as well as allocated goodwill.
Effective April 1, 2008, we terminated the existing lease agreement for Colorado River Medical
Center (Colorado River) and transferred substantially all of the operating assets and certain net
working capital of the hospital to the Needles Board of Trustees of Needles Desert Communities
Hospital (the Needles Board of Trustees). In connection with the termination of the lease
agreement we recognized a favorable impairment adjustment of $2.3 million, net of income taxes, or
$0.04 per diluted share during 2008. The impairment adjustment relates to the reversal of a portion
of the previously recognized impairment charge recognized during 2007 for certain net working
capital components for which we anticipated receiving no consideration that were ultimately
excluded from the assets transferred to the Needles Board of Trustees.
For the year ended December 31, 2007
In March 2007, we signed a letter of intent with the Needles Board of Trustees to transfer to
them substantially all of the operating assets and net working capital of Colorado River plus $1.5
million in cash, which approximated the net present value of future lease payments due under the
lease agreement between us and the Needles Board of Trustees in consideration for the termination
of the existing operating lease agreement. In connection with the signing of the letter of intent
in March 2007, we recognized an impairment charge of $8.7 million, net of income taxes, or $0.15
per diluted share during 2007. The impairment charge relates to goodwill impairment and the
write-down of the property and equipment and certain net working capital that was originally to be
transferred to the Needles Board of Trustees, for which we anticipated receiving no consideration.
55
Effective July 1, 2007, we completed the sale of Coastal Carolina Medical Center to Tenet
Healthcare Corporation (Tenet). In connection with the execution of the definitive agreement with
Tenet, during 2007, we recognized an impairment charge of $7.8 million, net of income taxes, or
$0.14 loss per diluted share. The impairment charges include the impairment of property and
equipment, certain net working capital and intangibles as well as allocated goodwill.
Liquidity and Capital Resources
Liquidity
Our primary sources of liquidity are cash flows provided by our operations and our debt
borrowings. We believe that our internally generated cash flows and amounts available under our
debt agreements will be adequate to service existing debt, finance internal growth, expend funds on
capital expenditures and fund certain small to mid-size hospital acquisitions.
The following table presents summarized cash flow information for the years ended December 31
for the periods indicated (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Net cash flows provided by continuing operations |
|
$ |
257.8 |
|
|
$ |
241.4 |
|
|
$ |
346.6 |
|
Less: Purchase of property and equipment |
|
|
(194.0 |
) |
|
|
(158.4 |
) |
|
|
(157.6 |
) |
|
|
|
|
|
|
|
|
|
|
Free operating cash flow |
|
|
63.8 |
|
|
|
83.0 |
|
|
|
189.0 |
|
|
|
|
|
|
|
|
|
|
|
Acquisitions, net of cash acquired |
|
|
(281.3 |
) |
|
|
|
|
|
|
(21.8 |
) |
Proceeds from sale of hospitals |
|
|
69.0 |
|
|
|
107.4 |
|
|
|
|
|
Proceeds from borrowings |
|
|
260.0 |
|
|
|
615.0 |
|
|
|
10.4 |
|
Payments on borrowings |
|
|
(110.0 |
) |
|
|
(765.9 |
) |
|
|
(10.1 |
) |
Proceeds from exercise of stock options |
|
|
0.6 |
|
|
|
12.7 |
|
|
|
3.6 |
|
Proceeds for the completion of a new hospital |
|
|
|
|
|
|
14.7 |
|
|
|
|
|
Payment of debt issue costs |
|
|
(1.0 |
) |
|
|
(14.2 |
) |
|
|
|
|
Repurchase of common stock |
|
|
|
|
|
|
(29.0 |
) |
|
|
(118.3 |
) |
Other |
|
|
(1.9 |
) |
|
|
1.2 |
|
|
|
(11.9 |
) |
Cash flows from operations (used in) provided by discontinued operations |
|
|
(11.9 |
) |
|
|
21.7 |
|
|
|
(12.5 |
) |
Cash flows from investing activities used in discontinued operations |
|
|
(5.5 |
) |
|
|
(5.7 |
) |
|
|
(5.8 |
) |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents |
|
$ |
(18.2 |
) |
|
$ |
40.9 |
|
|
$ |
22.6 |
|
|
|
|
|
|
|
|
|
|
|
The non-GAAP metric of free operating cash flow is an important liquidity measure for us. Our
computation of free operating cash flow consists of net cash flows provided by continuing
operations less cash flows used for purchase of property and equipment. Our cash flows provided by
continuing operating activities during 2008 were positively impacted by an increase in our income
from continuing operations as compared to 2007 and by a $57.0 million combined decrease in
interest and income tax payments during 2008 as compared to 2007. In addition, we have experienced
an increase in both up-front cash collections and collections related to insured receivables during
2008, as compared to 2007.
Our cash flows provided by continuing operations during 2007, as compared to 2006, were
negatively impacted by $16.4 million lower income from continuing operations and the timing related
to income tax payments. Cash paid for income taxes during 2007 was $103.2 million compared to $75.8
million during 2006.
We believe that free operating cash flow is useful to investors and management as a measure of
the ability of our business to generate cash and a measure of our ability to repay and incur
additional debt. Computations of free operating cash flow may differ from company to company.
Therefore, free operating cash flow should be used as a complement to, and in conjunction with, our
consolidated statements of cash flows presented in our consolidated financial statements included
elsewhere in this report.
56
Capital Expenditures
Our management believes that capital expenditures in key areas at our hospitals should
increase our local market share and help persuade patients to obtain healthcare services within
their communities.
The following table reflects our capital expenditures for the years indicated (dollars in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Capital projects |
|
$ |
118.7 |
|
|
$ |
112.1 |
|
|
$ |
102.3 |
|
Routine |
|
|
59.3 |
|
|
|
42.3 |
|
|
|
51.5 |
|
Information systems |
|
|
16.0 |
|
|
|
4.0 |
|
|
|
3.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
194.0 |
|
|
$ |
158.4 |
|
|
$ |
157.6 |
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense (excluding 2006 and 2007
purchase price allocation adjustments of $13.5
million and $3.2 million, respectively) |
|
$ |
117.2 |
|
|
$ |
124.0 |
|
|
$ |
130.9 |
|
|
|
|
|
|
|
|
|
|
|
Ratio of capital expenditures to depreciation expense |
|
|
166 |
% |
|
|
128 |
% |
|
|
120 |
% |
|
|
|
|
|
|
|
|
|
|
We have a formal and intensive review procedure for the authorization of capital expenditures.
The most important financial measure of acceptability for a discretionary capital project is
whether its projected discounted cash flow return on investment exceeds our projected cost of
capital for that project. We expect to continue to invest in modern technologies, emergency rooms
and operating room expansions, the construction of medical office buildings for physician expansion
and reconfiguring the flow of patient care.
Debt
An analysis and roll-forward of our long-term debt during 2008 is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
Proceeds from |
|
|
Payments of |
|
|
|
|
|
|
December 31, |
|
|
|
2007 |
|
|
Borrowings |
|
|
Borrowings |
|
|
Other (a) |
|
|
2008 |
|
Senior Secured Credit Facilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term B Loans |
|
$ |
706.0 |
|
|
$ |
0.4 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
706.4 |
|
Revolving Loans |
|
|
|
|
|
|
10.0 |
|
|
|
(10.0 |
) |
|
|
|
|
|
|
|
|
Province 71/2%
Senior Subordinated Notes |
|
|
6.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.1 |
|
Province 41/4%
Convertible Subordinated
Notes |
|
|
0.1 |
|
|
|
|
|
|
|
(0.1 |
) |
|
|
|
|
|
|
|
|
31/4% Debentures |
|
|
225.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
225.0 |
|
31/2% Notes |
|
|
575.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
575.0 |
|
Capital leases |
|
|
5.0 |
|
|
|
3.4 |
|
|
|
(5.0 |
) |
|
|
0.8 |
|
|
|
4.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,517.2 |
|
|
$ |
13.8 |
|
|
$ |
(15.1 |
) |
|
$ |
0.8 |
|
|
$ |
1,516.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Represents the assumption of capital leases obligations in connection with certain
acquisitions completed during the year ended December 31, 2008. |
57
We use leverage, or our total debt to total capitalization ratio, to make financing decisions.
The following table illustrates our financial statement leverage and the classification of our debt
(dollars in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
December 31, |
|
|
Increase |
|
|
|
2007 |
|
|
2008 |
|
|
(Decrease) |
|
Current portion of long-term debt |
|
$ |
0.5 |
|
|
$ |
1.1 |
|
|
$ |
0.6 |
|
Long-term debt |
|
|
1,516.7 |
|
|
|
1,515.6 |
|
|
|
(1.1 |
) |
|
|
|
|
|
|
|
|
|
|
Total debt |
|
|
1,517.2 |
|
|
|
1,516.7 |
|
|
|
(0.5 |
) |
Total stockholders equity |
|
|
1,544.2 |
|
|
|
1,578.6 |
|
|
|
34.4 |
|
|
|
|
|
|
|
|
|
|
|
Total capitalization |
|
$ |
3,061.4 |
|
|
$ |
3,095.3 |
|
|
$ |
33.9 |
|
|
|
|
|
|
|
|
|
|
|
Total debt to total capitalization |
|
|
49.6 |
% |
|
|
49.0 |
% |
|
(60bps |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of: |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed rate debt |
|
|
|
|
|
|
53.5 |
% |
|
|
53.4 |
% |
Variable rate debt (a) |
|
|
|
|
|
|
46.5 |
% |
|
|
46.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
Percentage of: |
|
|
|
|
|
|
|
|
|
|
|
|
Senior debt |
|
|
|
|
|
|
46.9 |
% |
|
|
46.8 |
% |
Subordinated debt |
|
|
|
|
|
|
53.1 |
|
|
|
53.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
The above calculation does not consider the effect of our interest rate swap. Our
interest rate swap mitigates our floating rate risk on our outstanding variable rate
borrowings which converts our variable rate debt to an annual fixed rate of 5.585%. Our
interest rate swap decreases our variable rate debt as a percentage of our outstanding debt
from 46.5% to zero as of December 31, 2007 and from 46.6% to 7.0% as of December 31, 2008.
Please refer to the Capital Resources-Interest Rate Swap section below for a discussion of
our interest rate swap agreement. |
Capital Resources
Senior Secured Credit Facilities
Terms
Our credit agreement with Citicorp North America, Inc. (CITI), administrative agent, and a
syndicate of lenders (the Credit Agreement), as amended, provides for secured term A loans up to
$250.0 million (the Term A Loans) , term B loans up to $1,450.0 million (the Term B Loans) and
revolving loans of up to $350.0 million (the Revolving Loans). In addition, the Credit Agreement
provides that we may request additional tranches of Term B Loans up to $400.0 million and
additional tranches of Revolving Loans up to $100.0 million. The Term B Loans mature on April 15,
2012 and are scheduled to be repaid beginning June 30, 2011 in four equal installments totaling
$706.4 million. The Term A Loans and Revolving Loans both mature on April 15, 2010. The Credit
Agreement is guaranteed on a senior secured basis by our subsidiaries with certain limited
exceptions. The Term B Loans are subject to additional mandatory prepayments with a certain
percentage of excess cash flow as specifically defined in the Credit Agreement. Additionally, the
Credit Agreement provides for the issuance of letters of credit up to $75.0 million. Issued
letters of credit reduce the amounts available under our Revolving Loans.
Letters of Credit and Availability
As of December 31, 2008, we had $38.4 million in letters of credit outstanding that were
related to the self-insured retention level of our general and professional liability insurance and
workers compensation programs as security for payment of claims. Under the terms of the Credit
Agreement, Revolving Loans available for borrowing were $411.6 million as of December 31, 2008,
including the $100.0 million available under the additional tranche. Under the terms of the Credit
Agreement, Term A Loans and Term B Loans available for borrowing were $250.0 million and $400.0
million, respectively, as of December 31, 2008, all of which is available under the additional
tranches.
58
Interest Rates
Interest on the outstanding balances of the Term B Loans is payable, at our option, at CITIs
base rate (the alternate base rate or ABR) plus a margin of 0.625% and/or at an adjusted London
Interbank Offered Rate (Adjusted LIBOR) plus a margin of 1.625%. Interest on the Revolving Loans
is payable at ABR plus a margin for ABR Revolving Loans or Adjusted LIBOR plus a margin for
eurodollar Revolving Loans. The margin on ABR Revolving Loans ranges from 0.25% to 1.25% based on
the total leverage ratio being less than 2.00:1.00 to greater than 4.50:1.00. The margin on the
eurodollar Revolving Loans ranges from 1.25% to 2.25% based on the total leverage ratio being less
than 2.00:1.00 to greater than 4.50:1.00.
As of December 31, 2008, the applicable annual interest rate under the Term B Loans was 3.82%,
which was based on the 90-day Adjusted LIBOR plus the applicable margin. The 90-day Adjusted LIBOR
was 2.19% at December 31, 2008. The weighted-average applicable annual interest rate for the year
ended December 31, 2008 under the Term B Loans was 4.85%.
Covenants
The Credit Agreement requires us to satisfy certain financial covenants, including a minimum
interest coverage ratio and a maximum total leverage ratio, as set forth in the Credit Agreement.
The minimum interest coverage ratio can be no less than 3.50:1.00 for all periods ending after
December 31, 2005. These calculations are based on the trailing four quarters. The maximum total
leverage ratios cannot exceed 4.25:1.00 for the periods ending on March 31, 2008 through December
31, 2008; 4.00:1.00 for the periods ending on March 31, 2009 through December 31, 2009; and
3.75:1.00 for the periods ending thereafter. In addition, on an annualized basis, we are limited
with respect to amounts we may spend on capital expenditures. Such amounts cannot exceed 10.0% of
revenues for all years ending after December 31, 2006.
The financial covenant requirements and ratios are as follows:
|
|
|
|
|
|
|
|
|
|
|
Level at |
|
|
Requirement |
|
December 31, 2008 |
Minimum Interest Coverage Ratio
|
|
≥ 3.50:1.00
|
|
|
5.88 |
|
Maximum Total Leverage Ratio
|
|
≤ 4.25:1.00
|
|
|
3.14 |
|
Capital Expenditure Ratio
|
|
≤ 10.0
|
% |
|
5.8 |
% |
In addition, the Credit Agreement contains customary affirmative and negative covenants, which
among other things, limit our ability to incur additional debt, create liens, pay dividends, effect
transactions with our affiliates, sell assets, pay subordinated debt, merge, consolidate, enter
into acquisitions and effect sale leaseback transactions.
Our Credit Agreement does not contain provisions that would accelerate the maturity date of
the loans under the Credit Agreement upon a downgrade in our credit rating. However, a downgrade in
the our credit rating could adversely affect our ability to obtain other capital sources in the
future and could increase our cost of borrowings.
31/2% Convertible Senior Subordinated Notes due May 15, 2014
Our 31/2% Notes bear interest at the rate of 31/2%
per year, payable semi-annually on May 15 and November 15. The 31/2% Notes
are convertible prior to March 15, 2014 under the following circumstances: (1) if the price of our
common stock reaches a specified threshold during specified periods; (2) if the trading price of
the 31/2% Notes is below a specified threshold; or (3) upon the occurrence of
specified corporate transactions or other events. On or after March 15, 2014, holders may convert
their 31/2% Notes at any time prior to the close of business on the scheduled
trading day immediately preceding May 15, 2014, regardless of whether any of the foregoing
circumstances has occurred.
59
Subject to certain exceptions, we will deliver cash and shares of our common stock upon
conversion of each $1,000 principal amount of our 31/2% Notes as follows: (i)
an amount in cash (the principal return) equal to the sum of, for each of the 20 volume-weighted
average price trading days during the conversion period, the lesser of the daily conversion value
for such volume-weighted average price trading day and $50; and (ii) a number of shares in an
amount equal to the sum of, for each of the 20 volume-weighted average price trading days during
the conversion period, any excess of the daily conversion value above $50. Our ability to pay the
principal return in cash is subject to important limitations imposed by the Credit Agreement and
other credit facilities or indebtedness we may incur in the future. If we do not make any payments
we are obligated to make under the terms of the 31/2% Notes, holders may
declare an event of default.
The initial conversion rate is 19.3095 shares of our common stock per $1,000 principal amount
of the 31/2% Notes (subject to certain events). This represents an initial
conversion price of approximately $51.79 per share of the Companys common stock. In addition, if
certain corporate transactions that constitute a change of control occur prior to maturity, we will
increase the conversion rate in certain circumstances.
Upon the occurrence of a fundamental change (as specified in the indenture), each holder of
the 31/2% Notes may require us to purchase some or all of the
31/2% Notes at a purchase price in cash equal to 100% of the principal amount
of the 31/2% Notes surrendered, plus any accrued and unpaid interest.
The indenture for the 31/2% Notes does not contain any financial
covenants or any restrictions on the payment of dividends, the incurrence of senior or secured debt
or other indebtedness, or the issuance or repurchase of securities by us. The indenture contains no
covenants or other provisions to protect holders of the 31/2% Notes in the
event of a highly leveraged transaction or other events that do not constitute a fundamental
change.
31/4% Convertible Senior Subordinated Debentures due August 15, 2025
Our 31/4% Debentures bear interest at the rate of
31/4% per year, payable semi-annually on February 15 and August 15. The
31/4% Debentures are convertible (subject to certain limitations imposed by
the Credit Agreement) under the following circumstances: (1) if the price of the our common stock
reaches a specified threshold during the specified periods; (2) if the trading price of the
31/4% Debentures is below a specified threshold; (3) if the
31/4% Debentures have been called for redemption; or (4) if specified
corporate transactions or other specified events occur. Subject to certain exceptions, we will
deliver cash and shares of our common stock, as follows: (i) an amount in cash (the principal
return) equal to the lesser of (a) the principal amount of the 31/4%
Debentures surrendered for conversion and (b) the product of the conversion rate and the average
price of our common stock, as set forth in the indenture governing the securities (the conversion
value); and (ii) if the conversion value is greater than the principal return, an amount in shares
of our common stock. Our ability to pay the principal return in cash is subject to important
limitations imposed by the Credit Agreement and other indebtedness we may incur in the future.
Based on the terms of the Credit Agreement, in certain circumstances, even if any of the foregoing
conditions to conversion have occurred, the 31/4% Debentures will not be
convertible, and holders of the 31/4% Debentures will not be able to declare
an event of default under the 31/4% Debentures.
The initial conversion rate for the 31/4% Debentures is 16.3345 shares
of our common stock per $1,000 principal amount of 31/4% Debentures (subject
to adjustment in certain events). This is equivalent to a conversion price of $61.22 per share of
common stock. In addition, if certain corporate transactions that constitute a change of control
occur on or prior to February 20, 2013, we will increase the conversion rate in certain
circumstances, unless such transaction constitutes a public acquirer change of control and we elect
to modify the conversion rate into public acquirer common stock.
On or after February 20, 2013, we may redeem for cash some or all of the
31/4% Debentures at any time at a price equal to 100% of the principal amount
of the 31/4% Debentures to be purchased, plus any accrued and unpaid
interest. Holders may require us to purchase for cash some or all of the
31/4% Debentures on February 15, 2013, February 15, 2015 and February 15,
2020 or upon the occurrence of a fundamental change, at 100% of the principal amount of the
31/4% Debentures to be purchased, plus any accrued and unpaid interest.
60
The indenture for the 31/4% Debentures does not contain any financial
covenants or any restrictions on the payment of dividends, the incurrence of senior or secured debt
or other indebtedness, or the issuance or repurchase of securities by us. The indenture contains no
covenants or other provisions to protect holders of the 31/4% Debentures in
the event of a highly leveraged transaction or fundamental change.
Interest Rate Swap
Our interest rate swap agreement with Citibank, N.A. (Citibank) as counterparty requires us
to make quarterly fixed rate payments to Citibank calculated on a notional amount as set forth in
the table below at an annual fixed rate of 5.585% while Citibank is obligated to make quarterly
floating payments to us based on the three-month LIBOR on the same referenced notional amount.
|
|
|
|
|
|
|
Notional Amount |
Date
Range |
|
(In millions) |
November 30, 2006 to November 30, 2007 |
|
$ |
900.0 |
|
November 30, 2007 to November 28, 2008 |
|
|
750.0 |
|
November 28, 2008 to November 30, 2009 |
|
|
600.0 |
|
November 30, 2009 to November 30, 2010 |
|
|
450.0 |
|
November 30, 2010 to May 30, 2011 |
|
|
300.0 |
|
We have designated our interest rate swap as a cash flow hedge instrument, which is recorded
in our consolidated balance sheet at its fair value. The fair value of our interest rate swap
agreement is determined in accordance with Statement of Financial Accounting Standards (SFAS) No.
157, Fair Value Measurements (SFAS No. 157) based on the amount at which it could be settled,
which is referred to in SFAS No. 157 as the exit price. The exit price is based upon observable
market assumptions and appropriate valuation adjustments for credit risk. We have categorized our
interest rate swap as Level 2 under SFAS No. 157.
The fair value of our interest rate swap at December 31, 2007 and 2008 reflects a liability of
approximately $31.0 million and $45.0 million, respectively, and is included in professional and
general liability claims and other liabilities in the accompanying consolidated balance sheets
included elsewhere in this report.
We do not hold or issue derivative financial instruments for trading purposes. We assess the
effectiveness of this cash flow hedge instrument on a quarterly basis. We completed an assessment
of the cash flow hedge instrument at December 31, 2006, and determined the hedge to be highly
effective in accordance with SFAS No. 133, Accounting for Derivative Instruments and Hedging
Activities (SFAS No. 133). We completed our quarterly assessments during the years ended
December 31, 2007 and 2008, and determined its cash flow hedge was partially ineffective. Because
the notional amount of the interest rate swap in effect at certain of the quarterly assessment
intervals exceeded our outstanding borrowings under our variable rate debt Credit Agreement, a
portion of the cash flow hedge instrument was determined to be ineffective. We recognized an
increase in interest expense of approximately $0.5 million and $0.6 million related to the
ineffective portion of our cash flow hedge during the years ended December 31, 2007 and 2008,
respectively. The interest rate swap agreement exposes us to credit risk in the event of
non-performance by Citibank. However, we do not anticipate non-performance by Citibank.
Liquidity and Capital Resources Outlook
We expect the level of capital expenditures in 2009 to be consistent with expenditures
occurred in 2008. We have large projects in process at a number of our facilities. We are
reconfiguring some of our hospitals to more effectively accommodate patient services and
restructuring existing surgical capacity in some of our hospitals to permit additional patient
volume and a greater variety of services. At December 31, 2008, we had projects under construction
with an estimated additional cost to complete and equip of approximately $169.8 million. See Note
10 to our consolidated financial statements included elsewhere in this report for a discussion of
required capital expenditures for certain facilities. We anticipate funding these expenditures
through cash provided by operating activities, available cash and borrowings available under our
credit arrangements.
We anticipate working on maturity date extensions on our Term A Loans and Revolving Loans
during 2009.
61
Our business strategy contemplates the selective acquisition of additional hospitals and other
healthcare service providers, and we regularly review potential acquisitions. These acquisitions
may, however, require additional financing. We regularly evaluate opportunities to sell additional
equity or debt securities, obtain credit facilities from lenders or restructure our long-term debt
or equity for strategic reasons or to further strengthen our financial position. The sale of
additional equity or convertible debt securities could result in additional dilution to our
stockholders.
We believe that cash generated from our operations and borrowings available under our credit
arrangements will be sufficient to meet our working capital needs, the purchase prices for any
potential facility acquisitions, planned capital expenditures and other expected operating needs
over the next twelve months and into the foreseeable future prior to the maturity dates of our
outstanding debt.
Contractual Obligations, Commitments and Off-Balance Sheet Arrangements
Contractual Obligations
We have various contractual obligations, which are recorded as liabilities in our consolidated
financial statements. Other items, such as certain purchase commitments and other executory
contracts, are not recognized as liabilities in our consolidated financial statements but are
required to be disclosed. For example, we are required to make certain minimum lease payments for
the use of property under certain of our operating lease agreements.
The following table summarizes our significant contractual obligations as of December 31, 2008
and the future periods in which such obligations are expected to be settled in cash (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment Due by Period |
|
Contractual Obligations |
|
Total |
|
|
2009 |
|
|
2010-2011 |
|
|
2012-2013 |
|
|
After 2013 |
|
Long-term debt obligations(a) |
|
$ |
1,861.2 |
|
|
$ |
74.8 |
|
|
$ |
653.5 |
|
|
$ |
240.3 |
|
|
$ |
892.6 |
|
Capital lease obligations |
|
|
4.7 |
|
|
|
1.3 |
|
|
|
2.1 |
|
|
|
1.3 |
|
|
|
|
|
Operating lease obligations(b) |
|
|
46.5 |
|
|
|
13.5 |
|
|
|
15.4 |
|
|
|
8.3 |
|
|
|
9.3 |
|
Other long-term liabilities(c) |
|
|
106.5 |
|
|
|
23.4 |
|
|
|
45.2 |
|
|
|
21.2 |
|
|
|
16.7 |
|
Purchase obligations(d) |
|
|
443.5 |
|
|
|
124.9 |
|
|
|
117.3 |
|
|
|
73.3 |
|
|
|
128.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,462.4 |
|
|
$ |
237.9 |
|
|
$ |
833.5 |
|
|
$ |
344.4 |
|
|
$ |
1,046.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
|
Included in long-term debt obligations are principal and interest owed on our outstanding
debt obligations, giving consideration to our interest rate swap. These obligations are
explained further in Note 7 to our consolidated financial statements included elsewhere in
this report. We used the 3.82% effective interest rate at December 31, 2008 for our $706.4
million outstanding Term B Loans to estimate interest payments on this variable rate debt
instrument. Our interest rate swap requires us to make quarterly interest payments at an
annual fixed rate of 5.585% while the counterparty is obligated to make quarterly floating
payments to us based on the three-month LIBOR on a decreasing notional amount. Our calculation
for long-term debt obligations includes an estimate for the net result of these payments
between us and the counterparty using the difference between our required annual fixed rate of
5.585% and the three-month LIBOR in effect as of December 31, 2008 of 2.19% based on the
effective notional amounts for the indicated period. Holders of our $225.0 million outstanding
31/4% Debentures may require us to purchase for cash some or all of the
31/4% Debentures on February 15, 2013, February 15, 2015, and February
15, 2020. For purposes of the above table, we assumed that our 31/4%
Debentures would be outstanding during the entire term, which ends on August 15, 2025. |
|
(b) |
|
This reflects our future minimum operating lease payments. We enter into operating leases in
the normal course of business. Substantially all of our operating lease agreements have fixed
payment terms based on the passage of time. Some lease agreements provide us with the option
to renew the lease. Our future operating lease obligations would change if we exercised these
renewal options and if we entered into additional operating lease agreements. Please refer to
Note 10 to our consolidated financial statements included elsewhere in this report for more
information regarding our operating leases. |
62
|
|
|
(c) |
|
Our professional and general liability claims and other liabilities balance was $146.2
million and our long-term income tax liability balance was $59.4 million in our consolidated
balance sheet as of December 31, 2008. The professional and general liability and other
liabilities balance reflected a $71.7 million long-term portion of our reserve for
professional and general liability claims, an interest rate swap liability balance of $45.0
million, a
$13.9 million deferred income liability, an $8.8 million long-term portion of our reserve for
workers compensation claims and $6.8 million related to other liabilities. Additionally, we
have included the current portion of our professional and general liability claims reserve of
$15.5 million and the current portion of our reserve for workers compensation claims of $7.1
million. The long-term income tax liability is a result of our adoption of FIN 48 effective
January 1, 2007. We excluded the $59.4 million long-term income tax liability and the $6.8
million of other liabilities because of the uncertainty of the dollar amounts to be ultimately
paid as well as the timing of such amounts. We excluded both the $13.9 million deferred income
liability and the $45.0 million interest rate swap liability as they are non-cash liabilities.
Please refer to Critical Accounting Estimates Professional and General Liability Claims in
this report for more information on our reserve for professional and general liability claims. |
|
(d) |
|
The following table summarizes our significant purchase obligations as of December 31, 2008
and the future periods in which such obligations are expected to be settled in cash (in
millions): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment Due by Period |
|
Purchase Obligations |
|
Total |
|
|
2009 |
|
|
2010-2011 |
|
|
2012-2013 |
|
|
After 2013 |
|
HCA-IT services(e) |
|
$ |
245.5 |
|
|
$ |
25.2 |
|
|
$ |
49.2 |
|
|
$ |
52.4 |
|
|
$ |
118.7 |
|
Capital expenditure obligations(f) |
|
|
24.4 |
|
|
|
23.2 |
|
|
|
1.2 |
|
|
|
|
|
|
|
|
|
Physician commitments(g) |
|
|
22.1 |
|
|
|
22.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
GEMS obligations(h) |
|
|
93.8 |
|
|
|
26.8 |
|
|
|
53.6 |
|
|
|
13.4 |
|
|
|
|
|
Other purchase obligations(i) |
|
|
57.7 |
|
|
|
27.6 |
|
|
|
13.3 |
|
|
|
7.5 |
|
|
|
9.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
443.5 |
|
|
$ |
124.9 |
|
|
$ |
117.3 |
|
|
$ |
73.3 |
|
|
$ |
128.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(e) |
|
HCA-IT provides various information systems services, including, but not limited to,
financial, clinical, patient accounting and network information services to us under a
contract that expires on December 31, 2017, including a wind-down period. The amounts are
based on estimated fees that will be charged to our hospitals as of October 1, 2008 with
an annual fee increase that is capped by the consumer price index increase. We used a 5.0%
annual rate increase as the estimated consumer price index increase for the contract
period. These fees will increase if we acquire additional hospitals and use HCA-IT for
information system conversion services at the acquired hospitals. |
|
(f) |
|
We had projects under construction with an estimated additional cost to complete and
equip of approximately $169.8 million as of December 31, 2008. Because we can terminate
substantially all of the related construction contracts at any time without paying a
termination fee, these costs are excluded from the above table except for amounts
contractually committed by us. |
|
(g) |
|
In consideration for a physician relocating to one of the communities in which our
hospitals are located and agreeing to engage in private practice for the benefit of the
respective community, we may advance certain amounts of money to that physician, normally
over a period of one year, to assist in establishing the physicians practice. Our
liability balance for contract-based physician minimum revenue guarantees was $22.2
million at December 31, 2008 and depends upon the cash collections of a physicians
private practice during the guarantee period. |
|
(h) |
|
General Electric Medical Services (GEMS) provides diagnostic imaging equipment
maintenance and bio-medical services to us pursuant to a contract that expires on June 30,
2012. |
|
(i) |
|
Reflects our minimum commitments to purchase goods or services under non-cancelable
contracts as of December 31, 2008. |
Off-Balance Sheet Arrangements
We had standby letters of credit outstanding of approximately $38.4 million as of December 31,
2008, all of which relates to the self-insured retention levels of our professional and general
liability insurance and workers compensation programs as security for the payment of claims.
63
Recently Issued Accounting Pronouncements
In December 2007, the Financial Accounting Standards Board (the FASB) issued SFAS No.
141(R), Business Combinations (SFAS No. 141(R)). SFAS No. 141(R) retains the purchase method of
accounting for acquisitions, but requires a number of changes, including changes in the way assets
and liabilities are recognized in the purchase accounting as well as requiring the expensing of
acquisition-related costs as incurred. Additionally, SFAS No. 141(R) provides guidance for
recognizing and measuring the goodwill acquired in the business combination and determines what
information to disclose to enable users of the financial statements to evaluate the nature and
financial effects of the business combination. Furthermore, this standard requires any adjustments
to acquired deferred tax assets and liabilities occurring after the related allocation period to be
made through earnings for both acquisitions occurring prior and subsequent to the effective date of
this standard. SFAS No. 141(R) is effective for us on January 1, 2009. Earlier adoption was
prohibited. The adoption of SFAS No. 141(R), prospectively, may have a material effect on our
results of operations and financial position, to the extent that we have material acquisitions, as
costs that have historically been capitalized as part of the purchase price will now be expensed,
such as accounting, legal and other professional fees.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated
Financial Statements An Amendment of ARB No. 51 (SFAS No. 160). SFAS No. 160 amends
Accounting Research Bulletin (ARB) No. 51, Consolidated Financial Statements (ARB No. 51), to
establish accounting and reporting standards for the noncontrolling interest in a subsidiary and
for the deconsolidation of a subsidiary. SFAS No. 160 clarifies that a noncontrolling interest in a
subsidiary is an ownership interest in the consolidated entity that should be reported as equity in
the consolidated financial statements. Additionally, SFAS No. 160 changes the way the consolidated
income statement is presented by requiring consolidated net income to be reported at amounts that
include the amounts attributable to both the parent and the noncontrolling interest.
SFAS No. 160 requires expanded disclosures in the consolidated financial statements that
clearly identify and distinguish between the interests of the parents owners and the interests of
the noncontrolling owners of a subsidiary, including a reconciliation of the beginning and ending
balances of the equity attributable to the parent and the noncontrolling owners and a schedule
showing the effects of changes in a parents ownership interest in a subsidiary on the equity
attributable to the parent. SFAS No. 160 does not change ARB No. 51s provisions related to
consolidation purposes or consolidation policy, or the requirement that a parent consolidate all
entities in which it has a controlling financial interest. SFAS No. 160 does, however, amend
certain of ARB No. 51s consolidation procedures to make them consistent with the requirements of
SFAS No. 141(R) as well as to provide definitions for certain terms and to clarify some
terminology. In addition to the amendments to ARB No. 51, SFAS No. 160 amends SFAS No. 128,
Earnings per Share, so that the calculation of earnings per share amounts in consolidated
financial statements will continue to be based on amounts attributable to the parent. SFAS No. 160
is effective for us on January 1, 2009. Earlier adoption was prohibited. SFAS No. 160 must be
applied prospectively as of the beginning of the fiscal year in which it is initially applied,
except for the presentation and disclosure requirements, which must be applied retrospectively for
all periods presented. The adoption of SFAS No. 160 is not
expected to have a material effect on our results
of operations, cash flows or financial position.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and
Hedging Activities, an amendment of FASB Statement No. 133 (SFAS No. 161). SFAS No. 161 applies
to all derivative instruments and related hedged items accounted for under SFAS No. 133. SFAS No.
161 requires entities to provide greater transparency about (a) how and why an entity uses
derivative instruments, (b) how derivative instruments and related hedged items are accounted for
under SFAS No. 133 and its related interpretations, and (c) how derivative instruments and related
hedged items affect an entitys financial position, results of operations, and cash flows. To meet
these objectives, SFAS No. 161 requires (1) qualitative disclosures about objectives for using
derivatives by primary underlying risk exposure and by purpose or strategy, (2) information about
the volume of derivative activity in a flexible format that the preparer believes is the most
relevant and practicable, (3) tabular disclosures about balance sheet location and gross fair value
amounts of derivative instruments, income statement and other comprehensive income location and
amounts of gains and losses on derivative instruments by type of contract, and (4) disclosures
about credit-risk related contingent features in derivative agreements. SFAS No. 161 is effective
for financial statements issued for fiscal years and interim periods beginning after November 15,
2008. Early application was encouraged, as were comparative disclosures for earlier periods, but
neither was required. The
adoption of SFAS No. 161 is not expected to have a material impact on our results of
operations, cash flows or financial position.
64
On May 9, 2008, the FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments
That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) (FSP APB 14-1).
FSP APB 14-1 specifies that issuers of certain convertible debt instruments must separately account
for the liability and equity components thereof and reflect interest expense at the entitys market
rate of borrowing for non-convertible debt instruments. FSP APB 14-1 is effective for financial
statements issued for fiscal years beginning after December 15, 2008, and interim periods within
those fiscal years. Early adoption was not permitted. FSP APB 14-1 requires retrospective
application to all periods presented in the annual financial statements for the period of adoption
and where applicable instruments were outstanding during an earlier period. The cumulative effect
of the change in accounting principle on periods prior to those presented shall be recognized as of
the beginning of the first period presented. An offsetting adjustment shall be made to the opening
balance of retained earnings for that period, presented separately. We estimate that this new
accounting standard will increase our interest expense by $21.1 million and adversely affect our
diluted earnings per share by approximately $0.24 per share during 2009.
Critical Accounting Estimates
The preparation of financial statements in accordance with U.S. generally accepted accounting
principles requires us to make estimates and assumptions that affect reported amounts and related
disclosures. We consider an accounting estimate to be critical if:
|
|
|
it requires assumptions to be made that were uncertain at the time the estimate was
made; and |
|
|
|
|
changes in the estimate or different estimates that could have been made could have
a material impact on our consolidated results of operations or financial condition. |
Our management has discussed the development and selection of these critical accounting
estimates with the audit committee of our Board of Directors and with our independent registered
public accounting firm, and they both have reviewed the disclosure presented below relating to our
critical accounting estimates. Our critical accounting estimates include the following areas:
|
|
|
Revenue recognition/Allowance for contractual discounts; |
|
|
|
|
Allowance for doubtful accounts and provision for doubtful accounts; |
|
|
|
|
Goodwill impairment analysis; |
|
|
|
|
Professional and general liability claims; |
|
|
|
|
Accounting for stock-based compensation; and |
|
|
|
|
Accounting for income taxes. |
The following discussion of critical accounting estimates is not intended to be a
comprehensive list of all of our accounting policies that require estimates. We believe that of our
significant accounting policies, as discussed in Note 1 of our consolidated financial statements
included elsewhere in this report, the estimates discussed below involve a higher degree of
judgment and complexity. We believe the current assumptions and other considerations used to
estimate amounts reflected in our consolidated financial statements are appropriate. However, if
actual experience differs from the assumptions and other considerations used in estimating amounts
reflected in our consolidated financial statements, the resulting changes could have a material
adverse effect on our consolidated results of operations and our financial condition.
65
The discussion that follows presents information about our critical accounting estimates, as
well as the effects of hypothetical changes in the material assumptions used to develop each
estimate:
Revenue Recognition/Allowance for Contractual Discounts
We recognize revenues in the period in which services are provided. Accounts receivable
primarily consist of amounts due from third-party payors and patients. Amounts we receive for
treatment of patients covered by governmental programs, such as Medicare and Medicaid, and other
third-party payors such as HMOs, PPOs and other private insurers, are generally less than our
established billing rates. Accordingly, our gross revenues and accounts receivable are reduced to
net realizable value through an allowance for contractual discounts.
Approximately 84.1%, 85.0% and 85.2% of our revenues during the years ended December 31, 2006,
2007 and 2008, respectively, relate to discounted charges, which were comprised of the following
sources (as a percentage of total revenues):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Medicare |
|
|
34.8 |
% |
|
|
32.6 |
% |
|
|
31.2 |
% |
Medicaid |
|
|
10.1 |
|
|
|
9.7 |
|
|
|
9.5 |
|
HMOs, PPOs and other private insurers |
|
|
39.2 |
|
|
|
42.7 |
|
|
|
44.5 |
|
Revenues are recorded at estimated net amounts due from patients, third-party payors and
others for healthcare services provided. For certain payors, such as Medicare, Medicaid, as well as
some managed care payors with which we have contractual arrangements, the contractual allowances
are calculated by computerized logging systems based on defined payment terms. For other payors,
the contractual allowances are determined based on historical data by insurance plan. All
contractual adjustments, regardless of type of payor or method of calculation, are reviewed and
compared to actual experience.
We monitor our processes for calculating contractual allowances through:
|
|
|
review of payment discrepancy reports for logged payors; |
|
|
|
|
analysis of historical contractual allowance trends based on actual claims paid by
HMOs, PPOs and other private insurers; |
|
|
|
|
review of contractual allowance information reflecting current contract terms; |
|
|
|
|
consideration and analysis of changes in charge rates and payor mix reimbursement
levels; and |
|
|
|
|
other issues that may impact contractual allowances. |
Medicare and Medicaid
The majority of services performed on Medicare and Medicaid patients are reimbursed at
predetermined reimbursement rates. The differences between the established billing rates (i.e.,
gross charges) and the predetermined reimbursement rates are recorded as contractual discounts and
deducted from gross charges. Under this prospective reimbursement system, there is no adjustment or
settlement of the difference between the actual cost to provide the service and the predetermined
reimbursement rates.
Discounts for retrospectively cost-based revenues are estimated based on historical and
current factors and are adjusted in future periods when settlements of filed cost reports are
received. Final settlements under these programs are subject to adjustment based on administrative
review and audit by third party intermediaries, which can take several years to resolve completely.
Adjustments related to final settlements increased our revenues by $12.6 million, $8.0 million and
$7.1 million for the years ended December 31, 2006, 2007 and 2008, respectively.
Because the laws and regulations governing the Medicare and Medicaid programs are complex and
subject to change, the estimates of contractual discounts we record could change by material
amounts. A significant increase in our estimate of contractual discounts for Medicare and Medicaid
would lower our earnings. This would adversely affect our results of operations, financial
condition, liquidity and future access to capital.
66
HMOs, PPOs and Other Private Insurers
Amounts we receive for the treatment of patients covered by HMOs, PPOs and other private
insurers (collectively managed care plans) are generally less than our established billing rates.
We include contractual allowances as a reduction to revenues in our financial statements based on
payor specific identification and payor specific factors for rate increases and denials. For most
managed care plans, estimated contractual allowances are adjusted to actual contractual allowances
as cash is received and claims are reconciled.
If our overall estimated contractual discount percentage on our managed care program revenues
for the year ended December 31, 2008 were changed by 1%, our after-tax income from continuing
operations would change by approximately $6.5 million, or diluted earnings per share of $0.12. This
is only one example of reasonably possible sensitivity scenarios. The process of determining the
allowance requires us to estimate the amount expected to be received based on payor contract
provisions, historical collection data as well as other factors and requires a high degree of
judgment. It is impacted by changes in managed care contracts and other related factors. A
significant increase in our estimate of contractual discounts for managed care plans would lower
our earnings. This would adversely affect our results of operations, financial condition, liquidity
and future access to capital.
Allowance for Doubtful Accounts and Provision for Doubtful Accounts
Accounts receivable primarily consist of amounts due from third-party payors and patients. Our
ability to collect outstanding receivables is critical to our results of operations and cash flows.
To provide for accounts receivable that could become uncollectible in the future, we establish an
allowance for doubtful accounts to reduce the carrying value of such receivables to their estimated
net realizable value. The primary uncertainty lies with uninsured patient receivables and
deductibles, co-payments or other amounts due from individual patients.
Our allowance for doubtful accounts, included in our consolidated balance sheets as of
December 31, 2007 and 2008 was $376.3 million and $374.4 million, respectively. Our provision for
doubtful accounts, included in our consolidated results of operations for the years ended December
31, 2006, 2007 and 2008, was $250.0 million, $307.0 million and $313.2 million, respectively.
The largest component of our allowance for doubtful accounts relates to accounts for which
patients are responsible, which we refer to as patient responsibility accounts or self-pay
accounts. These accounts include both amounts payable by uninsured patients and co-payments and
deductibles payable by insured patients. In general, we attempt to collect deductibles, co-payments
and self-pay accounts prior to the time of service for non-emergency care. If we do not collect
these patient responsibility accounts prior to the delivery of care, the accounts are handled
through our billing and collections processes.
The approximate amounts and percentages of billed insured and uninsured (including self-pay,
co-payments, deductibles and Medicaid pending) gross accounts receivable (prior to allowance for
contractual discounts and allowance for doubtful accounts) in summarized aging categories are as
follows for the periods presented (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008 |
|
|
|
Insured Receivables |
|
|
Uninsured Receivables |
|
|
Combined |
|
|
|
|
|
|
|
Percent of |
|
|
|
|
|
|
Percent of |
|
|
|
|
|
|
Percent of |
|
|
|
Amount |
|
|
Receivables |
|
|
Amount |
|
|
Receivables |
|
|
Amount |
|
|
Receivables |
|
0 to 90 days |
|
$ |
350.8 |
|
|
|
87.7 |
% |
|
$ |
110.3 |
|
|
|
24.9 |
% |
|
$ |
461.1 |
|
|
|
54.7 |
% |
91 to 150 days |
|
|
24.8 |
|
|
|
6.2 |
|
|
|
69.5 |
|
|
|
15.7 |
|
|
|
94.3 |
|
|
|
11.2 |
|
151 to 360 days |
|
|
19.1 |
|
|
|
4.8 |
|
|
|
180.3 |
|
|
|
40.6 |
|
|
|
199.4 |
|
|
|
23.6 |
|
Over 361 |
|
|
5.1 |
|
|
|
1.3 |
|
|
|
83.7 |
|
|
|
18.8 |
|
|
|
88.8 |
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
399.8 |
|
|
|
100.0 |
% |
|
$ |
443.8 |
|
|
|
100.0 |
% |
|
$ |
843.6 |
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
|
Insured Receivables |
|
|
Uninsured Receivables |
|
|
Combined |
|
|
|
|
|
|
|
Percent of |
|
|
|
|
|
|
Percent of |
|
|
|
|
|
|
Percent of |
|
|
|
Amount |
|
|
Receivables |
|
|
Amount |
|
|
Receivables |
|
|
Amount |
|
|
Receivables |
|
0 to 90 days |
|
$ |
355.1 |
|
|
|
86.5 |
% |
|
$ |
106.9 |
|
|
|
23.9 |
% |
|
$ |
462.0 |
|
|
|
53.8 |
% |
91 to 150 days |
|
|
29.5 |
|
|
|
7.2 |
|
|
|
67.0 |
|
|
|
15.0 |
|
|
|
96.5 |
|
|
|
11.2 |
|
151 to 360 days |
|
|
22.5 |
|
|
|
5.5 |
|
|
|
213.4 |
|
|
|
47.6 |
|
|
|
235.9 |
|
|
|
27.5 |
|
Over 361 |
|
|
3.6 |
|
|
|
0.8 |
|
|
|
60.7 |
|
|
|
13.5 |
|
|
|
64.3 |
|
|
|
7.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
410.7 |
|
|
|
100.0 |
% |
|
$ |
448.0 |
|
|
|
100.0 |
% |
|
$ |
858.7 |
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We verify each patients insurance coverage as early as possible before a scheduled admission
or procedure, including with respect to eligibility, benefits and authorization/pre-certification
requirements, in order to notify patients of the amounts for which they will be responsible. We
attempt to verify insurance coverage within a reasonable amount of time for all emergency room
visits and urgent admissions in compliance with EMTALA.
In general, we perform the following steps in collecting accounts receivable:
|
|
|
if possible, cash collection of deductibles, co-payments and self-pay accounts
prior to or at the time service is provided; |
|
|
|
|
billing and follow-up with third party payors; |
|
|
|
|
collection calls; |
|
|
|
|
utilization of collection agencies; and |
|
|
|
|
if collection efforts are unsuccessful, write-off of the accounts. |
Our policy is to write-off accounts after all collection efforts have failed, which is
generally one year after the date of discharge of the patient. Patient responsibility accounts
represent the majority of our write-offs. All of our hospitals retain third-party collection
agencies for billing and collection of delinquent accounts. At most of our hospitals, more than one
collection agency is used to promote competition and improve performance results. The selection of
collection agencies and the timing of referral of an account to a collection agency vary among our
hospitals.
We determine the adequacy of the allowance for doubtful accounts utilizing a number of
analytical tools and benchmarks. No single statistic or measurement alone determines the adequacy
of the allowance. Specifically, we monitor the revenue trends by payor classification on a
month-by-month basis along with the composition of our accounts receivable agings. This review is
focused primarily on trends in self-pay revenues, accounts receivable, co-payment receivables and
historic payment patterns. In addition, we analyze other factors such as revenue days in accounts
receivable and we review admissions and charges by physicians, primarily focusing on recently
recruited physicians.
The process of determining our allowance for doubtful accounts requires us to estimate
uncollectible self-pay accounts. Our estimate of uncollectible self-pay accounts is primarily based
on our collection history, adjusted for anticipated changes in collection trends, if significant.
Our estimate may be impacted by changes in regional economic conditions, business office
operations, payor mix and trends in federal or state governmental healthcare coverage or other
third party payors. If the actual self-pay collection percentage would change by 1.5% from our
estimated self-pay collection percentage for the year ended December 31, 2008, our after-tax income
from continuing operations would change by approximately $0.8 million, or diluted earnings per
share of $0.02, and our net accounts receivable would change by $1.3 million at December 31, 2008.
The resulting change in this analytical tool is considered to be a reasonably likely change that
would affect our overall assessment of this critical accounting estimate.
68
Goodwill Impairment Analysis
Goodwill represents the excess of the purchase price over the fair value of the net assets of
acquired businesses. Our goodwill included in our consolidated balance sheets as of December 31,
2007 and 2008 was $1,512.0 and $1,516.5 million, respectively. Please refer to Note 4 to our
consolidated financial statements included elsewhere in this report for a detailed rollforward of
our goodwill.
Under SFAS No. 142, Goodwill and Other Intangible Assets, (SFAS No. 142), goodwill and
intangible assets with indefinite lives are reviewed by us at least annually for impairment. Our
business comprises a single operating reporting unit for impairment test purposes. For the purposes
of these analyses, our estimate of fair value are based on a combination of the income approach,
which estimates the fair value of us based on our future discounted cash flows, and the market
approach, which estimates the fair value of us based on comparable market prices. Our estimate of
future discounted cash flows is based on assumptions and projections we believe to be currently
reasonable and supportable. Our assumptions take into account revenue and expense growth rates,
patient volumes, changes in payor mix, and changes in legislation and other payor payment patterns.
If we determine the carrying value of goodwill is impaired, or if the carrying value of a
business that is to be sold or otherwise disposed of exceeds its fair value, then we reduce the
carrying value, including any allocated goodwill, to fair value. During the years ended December
31, 2006 and 2007, we performed our annual impairment tests as of October 1, 2006 and 2007, and did
not incur an impairment charge. During the year ended December 31, 2008, as a result of recent
economic events and the decline in our stock price, we performed goodwill impairment testing as of
September 30, 2008 and December 31, 2008. We determined that no goodwill impairment charge was
required as a result of either analysis and will continue to monitor the relationship of our fair
value to its book value as economic events and changes to its stock price occur. If actual future
results are not consistent with our assumptions and estimates, we may be required to record
goodwill impairment charges in the future.
Professional and General Liability Claims
We are subject to potential medical malpractice lawsuits and other claims. To mitigate a
portion of this risk, we maintain insurance for individual malpractice claims exceeding a
self-insured retention amount. For 2006 through 2008, our self-insured retention levels ranged from
$15.0 million to $25.0 million, with the exception of certain facilities we operate in states
having state specific medical malpractice programs.
Each year, we obtain quotes from various malpractice insurers with respect to the cost of
obtaining medical malpractice insurance coverage. We compare these quotes to our most recent
actuarially determined estimates of losses at various self-insured retention levels. Accordingly,
changes in insurance costs affect the self-insurance retention level we choose each year. As
insurance costs have increased in recent years, we have accepted a higher level of risk in self-
insured retention levels.
Our reserve for professional and general liability claims reflects the current estimate of all
outstanding losses, including incurred but not reported losses, based upon actuarial calculations
as of the balance sheet date. The loss estimates included in the actuarial calculations may change
in the future based upon updated facts and circumstances.
Our expense for professional and general liability coverage each year
includes: the actuarially determined estimate of losses for the current year, including claims
incurred but not reported; the change in the estimate of losses for prior years based upon actual
claims development experience as compared to prior actuarial projections; the insurance premiums
for losses in excess of our self-insured retention levels; the administrative costs of the
insurance program; and interest expense related to the discounted portion of the liability.
69
During 2008, we modified our quarterly process for estimating our reserve for professional and
general liability claims by reducing the number of actuarial calculations upon which the reserve is
determined from the average of two calculations to one. Our reserve calculations consider
historical claims data, demographic considerations, severity factors and other actuarial
assumptions, which are discounted to present value. We have discounted our professional and general
liability claims reserves to their present value using a discount rate of 5% at December 31, 2007
and 4% at December 31, 2008. As a result of this decrease in discount rate, our 2008 professional
and general liability claims expense increased by approximately $2.4 million, which decreased our
net income by approximately $1.5 million and decreased our diluted earnings per share by $0.03. We
select a discount rate by considering a risk-free interest rate that corresponds to the period when
the professional and general liability claims are incurred and projected to be paid.
The following table provides information regarding our reserve for professional and general
liability claims at December 31, 2007 and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
December 31, 2008 |
Undiscounted |
|
$ |
77.6 |
|
|
$ |
97.1 |
|
Discounted (as reported) |
|
$ |
69.4 |
|
|
$ |
87.2 |
|
The following table presents the changes in our professional and general liability claims
reserve for the years ended December 31, 2006, 2007 and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Reserve at the beginning of the period |
|
$ |
55.8 |
|
|
$ |
62.4 |
|
|
$ |
69.4 |
|
Increase for the provision of current year
claims, including discontinued operations |
|
|
29.3 |
|
|
|
26.0 |
|
|
|
29.5 |
|
Increase (decrease) for the provision of
prior year claims, including discontinued
operations |
|
|
(11.8 |
) |
|
|
1.2 |
|
|
|
7.8 |
|
Payments related to current year claims |
|
|
(0.4 |
) |
|
|
(2.2 |
) |
|
|
(1.2 |
) |
Payments related to prior year claims |
|
|
(10.5 |
) |
|
|
(18.0 |
) |
|
|
(20.7 |
) |
Provision for the change in discount rate |
|
|
|
|
|
|
|
|
|
|
2.4 |
|
|
|
|
|
|
|
|
|
|
|
Reserve at the end of the period |
|
$ |
62.4 |
|
|
$ |
69.4 |
|
|
$ |
87.2 |
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2007 and 2008, approximately 1.5% of our professional and general liability
claims reserves represent reserves for settled and unpaid claims. Our average lag time between the
settlement and payment of a professional and general liability claim ranges from 2 to 4 weeks.
Our estimated reserve for professional and general liability claims will be significantly
affected if current and future claims differ from historical trends. While we monitor reported
claims closely and consider potential outcomes when determining our professional and general
liability reserves, the complexity of the claims, the extended period of time to settle the claims
and the wide range of potential outcomes complicates the estimation process. In addition, certain
states have passed varying forms of tort reform which attempt to limit the amount of medical
malpractice awards. If such laws are passed in the states where our hospitals are located, our loss
estimates could decrease.
Our estimate of professional and general liability claim reserves are based upon actuarial
calculations that are completed quarterly and are significantly influenced by key assumptions and
other factors. These factors include, but are not limited to: historical paid claims; trending of
loss development factors; trends in the frequency and severity of claims, which can differ
significantly by jurisdiction as a result of the legislative and judicial climate in such
jurisdictions; coverage limits of third-party insurance and actuarial determined statistical
confidence levels. Given the number of assumptions and characteristics of each assumption
considered in establishing the reserves for professional and general liability claims, it is
difficult to compute the individual financial impact of each assumption or groups of assumptions.
Some of the assumptions are dependent upon the quantitative measurement of other assumptions, and
therefore are not accurately evaluated in isolation. For example, a change in the frequency of
claims assumption is also affected by the estimated severity of these claims resulting in an
inability to properly isolate and quantify the impact of a change in this assumption.
Professional and general liability claims are typically resolved over an extended period of
time, often as long as five years or more. Our professional and general liability claim reserves
are comprised of estimated indemnity and expense payments related to reported events and incurred
but not reported events as of the end of the period. We have the ability to reliably
determine the amount and timing of payments based on sufficient history of our claims development,
the use of external actuarial expertise and our rigorous review process. Actuarial payment patterns
are based on our individual hospital historical data both prior to and after our inception in 1999.
The processes, performed by both external actuaries and our management, enable us to reliably
determine the amount of our ultimate losses as well as the timing of the loss settlements such that
discounting of the professional and general liability claims reserve is appropriate.
Given the number of factors considered in establishing the reserves for professional and
general liability claims, it is neither practical nor meaningful to isolate a particular assumption
or parameter of the process and calculate the impact of changing that single item.
Ultimately, from an actuarial standpoint, the sensitivity in the estimates of professional and
general liability claim reserves is reflected in the various actuarial confidence levels. Our best
estimate of our professional and general liability claim reserves utilizes a statistical confidence
level that is 50%. Higher statistical confidence levels, while not representative of our best
estimate, reflect reasonably likely outcomes upon the ultimate resolution of related claims. Using
a higher statistical confidence level would increase the estimated professional and general
liability claims reserve. Changes in our estimates of professional and general liability claims
reserves are non-cash charges and accordingly, do not impact our liquidity or capital resources.
The assumptions included in the table below are presented for the sensitivity analysis (in
millions):
|
|
|
|
|
December 31, 2007 reserve: |
|
|
|
|
As reported |
|
$ |
69.4 |
|
With 70% Confidence Level |
|
$ |
79.1 |
|
With 80% Confidence Level |
|
$ |
84.1 |
|
With 90% Confidence Level |
|
$ |
98.6 |
|
70
|
|
|
|
|
December 31, 2008 reserve: |
|
|
|
|
As reported |
|
$ |
87.2 |
|
With 70% Confidence Level |
|
$ |
88.4 |
|
With 80% Confidence Level |
|
$ |
93.9 |
|
With 90% Confidence Level |
|
$ |
110.2 |
|
Favorable trending in our development factors (actuarial value of our accuracy in predicting
ultimate losses) and favorable underlying loss experience within the industry were key factors that
resulted in reductions to our prior year reserve levels of professional and general liability
claims during 2006. We became independent and publicly traded on May 11, 1999 when HCA Inc.
distributed all outstanding shares of our stock to our stockholders. We were indemnified by HCA for
losses related to insured risks prior to May 11, 1999. During the early period of our spin-off from
HCA, we established initial professional and general liability claims reserves based on our limited
operating experience as a stand-alone company. As our professional and general liability claims
reserves matured and consistency in the loss development factors occurred, actuarial results
required reductions to our prior year reserve levels of professional and general liability claims
for 2006. State medical malpractice tort law reform legislation also contributed to the improving
loss experience throughout the professional and general liability insurance industry during this
time period. This reform favorably affected both the frequency and severity of claims paid
throughout the industry.
Professional and general liability claims are typically resolved over an extended period of
time, often as long as five years or more. The combination of changing conditions and the extended
time required for claim resolution results in a loss estimation process that requires actuarial
skill and the application of judgment, and such estimates require periodic revision. As a result of
the variety of factors that must be considered, there is a risk that actual incurred losses may
develop differently from estimates. The results of our quarterly completed actuarial calculations
resulted in changes to our reserve levels of professional and general liability claims for prior
years. As a result, this reduced our related professional and general liability insurance expense
(continuing operations) by $11.1 million for 2006. For 2007 and 2008, this increased our related professional and general
liability insurance expense (continuing operations) by $0.7 million and $4.8 million, respectively. Changes in our initial
estimates of professional and general liability claims are non-cash charges and accordingly, there
would be no material impact on our liquidity or capital resources.
Accounting for Stock-Based Compensation
We issue stock options and other stock-based awards (nonvested stock, restricted stock and
deferred stock units) to key employees and directors under our various stockholder-approved
stock-based compensation plans. We account for our stock-based awards in accordance with the
provisions of SFAS No. 123(R), Share-Based Payment (SFAS No. 123(R)). In accordance with SFAS
No. 123(R), we recognize compensation expense based on the estimated grant date fair value of each
stock-based award. Our stock-based compensation from continuing operations, included in our
consolidated results of operations, was $13.1 million, $18.7 million and $23.4 million for 2006,
2007 and 2008, respectively.
The fair value of other stock-based awards (nonvested stock and restricted stock units) are
determined based on the closing price of our common stock on the day prior to the grant date. The
nonvested stock requires no payment from employees and directors, and stock-based compensation
expense is recorded equally over the vesting periods ranging from six months to five years.
We estimate the fair value of stock options granted using the Hull-White II Valuation Model
(HW-II) lattice option valuation model and a single option award approach. We use the HW-II
because it considers characteristics of fair value option pricing, such as an options contractual
term and the probability of exercise before the end of the contractual term. In addition, the
complications surrounding the expected term of an option are material, as clarified by the SEC
focus on the matter in SAB No. 107. Given our reasonably large pool of unexercised options, we
believe a lattice model that specifically addresses this fact and models a full term of exercises
is the most appropriate and reliable means of valuing our stock options. We are amortizing the fair
value on a straight-line basis over the requisite service periods of the awards, which are the
vesting periods of three years. The stock options vest 33.3% on each grant anniversary date over
three years of continued employment.
71
The following table shows the weighted average assumptions we used to develop the fair value
estimates under our HW-II option valuation model and the resulting estimates of weighted-average
fair value per share of stock options granted during 2006, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Expected volatility |
|
|
32.8 |
% |
|
|
27.2 |
% |
|
|
31.9 |
% |
Risk free interest rate (range) |
|
|
4.38% - 5.21 |
% |
|
|
3.34% - 5.21 |
% |
|
|
0.09% - 3.89 |
% |
Expected dividends |
|
|
|
|
|
|
|
|
|
|
|
|
Average expected term (years) |
|
|
5.4 |
|
|
|
4.7 |
|
|
|
5.3 |
|
Fair value per share of stock options granted |
|
$ |
11.15 |
|
|
$ |
10.24 |
|
|
$ |
8.14 |
|
Population Stratification
Under SFAS No. 123(R), a company should aggregate individual awards into relatively
homogeneous groups with respect to exercise and post-vesting employment behaviors for the purpose
of refining the expected term assumption, regardless of the valuation technique used to estimate
the fair value. In addition, SAB No. 107 clarifies that a company may generally make a reasonable
fair value estimate with as few as one or two groupings. Prior to January 1, 2008, we stratified
our employee population into two groups: (i) Insiders, who were the Section 16 filers under SEC
rules; and (ii) Non-insiders, who were the rest of the employee population. Effective January 1,
2008, we determined that a single employee population group was more appropriate. We derived our
two group stratification prior to January 1, 2008 and post January 1, 2008 single employee grouping
based on an analysis of our historical exercise patterns.
Expected Volatility
Volatility is a measure of the tendency of investment returns to vary around a long-term
average rate. Historical volatility is an appropriate starting point for setting this assumption
under SFAS No. 123(R). According to SFAS No. 123(R), companies should also consider how future
experience may differ from the past. This may require using other factors to adjust historical
volatility, such as implied volatility, peer-group volatility and the range and mean-reversion of
volatility estimates over various historical periods. SFAS No. 123(R) and SAB No. 107 acknowledge
that there is likely to be a range of reasonable estimates for volatility. In addition, SFAS No.
123(R) requires that if a best estimate cannot be made, management should use the mid-point in the
range of reasonable estimates for volatility. We estimate the volatility of our common stock at the
date of grant based on both historical volatility and implied volatility from traded options of our
common stock, consistent with SFAS No. 123(R) and SAB No. 107.
Risk-Free Interest Rate
Lattice models require risk-free interest rates for all potential times of exercise obtained
by using a grant-date yield curve. A lattice model would, therefore, require the yield curve for
the entire time period during which employees might exercise their options. We base the risk-free
rate on the implied yield in effect at the time of option grant on United States Treasury
zero-coupon issues with equivalent remaining terms.
Expected Dividends
We have never paid any cash dividends on our common stock and do not anticipate paying any
cash dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero.
Pre-Vesting Forfeitures
Pre-vesting forfeitures do not affect the fair value calculation, but they affect the expense
calculation. SFAS No. 123(R) requires us to estimate pre-vesting forfeitures at the time of grant
and revise those estimates in subsequent periods if actual forfeitures differ from those estimates.
We use historical data to estimate pre-vesting forfeitures and record share-based compensation
expense only for those awards that are expected to vest.
72
During 2007, we changed from a static forfeiture rate methodology to a dynamic forfeiture rate
methodology. The dynamic forfeiture rate methodology incorporates the lapse of time into the
resulting expense calculation and results in a forfeiture rate that diminishes as the granted
awards approach its vest date. Accordingly, the dynamic forfeiture rate methodology results in a
more consistent stock compensation expense calculation over the vesting period of the award.
Additionally, during 2007, we performed an analysis of our initial pre-vesting forfeiture rate
percentage and increased our initial pre-vesting forfeiture rate ranging from 3.0% to 7.5%, up to
an initial pre-vesting forfeiture rate of 12.5%. The increase in our initial pre-vesting forfeiture
rate reflects the recent forfeiture trends that we experienced and expectations of future
forfeitures. As previously discussed, we utilize the dynamic forfeiture rate methodology, this rate
is updated and is reduced accordingly as time lapses until it
ultimately reaches zero on the
vesting date, contingent upon the continued employment of the grantee.
Post-Vesting Cancellations
Post-vesting cancellations include vested options that are cancelled, exercised or expire
unexercised. Lattice models treat post-vesting cancellations and voluntary early exercise behavior
as two separate assumptions. We use historical data to estimate post-vesting cancellations.
Expected Term
SFAS No. 123(R) calls for an extinguishment calculation, dependent upon how long a granted
option remains outstanding before it is fully extinguished. While extinguishment may result from
exercise, it can also result from post-vesting cancellation or expiration at the contractual term.
Expected term is an output in lattice models so we do not have to determine this amount.
The fair value calculations of our stock option grants are affected by assumptions that are
believed to be reasonable based upon the facts and circumstances at the time of grant. Changes in
our volatility estimates can materially affect the fair values of our stock option grants. If our
estimated weighted-average volatility for 2008 were 10% higher, our after-tax income from
continuing operations would decrease by approximately $0.3 million, or $0.01 per diluted share.
Accounting for Income Taxes
Deferred tax assets generally represent items that will result in a tax deduction in future
years for which we have already recorded the tax benefit in our income statement. We assess the
likelihood that deferred tax assets will be recovered from future taxable income. To the extent we
believe that recovery is not probable, a valuation allowance is established. To the extent we
establish a valuation allowance or increase this allowance, we must include an expense as part of
the income tax provision in our results of operations. Our deferred tax asset balances in our
consolidated balance sheets were $206.9 million and $207.8 million as of December 31, 2007 and
2008, respectively. Our valuation allowances for deferred tax assets in our consolidated balance
sheets were $39.4 million and $46.5 million as of December 31, 2007 and 2008, respectively.
In addition, significant judgment is required in determining and assessing the impact of
certain tax-related contingencies. We establish accruals when, despite our belief that our tax
return positions are fully supportable, it is probable that we have incurred a loss related to tax
contingencies and the loss or range of loss can be reasonably estimated. We adjust the accruals
related to tax contingencies as part of our provision for income taxes in our results of operations
based upon changing facts and circumstances, such as progress of a tax audit, development of
industry related examination issues, as well as legislative, regulatory or judicial developments. A
number of years may elapse before a particular matter, for which we have established an accrual, is
audited and resolved.
The first step in determining the deferred tax asset valuation allowance is identifying
reporting jurisdictions where we have a history of tax and operating losses or are projected to
have losses in future periods as a result of changes in operational performance. We then determine
if a valuation allowance should be established against the deferred tax assets for that reporting
jurisdiction.
73
The second step is to determine the amount of the valuation allowance. We will generally
establish a valuation allowance equal to the net deferred tax asset (deferred tax assets less
deferred tax liabilities) related to the jurisdiction identified in step one of the analysis. In
certain cases, we may not reduce the valuation allowance by the amount of the deferred tax
liabilities depending on the nature and timing of future taxable income attributable to deferred
tax liabilities.
In assessing tax contingencies, we apply the provisions of FIN 48, which we adopted on January
1, 2007. We apply the recognition threshold and measurement of a tax position taken or expected to
be taken in a tax return and follow the guidance on various matters such as derecognition,
interest, penalties and disclosure. We elected to continue our historical practice of classifying
interest and penalties as a component of income tax expense.
During each reporting period, we assess the facts and circumstances related to recorded tax
contingencies. If tax contingencies are no longer deemed probable based upon new facts and
circumstances, the contingency is reflected as a reduction of the provision for income taxes in the
current period.
Our deferred tax assets exceeded our deferred tax liabilities by $46.8 million as of December
31, 2008, excluding the impact of valuation allowances. Historically, we have produced federal
taxable income. Therefore, we believe that the likelihood of our not realizing the federal tax
benefit of our deferred tax assets is remote.
However, we do have subsidiaries with a history of tax losses in certain state jurisdictions
and, based upon those historical tax losses, we assumed that the subsidiaries would not be
profitable in the future for those states tax purposes. If our assertion regarding the future
profitability of those subsidiaries were incorrect, then our deferred tax assets would be
understated by the amount of the valuation allowance of $46.5 million at December 31, 2008.
The IRS may propose adjustments for items we have failed to identify as tax contingencies. If
the IRS were to propose and sustain assessments equal to 10% of our taxable income for 2008, we
would incur $7.6 million of additional tax payments for 2008 plus applicable penalties and
interest.
Segment Reporting
We have six operating divisions as of December 31, 2008. Each of these six operating divisions
has similar economic characteristics consisting of acute care hospitals in non-urban communities.
We realign these operating divisions frequently based upon changing circumstances, including
acquisition and divestiture activity. We consider these six operating divisions as one operating
segment, healthcare services, for segment reporting purposes and for goodwill impairment testing in
accordance with SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information
(SFAS No. 131), and SFAS No. 142.
We have determined that our six operating divisions comprise one segment because of their
similar economic characteristics in accordance with paragraph 17 of SFAS No. 131 for the following
reasons:
|
|
|
the treatment of patients in a hospital setting is the only material source of revenues
for each of our six operating divisions; |
|
|
|
|
the healthcare services provided by each of our operating divisions are generally the
same; |
|
|
|
|
the healthcare services provided by each of our operating divisions are generally
provided to similar types of patients, which is patients in a hospital setting; |
|
|
|
|
the healthcare services are primarily provided by the direction of affiliated or
employed physicians and by the nurses, lab technicians, and others employed or contracted
at each of our hospitals; and |
|
|
|
|
the healthcare regulatory environment is generally similar for each of our six
operating divisions. |
74
Additionally, as discussed in Emerging Issues Task Force (EITF) Topic D-101, Clarification
of Reporting Unit Guidance in Paragraph 30 of FASB Statement No. 142 (EITF D-101), we determined
that our six operating divisions comprise one reporting unit because of their similar economic
characteristics in each of the following areas:
|
|
|
the way we manage our operations and extent to which our acquired facilities are
integrated into our existing operations as a single reporting unit; |
|
|
|
|
our goodwill is recoverable from the collective operations of our six operating
divisions and not individually from one single operating division; |
|
|
|
|
our operating divisions are frequently realigned based upon changing circumstances,
including acquisition and divestiture activity; and |
|
|
|
|
because of the collective size of its six operating divisions, each division benefits
from its participation in a group purchasing organization. |
Inflation
The healthcare industry is labor-intensive. Wages and other expenses increase during periods
of inflation and when labor shortages in marketplaces occur. In addition, suppliers pass along
rising costs to us in the form of higher prices. Private insurers pass along their rising costs in
the form of lower reimbursement to us. Our ability to pass on these increased costs in increased
rates is limited because of increasing regulatory and competitive pressures and the fact that the
majority of our revenues are fee-based. Accordingly, inflationary pressures could have a material
adverse effect on our results of operations.
|
|
|
Item 7A. |
|
Quantitative and Qualitative Disclosures about Market Risk. |
The following discussion relates to our exposure to market risk based on changes in interest
rates:
Outstanding Debt
We have an interest rate swap to manage our exposure to changes in interest rates. The
interest rate swap converts a portion of our indebtedness to a fixed rate with a notional amount of
$600.0 million at December 31, 2008 and at an annual fixed rate of 5.585%. Accordingly, we are
slightly exposed to market risk related to fluctuations in interest rates. The notional amount of
the swap agreement represents a balance used to calculate the exchange of cash flows and is not an
asset or liability. Any market risk or opportunity associated with this swap agreement is offset by
the opposite market impact on the related debt. Our interest rate swap agreement exposes us to
credit risk in the event of non-performance by Citibank. However, we do not anticipate
non-performance by Citibank.
As of December 31, 2008, we had outstanding debt of $1,516.7 million, 46.6%, or $706.4
million, of which was subject to variable rates of interest. However, our interest rate swap
decreases our variable rate debt as a percentage of our outstanding debt from 46.6% to 7.0% as of
December 31, 2008.
Our
Term B Loans,
31/2% Notes and
31/4%
Debentures were the only long-term debt instruments where the carrying amounts
differed from their fair value as of December 31, 2007 and 2008. The carrying amount and fair value
of these instruments as of December 31, 2007 and 2008 were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Amount |
|
Fair Value |
|
|
2007 |
|
2008 |
|
2007 |
|
2008 |
Term B Loans |
|
$ |
706.0 |
|
|
$ |
706.4 |
|
|
$ |
670.7 |
|
|
$ |
586.3 |
|
31/2% Notes |
|
|
575.0 |
|
|
|
575.0 |
|
|
|
513.2 |
|
|
|
387.3 |
|
31/4% Debentures |
|
|
225.0 |
|
|
|
225.0 |
|
|
|
194.1 |
|
|
|
162.0 |
|
The fair values of our
Term B Loans, 31/4% Debentures and 31/2% Notes were based on the
quoted prices at December 31, 2007 and 2008.
Cash Balances
Certain of our outstanding cash balances are invested overnight with high credit quality
financial institutions. We do not hold direct investments in auction rate securities,
collateralized debt obligations, structured investment vehicles or mortgage-backed securities. We
do not have significant exposure to changing interest rates on invested cash at December 31, 2008.
As a result, the interest rate market risk implicit in these investments at December 31, 2008, if
any, is low.
75
|
|
|
Item 8. |
|
Financial Statements and Supplementary Data. |
Information with respect to this Item is contained in our consolidated financial statements
beginning on Page F-1 of this report.
|
|
|
Item 9. |
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. |
We did not experience a change in or disagreement with our accountants during the year ended
December 31, 2008.
|
|
|
Item 9A. |
|
Controls and Procedures. |
Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of management,
including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the
design and operation of our disclosure controls and procedures as of the end of the period covered
by this report pursuant to Rule 13a-15 of the Exchange Act. Based upon that evaluation, our Chief
Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures
were effective in ensuring that information required to be disclosed by us (including our
consolidated subsidiaries) in reports that we file or submit under the Exchange Act is recorded,
processed, summarized and reported on a timely basis.
Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we have included a report of
managements assessment of the design and operating effectiveness of our internal controls as part
of this report. Our independent registered public accounting firm also attested to, and reported
on, the effectiveness of internal control over financial reporting. Managements report and the
independent registered public accounting firms attestation report are included in our consolidated
financial statements beginning on page F-1 of this report under the captions entitled Managements
Report on Internal Control Over Financial Reporting and Report of Independent Registered Public
Accounting Firm.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting during the fourth
quarter ended December 31, 2008 that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.
|
|
|
Item 9B. |
|
Other Information. |
None.
76
PART III
|
|
|
Item 10. |
|
Directors, Executive Officers and Corporate Governance. |
Executive Officers
Information with respect to our executive officers is incorporated by reference to the
information contained under the caption Compensation of Executive Officers Executive Officers
of the Company included in our proxy statement relating to our 2009 annual meeting of
stockholders.
Code of Ethics
Our Board of Directors expects its members, as well as our officers and employees, to act
ethically at all times and to acknowledge in writing their adherence to the policies comprising our
Code of Conduct, which is known as Common Ground, and, as applicable, our Code of Ethics for
Senior Financial Officers and Chief Executive Officer (Code of Ethics). The Code of Ethics and
Common Ground are posted on our website located at www.lifepointhospitals.com under the
heading Corporate Governance. We intend to disclose any amendments to our Code of Ethics and any
waiver from a provision of our code, as required by the SEC, on our website within four business
days following such amendment or waiver.
Directors
Information with respect to our directors is incorporated by reference to the information
contained under the caption Proposal 1: Election of Directors included in our proxy statement
relating to our 2009 annual meeting of stockholders.
Compliance with Section 16(a) of the Exchange Act
Information with respect to compliance with Section 16(a) of the Exchange Act is incorporated by reference to the information contained under the caption Additional
Information Section 16(a) Beneficial Ownership Reporting Compliance included in our proxy
statement relating to our 2009 annual meeting of stockholders.
Stockholder Nominees
Information with respect to the procedures by which stockholders may recommend nominees to the
Board of Directors is incorporated by reference to the information contained under the caption
Board of Directors and Committees Director Nomination Process included in our proxy statement
relating to our 2009 annual meeting of stockholders.
Audit and Compliance Committee
Information with respect to the Audit and Compliance Committee is incorporated by reference to
the information contained under the caption Audit and Compliance Committee Report included in our
proxy statement relating to our 2009 annual meeting of stockholders.
|
|
|
Item 11. |
|
Executive Compensation. |
This information is incorporated by reference to the information contained under the captions
Compensation Committee Report, Compensation Discussion and Analysis, Compensation of Executive
Officers, and Board of Directors and Committees Compensation Committee Interlocks and Insider
Participation, and Compensation of Directors, included in our proxy statement relating to our
2009 annual meeting of stockholders.
77
|
|
|
Item 12. |
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters. |
This information is incorporated by reference to the information contained under the captions
Security Ownership of Certain Beneficial Owners and Management, Compensation of Executive
Officers Change in Control Arrangements and Compensation of Executive Officers Executive
Severance and Restrictive Covenant Agreement with Mr. Carpenter included in our proxy statement
relating to our 2009 annual meeting of stockholders.
Information concerning our equity compensation plans are included in Part II, Item 5. of this
report under the caption Equity Compensation Plan Information.
|
|
|
Item 13. |
|
Certain Relationships and Related Transactions, and Director Independence. |
This information is incorporated by reference to the information contained under the captions
Corporate Governance Certain Relationships and Related Transactions and Corporate Governance
Independence of Directors included in our proxy statement relating to our 2009 annual meeting
of stockholders.
|
|
|
Item 14. |
|
Principal Accountant Fees and Services. |
This information is incorporated by reference to the information contained under the caption
Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm and Fees
and Services of the Independent Registered Public Accounting Firm included in our proxy statement
relating to our 2009 annual meeting of stockholders.
78
PART IV
|
|
|
Item 15. |
|
Exhibits and Financial Statement Schedules. |
(a) Index to Consolidated Financial Statements, Financial Statement Schedules and Exhibits:
(1) Consolidated Financial Statements:
|
|
|
See Item 8 in this report. |
|
|
|
|
The consolidated financial statements required to be included in Part II, Item 8,
Financial Statements and Supplementary Data, begin on Page F-1 and are submitted as a
separate section of this report. |
(2) Consolidated Financial Statement Schedules:
|
|
|
All schedules are omitted because they are not applicable or not required, or because
the required information is included in the consolidated financial statements or notes
in this report. |
(3) Exhibits:
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
3.1
|
|
|
|
Amended and Restated Certificate of Incorporation (incorporated by reference
from exhibits to the Registration Statement on Form S-8 filed by LifePoint
Hospitals, Inc. on April 19, 2005, File No. 333-124151). |
|
|
|
|
|
3.2
|
|
|
|
Second Amended and Restated Bylaws of LifePoint Hospitals, Inc. (incorporated
by reference from exhibits to the LifePoint Hospitals, Inc. Current Report on
Form 8-K dated October 16, 2006, File No. 000-51251). |
|
|
|
|
|
3.3
|
|
|
|
Amendment No. 1 to the Second Amended and Restated Bylaws of LifePoint
Hospitals, Inc. (incorporated by reference from exhibits to the LifePoint
Hospitals, Inc. Current Report on Form 8-K dated May 20, 2008, File No.
000-51251). |
|
|
|
|
|
4.1
|
|
|
|
Form of Specimen Stock Certificate (incorporated by reference from exhibits to
the Registration Statement on Form S-4, as amended, filed by LifePoint
Hospitals, Inc. on October 25, 2004, File No. 333-119929). |
|
|
|
|
|
4.2
|
|
|
|
Form of 3.25% Convertible Senior Subordinated Debenture due 2025 (incorporated
by reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated August 10, 2005, File No. 000-51251). |
|
|
|
|
|
4.3
|
|
|
|
Registration Rights Agreement, dated August 10, 2005, between LifePoint
Hospitals, Inc. and Citigroup Global Markets Inc. as Representatives of the
Initial Purchasers (incorporated by reference from exhibits to LifePoint
Hospitals Current Report on Form 8-K dated August 10, 2005, File No.
000-51251). |
|
|
|
|
|
4.4
|
|
|
|
Rights Agreement, dated as of April 15, 2005, by and between LifePoint
Hospitals, Inc. and National City Bank, as Rights Agent (incorporated by
reference from exhibits to the Registration Statement on Form S-8 filed by
Historic LifePoint Hospitals, Inc. on April 15, 2005, File No. 333-124093). |
|
|
|
|
|
4.5
|
|
|
|
Subordinated Indenture, dated as of May 27, 2003, between Province Healthcare
Company and U.S. Bank Trust National Association, as Trustee (incorporated by
reference from exhibits to Province Healthcare Companys Quarterly Report on
Form 10-Q for the quarter ended June 30, 2003, File No. 001-31320). |
|
|
|
|
|
4.6
|
|
|
|
First Supplemental Indenture to Subordinated Indenture, dated as of May 27,
2003, by and among Province Healthcare Company and U.S. Bank National
Association, as Trustee, relating to Province Healthcare Companys
71/2% Senior Subordinated Notes due 2013 (incorporated by
reference from exhibits to Province Healthcare Companys Quarterly Report on
Form 10-Q for the quarter ended June 30, 2003, File No. 001-31320). |
79
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
4.7
|
|
|
|
Second Supplemental Indenture to Subordinated Indenture, dated as of April 1,
2005, by and among Province Healthcare Company and U.S. Bank National
Association, as Trustee (incorporated by reference from exhibits to Province
Healthcare Companys Current Report on Form 8-K dated April 1, 2005, File No.
001-31320). |
|
|
|
|
|
4.8
|
|
|
|
Indenture, dated as of October 10, 2001, between Province Healthcare Company
and National City Bank, including the forms of Province Healthcare Companys
41/4% Convertible Subordinated Notes due 2008
(incorporated by reference from exhibits to the Registration Statement on Form
S-3, filed by Province Healthcare Company on December 20, 2001, File No.
333-75646). |
|
|
|
|
|
4.9
|
|
|
|
First Supplemental Indenture, dated as of April 15, 2005, by and among Province
Healthcare Company, LifePoint Hospitals, Inc. and U.S. Bank National
Association (as successor in interest to National City Bank), as trustee to the
Indenture dated as of October 10, 2001, relating to Province Healthcare
Companys 41/4% Convertible Subordinated Notes due 2008
(incorporated by reference from exhibits to the Historic LifePoint Hospitals,
Inc. Current Report on Form 8-K dated April 15, 2005, File No. 000-29818. |
|
|
|
|
|
4.10
|
|
|
|
Indenture, dated August 10, 2005, between LifePoint Hospitals, Inc. and
Citibank, N.A., as Trustee (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K dated August 10, 2005, File No.
000-51251). |
|
|
|
|
|
4.11
|
|
|
|
Indenture, dated May 29, 2007, by and between LifePoint Hospitals, Inc. as
Issuer and The Bank of New York Trust Company, N.A., as Trustee (incorporated
by reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated May 31, 2007, File No. 000-51251). |
|
|
|
|
|
10.1
|
|
|
|
Tax Sharing and Indemnification Agreement, dated May 11, 1999, by and among
Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc. (incorporated
by reference from exhibits to Historic LifePoint Hospitals Quarterly Report on
Form 10-Q for the quarter ended March 31, 1999, File No. 000-29818). |
|
|
|
|
|
10.2
|
|
|
|
Benefits and Employment Matters Agreement, dated May 11, 1999 by and among
Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc. (incorporated
by reference from exhibits to Historic LifePoint Hospitals Quarterly Report on
Form 10-Q for the quarter ended March 31, 1999, File No. 000-29818). |
|
|
|
|
|
10.3
|
|
|
|
Insurance Allocation and Administration Agreement, dated May 11, 1999, by and
among Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc.
(incorporated by reference from exhibits to Historic LifePoint Hospitals
Quarterly Report on Form 10-Q for the quarter ended March 31, 1999, File No.
000-29818). |
|
|
|
|
|
10.4
|
|
|
|
Computer and Data Processing Services Agreement, dated May 19, 2008, by and
between HCA Information Technology Services, Inc. and LifePoint Hospitals, Inc.
(incorporated by reference from exhibits to the LifePoint Hospitals, Inc.
Current Report on Form 8-K dated May 21, 2008, File No. 000-51251). |
|
|
|
|
|
10.5
|
|
|
|
Comprehensive Service Agreement for Diagnostic Imaging and Biomedical Services,
executed on January 7, 2005, between LifePoint Hospital Holdings, Inc. and GE
Healthcare Technologies (incorporated by reference from exhibits to Historic
LifePoint Hospitals Annual Report on Form 10-K for the year ended December 31,
2004, File No. 000-29818). |
|
|
|
|
|
10.6
|
|
|
|
Amended and Restated 1998 Long Term Incentive Plan (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated July 7,
2005, File No. 000-51251).* |
|
|
|
|
|
10.7
|
|
|
|
First Amendment, dated May 13, 2008, to the LifePoint Hospitals, Inc. Amended
and Restated 1998 Long-Term Incentive Plan (incorporated by reference from
Appendix A to the LifePoint Hospitals, Inc. Proxy Statement filed March 31,
2008, File No. 000-51251).* |
|
|
|
|
|
10.8
|
|
|
|
Second Amendment, dated December 10, 2008, to the to the LifePoint Hospitals,
Inc. Amended and Restated 1998 Long-Term Incentive Plan (filed herewith).* |
80
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
10.9
|
|
|
|
LifePoint Hospitals, Inc. Executive Performance Incentive Plan (incorporated by
reference from Appendix C to Historic LifePoint Hospitals Proxy Statement
dated April 28, 2004, File No. 000-29818).* |
|
|
|
|
|
10.10
|
|
|
|
First Amendment, dated December 10, 2008, to the LifePoint Hospitals, Inc.
Executive Performance Incentive Plan (filed herewith).* |
|
|
|
|
|
10.11
|
|
|
|
Form of LifePoint Hospitals, Inc. Nonqualified Stock Option Agreement
(incorporated by reference from exhibits to LifePoint Hospitals Quarterly
Report on Form 10-Q for the quarter ended March 31, 2007, File No. 000-51251).* |
|
|
|
|
|
10.12
|
|
|
|
Form of LifePoint Hospitals, Inc. Restricted Stock Award Agreement
(incorporated by reference from exhibits to LifePoint Hospitals Quarterly
Report on Form 10-Q for the quarter ended June 30, 2005, File No. 000-51251).* |
|
|
|
|
|
10.13
|
|
|
|
Form of LifePoint Hospitals, Inc. Deferred Restricted Stock Award (incorporated
by reference from exhibits to LifePoint Hospitals Quarterly Report on Form
10-Q for the quarter ended June 30, 2008, File No. 000-51251).* |
|
|
|
|
|
10.14
|
|
|
|
LifePoint Hospitals, Inc. Employee Stock Purchase Plan (incorporated by
reference from exhibits to Historic LifePoint Hospitals Annual Report on Form
10-K for the year ended December 31, 2001, File No. 000-29818).* |
|
|
|
|
|
10.15
|
|
|
|
First Amendment to the LifePoint Hospitals, Inc. Employee Stock Purchase Plan
(incorporated by reference from exhibits to the Registration Statement on Form
S-8 filed by Historic LifePoint Hospitals, Inc. on June 2, 2003, File No.
333-105775).* |
|
|
|
|
|
10.16
|
|
|
|
Second Amendment To Employee Stock Purchase Plan (incorporated by reference
from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the
quarter ended March 31, 2006, File No. 000-51251).* |
|
|
|
|
|
10.17
|
|
|
|
LifePoint Hospitals, Inc. Change in Control Severance Plan, as amended and
restated December 10, 2008 (incorporated by reference from exhibits to the
LifePoint Hospitals, Inc. Current Report on Form 8-K dated December 10/16,
2008, File No. 000-51251).* |
|
|
|
|
|
10.18
|
|
|
|
LifePoint Hospitals, Inc. Management Stock Purchase Plan, as amended and
restated (incorporated by reference from exhibits to Historic LifePoint
Hospitals Annual Report on Form 10-K for the year ended December 31, 2002,
File No. 000-29818).* |
|
|
|
|
|
10.19
|
|
|
|
First Amendment, dated May 13, 2008, to the LifePoint Hospitals, Inc.
Management Stock Purchase Plan (incorporated by reference from Appendix B to
the LifePoint Hospitals, Inc. Proxy Statement filed March 31, 2008, File No.
000-51251). * |
|
|
|
|
|
10.20
|
|
|
|
Second Amendment, dated December 10, 2008, to the LifePoint Hospitals, Inc.
Management Stock Purchase Plan (filed herewith).* |
|
|
|
|
|
10.21
|
|
|
|
Form of Outside Directors Restricted Stock Agreement (incorporated by reference
from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the
quarter ended March 31, 2006, File No. 000-51251).* |
|
|
|
|
|
10.22
|
|
|
|
Amended and Restated LifePoint Hospitals, Inc. Outside Directors Stock and
Incentive Compensation Plan, dated May 14, 2008 (incorporated by reference from
exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the quarter
ended June 30, 2008, File No. 000-51251).* |
|
|
|
|
|
10.25
|
|
|
|
Credit Agreement, dated as of April 15, 2005, by and among LifePoint Hospitals,
Inc., as borrower, the lenders referred to therein, Citicorp North America,
Inc. as administrative agent, Bank of America, N.A., CIBC World Markets Corp.,
SunTrust Bank, UBS Securities LLC, as co syndication agents and Citigroup
Global Markets, Inc., as sole lead arranger and sole bookrunner (incorporated
by reference from exhibits to Historic LifePoint Hospitals Current Report on
Form 8-K dated April 15, 2005, File No. 000-29818). |
81
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
10.26
|
|
|
|
Incremental Facility Amendment dated August 23, 2005, among LifePoint
Hospitals, Inc., as borrower, Citicorp North America, Inc., as administrative
agent and the lenders party thereto (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K dated August 23, 2005, File No.
000-51251). |
|
|
|
|
|
10.27
|
|
|
|
Amendment No. 2 to the Credit Agreement, dated October 14, 2005, among
LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc., as
administrative agent and the lenders party thereto (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated October
18, 2005, File No. 000-51251). |
|
|
|
|
|
10.28
|
|
|
|
Incremental Facility Amendment No. 3 to the Credit Agreement, dated June 30,
2006 among LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc.
as administrative agent and the lenders party thereto. (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated June 30, 2006, File No. 000-51251). |
|
|
|
|
|
10.29
|
|
|
|
Incremental Facility Amendment No. 4 to the Credit Agreement, dated September
8, 2006, among LifePoint Hospitals, Inc. as borrower, Citicorp North America,
Inc. as administrative agent and the lenders party thereto (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated September 12, 2006, File No. 000-51251). |
|
|
|
|
|
10.30
|
|
|
|
Amendment No. 5 to the Credit Agreement, dated as of May 11, 2007, among
LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc., as
administrative agent and the lenders party thereto (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated May 24,
2007, File No. 000-51251). |
|
|
|
|
|
10.31
|
|
|
|
ISDA 2002 Master Agreement, dated as of June 1, 2006, between Citibank, N.A.
and LifePoint Hospitals, Inc. (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K/A dated September 8, 2006, File
No. 000-51251). |
|
|
|
|
|
10.32
|
|
|
|
Schedule to the ISDA 2002 Master Agreement (incorporated by reference from
exhibits to LifePoint Hospitals Current Report on Form 8-K/A dated September
8, 2006, File No. 000-51251). |
|
|
|
|
|
10.33
|
|
|
|
Confirmation, dated as of June 2, 2006, between LifePoint Hospitals, Inc. and
Citibank, N.A. (incorporated by reference from exhibits to LifePoint Hospitals
Current Report on Form 8-K/A dated September 8, 2006, File No. 000-51251). |
|
|
|
|
|
10.34
|
|
|
|
Stock Purchase Agreement, dated July 14, 2005, by HCA Inc. and LifePoint
Hospitals, Inc. (incorporated by reference from exhibits to LifePoint
Hospitals Quarterly Report on Form 10-Q for the quarter ended June 30, 2006,
File No. 000-51251). |
|
|
|
|
|
10.35
|
|
|
|
Amendment to the Stock Purchase Agreement, dated June 2, 2006 (incorporated by
reference from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q
for the quarter ended June 30, 2006, File No. 000-51251). |
|
|
|
|
|
10.36
|
|
|
|
Repurchase Agreement, dated June 30, 2006, by and between HCA Inc. and
LifePoint Hospitals, Inc. (incorporated by reference from exhibits to LifePoint
Hospitals Quarterly Report on Form 10-Q for the quarter ended June 30, 2006,
File No. 000-51251). |
|
|
|
|
|
10.37
|
|
|
|
Executive Severance and Restrictive Covenant Agreement, dated December 11,
2008, by and between LifePoint CSGP, LLC and William F. Carpenter III
(filed herewith).* |
|
|
|
|
|
10.38
|
|
|
|
Agreement to Cooperate and General Release, entered into on May 4, 2007, by and
between LifePoint Hospitals, CSGP, LLC and Michael J. Culotta (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated May 10, 2007, File No. 000-51251).* |
|
|
|
|
|
10.39
|
|
|
|
Retirement Agreement and General Release, dated August 21, 2008, by and between
LifePoint CSGP, LLC and William M. Gracey . (incorporated by reference from
exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the quarter
ended September 30, 2008, File No. 000-51251).* |
82
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
10.40
|
|
|
|
Form of Indemnification Agreement (incorporated by reference from exhibits to
the LifePoint Hospitals, Inc. Current Report on Form 8-K dated August 29, 2008,
File No. 000-51251). |
|
|
|
|
|
10.41
|
|
|
|
Recoupment Policy Relating to Unearned Incentive Compensation of Executive
Officers (incorporated by reference from exhibits to the LifePoint Hospitals,
Inc. Current Report on Form 8-K dated May 20, 2008, File No. 000-51251). |
|
|
|
|
|
12.1
|
|
|
|
Ratio of Earnings to Fixed Charges |
|
|
|
|
|
21.1
|
|
|
|
List of Subsidiaries |
|
|
|
|
|
23.1
|
|
|
|
Consent of Independent Registered Public Accounting Firm |
|
|
|
|
|
31.1
|
|
|
|
Certification of the Chief Executive Officer of LifePoint Hospitals, Inc.
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
31.2
|
|
|
|
Certification of the Chief Financial Officer of LifePoint Hospitals, Inc.
pursuant to Section 302 of the Sarbanes Oxley Act of 2002 |
|
|
|
|
|
32.1
|
|
|
|
Certification of the Chief Executive Officer of LifePoint Hospitals, Inc.
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
32.2
|
|
|
|
Certification of the Chief Financial Officer of LifePoint Hospitals, Inc.
pursuant to Section 906 of the Sarbanes Oxley Act of 2002 |
|
|
|
* |
|
- Management Compensation Plan or Arrangement |
83
INDEX TO FINANCIAL STATEMENTS
|
|
|
|
|
|
|
Page |
|
|
|
F-2 |
|
|
|
|
F-3 |
|
|
|
|
F-4 |
|
|
|
|
F-5 |
|
|
|
|
F-6 |
|
|
|
|
F-7 |
|
|
|
|
F-8 |
|
|
|
|
F-9 |
|
F-1
Managements Report on Internal Control Over Financial Reporting
Management of LifePoint Hospitals, Inc. is responsible for the preparation, integrity and fair
presentation of its published consolidated financial statements. The financial statements have been
prepared in accordance with U.S. generally accepted accounting principles and, as such, include
amounts based on judgments and estimates made by management. The Company also prepared the other
information included in the annual report and is responsible for its accuracy and consistency with
the consolidated financial statements.
Management is also responsible for establishing and maintaining effective internal control
over financial reporting. The Companys internal control over financial reporting includes those
policies and procedures that pertain to the Companys ability to record, process, summarize and
report reliable financial data. The Company maintains a system of internal control over financial
reporting, which is designed to provide reasonable assurance to the Companys management and board
of directors regarding the preparation of reliable published financial statements and safeguarding
of the Companys assets. The system includes a documented organizational structure and division of
responsibility, established policies and procedures, including a code of conduct to foster a strong
ethical climate, which are communicated throughout the Company, and the careful selection, training
and development of our people.
The Board of Directors, acting through its Audit and Compliance Committee, is responsible for
the oversight of the Companys accounting policies, financial reporting and internal control. The
Audit and Compliance Committee of the Board of Directors is comprised entirely of outside directors
who are independent of management. The Audit and Compliance Committee is responsible for the
appointment and compensation of the independent registered public accounting firm. It meets
periodically with management, the independent registered public accounting firm and the internal
auditors to ensure that they are carrying out their responsibilities. The Audit and Compliance
Committee is also responsible for performing an oversight role by reviewing and monitoring the
financial, accounting and auditing procedures of the Company in addition to reviewing the Companys
financial reports. Internal auditors monitor the operation of the internal control system and
report findings and recommendations to management and the Audit and Compliance Committee.
Corrective actions are taken to address control deficiencies and other opportunities for improving
the internal control system as they are identified. The independent registered public accounting
firm and the internal auditors have full and unlimited access to the Audit and Compliance
Committee, with or without management, to discuss the adequacy of internal control over financial
reporting, and any other matters which they believe should be brought to the attention of the Audit
and Compliance Committee.
Management recognizes that there are inherent limitations in the effectiveness of any system
of internal control over financial reporting, including the possibility of human error and the
circumvention or overriding of internal control. Accordingly, even effective internal control over
financial reporting can provide only reasonable assurance with respect to financial statement
preparation and may not prevent or detect misstatements. Further, because of changes in conditions,
the effectiveness of internal control over financial reporting may vary over time.
The Company assessed its internal control system as of December 31, 2008 in relation to
criteria for effective internal control over financial reporting described in Internal Control
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission. Based on its assessment, the Company has determined that, as of December 31, 2008, its
system of internal control over financial reporting was effective.
The consolidated financial statements have been audited by the independent registered public
accounting firm of Ernst & Young LLP, which was given unrestricted access to all financial records
and related data, including minutes of all meetings of stockholders, the Board of Directors and
committees of the Board. Reports of the independent registered public accounting firm, which
includes the independent registered public accounting firms attestation report on the Companys
internal control over financial reporting, are also presented within this document.
|
|
|
|
/s/ William F. Carpenter III
|
|
/s/ David M. Dill |
President and Chief Executive Officer
|
|
Executive Vice President and Chief Financial Officer |
|
|
|
Brentwood, Tennessee
February 18, 2009 |
|
|
F-2
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders of LifePoint Hospitals, Inc.
We have audited LifePoint Hospitals Inc.s (the Company) internal control over financial
reporting as of December 31, 2008, based on criteria established in Internal ControlIntegrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO
criteria). The Companys management is responsible for maintaining effective internal control over
financial reporting, and for its assessment of the effectiveness of internal control over financial
reporting included in the accompanying Managements Report on Internal Control over Financial
Reporting. Our responsibility is to express an opinion on the companys internal control over
financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control over financial reporting was
maintained in all material respects. Our audit included obtaining an understanding of internal
control over financial reporting, assessing the risk that a material weakness exists, testing and
evaluating the design and operating effectiveness of internal control based on the assessed risk,
and performing such other procedures as we considered necessary in the circumstances. We believe
that our audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
companys internal control over financial reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
In our opinion, LifePoint Hospitals, Inc. maintained, in all material respects, effective internal
control over financial reporting as of December 31, 2008, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), the consolidated balance sheets of LifePoint Hospitals, Inc. as of December
31, 2008 and 2007 and the related consolidated statements of operations, stockholders equity and
cash flows for each of the three years in the period ended December 31, 2008 of LifePoint
Hospitals, Inc. and our report dated February 18, 2009 expressed an unqualified opinion thereon.
Nashville, Tennessee
February 18, 2009
F-3
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders of LifePoint Hospitals, Inc.
We have audited the accompanying consolidated balance sheets of LifePoint Hospitals, Inc. (the
Company) as of December 31, 2008 and 2007, and the related consolidated statements of operations,
stockholders equity, and cash flows for each of the three years in the period ended December 31,
2008. These financial statements are the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the consolidated financial position of LifePoint Hospitals, Inc. at December 31, 2008 and
2007, and the consolidated results of its operations and its cash flows for each of the three years
in the period ended December 31, 2008, in conformity with U.S. generally accepted accounting
principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight
Board (United States), LifePoint Hospitals, Inc.s internal control over financial reporting as of
December 31, 2008, based on criteria established in Internal Control-Integrated Framework issued by
the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February
18, 2009 expressed an unqualified opinion thereon.
February 18, 2009
Nashville, Tennessee
F-4
LIFEPOINT HOSPITALS, INC.
CONSOLIDATED BALANCE SHEETS
December 31, 2007 and 2008
(Dollars in millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
53.1 |
|
|
$ |
75.7 |
|
Accounts receivable, less allowances for doubtful accounts of $376.3 and $374.4
at December 31, 2007 and 2008, respectively |
|
|
304.5 |
|
|
|
315.9 |
|
Inventories |
|
|
67.1 |
|
|
|
69.6 |
|
Assets held for sale |
|
|
37.0 |
|
|
|
21.6 |
|
Prepaid expenses |
|
|
12.3 |
|
|
|
12.0 |
|
Income taxes receivable |
|
|
27.9 |
|
|
|
19.9 |
|
Deferred tax assets |
|
|
123.0 |
|
|
|
103.4 |
|
Other current assets |
|
|
20.6 |
|
|
|
19.2 |
|
|
|
|
|
|
|
|
|
|
|
645.5 |
|
|
|
637.3 |
|
|
|
|
|
|
|
|
|
|
Property and equipment: |
|
|
70.4 |
|
|
|
71.1 |
|
Land |
|
|
1,195.3 |
|
|
|
1,257.2 |
|
Buildings and improvements |
|
|
659.6 |
|
|
|
737.9 |
|
Equipment
Construction in progress (estimated cost to complete and equip after December
31, 2008 is $169.8) |
|
|
32.6 |
|
|
|
39.7 |
|
|
|
|
|
|
|
|
|
|
|
1,957.9 |
|
|
|
2,105.9 |
|
Accumulated depreciation |
|
|
(574.9 |
) |
|
|
(689.9 |
) |
|
|
|
|
|
|
|
|
|
|
1,383.0 |
|
|
|
1,416.0 |
|
|
|
|
|
|
|
|
|
|
Deferred loan costs, net |
|
|
38.6 |
|
|
|
31.3 |
|
Intangible assets, net |
|
|
52.4 |
|
|
|
68.8 |
|
Other |
|
|
4.4 |
|
|
|
10.4 |
|
Goodwill |
|
|
1,512.0 |
|
|
|
1,516.5 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
3,635.9 |
|
|
$ |
3,680.3 |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
95.6 |
|
|
$ |
92.3 |
|
Accrued salaries |
|
|
66.0 |
|
|
|
73.2 |
|
Other current liabilities |
|
|
109.8 |
|
|
|
94.5 |
|
Current maturities of long-term debt |
|
|
0.5 |
|
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
|
271.9 |
|
|
|
261.1 |
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,516.7 |
|
|
|
1,515.6 |
|
Deferred income taxes |
|
|
113.2 |
|
|
|
103.1 |
|
Professional and general liability claims and other liabilities |
|
|
109.8 |
|
|
|
146.2 |
|
Long-term income tax liability |
|
|
64.9 |
|
|
|
59.4 |
|
|
Minority interests in equity of consolidated entities |
|
|
15.2 |
|
|
|
16.3 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,091.7 |
|
|
|
2,101.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued |
|
|
|
|
|
|
|
|
Common stock, $0.01 par value; 90,000,000 shares authorized; 58,101,477 and
58,787,009 shares issued at December 31, 2007 and 2008, respectively |
|
|
0.6 |
|
|
|
0.6 |
|
Capital in excess of par value |
|
|
1,084.9 |
|
|
|
1,116.3 |
|
Unearned ESOP compensation |
|
|
(3.1 |
) |
|
|
|
|
Accumulated other comprehensive loss |
|
|
(19.8 |
) |
|
|
(28.3 |
) |
Retained earnings |
|
|
522.8 |
|
|
|
637.3 |
|
Common stock in treasury, at cost, 1,356,487 and 5,346,156 shares at December
31, 2007 and 2008, respectively |
|
|
(41.2 |
) |
|
|
(147.3 |
) |
|
|
|
|
|
|
|
Total stockholders equity |
|
|
1,544.2 |
|
|
|
1,578.6 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
3,635.9 |
|
|
$ |
3,680.3 |
|
|
|
|
|
|
|
|
F-5
LIFEPOINT HOSPITALS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Years Ended December 31, 2006, 2007 and 2008
(In millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Revenues |
|
$ |
2,336.5 |
|
|
$ |
2,568.4 |
|
|
$ |
2,700.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
918.0 |
|
|
|
1,006.1 |
|
|
|
1,065.4 |
|
Supplies |
|
|
326.1 |
|
|
|
352.2 |
|
|
|
372.6 |
|
Other operating expenses |
|
|
397.4 |
|
|
|
464.0 |
|
|
|
499.8 |
|
Provision for doubtful accounts |
|
|
250.0 |
|
|
|
307.0 |
|
|
|
313.2 |
|
Depreciation and amortization |
|
|
105.4 |
|
|
|
129.4 |
|
|
|
132.1 |
|
Interest expense, net |
|
|
100.8 |
|
|
|
94.5 |
|
|
|
88.0 |
|
Impairment loss |
|
|
|
|
|
|
|
|
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,097.7 |
|
|
|
2,353.2 |
|
|
|
2,472.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before minority interests and income
taxes |
|
|
238.8 |
|
|
|
215.2 |
|
|
|
228.5 |
|
Minority interests in earnings of consolidated entities |
|
|
1.4 |
|
|
|
1.7 |
|
|
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes |
|
|
237.4 |
|
|
|
213.5 |
|
|
|
226.3 |
|
Provision for income taxes |
|
|
93.2 |
|
|
|
85.8 |
|
|
|
88.1 |
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
144.2 |
|
|
|
127.7 |
|
|
|
138.2 |
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations, net of income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations |
|
|
(2.9 |
) |
|
|
(8.6 |
) |
|
|
(6.3 |
) |
Impairment charge |
|
|
|
|
|
|
(16.5 |
) |
|
|
(17.1 |
) |
Gain (loss) on sale of hospitals |
|
|
4.2 |
|
|
|
(0.6 |
) |
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations |
|
|
1.3 |
|
|
|
(25.7 |
) |
|
|
(23.7 |
) |
Cumulative effect of change in accounting principle, net of income taxes |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
146.2 |
|
|
$ |
102.0 |
|
|
$ |
114.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
2.59 |
|
|
$ |
2.27 |
|
|
$ |
2.63 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
(0.45 |
) |
|
|
(0.45 |
) |
Cumulative effect of change in accounting principle |
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
2.63 |
|
|
$ |
1.82 |
|
|
$ |
2.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
2.56 |
|
|
$ |
2.23 |
|
|
$ |
2.58 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
(0.44 |
) |
|
|
(0.44 |
) |
Cumulative effect of change in accounting principle |
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
2.60 |
|
|
$ |
1.79 |
|
|
$ |
2.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares and dilutive securities outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
55.6 |
|
|
|
56.2 |
|
|
|
52.5 |
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
56.3 |
|
|
|
57.2 |
|
|
|
53.5 |
|
|
|
|
|
|
|
|
|
|
|
F-6
LIFEPOINT HOSPITALS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2006, 2007 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
146.2 |
|
|
$ |
102.0 |
|
|
$ |
114.5 |
|
Adjustments to reconcile net income to net cash provided by operating
activities: |
|
|
|
|
|
|
|
|
|
|
|
|
(Income) loss from discontinued operations |
|
|
(1.3 |
) |
|
|
25.7 |
|
|
|
23.7 |
|
Cumulative effect of change in accounting principle, net of income taxes |
|
|
(0.7 |
) |
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
13.1 |
|
|
|
18.7 |
|
|
|
23.4 |
|
ESOP expense (non-cash portion) |
|
|
8.7 |
|
|
|
8.6 |
|
|
|
7.6 |
|
Depreciation and amortization |
|
|
105.4 |
|
|
|
129.4 |
|
|
|
132.1 |
|
Amortization of physician minimum revenue guarantees |
|
|
1.6 |
|
|
|
5.4 |
|
|
|
9.3 |
|
Amortization of deferred loan costs |
|
|
5.3 |
|
|
|
6.7 |
|
|
|
7.3 |
|
Minority interests in earnings of consolidated entities |
|
|
1.4 |
|
|
|
1.7 |
|
|
|
2.2 |
|
Deferred income taxes (benefit) |
|
|
45.2 |
|
|
|
(14.9 |
) |
|
|
3.7 |
|
Reserve for professional and general liability claims, net |
|
|
5.1 |
|
|
|
8.2 |
|
|
|
17.6 |
|
Increase (decrease) in cash from operating assets and liabilities, net
of effects from acquisitions and divestitures: |
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(51.7 |
) |
|
|
(13.7 |
) |
|
|
(11.2 |
) |
Inventories and other current assets |
|
|
(11.4 |
) |
|
|
(6.2 |
) |
|
|
(2.0 |
) |
Accounts payable and accrued expenses |
|
|
21.7 |
|
|
|
(28.1 |
) |
|
|
(11.1 |
) |
Income taxes payable /receivable |
|
|
(32.1 |
) |
|
|
(2.8 |
) |
|
|
26.2 |
|
Other |
|
|
1.3 |
|
|
|
0.7 |
|
|
|
3.3 |
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities-continuing operations |
|
|
257.8 |
|
|
|
241.4 |
|
|
|
346.6 |
|
Net cash (used in) provided by operating activities-discontinued operations |
|
|
(11.9 |
) |
|
|
21.7 |
|
|
|
(12.5 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
245.9 |
|
|
|
263.1 |
|
|
|
334.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment |
|
|
(194.0 |
) |
|
|
(158.4 |
) |
|
|
(157.6 |
) |
Acquisitions, net of cash acquired |
|
|
(281.3 |
) |
|
|
|
|
|
|
(21.8 |
) |
Other |
|
|
(0.5 |
) |
|
|
0.1 |
|
|
|
(5.9 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities-continuing operations |
|
|
(475.8 |
) |
|
|
(158.3 |
) |
|
|
(185.3 |
) |
Net cash provided by (used in) investing activities-discontinued operations |
|
|
63.5 |
|
|
|
101.7 |
|
|
|
(5.8 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(412.3 |
) |
|
|
(56.6 |
) |
|
|
(191.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from borrowings |
|
|
260.0 |
|
|
|
615.0 |
|
|
|
10.4 |
|
Payments of borrowings |
|
|
(110.0 |
) |
|
|
(765.9 |
) |
|
|
(10.1 |
) |
Proceeds from exercise of stock options |
|
|
0.6 |
|
|
|
12.7 |
|
|
|
3.6 |
|
Proceeds from employee stock purchase plans |
|
|
3.0 |
|
|
|
1.3 |
|
|
|
0.8 |
|
Proceeds for the completion of a new hospital |
|
|
|
|
|
|
14.7 |
|
|
|
|
|
Repurchase of common stock |
|
|
|
|
|
|
(29.0 |
) |
|
|
(118.3 |
) |
Payment of debt issue costs |
|
|
(1.0 |
) |
|
|
(14.2 |
) |
|
|
|
|
(Distributions to) proceeds from minority investors in joint ventures |
|
|
(3.1 |
) |
|
|
0.4 |
|
|
|
(0.7 |
) |
Capital lease payments and other |
|
|
(1.0 |
) |
|
|
(0.6 |
) |
|
|
(5.0 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities continuing operations |
|
|
148.5 |
|
|
|
(165.6 |
) |
|
|
(119.3 |
) |
Net cash used in financing activities-discontinued operations |
|
|
(0.3 |
) |
|
|
|
|
|
|
(1.1 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities |
|
|
148.2 |
|
|
|
(165.6 |
) |
|
|
(120.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents |
|
|
(18.2 |
) |
|
|
40.9 |
|
|
|
22.6 |
|
Cash and cash equivalents at beginning of year |
|
|
30.4 |
|
|
|
12.2 |
|
|
|
53.1 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year |
|
$ |
12.2 |
|
|
$ |
53.1 |
|
|
$ |
75.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
|
|
|
|
Interest payments |
|
$ |
107.2 |
|
|
$ |
95.6 |
|
|
$ |
82.6 |
|
|
|
|
|
|
|
|
|
|
|
Capitalized interest |
|
$ |
1.2 |
|
|
$ |
1.7 |
|
|
$ |
0.9 |
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid, net |
|
$ |
75.8 |
|
|
$ |
103.2 |
|
|
$ |
59.2 |
|
|
|
|
|
|
|
|
|
|
|
F-7
LIFEPOINT HOSPITALS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
For the Years Ended December 31, 2006, 2007 and 2008
(In millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned |
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital in |
|
|
Unearned |
|
|
Compensation |
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Excess of |
|
|
ESOP |
|
|
on Nonvested |
|
|
Comprehensive |
|
|
Retained |
|
|
Treasury |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Par Value |
|
|
Compensation |
|
|
Stock |
|
|
Loss |
|
|
Earnings |
|
|
Stock |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2005 |
|
|
57.1 |
|
|
$ |
0.6 |
|
|
$ |
1,053.1 |
|
|
$ |
(9.7 |
) |
|
$ |
(31.0 |
) |
|
$ |
|
|
|
$ |
274.8 |
|
|
$ |
|
|
|
$ |
1,287.8 |
|
Comprehensive income:
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146.2 |
|
|
|
|
|
|
|
146.2 |
|
Net change in fair value
of interest rate swap,
net of tax benefit of
$5.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(9.6 |
) |
|
|
|
|
|
|
|
|
|
|
(9.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
136.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reclassification of
unearned compensation on
nonvested stock balance
upon adoption of SFAS No.
123(R) |
|
|
|
|
|
|
|
|
|
|
(31.0 |
) |
|
|
|
|
|
|
31.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash ESOP compensation
earned |
|
|
|
|
|
|
|
|
|
|
6.4 |
|
|
|
3.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.7 |
|
Exercise of stock options,
including tax benefits and
other |
|
|
|
|
|
|
|
|
|
|
0.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.6 |
|
Stock activity in
connection with employee
stock purchase plans |
|
|
|
|
|
|
|
|
|
|
3.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.0 |
|
Stock-based compensation |
|
|
0.3 |
|
|
|
|
|
|
|
12.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2006 |
|
|
57.4 |
|
|
|
0.6 |
|
|
|
1,044.4 |
|
|
|
(6.4 |
) |
|
|
|
|
|
|
(9.6 |
) |
|
|
421.0 |
|
|
|
|
|
|
|
1,450.0 |
|
Comprehensive income:
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102.0 |
|
|
|
|
|
|
|
102.0 |
|
Net change in fair value
of interest rate swap,
net of tax benefit of
$5.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10.2 |
) |
|
|
|
|
|
|
|
|
|
|
(10.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
91.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative impact of change
in accounting for
uncertainties in income
taxes (FIN 48) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.2 |
) |
|
|
|
|
|
|
(0.2 |
) |
Non-cash ESOP compensation
earned |
|
|
|
|
|
|
|
|
|
|
6.2 |
|
|
|
3.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.5 |
|
Exercise of stock options,
including tax benefits and
other |
|
|
0.4 |
|
|
|
|
|
|
|
13.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.9 |
|
Stock activity in
connection with employee
stock purchase plans |
|
|
|
|
|
|
|
|
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.6 |
|
Stock-based compensation |
|
|
0.3 |
|
|
|
|
|
|
|
18.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.8 |
|
Repurchases of common
stock, at cost |
|
|
(1.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(41.2 |
) |
|
|
(41.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2007 |
|
|
56.7 |
|
|
|
0.6 |
|
|
|
1,084.9 |
|
|
|
(3.1 |
) |
|
|
|
|
|
|
(19.8 |
) |
|
|
522.8 |
|
|
|
(41.2 |
) |
|
|
1,544.2 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
114.5 |
|
|
|
|
|
|
|
114.5 |
|
Net change in fair value
of interest rate swap,
net of tax benefit of
$4.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8.5 |
) |
|
|
|
|
|
|
|
|
|
|
(8.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash ESOP compensation
earned |
|
|
|
|
|
|
|
|
|
|
4.7 |
|
|
|
3.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.8 |
|
Exercise of stock options,
including tax benefits and
other |
|
|
0.2 |
|
|
|
|
|
|
|
2.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.5 |
|
Stock activity in
connection with employee
stock purchase plan |
|
|
|
|
|
|
|
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.8 |
|
Stock-based compensation |
|
|
0.4 |
|
|
|
|
|
|
|
23.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.4 |
|
Repurchases of common
stock, at cost |
|
|
(3.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(106.1 |
) |
|
|
(106.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008 |
|
|
53.4 |
|
|
$ |
0.6 |
|
|
$ |
1,116.3 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(28.3 |
) |
|
$ |
637.3 |
|
|
$ |
(147.3 |
) |
|
$ |
1,578.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-8
LIFEPOINT HOSPITALS, INC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2008
Note 1. Organization and Summary of Significant Accounting Policies
Organization
LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates
general acute care hospitals in non-urban communities in the United States. Unless the context
otherwise requires, LifePoint and its subsidiaries are referred to herein as LifePoint, the
Company, we, our, or us. At December 31, 2008, on a consolidated basis, the Companys
subsidiaries owned or leased 48 hospitals, including two hospitals that are held for sale, and
serving non-urban communities in 17 states. Unless noted otherwise, discussions in these notes
pertain to the Companys continuing operations.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and all
subsidiaries and entities controlled by the Company through the Companys direct or indirect
ownership of a majority interest and exclusive rights granted to the Company as the sole general
partner of such entities. All significant intercompany accounts and transactions within the Company
have been eliminated in consolidation.
Use of Estimates
The preparation of the accompanying consolidated financial statements in conformity with U.S.
generally accepted accounting principles requires management to make estimates and assumptions that
affect the amounts reported in the consolidated financial statements and accompanying notes. Actual
results could differ from those estimates.
Reclassifications
None of the reclassifications mentioned
below have an
impact on the Companys total assets, total liabilities, stockholders equity, net income or cash flows.
Certain prior year amounts have been reclassified to conform to current year
presentation for discontinued operations.
Certain prior year statements of cash flow amounts have been reclassified to conform to the
current year presentation for (distributions to) proceeds from minority investors in joint
ventures. Previously, the Company classified (distributions to) proceeds from minority investors in
joint ventures as an other investing activity. The Company has determined this type of activity is
properly classified as a financing activity.
The Company has historically classified its total reserve for professional and general
liability claims as a long-term liability on its consolidated balance sheet. In addition, the Company has historically classified its total reserve for workers compensation
claims as a current liability on its consolidated balance sheet. During the year ended December 31, 2008, the Company concluded that a portion of its reserve for professional and general liability claims should be classified as a current liability and a portion of its
reserve for workers compensation claims should be classified as a long-term liability. As a result of these reclassifications, the Company has revised the accompanying December 31, 2007 consolidated balance sheet to conform to the
December 31, 2008 presentation.
The following is a summary of the line items impacted by the revision of the December 31, 2007 consolidated balance sheet (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
Previously
Reported |
|
|
Adjustments |
|
|
Revised |
|
Other current
liabilities |
|
$ |
99.6 |
|
|
$ |
10.2 |
|
|
$ |
109.8 |
|
Total current
liabilities |
|
$ |
261.7 |
|
|
$ |
10.2 |
|
|
$ |
271.9 |
|
Professional
and general liability claims and other liabilities |
|
$ |
120.0 |
|
|
$ |
(10.2 |
) |
|
$ |
109.8 |
|
For
the Companys consolidated balance sheet as of December 31, 2007, the Company
increased both its deferred tax assets and long-term income tax liability by $9.4
million to report them gross of the federal income tax benefit. Previously,
for the Companys consolidated balance sheet as of
December 31, 2007, the Company reported its deferred tax assets and long-term income tax liability
net of the federal income tax benefit. The Company has determined
that it is appropriate to
report the deferred tax assets and long-term income tax liability on a gross basis.
F-9
Discontinued Operations
In accordance with the provisions of Statement of Financial Accounting Standards (SFAS) No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS No. 144), the Company
has presented the operating results, financial position and cash flows of Bartow Memorial Hospital
(Bartow), Ashland Regional Medical Center (Ashland), Medical Center of Southern Indiana
(Southern Indiana), Palo Verde Hospital (Palo Verde), Smith County Memorial Hospital (Smith
County), St. Josephs Hospital (St. Josephs), Saint Francis Hospital (Saint Francis),
Colorado River Medical Center (Colorado River), Coastal Carolina Medical Center (Coastal),
Doctors Hospital of Opelousas (Opelousas) and Starke Memorial Hospital (Starke) as
discontinued operations in the accompanying consolidated financial statements. The results of
operations of these 11 hospitals have been reflected as discontinued operations, net of income
taxes, in the accompanying consolidated statements of operations and certain assets of these 11
hospitals are reflected as assets held for sale prior to disposal in the accompanying consolidated
balance sheets, as further described in Note 3.
General and Administrative Costs
The majority of the Companys expenses are cost of revenue items. Costs that could be
classified as general and administrative by the Company would include its corporate overhead
costs, which were $77.2 million, $84.2 million and $89.6 million for the years ended December 31,
2006, 2007, and 2008, respectively.
Fair Value of Financial Instruments
On January 1, 2008, the Company adopted the provisions of SFAS No. 157, Fair Value
Measurements (SFAS No. 157) with respect to the valuation of its interest rate swap instrument,
as described in detail within this note. The Company did not adopt the provisions of SFAS No. 157
with respect to nonfinancial assets pursuant to FSP FAS 157-2, Effective Date of FASB Statement
No. 157 . SFAS No. 157 clarifies how companies are required to use a fair value measure for
recognition and disclosure by establishing a common definition of fair value, creating a framework
for measuring fair value, and expanding disclosures about fair value measurements. SFAS No. 157
establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active
markets; Level 2, defined as inputs other than quoted prices in active markets that are either
directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or
no market data exists, therefore requiring an entity to develop its own assumptions. The adoption
of SFAS No. 157 did not have a material impact on the Companys results of operations or financial
position.
Cash and Cash Equivalents, Accounts Receivable and Accounts Payable. The carrying amounts
reported in the accompanying consolidated balance sheets for cash and cash equivalents, accounts receivable and
accounts payable approximate fair value because of the short-term maturity of these instruments.
LongTerm Debt. The Companys term B loans under its credit agreement (the Term B Loans), 31/2% Convertible Senior Subordinated
Notes due May 15, 2014 (the 31/2% Notes) and 31/4%
Convertible Senior Subordinated Debentures due August 15, 2025 (the 31/4%
Debentures) were the only long-term debt instruments where the carrying amounts
differed from their fair value as of December 31, 2007 and 2008. The carrying amount and fair value
of these instruments as of December 31, 2007 and 2008 were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Amount |
|
Fair Value |
|
|
2007 |
|
2008 |
|
2007 |
|
2008 |
Term B Loans |
|
$ |
706.0 |
|
|
$ |
706.4 |
|
|
$ |
670.7 |
|
|
$ |
586.3 |
|
31/2% Notes |
|
|
575.0 |
|
|
|
575.0 |
|
|
|
513.2 |
|
|
|
387.3 |
|
31/4% Debentures |
|
|
225.0 |
|
|
|
225.0 |
|
|
|
194.1 |
|
|
|
162.0 |
|
The fair values of the Companys Term B Loans,
31/4% Debentures and 31/2% Notes were based on the
quoted prices at December 31, 2007 and 2008. The Companys long-term debt instruments are further
discussed in Note 7.
F-10
Interest Rate Swap. The Company has designated its interest rate swap as a cash flow hedge
instrument, which is recorded in the Companys accompanying
consolidated balance sheets at its fair value. The
fair value of the Companys interest rate swap agreement is determined in accordance with SFAS No.
157 based on the amount at which it could be settled, which is referred to in SFAS No. 157 as the
exit price. The exit price is based upon observable market assumptions and appropriate valuation
adjustments for credit risk. The Company has categorized its interest rate swap as Level 2 under
SFAS No. 157.
The fair value of the Companys interest rate swap at December 31, 2007 and 2008 reflects a
liability of approximately $31.0 million and $45.0 million, respectively, and is included in
professional and general liability claims and other liabilities in the accompanying consolidated
balance sheets. The Companys interest rate swap is further described in Note 7.
Revenue Recognition and Allowance for Contractual Discounts
The Company recognizes revenues in the period in which services are performed. Accounts
receivable primarily consist of amounts due from third-party payors and patients. Amounts the
Company receives for treatment of patients covered by governmental programs such as Medicare and
Medicaid and other third-party payors such as health maintenance organizations, preferred provider
organizations and other private insurers are generally less than the Companys established billing
rates. Accordingly, the revenues and accounts receivable reported in the Companys consolidated
financial statements are recorded at the net amount expected to be received.
The Company derives a significant portion of its revenues from Medicare, Medicaid and other
payors that receive discounts from its established billing rates. The Company must estimate the
total amount of these discounts to prepare its consolidated financial statements. The Medicare and
Medicaid regulations and various managed care contracts under which these discounts must be
calculated are complex and are subject to interpretation and adjustment. The Company estimates the
allowance for contractual discounts on a payor-specific basis given its interpretation of the
applicable regulations or contract terms. These interpretations sometimes result in payments that
differ from the Companys estimates. Additionally, updated regulations and contract renegotiations
occur frequently, necessitating regular review and assessment of the estimation process by
management. Changes in estimates related to the allowance for contractual discounts affect revenues
reported in the Companys accompanying consolidated statements of operations.
Self-pay revenues are derived primarily from patients who do not have any form of healthcare
coverage. The revenues associated with self-pay patients are generally reported at the Companys
gross charges. The Company evaluates these patients, after the patients medical condition is
determined to be stable, for their ability to pay based upon federal and state poverty guidelines,
qualifications for Medicaid or other governmental assistance programs, as well as the local
hospitals policy for charity/indigent care. The Company provides care without charge to certain
patients that qualify under the local charity/indigent care policy of each of its hospitals. For
the years ended December 31, 2006, 2007 and 2008, the Company estimates that services provided
under its charity/indigent care programs approximated $40.5 million, $50.5 million and $53.7
million, respectively, based on gross charges. The Company does not report a charity/indigent care
patients charges in revenues or in the provision for doubtful accounts as it is the Companys
policy not to pursue collection of amounts related to these patients.
Cost report settlements under reimbursement agreements with Medicare and Medicaid are
estimated and recorded in the period the related services are rendered and are adjusted in future
periods as final settlements are determined. There is a reasonable possibility that recorded
estimates will change by a material amount in the near term. The net adjustments to estimated cost
report settlements resulted in increases to revenues of approximately $12.6 million, $8.0 million
and $7.1 million, increases to net income of approximately $7.6 million, $4.8 million $4.4 million,
and increases to diluted earnings per share of approximately $0.14, $0.08 and $0.08, for the years
ended December 31, 2006, 2007, and 2008, respectively. The net estimated cost report settlements
due to the Company as of December 31, 2007 and 2008 included in accounts receivable in the accompanying consolidated balance sheets were
approximately $5.1 million and $6.2 million, respectively. The Companys management believes that
adequate provisions have been made for adjustments that may result from final determination of
amounts earned under these programs.
F-11
Laws and regulations governing Medicare and Medicaid programs are complex and subject to
interpretation. The Company believes that it is in compliance with all applicable laws and
regulations and is not aware of any pending or threatened investigations involving allegations of
potential wrongdoing that would have a material effect on the Companys financial statements.
Compliance with such laws and regulations can be subject to future government review and
interpretation as well as significant regulatory action including fines, penalties and exclusion
from the Medicare and Medicaid programs.
Concentration of Revenues
During the years ended December 31, 2006, 2007, and 2008, approximately 44.9%, 42.3% and
40.7%, respectively, of the Companys revenues related to patients participating in the Medicare
and Medicaid programs. The Companys management recognizes that revenues and receivables from
government agencies are significant to the Companys operations, but it does not believe that there
are significant credit risks associated with these government agencies. The Companys management
does not believe that there are any other significant concentrations of revenues from any
particular payor that would subject the Company to any significant credit risks in the collection
of its accounts receivable.
The Companys revenues are particularly sensitive to regulatory and economic changes in
certain states where the Company generates significant revenues. The following is an analysis by
state of revenues as a percentage of the Companys total revenues for those states in which the
Company generates significant revenues for the years ended December 31, 2006, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospitals |
|
Percentage of |
|
|
in State as of |
|
Total Revenues |
State |
|
December 31, 2008 |
|
2006 |
|
2007 |
|
2008 |
Kentucky |
|
|
8 |
|
|
|
17.3 |
% |
|
|
17.0 |
% |
|
|
17.2 |
% |
Virginia |
|
|
4 |
|
|
|
14.6 |
|
|
|
14.4 |
|
|
|
14.1 |
|
New Mexico |
|
|
2 |
|
|
|
9.0 |
|
|
|
8.8 |
|
|
|
9.1 |
|
West Virginia |
|
|
2 |
|
|
|
6.5 |
|
|
|
8.9 |
|
|
|
9.0 |
|
Tennessee |
|
|
6 |
|
|
|
8.5 |
|
|
|
8.2 |
|
|
|
8.3 |
|
Alabama |
|
|
5 |
|
|
|
8.0 |
|
|
|
7.4 |
|
|
|
7.5 |
|
Louisiana |
|
|
5 |
|
|
|
7.3 |
|
|
|
7.4 |
|
|
|
7.2 |
|
Arizona |
|
|
2 |
|
|
|
5.7 |
|
|
|
6.5 |
|
|
|
6.4 |
|
Texas |
|
|
3 |
|
|
|
5.8 |
|
|
|
5.3 |
|
|
|
5.3 |
|
Cash and Cash Equivalents
Cash and cash equivalents consist of cash on hand and marketable securities with original
maturities of three months or less. The Company places its cash in financial institutions that are
federally insured in limited amounts.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable primarily consist of amounts due from third-party payors and patients. The
Companys ability to collect outstanding receivables is critical to its results of operations and
cash flows. To provide for accounts receivable that could become uncollectible in the future, the
Company establishes an allowance for doubtful accounts to reduce the carrying value of such
receivables to their estimated net realizable value. The primary uncertainty of such allowances
lies with uninsured patient receivables and deductibles, co-payments or other amounts due from
individual patients.
The Company has an established process to determine the adequacy of the allowance for doubtful
accounts that relies on a number of analytical tools and benchmarks to arrive at a reasonable
allowance. No single statistic or measurement determines the adequacy of the allowance for doubtful
accounts. Some of the analytical tools that the Company utilizes include, but are not limited to,
historical cash collection experience, revenue trends by payor classification and revenue days in
accounts receivable. Accounts receivable are written off after collection efforts have been
followed in accordance with the Companys policies.
F-12
A summary of activity in the Companys allowance for doubtful accounts is as follows (in
millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances |
|
Additions |
|
Accounts |
|
|
|
|
at |
|
Charged to |
|
Written Off, |
|
Balances |
|
|
Beginning |
|
Costs and |
|
Net of |
|
at End |
|
|
of Year |
|
Expenses(a) |
|
Recoveries |
|
of Year |
Year ended December 31, 2006 |
|
$ |
251.4 |
|
|
$ |
273.9 |
|
|
$ |
(199.1 |
) |
|
$ |
326.2 |
|
Year ended December 31, 2007 |
|
|
326.2 |
|
|
|
324.0 |
|
|
|
(273.9 |
) |
|
|
376.3 |
|
Year ended December 31, 2008 |
|
|
376.3 |
|
|
|
318.3 |
|
|
|
(320.2 |
) |
|
|
374.4 |
|
|
|
|
(a) |
|
Additions charged to costs and expenses include amounts related to the Companys continuing
and discontinued operations in the Companys accompanying consolidated financial statements. |
Inventories
Inventories are stated at the lower of cost (first-in, first-out) or market and are composed
of purchased items. These inventory items are primarily operating supplies used in the direct or
indirect treatment of patients.
Long-Lived Assets
Property and Equipment
Purchases of property and equipment are recorded at cost. Property and equipment acquired
in connection with business combinations are recorded at estimated fair value in accordance with
the purchase method of accounting as prescribed in SFAS No. 141, Business Combinations (SFAS No.
141). Routine maintenance and repairs are charged to expense as incurred. Expenditures that
increase capacities or extend useful lives are capitalized. Fully depreciated assets are retained
in property and equipment accounts until they are disposed of. Allocated interest on funds used to
pay for the construction or purchase of major capital additions is included in the cost of each
capital addition.
Depreciation is computed by applying the straight-line method over the estimated useful lives
of buildings and improvements and equipment. Assets under capital leases are amortized using the
straight-line method over the shorter of the estimated useful life of the assets or life of the
lease term, excluding any lease renewals, unless the lease renewals are reasonably assured. Useful
lives are as follows:
|
|
|
|
|
|
Years |
Buildings and improvements (including those under capital leases) |
|
|
10 - 40 |
Equipment |
|
|
3 - 10 |
Equipment under capital leases |
|
|
3 - 5 |
Depreciation expense was $103.7 million, $127.2 million and $130.9 million for the years ended
December 31, 2006, 2007 and 2008, respectively. Amortization expense related to assets under
capital leases is included in depreciation expense.
As of December 31, 2008, the majority of the Companys assets under capital leases are
primarily comprised of prepaid capital leases. The Companys assets under capital leases are set
forth in the following table at December 31, 2007 and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Buildings and improvements |
|
$ |
198.3 |
|
|
$ |
205.3 |
|
Equipment |
|
|
34.6 |
|
|
|
37.6 |
|
|
|
|
|
|
|
|
|
|
|
232.9 |
|
|
|
242.9 |
|
Accumulated amortization |
|
|
(33.5 |
) |
|
|
(48.9 |
) |
|
|
|
|
|
|
|
|
|
$ |
199.4 |
|
|
$ |
194.0 |
|
|
|
|
|
|
|
|
F-13
The Company evaluates its long-lived assets for possible impairment whenever circumstances
indicate that the carrying amount of the asset, or related group of assets, may not be recoverable
from estimated future cash flows, in accordance with SFAS No. 144. Fair value estimates are derived
from established market values of comparable assets or internal calculations of estimated future
net cash flows. The Companys estimates of future cash flows are based on assumptions and
projections it believes to be reasonable and supportable. The Companys assumptions take into
account revenue and expense growth rates, patient volumes, changes in payor mix and changes in
legislation and other payor payment patterns. These assumptions vary by type of facility. The
Company incurred a $16.5 million and $17.1 million impairment charge, net of income tax benefits,
in discontinued operations during the years ended December 31, 2007 and 2008, respectively, as
further described in Note 3. Additionally, the Company incurred a $1.2 million pre-tax impairment
loss in continuing operations during the year ended December 31, 2008. This impairment charge
relates to the impairment of certain operating assets for which the Company considered its existing
carrying amount exceeded the current estimated fair value of these assets.
Deferred Loan Costs
The Company records deferred loan costs for expenditures related to acquiring or issuing new
debt instruments. These expenditures include bank fees and premiums as well as attorneys and
filing fees. The Company amortizes these deferred loan costs over the life of the respective debt
instrument using the effective interest method.
Goodwill and Intangible Assets
The Company accounts for its acquisitions in accordance with SFAS No. 141 using the purchase
method of accounting. Goodwill represents the excess of the cost of an acquired entity over the net
amounts assigned to assets acquired and liabilities assumed. Under SFAS No. 142, Goodwill and
Other Intangible Assets, (SFAS No. 142), goodwill and intangible assets with indefinite lives
are reviewed by the Company at least annually for impairment. The Companys business comprises a
single operating reporting unit for impairment test purposes. For the purposes of these analyses,
the Companys estimates of fair value are based on a combination of the income approach, which
estimates the fair value of the Company based on its future discounted cash flows, and the market
approach, which estimates the fair value of the Company based on comparable market prices. During
the years ended December 31, 2006 and 2007, the Company performed its annual impairment tests as of
October 1, 2006 and 2007, and did not incur an impairment charge.
During
the year ended December 31, 2008 as a result of recent economic events and a decline
in the Companys stock price, the Company performed goodwill impairment testing as of September 30,
2008 and December 31, 2008. The Company determined that no goodwill impairment charge was required
as a result of either analysis and will continue to monitor the relationship of its fair value to
its book value as economic events and changes to its stock price occur.
The Companys intangible assets relate to contract-based physician minimum revenue guarantees,
certificates of need and non-competition agreements. Contract-based physician minimum revenue
guarantees and non-competition agreements are amortized over the terms of the agreements. The
certificates of need have been determined to have indefinite lives and, accordingly, are not
amortized. The Companys goodwill and intangible assets are further described in Note 4.
Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method,
deferred tax assets and liabilities are recognized for the future tax consequences attributable to
differences between the financial statement carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date. The Company
assesses the likelihood that deferred tax assets will be recovered from future taxable income. To
the extent the Company believes that recovery is not likely, a valuation allowance is established.
To the extent the Company establishes a valuation allowance or increases this allowance, the
Company must include an expense within the provision for income taxes in the consolidated
statements of operations. The Company classifies interest and penalties related to its tax
positions as a component of income tax expense. Income taxes are further described in Note 5.
F-14
Point of Life Indemnity, Ltd.
The Company operates a captive insurance company under the name Point of Life Indemnity, Ltd.
This captive insurance company, which was approved by the Cayman Islands Monetary Authority and
which operates as a wholly-owned subsidiary of the Company, issues malpractice insurance policies
to certain of the Companys employed physicians and voluntary attending physicians. When earned,
fees charged to voluntary attending physicians are included in revenues in the accompanying
consolidated statements of operations and approximated $1.3 million, $1.7 million and $0.4 million
during the years ended December 31, 2006, 2007 and 2008, respectively. Fees charged to employed
physicians are eliminated in consolidation. Reserves for the current estimate of the related
outstanding claims, including incurred but not reported losses, are
actuarially determined and are
included as a component of the Companys reserves for professional and general liability claims and
other liabilities in the accompanying consolidated balance sheets as of December 31, 2007 and 2008,
as discussed below.
Professional and General Liability Claims
Given the nature of the Companys operating environment, the Company is subject to potential
medical malpractice lawsuits and other claims as part of providing healthcare services. To mitigate
a portion of this risk, the Company maintained insurance for individual malpractice claims
exceeding its self insured retention levels. These self insured retention levels ranged from $15.0
million to $25.0 million during the years ended December 31, 2006, 2007 and 2008, with the
exception of certain facilities located in states having state-specific medical malpractice
programs.
During the year ended December 31, 2008, the Company modified its quarterly process for
estimating its reserve for professional and general liability claims by reducing the number of
actuarial calculations upon which the reserve is determined from the average of two calculations to
one. The Companys reserve calculations consider historical claims data, demographic
considerations, severity factors, and other actuarial assumptions, which are discounted to present
value. During the year ended December 31, 2008 the Company reduced its discount rate from 5.0% to
4.0%. As a result, the Companys professional and general liability insurance expense increased by
approximately $2.4 million, which decreased the Companys net income by approximately $1.5 million
or $0.03 earnings per diluted share.
The Companys reserve for professional and general liability claims as of the balance sheet
dates reflect the current estimate of all outstanding losses, including incurred but not reported
losses. The loss estimates included in the actuarial calculations may change in the future based
upon updated facts and circumstances. The Companys reserve for
professional and general liability claims has both a current and
long-term portion. The current portion is included in other current
liabilities and the long-term portion is included in professional and
general liability claims and other liabilities in the accompanying
consolidated balance sheets. The following table
provides information regarding the classification of the
Companys reserve for professional and general liability claims
at December 31, 2007 and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Current
portion |
|
$ |
17.4 |
|
|
$ |
15.5 |
|
Long-term
portion |
|
|
52.0 |
|
|
|
71.7 |
|
|
|
|
|
|
|
|
|
|
|
$ |
69.4 |
|
|
$ |
87.2 |
|
|
|
|
|
|
|
|
|
The Companys expense for professional and general liability claims each year includes: the
actuarially determined estimate of losses for the current year, including claims incurred but not
reported; the change in the estimate of losses for prior years based upon actual claims development
experience as compared to prior actuarial projections; the insurance premiums for losses in excess
of the Companys self-insured retention level; the administrative costs of the insurance program;
and interest expense related to the discounted portion of the liability. The total expense recorded
for professional and general liability claims for the years ended December 31, 2006, 2007 and 2008
was approximately $19.3 million, $29.1 million and $36.5 million, respectively.
During the years ended December 31, 2006, 2007 and 2008, the results of the Companys
quarterly completed actuarial calculations resulted in changes to the Companys reserve levels of
professional and general liability claims for prior years. As a result, this decreased the
Companys professional and general liability insurance expense by approximately $11.1 million,
which increased the Companys net income by approximately $6.8 million, or $0.12 earnings per
diluted share for the year ended December 31, 2006. For the years ended December 31, 2007 and 2008,
this increased the Companys professional and general liability insurance expense by approximately
$0.7 million and $4.8 million, which reduced the Companys net income by approximately $0.4 million
and $3.0 million, or $0.01 and $0.06 earnings per diluted share, respectively.
F-15
Workers Compensation Reserves
Given the nature of the Companys operating environment, it is subject to potential workers
compensation claims as part of providing healthcare services. To mitigate a portion of this risk,
the Company maintained insurance for individual workers compensation claims exceeding a range of
$1.0 million to $2.0 million for the years ended December 31, 2006, 2007 and 2008 with the
exception of the Companys facilities located in West Virginia and Wyoming which participated in
state-specific programs rather than the Companys established program.
The Companys reserve for workers compensation is based upon one annual actuarial
calculation, which considers historical claims data, demographic considerations, development
patterns, severity factors and other actuarial assumptions, which are discounted to present value.
During the year ended December 31, 2008, the Company reduced its discount rate from 5% to 4%. As a
result, the Companys workers compensation claims expense increased by approximately $0.6 million,
which decreased the Companys net income by approximately $0.4 million, or $0.01 earnings per
diluted share. The reserve for workers compensation claims at the balance sheet date reflects the
current estimate of all outstanding losses. The loss estimates included in the actuarial
calculation may change based upon updated facts and circumstances.
The Companys reserve for workers compensation claims has
both a current and long-term portion. The current portion is included
in other current liabilities and the long-term portion is included in
professional and general liability claims and other liabilities in
the accompanying consolidated balance sheets. The
following table provides
information regarding the classification of the Companys
reserve for workers compensation claims at December 31, 2007
and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Current
portion |
|
$ |
6.6 |
|
|
$ |
7.1 |
|
Long-term
portion |
|
|
6.4 |
|
|
|
8.8 |
|
|
|
|
|
|
|
|
|
|
|
$ |
13.0 |
|
|
$ |
15.9 |
|
|
|
|
|
|
|
|
|
The Companys expense for workers compensation claims each year includes: the actuarially
determined estimate of losses for the current year; the change in the estimate of losses for prior
years based upon actual claims development experience as compared to prior actuarial projections;
the insurance premiums for losses in excess of the Companys self-insured retention level; the
administrative costs of the insurance program; and interest expense related to the discounted
portion of the liability. The total expense recorded for workers compensation claims for the years
ended December 31, 2006, 2007 and 2008 was approximately $9.1 million, $11.6 million and $10.8
million, respectively.
Self-Insured Medical Benefits
The Company is self-insured for substantially all of the medical expenses and benefits of its
employees. The reserve for medical benefits primarily reflects the current estimate of incurred but
not reported losses, based upon one actuarial calculation of the incurred but not reported lag
period as of the balance sheet date. The undiscounted reserve for self-insured medical benefits was
$14.3 million and $12.9 million at December 31, 2007 and 2008, respectively.
Minority Interests in Consolidated Entities
The consolidated financial statements include all assets, liabilities, revenues, and expenses
of less-than-100%-owned entities that the Company controls. Accordingly, the Company recorded
minority interests in the earnings and equity of such entities. The Company records adjustments to
minority interest for the allocable portion of income or loss to which the minority interest
holders are entitled based upon their portion of certain of the subsidiaries that they own.
Segment Reporting
The Company has six operating divisions as of December 31, 2008. Each of these six operating
divisions has similar economic characteristics consisting of acute care hospitals in non-urban
communities. The Company realigns these operating divisions frequently based upon changing
circumstances, including acquisition and divestiture activity. The Company considers these six
operating divisions as one operating segment, healthcare services, for segment reporting purposes
and for goodwill impairment testing in accordance with SFAS No. 131, Disclosures about Segments of
an Enterprise and Related Information (SFAS No. 131), and SFAS No. 142.
F-16
The Company has determined that its six operating divisions comprise one segment because of
their similar economic characteristics in accordance with paragraph 17 of SFAS No. 131 for the
following reasons:
|
|
|
the treatment of patients in a hospital setting is the only material source of revenues
for each of the Companys six operating divisions; |
|
|
|
|
the healthcare services provided by each of the Companys operating divisions are
generally the same; |
|
|
|
|
the healthcare services provided by each of the Companys operating divisions are
generally provided to similar types of patients, which is patients in a hospital setting; |
|
|
|
|
the healthcare services are primarily provided by the direction of affiliated or
employed physicians and by the nurses, lab technicians, and others employed or contracted
at each of the Companys hospitals; and |
|
|
|
|
the healthcare regulatory environment is generally similar for each of the Companys
six operating divisions. |
Additionally, as discussed in Emerging Issues Task Force (EITF) Topic D-101, Clarification
of Reporting Unit Guidance in Paragraph 30 of FASB Statement No. 142 the Company
determined that its six operating divisions comprise one reporting unit because of their similar
economic characteristics in each of the following areas:
|
|
|
the way the Company manages its operations and extent to which its acquired facilities
are integrated into its existing operations as a single reporting unit; |
|
|
|
|
the Companys goodwill is recoverable from the collective operations of its six
operating divisions and not individually from one single operating division; |
|
|
|
|
its operating divisions are frequently realigned based upon changing circumstances,
including acquisition and divestiture activity; and |
|
|
|
|
because of the collective size of its six operating divisions, each division benefits
from its participation in a group purchasing organization. |
Stock-Based Compensation
The Company issues stock options and other stock-based awards to key employees and directors
under various stockholder-approved stock-based compensation plans, as described in Note 9. The
Company accounts for its stock-based awards in accordance with the provisions of SFAS No. 123(R),
Share-Based Payment (SFAS No. 123(R)). In accordance with SFAS No. 123(R), the Company
recognizes compensation expense based on the estimated grant date fair value of each stock-based
award.
Earnings (Loss) Per Share
Earnings (loss) per share (EPS) is based on the weighted average number of common shares
outstanding and dilutive stock options, convertible notes, when dilutive, and nonvested shares,
adjusted for the shares issued to the Employee Stock Ownership Plan (ESOP). On December 31, 2008,
as more fully discussed in Note 8, the ESOP concluded. As the ESOP shares were committed to be
released, the shares became outstanding for EPS calculations. As of December 31, 2008, all of the
ESOP shares were considered outstanding for EPS calculations. In addition, the numerator of EPS,
net income, is adjusted for interest expense related to the Companys convertible notes, when
dilutive, which is discussed further in Note 7 and Note 11. The computation of the Companys basic
and diluted EPS is set forth in Note 11.
F-17
Recently Issued Accounting Pronouncements
In December 2007, the Financial Accounting Standards Board (the FASB) issued SFAS No.
141(R), Business Combinations (SFAS No. 141(R)). SFAS No. 141(R) retains the purchase method of
accounting for acquisitions, but requires a number of changes, including changes in the way assets
and liabilities are recognized in the purchase accounting as well as requiring the expensing of
acquisition-related costs as incurred. Additionally, SFAS No. 141(R) provides guidance for
recognizing and measuring the goodwill acquired in the business combination and determines what
information to disclose to enable users of the financial statements to evaluate the nature and
financial effects of the business combination. Furthermore, this standard requires any adjustments
to acquired deferred tax assets and liabilities occurring after the related allocation period to be
made through earnings for both acquisitions occurring prior and subsequent to the effective date of
this standard. SFAS No. 141(R) is effective on January 1, 2009 for the Company. Earlier adoption
was prohibited. The adoption of SFAS No. 141(R), prospectively, may have a material effect on the
Companys results of operations and financial position, to the extent that the Company has material
acquisitions, as costs that have historically been capitalized as part of the purchase price will
now be expensed, such as accounting, legal and other professional fees.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated
Financial Statements An Amendment of ARB No. 51 (SFAS No. 160). SFAS No. 160 amends
Accounting Research Bulletin (ARB) No. 51, Consolidated Financial Statements (ARB No. 51), to
establish accounting and reporting standards for the noncontrolling interest in a subsidiary and
for the deconsolidation of a subsidiary. SFAS No. 160 clarifies that a noncontrolling interest in a
subsidiary is an ownership interest in the consolidated entity that should be reported as equity in
the consolidated financial statements. Additionally, SFAS No. 160 changes the way the consolidated
income statement is presented by requiring consolidated net income to be reported at amounts that
include the amounts attributable to both the parent and the noncontrolling interest.
SFAS No. 160 requires expanded disclosures in the consolidated financial statements that
clearly identify and distinguish between the interests of the parents owners and the interests of
the noncontrolling owners of a subsidiary, including a reconciliation of the beginning and ending
balances of the equity attributable to the parent and the noncontrolling owners and a schedule
showing the effects of changes in a parents ownership interest in a subsidiary on the equity
attributable to the parent. SFAS No. 160 does not change ARB No. 51s provisions related to
consolidation purposes or consolidation policy, or the requirement that a parent consolidate all
entities in which it has a controlling financial interest. SFAS No. 160 does, however, amend
certain of ARB No. 51s consolidation procedures to make them consistent with the requirements of
SFAS No. 141(R) as well as to provide definitions for certain terms and to clarify some
terminology. In addition to the amendments to ARB No. 51, SFAS No. 160 amends SFAS No. 128,
Earnings per Share, so that the calculation of earnings per share amounts in consolidated
financial statements will continue to be based on amounts attributable to the parent. SFAS No. 160
is effective on January 1, 2009 for the Company. Earlier adoption was prohibited. SFAS No. 160 must
be applied prospectively as of the beginning of the fiscal year in which it is initially applied,
except for the presentation and disclosure requirements, which must be applied retrospectively for
all periods presented. The adoption of SFAS No. 160 is not
expected to have a material effect on the
Companys results of operations, cash flows or financial position.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and
Hedging Activities, an amendment of FASB Statement No. 133 (SFAS No. 161). SFAS No. 161 applies
to all derivative instruments and related hedged items accounted for under SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities (SFAS No. 133). SFAS No. 161
requires entities to provide greater transparency about (a) how and why an entity uses derivative
instruments, (b) how derivative instruments and related hedged items are accounted for under SFAS
No. 133 and its related interpretations, and (c) how derivative instruments and related hedged
items affect an entitys financial position, results of operations, and cash flows. To meet these
objectives, SFAS No. 161 requires (1) qualitative disclosures about objectives for using
derivatives by primary underlying risk exposure and by purpose or strategy, (2) information about
the volume of derivative activity in a flexible format that the preparer believes is the most
relevant and practicable, (3) tabular disclosures about balance sheet location and gross fair value
amounts of derivative instruments, income statement and other comprehensive income location and
amounts of gains and losses on derivative instruments by type of contract, and (4) disclosures
about credit-risk related contingent features in derivative agreements. SFAS No. 161 is effective
for financial statements issued for fiscal years and interim periods beginning after November 15,
2008. Early application was encouraged, as were
comparative disclosures for earlier periods, but neither was required. The adoption of SFAS
No. 161 is not expected to have a material impact on the Companys results of operations, cash
flows or financial position.
F-18
On May 9, 2008, the FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments
That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) (FSP APB 14-1).
FSP APB 14-1 specifies that issuers of certain convertible debt instruments must separately account
for the liability and equity components thereof and reflect interest expense at the entitys market
rate of borrowing for non-convertible debt instruments. FSP APB 14-1 is effective for financial
statements issued for fiscal years beginning after December 15, 2008, and interim periods within
those fiscal years. Early adoption was not permitted. FSP APB 14-1 requires retrospective
application to all periods presented in the annual financial statements for the period of adoption
and where applicable instruments were outstanding during an earlier period. The cumulative effect
of the change in accounting principle on periods prior to those presented shall be recognized as of
the beginning of the first period presented. An offsetting adjustment shall be made to the opening
balance of retained earnings for that period, presented separately. The Company estimates that this
new accounting standard will increase its interest expense by
$21.1 million and adversely affect its diluted earnings per share by approximately $0.24
per share during the year ending December 31, 2009.
Note 2. Acquisitions
Acquisitions 2007 and 2008
The Company did not complete any significant acquisitions during the year ended December 31,
2007 and completed miscellaneous ancillary service-line acquisitions
totaling $21.8 million during the year ended December 31, 2008.
Acquisitions 2006
Four Former HCA Hospitals
Effective July 1, 2006, the Company completed its acquisition of four hospitals from HCA Inc.
(HCA) for a purchase price of $239.0 million plus specific working capital and capital
expenditures as set forth in the purchase agreement. The four hospitals that the Company acquired
were Clinch Valley Medical Center, a 200-bed facility located in Richlands, Virginia; St. Josephs
Hospital, a 325-bed facility located in Parkersburg, West Virginia; Saint Francis Hospital, a
155-bed facility located in Charleston, West Virginia; and Raleigh General Hospital, a 369-bed
facility located in Beckley, West Virginia (collectively the Four Former HCA Hospitals). The
Company borrowed $250.0 million under its Credit Agreement to pay for this acquisition.
Under the purchase method of accounting, in accordance with SFAS No. 141, the total purchase
price of the Four Former HCA Hospitals was allocated to the net tangible and intangible assets
based upon their estimated fair values as of July 1, 2006. The excess of the purchase price over
the estimated fair value of the net tangible and intangible assets was recorded as goodwill. The
results of operations of these hospitals are included in LifePoints results of operations
beginning July 1, 2006. The Company finalized the purchase price allocation for the Four Former HCA
Hospitals during the third quarter of 2007.
The fair values of assets acquired and liabilities assumed at the date of acquisition were as
follows (in millions):
|
|
|
|
|
Inventories |
|
$ |
13.0 |
|
Prepaid expenses |
|
|
1.6 |
|
Other current assets |
|
|
0.8 |
|
Property and equipment |
|
|
198.0 |
|
Intangible assets: |
|
|
|
|
Certificates of need |
|
|
4.3 |
|
Non-competition agreements |
|
|
0.7 |
|
Goodwill |
|
|
47.5 |
|
|
|
|
|
Total assets acquired, excluding cash |
|
|
265.9 |
|
|
|
|
|
Accounts payable |
|
|
0.2 |
|
Accrued salaries |
|
|
5.6 |
|
Other current liabilities |
|
|
2.4 |
|
|
|
|
|
Total liabilities assumed |
|
|
8.2 |
|
|
|
|
|
Net assets acquired |
|
$ |
257.7 |
|
|
|
|
|
F-19
The Company classified St. Josephs and Saint Francis as assets held for sale/discontinued
operations, in accordance with the provisions of SFAS No. 144, effective as of the acquisition date
of July 1, 2006. The Company sold Saint Francis effective January 1, 2007 and St. Josephs
effective May 1, 2007, as further discussed in Note 3.
Havasu Joint Venture
Effective September 1, 2006, Havasu Surgery Center, Inc., (HSC), an Arizona corporation
owned by physicians and other individuals transferred substantially all of its assets to Havasu
Regional Medical Center, LLC, a newly-formed Delaware limited liability company (the Havasu LLC),
in exchange for all of the Class A units in the Havasu LLC, plus cash. Also effective September 1,
2006, PHC-Lake Havasu, Inc., a wholly-owned subsidiary of the Company which operated Havasu
Regional Medical Center (HRMC), contributed to the Havasu LLC substantially all of the assets
used in the operation of HRMC (except for real estate and home health assets), plus cash, in
exchange for all of the Class B units in the Havasu LLC (the Class B Units). The Class B Units
represented an approximate 96% equity interest in the Havasu LLC. The Company accounted for the HSC
transaction as an acquisition with a purchase price of approximately $27.0 million, which consisted
of $18.9 million in cash and a non-cash $8.1 million capital contribution from the minority
physician partners. Goodwill recognized in connection with the acquisition of the HSC totaled $8.9
million.
Impact of Final Valuations of Fixed Assets
In connection with the purchase price allocation of the Four Former HCA Hospitals , the
Company recognized an increase in depreciation and amortization expense of approximately $3.2
million ($1.9 million, net of income taxes), or $0.03 per diluted share, during the year ended
December 31, 2007. This increased depreciation and amortization expense was the result of higher
values of certain buildings, equipment and intangible assets than the Company originally
anticipated in the preliminary purchase price allocations.
In connection with the finalization of the purchase price allocations of the July 1, 2005
Danville Regional Medical Center acquisition and the April 15, 2005 Province Healthcare Company
(Province) business combination (the Province Business Combination), the Company recognized a
reduction in depreciation expense of approximately $13.5 million ($8.1 million, net of income
taxes), or $0.14 per diluted share, during the year ended December 31, 2006. This decreased
depreciation expense was the result of lower fair values of certain property and equipment than
originally anticipated in the preliminary purchase price allocations.
Note 3. Discontinued Operations
Facilities
Identified as Discontinued Operations 2008
In September 2008, the Companys management committed to sell Opelousas, a 171 bed facility
located in Opelousas, Louisiana, and Starke, a 53 bed facility located in Knox, Indiana. The
Company is actively engaged in negotiations with respect to both facilities. The Company has
classified these two hospitals as held for sale in the accompanying consolidated balance sheets as
of December 31, 2007 and 2008.
Facilities
Identified as Discontinued Operations 2007
In March 2007, the Company signed a letter of intent to transfer to a third party
substantially all of the operating assets and net working capital of Colorado River. Effective
April 1, 2008, the Company terminated its existing lease agreement as discussed in detail within
this note.
Effective July 1, 2007, the Company sold Coastal, a 41 bed facility located in Hardeeville,
South Carolina, to Tenet Healthcare Corporation (Tenet) for approximately $35.0 million, plus
working capital, as discussed in detail within this note.
F-20
Effective May 1, 2007, the Company sold St. Josephs to Signature Hospital, LLC for
approximately $68.5 million, plus working capital. Effective January 1, 2007, the Company sold
Saint Francis to the Herbert J. Thomas Memorial Hospital Association for approximately $37.5
million, plus working capital. Both St. Josephs and St. Francis were acquired in connection with
the acquisition of the Four Former HCA Hospitals and immediately classified as discontinued
operations as of the acquisition date of July 1, 2006 as further discussed in Note 2. There were no
gains or losses recognized in connection with the disposal of these two facilities.
Facilities
Identified as Discontinued Operations 2006
Effective March 31, 2006, the Company sold Smith County, a 63 bed facility located in
Carthage, Tennessee to Sumner Regional Health System for approximately $20.0 million, plus working
capital and recognized a gain on the sale of approximately $3.8 million, net of income taxes, or
$0.07 per diluted share, during the year ended December 31, 2006.
Effective May 1, 2006, the Company sold Southern Indiana, a 96 bed facility located in
Charlestown, Indiana, and Ashland, a 123 bed facility located in Ashland, Pennsylvania to Saint
Catherine Healthcare for approximately $7.2 million, plus working capital and recognized a gain on
the sale of approximately $0.4 million, net of income taxes, or $0.1 per diluted share, during the
year ended December 31, 2006.
Impact of Discontinued Operations
The results of operations, net of income taxes, of the Companys two held-for-sale facilities
as of December 31, 2008, as well as its previously disposed facilities are reflected in the
accompanying consolidated financial statements as discontinued operations in accordance with SFAS
No. 144.
For those disposed assets that were part of an acquisition group for which specifically
identifiable debt was incurred, interest expense was allocated to discontinued operations based on
the ratio of the disposed net assets to the sum of total net assets of the acquisition group plus
the debt that was incurred. For those asset acquisitions for which specifically identifiable debt
was not incurred, interest expense was allocated to discontinued operations based on the ratio of
disposed net assets to the sum of total net assets of the Company plus the Companys total
outstanding debt. The Company allocated to discontinued operations interest expense of $7.1
million, $3.8 million and $1.2 million for the years ended December 31, 2006, 2007 and 2008,
respectively.
The revenues, loss before income taxes and loss net of income taxes, excluding impairment
charge and gain (loss) on sale of hospitals, of discontinued operations for the years ended
December 31, 2006, 2007 and 2008 were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
Revenues |
|
$ |
212.0 |
|
|
$ |
120.6 |
|
|
$ |
53.0 |
|
Loss before income taxes |
|
$ |
(3.1 |
) |
|
$ |
(12.9 |
) |
|
$ |
(12.2 |
) |
Loss net of income taxes |
|
$ |
(2.9 |
) |
|
$ |
(8.6 |
) |
|
$ |
(6.3 |
) |
Changes in the Companys assets held for sale for the year ended December 31, 2008 are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current |
|
|
Property and |
|
|
|
|
|
|
Assets |
|
|
Equipment |
|
|
Total |
|
Balance at December 31, 2007 |
|
$ |
2.3 |
|
|
$ |
34.7 |
|
|
$ |
37.0 |
|
Impairment of Opelousas |
|
|
(0.6 |
) |
|
|
(10.0 |
) |
|
|
(10.6 |
) |
Impairment of Starke |
|
|
|
|
|
|
(4.4 |
) |
|
|
(4.4 |
) |
Other |
|
|
(0.4 |
) |
|
|
|
|
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008 |
|
$ |
1.3 |
|
|
$ |
20.3 |
|
|
$ |
21.6 |
|
|
|
|
|
|
|
|
|
|
|
F-21
Impairment Charges
During the year ended December 31, 2008 the Company recognized total impairment charges, net
of taxes of $17.1 million. These impairment charges included a
$13.9 million charge for Opelousas and
a $5.5 million charge for Starke. These charges were partially
off set by a reversal of the
previously recognized impairment charge of $2.3 million for Colorado River. During the year ended
December 31, 2007 the Company recognized total impairment charges, net of taxes of $16.5 million.
These impairment charges included an $8.7 million charge for Colorado River and a $7.8 million
charge for Coastal. The Company allocated goodwill to each of these facilities based on the ratio
of its estimated fair value to the estimated fair value of the Company.
Impairment Opelousas
In connection with the Companys commitment to sell Opelousas, the Company recognized an
impairment charge of $13.9 million, net of income taxes, or $0.26 loss per diluted share, for the
year ended December 31, 2008. The impairment charge includes the impairment of property and
equipment, allocated goodwill, inventory and certain intangible assets.
The following table sets forth the components of Opelousas impairment charge during the year
ended December 31, 2008 (in millions):
|
|
|
|
|
Property and equipment |
|
$ |
10.0 |
|
Goodwill |
|
|
8.7 |
|
Inventory |
|
|
0.6 |
|
Intangible assets |
|
|
0.5 |
|
|
|
|
|
|
|
|
19.8 |
|
Income tax benefit |
|
|
(5.9 |
) |
|
|
|
|
|
|
$ |
13.9 |
|
|
|
|
|
Impairment Starke
In connection with the Companys commitment to sell Starke, the Company recognized an
impairment charge of $5.5 million, net of income taxes, or $0.10 loss per diluted share, for the
year ended December 31, 2008. The impairment charge includes the impairment of property and
equipment, allocated goodwill and certain intangible assets.
The following table sets forth the components of Starkes impairment charge during the year
ended December 31, 2008 (in millions):
|
|
|
|
|
Property and equipment |
|
$ |
4.4 |
|
Goodwill |
|
|
2.9 |
|
Intangible assets |
|
|
0.3 |
|
|
|
|
|
|
|
|
7.6 |
|
Income tax benefit |
|
|
(2.1 |
) |
|
|
|
|
|
|
$ |
5.5 |
|
|
|
|
|
F-22
Impairment Colorado River
In March 2007, the Company, through its indirect subsidiary, Principal-Needles, Inc. (PNI),
signed a letter of intent with the Needles Board of Trustees of Needles Desert Communities Hospital
(the Needles Board of Trustees) to transfer to the Needles Board of Trustees substantially all of
the operating assets and net working capital of Colorado River plus $1.5 million in cash, which
approximated the net present value of future lease payments due under the lease agreement between
PNI and the Needles Board of Trustees in consideration for the termination of the existing
operating lease agreement. Subsequently, in December 2007, the Company entered into a definitive
agreement with the Needles Board of Trustees that terminated the existing lease agreement effective
April 1, 2008, on which date the Company transferred Colorado River to the Needles Board of
Trustees. In connection with the signing of the letter of intent in March 2007, the Company
recognized an impairment charge of $8.7 million, net of income taxes, or $0.15 per diluted share
for the year ended December 31, 2007. The impairment charge relates to goodwill impairment and the
write-down of the property and equipment and certain net working capital that was originally to be
transferred to the Needles Board of Trustees, for which the Company anticipated receiving no
consideration. The Company recognized a favorable impairment adjustment of ($2.3) million, net of
income taxes, or ($0.04) per diluted share for the year ended December 31, 2008. The impairment
adjustment relates to the reversal of a portion of the previously recognized impairment charge for
certain net working capital components that were ultimately excluded from the assets transferred
effective April 1, 2008.
The following table sets forth the components of Colorado Rivers impairment charge
(adjustment) during the years ended December 31, 2007 and 2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Property and equipment |
|
$ |
4.9 |
|
|
$ |
|
|
Net working capital |
|
|
4.7 |
|
|
|
(3.6 |
) |
Goodwill |
|
|
3.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.7 |
|
|
|
(3.6 |
) |
Income tax (benefit) provision |
|
|
(4.0 |
) |
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
$ |
8.7 |
|
|
$ |
(2.3 |
) |
|
|
|
|
|
|
|
Impairment Coastal
Effective July 1, 2007, the Company completed the sale of Coastal to Tenet. In connection with
the execution of the definitive agreement with Tenet, during the year ended December 31, 2007, the
Company recognized an impairment charge of $7.8 million, net of income taxes, or $0.14 loss per
diluted share. The impairment charge includes the impairment of allocated goodwill and certain
intangible assets.
The following table sets forth the components of Coastals impairment charge during the year
ended December 31, 2007 (in millions):
|
|
|
|
|
Goodwill |
|
$ |
7.2 |
|
Intangible assets |
|
|
0.4 |
|
|
|
|
|
|
|
|
7.6 |
|
Income tax provision |
|
|
0.2 |
|
|
|
|
|
|
|
$ |
7.8 |
|
|
|
|
|
F-23
Note 4. Goodwill and Intangible Assets
The following table presents the changes in the carrying amount of goodwill during the years
ended December 31, 2007 and 2008 (in millions):
|
|
|
|
|
Balance at December 31, 2006 |
|
$ |
1,581.3 |
|
Impairment related to Colorado River |
|
|
(3.1 |
) |
Sale of
Coastal (including impairment of $7.2 million) |
|
|
(14.1 |
) |
Consideration and purchase price adjustments for acquisitions |
|
|
(52.1 |
) |
|
|
|
|
Balance at December 31, 2007 |
|
|
1,512.0 |
|
Impairment related to Starke |
|
|
(2.9 |
) |
Impairment related to Opelousas |
|
|
(8.7 |
) |
Consideration
for acquisitions |
|
|
16.1 |
|
|
|
|
|
Balance at December 31, 2008 |
|
$ |
1,516.5 |
|
|
|
|
|
The following table provides information regarding the Companys intangible assets, which are
included in the accompanying consolidated balance sheets at December 31, 2007 and 2008 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Amortized intangible assets: |
|
|
|
|
|
|
|
|
Contract-based physician minimum revenue guarantees |
|
|
|
|
|
|
|
|
Gross carrying amount |
|
$ |
44.0 |
|
|
$ |
66.4 |
|
Accumulated amortization |
|
|
(8.8 |
) |
|
|
(16.2 |
) |
|
|
|
|
|
|
|
Net total |
|
|
35.2 |
|
|
|
50.2 |
|
Non-competition agreements |
|
|
|
|
|
|
|
|
Gross carrying amount |
|
|
17.3 |
|
|
|
20.2 |
|
Accumulated amortization |
|
|
(7.0 |
) |
|
|
(8.1 |
) |
|
|
|
|
|
|
|
Net total |
|
|
10.3 |
|
|
|
12.1 |
|
Total amortized intangible assets |
|
|
|
|
|
|
|
|
Gross carrying amount |
|
|
61.3 |
|
|
|
86.6 |
|
Accumulated amortization |
|
|
(15.8 |
) |
|
|
(24.3 |
) |
|
|
|
|
|
|
|
Net total |
|
|
45.5 |
|
|
|
62.3 |
|
|
|
|
|
|
|
|
|
|
Indefinite-lived intangible assets: |
|
|
|
|
|
|
|
|
Certificates of need |
|
|
6.9 |
|
|
|
6.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets: |
|
|
|
|
|
|
|
|
Gross carrying amount |
|
|
68.2 |
|
|
|
93.1 |
|
Accumulated amortization |
|
|
(15.8 |
) |
|
|
(24.3 |
) |
|
|
|
|
|
|
|
Net total |
|
$ |
52.4 |
|
|
$ |
68.8 |
|
|
|
|
|
|
|
|
Contract-Based Physician Minimum Revenue Guarantees
The Company has committed to provide certain financial assistance pursuant to recruiting
agreements, or physician minimum revenue guarantees, with various physicians practicing in the
communities it serves. In consideration for a physician relocating to one of its communities and
agreeing to engage in private practice for the benefit of the respective community, the Company may
advance certain amounts of money to a physician to assist in establishing his or her practice.
The Company accounts for its physician minimum revenue guarantees in accordance with the
provisions of FASB Staff Position No. FIN 45-3, Application of FASB Interpretation No. 45 to
Minimum Revenue Guarantees Granted to a Business or Its Owners (FSP FIN 45-3). Under FSP FIN
45-3, the Company records a contract-based intangible asset and a related guarantee liability for
new physician minimum revenue guarantees. The contract-based intangible asset is amortized to
other operating expenses, in the accompanying consolidated statements of operations, over the
period of the physician contract, which typically ranges from four to five years. As of December
31, 2007 and 2008, the Companys liability for contract-based physician minimum revenue guarantees
was $15.3 million and $22.2 million, respectively. These amounts are included in other current
liabilities in the Companys accompanying consolidated balance sheets.
F-24
Non-Competition Agreements
The Company has entered into non-competition agreements with certain physicians and other
individuals which are amortized on a straight-line basis over the term of the agreements.
Certificates of Need
The construction of new facilities, the acquisition or expansion of existing facilities and
the addition of new services and certain equipment at the Companys facilities may be subject to
state laws that require prior approval by state regulatory agencies. These certificates of need
laws generally require that a state agency determine the public need and give approval prior to the
construction or acquisition of facilities or the addition of new services. The Company operates
hospitals in certain states that have adopted certificate of need laws. If the Company fails to
obtain necessary state approval, the Company will not be able to expand its facilities, complete
acquisitions or add new services at its facilities in these states. These intangible assets have
been determined to have indefinite lives and, accordingly, are not amortized.
Amortization Expense
Amortization expense for the Companys intangible assets, including physician minimum revenue
guarantee expense under FSP FIN 45-3, during the years ended December 31, 2006, 2007 and 2008 were
$3.3 million, $7.6 million and $10.5 million, respectively.
Total estimated amortization expense for the Companys intangible assets during the next five
years and thereafter are as follows (in millions):
|
|
|
|
|
2009 |
|
$ |
15.6 |
|
2010 |
|
|
15.1 |
|
2011 |
|
|
13.1 |
|
2012 |
|
|
9.5 |
|
2013 |
|
|
3.5 |
|
Thereafter |
|
|
5.5 |
|
|
|
|
|
|
|
$ |
62.3 |
|
|
|
|
|
Note 5. Accounting for Income Taxes
The provision for income taxes for the years ended December 31, 2006, 2007, and 2008 consists
of the following (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
53.2 |
|
|
$ |
77.8 |
|
|
$ |
69.0 |
|
State |
|
|
5.4 |
|
|
|
6.7 |
|
|
|
4.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58.6 |
|
|
|
84.5 |
|
|
|
73.3 |
|
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
|
32.0 |
|
|
|
0.9 |
|
|
|
10.6 |
|
State |
|
|
(0.8 |
) |
|
|
(3.9 |
) |
|
|
(0.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2 |
|
|
|
(3.0 |
) |
|
|
9.7 |
|
Increase in valuation allowance |
|
|
3.4 |
|
|
|
4.3 |
|
|
|
5.1 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
93.2 |
|
|
$ |
85.8 |
|
|
$ |
88.1 |
|
|
|
|
|
|
|
|
|
|
|
The increases in the valuation allowance during the years ended December 31, 2006, 2007 and
2008, were primarily the result of state net operating loss carry forwards that management believes
may not be fully utilized because of the uncertainty regarding the Companys ability to generate
taxable income in certain states. Various subsidiaries have state net operating loss carry forwards
in the aggregate of approximately $559.9 million (primarily in Alabama, Florida, Indiana,
Louisiana, Pennsylvania, Tennessee, Virginia and West Virginia) with expiration dates through the
year 2028.
F-25
A reconciliation of the statutory federal income tax rate to the Companys effective income
tax rate on income from continuing operations before income taxes for the years ended December 31,
2006, 2007 and 2008 follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Federal statutory rate |
|
|
35.0 |
% |
|
|
35.0 |
% |
|
|
35.0 |
% |
State income taxes, net of federal income tax benefit |
|
|
2.0 |
|
|
|
1.3 |
|
|
|
2.0 |
|
ESOP expense |
|
|
0.8 |
|
|
|
0.9 |
|
|
|
0.7 |
|
Valuation allowance |
|
|
1.4 |
|
|
|
2.0 |
|
|
|
2.2 |
|
Other items, net |
|
|
|
|
|
|
1.0 |
|
|
|
(1.0 |
) |
|
|
|
|
|
|
|
|
|
|
Effective income tax rate |
|
|
39.2 |
% |
|
|
40.2 |
% |
|
|
38.9 |
% |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes result from temporary differences in the recognition of assets,
liabilities, revenues and expenses for financial accounting and tax purposes. Sources of these
differences and the related tax effects are as follows as of December 31, 2007 and 2008 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Deferred income tax liabilities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
$ |
(155.2 |
) |
|
$ |
(157.2 |
) |
Prepaid expenses |
|
|
(2.4 |
) |
|
|
(1.2 |
) |
Other |
|
|
(0.1 |
) |
|
|
(2.6 |
) |
|
|
|
|
|
|
|
Total deferred income tax liabilities |
|
|
(157.7 |
) |
|
|
(161.0 |
) |
|
|
|
|
|
|
|
Deferred income tax assets: |
|
|
|
|
|
|
|
|
Provision for doubtful accounts |
|
|
84.5 |
|
|
|
68.4 |
|
Employee compensation |
|
|
33.7 |
|
|
|
43.8 |
|
Professional liability claims |
|
|
26.3 |
|
|
|
31.0 |
|
Interest rate swap |
|
|
10.9 |
|
|
|
15.8 |
|
Other |
|
|
51.5 |
|
|
|
48.8 |
|
|
|
|
|
|
|
|
Total deferred income tax assets |
|
|
206.9 |
|
|
|
207.8 |
|
Valuation allowance |
|
|
(39.4 |
) |
|
|
(46.5 |
) |
|
|
|
|
|
|
|
Net deferred income tax assets |
|
|
167.5 |
|
|
|
161.3 |
|
|
|
|
|
|
|
|
Net deferred income tax assets (liabilities) |
|
$ |
9.8 |
|
|
$ |
0.3 |
|
|
|
|
|
|
|
|
The balance sheet classification of deferred income tax assets (liabilities) at December 31,
2007 and 2008 is as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Current |
|
$ |
123.0 |
|
|
$ |
103.4 |
|
Long-term |
|
|
(113.2 |
) |
|
|
(103.1 |
) |
|
|
|
|
|
|
|
Total |
|
$ |
9.8 |
|
|
$ |
0.3 |
|
|
|
|
|
|
|
|
The Companys income taxes receivable balance was $27.9 million, and $19.9 million at December
31, 2007 and 2008, respectively. The tax benefits associated with the Companys employee
stock-based compensation plans were $0.1 million, $1.2 million and $1.1 million for the years ended
December 31, 2006, 2007 and 2008, respectively. These tax benefits reduced current taxes payable,
increased capital in excess of par value, and increased deferred tax assets attributable to state
net operating loss carry forwards by $1.2 million and
$1.1 million for the years ended December 31, 2007 and 2008, respectively.
The Company adopted the provisions of FIN 48 on January 1, 2007. In connection with the
adoption of FIN 48, the Company recorded a $52.0 million net liability for unrecognized tax
benefits, accrued interest and penalties.
F-26
A reconciliation of the beginning and ending liability for gross unrecognized tax benefits at
December 31, 2007 and 2008 is as follows (in millions).
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Balance at
beginning of year |
|
$ |
51.9 |
|
|
$ |
52.2 |
|
Additions for tax positions of prior years |
|
|
3.3 |
|
|
|
2.4 |
|
Reductions for tax positions of prior years |
|
|
|
|
|
|
(0.9 |
) |
Reductions for settlements with taxing authorities |
|
|
(0.9 |
) |
|
|
(1.3 |
) |
Reductions for lapse of statutes of limitations |
|
|
(2.1 |
) |
|
|
(4.2 |
) |
|
|
|
|
|
|
|
Balance at
end of year |
|
$ |
52.2 |
|
|
$ |
48.2 |
|
|
|
|
|
|
|
|
The components of the long-term income tax liability at December 31, 2007 and 2008 are as
follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Unrecognized tax benefits |
|
$ |
52.2 |
|
|
$ |
48.2 |
|
Accrued interest and penalties |
|
|
12.7 |
|
|
|
11.2 |
|
|
|
|
|
|
|
|
|
|
$ |
64.9 |
|
|
$ |
59.4 |
|
|
|
|
|
|
|
|
Of the $48.2 million of unrecognized tax benefits at December 31, 2008, $7.8 million, if
recognized, would affect the Companys effective tax rate. Included in the balance of unrecognized
tax benefits at December 31, 2008 are tax positions of $40.4 million for which the ultimate
deductibility is highly certain but for which there is uncertainty about the timing of such
deductibility. Because of the impact of deferred income tax accounting, other than for interest and
penalties, the disallowance of the shorter deductibility period would not affect the effective
income tax rate but would accelerate the payment of cash to the taxing authority to an earlier
period.
Upon adoption of FIN 48 on January 1, 2007, the Company elected to continue its historical
practice of classifying interest and penalties as a component of income tax expense. During the
year ended December 31, 2008, the Company recorded a net $0.7 million reduction of interest expense
related to unrecognized tax benefits in income tax expense, which is comprised of an interest
benefit of $2.9 million from the expiration of state statutes of limitation and interest expense of
$2.2 million on unrecognized tax benefits from prior years.
The Companys U.S. federal income tax returns for tax years 1999 and beyond (except tax year
2004, for which the statute of limitation lapsed on December 31, 2008) remain subject to
examination by the Internal Revenue Service (IRS). During 2003, the IRS notified the Company
regarding its findings relating to the examination of the Companys tax returns for the years ended
December 31, 1999, 2000 and 2001. The Company reached a partial settlement with the IRS on all
issues except for the Companys method of determining its bad debt deduction, for which the IRS has
proposed an additional assessment of $7.4 million. All of the adjustments proposed by the IRS are
temporary differences. The IRS has delayed final settlement of this assessment until resolution of
certain pending court proceedings related to the use of this bad debt deduction method by HCA. On
October 4, 2004, HCA was denied certiorari on its appeal of this matter to the United States
Supreme Court. As a result, HCA and the IRS are currently working through the complex calculations
for the many HCA tax years that are impacted. Due to the complex computations and many impacted HCA
tax years (including HCA tax years preceding the spin-off of the Company from HCA), neither the
Company nor HCA is currently able to estimate when the final settlement of the HCA tax years will
occur. The Company cannot reach resolution of its IRS examination until after the final settlement
of HCAs tax years preceding the spin-off of the Company from HCA on May 11, 1999. The Company
applied its 2002 federal income tax refund in the amount of $6.6 million as a deposit against any
potential settlement to forestall the tolling of interest on such settlement beyond the March 15,
2003 deposit date. The Company has extended the statutes of limitation for the federal tax returns
for tax years ended December 31, 1999, 2000 and 2001 through December 31, 2009.
In 2005, the IRS commenced an examination of the Companys federal income tax return for the
year ended December 31, 2003. Furthermore, during the second quarter of 2006, the IRS commenced an
examination of select items within the Companys federal income tax return for the year ended
December 31, 2002, thereby allowing the IRS to incorporate any carry forward adjustments from the
examination of the 1999 through 2001 federal income tax returns. The Company reached a partial
settlement with the IRS on all of the adjustments proposed by the IRS except for the Companys
method of determining its bad debts deduction, which may be impacted by the outcome of
the complex computations from the HCA tax years (discussed above), with the Company making a
$1.8 million payment (including interest) in settlement of the agreed-upon matters. The $1.8
payment reduced the long-term income tax liability. The Company has extended the statute of
limitation for its 2002 and 2003 returns through December 31, 2009 and will likely extend the
statute of limitation further.
F-27
Finally, in 2005, the IRS commenced an examination of the federal income tax return of
Province, which the Company merged with effective April 15, 2005, for the year ended December 31,
2003. During the quarter ended June 30, 2007, the Company and the IRS concluded the examination of
Provinces federal income tax return for the year ended December 31, 2003, with the Company making
a $1.4 million payment (including interest) in settlement of all matters. Of the $1.4 million
payment, $0.8 million reduced the Companys long-term income tax liability, and $0.6 million
decreased non-current deferred tax liabilities. In addition, the Company reduced its long-term
income tax liability by $0.8 million and decreased the goodwill associated with the Province
Business Combination in accordance with SFAS No. 109. Provinces federal income tax return for tax
year ended April 15, 2005 remains subject to examination by the IRS.
The expiration of the statute of limitation related to the various state income tax returns
that the Company and its subsidiaries file, varies by state. Generally, the Companys various state
income tax returns for tax years 2002 and beyond remain subject to examination by various state
taxing authorities.
Based on the outcome of these examinations or as a result of the expiration of statutes of
limitation for specific taxing jurisdictions, it is reasonably possible that unrecognized tax
positions could change within the next twelve months by a range of zero to $3.0 million.
Note 6. Other Current Liabilities
The following table provides information regarding the Companys other current liabilities,
which are included in the accompanying consolidated balance sheets at December 31, 2007 and 2008
(in millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Accrued interest |
|
$ |
10.6 |
|
|
$ |
10.6 |
|
Short-term portion of professional and general liability claims |
|
|
17.4 |
|
|
|
15.5 |
|
Short-term portion of workers compensation reserves |
|
|
6.6 |
|
|
|
7.1 |
|
Medical benefits liability |
|
|
14.3 |
|
|
|
12.9 |
|
Physician minimum revenue guarantee liability |
|
|
15.3 |
|
|
|
22.2 |
|
Share repurchase payable |
|
|
12.2 |
|
|
|
|
|
Other |
|
|
33.4 |
|
|
|
26.2 |
|
|
|
|
|
|
|
|
|
|
$ |
109.8 |
|
|
$ |
94.5 |
|
|
|
|
|
|
|
|
Note 7. Long-Term Debt
The Companys long-term debt consists of the following at December 31, 2007 and 2008 (in
millions):
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2008 |
|
Senior Borrowings: |
|
|
|
|
|
|
|
|
Credit Agreement: |
|
|
|
|
|
|
|
|
Term B Loans |
|
$ |
706.0 |
|
|
$ |
706.4 |
|
Revolving Loans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
706.0 |
|
|
|
706.4 |
|
|
|
|
|
|
|
|
Subordinated Borrowings: |
|
|
|
|
|
|
|
|
31/2% Notes |
|
|
575.0 |
|
|
|
575.0 |
|
31/4% Debentures |
|
|
225.0 |
|
|
|
225.0 |
|
Province 71/2% Notes |
|
|
6.1 |
|
|
|
6.1 |
|
Province 41/4% Notes |
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
806.2 |
|
|
|
806.1 |
|
Capital leases |
|
|
5.0 |
|
|
|
4.2 |
|
|
|
|
|
|
|
|
Total long-term debt |
|
|
1,517.2 |
|
|
|
1,516.7 |
|
Less: current portion |
|
|
0.5 |
|
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
$ |
1,516.7 |
|
|
$ |
1,515.6 |
|
|
|
|
|
|
|
|
F-28
Maturities of the Companys long-term debt at December 31, 2008 are as follows for the years
indicated (in millions):
|
|
|
|
|
2009 |
|
$ |
1.1 |
|
2010 |
|
|
1.0 |
|
2011 |
|
|
530.6 |
|
2012 |
|
|
177.5 |
|
2013 |
|
|
6.5 |
|
Thereafter |
|
|
800.0 |
|
|
|
|
|
|
|
$ |
1,516.7 |
|
|
|
|
|
Senior Secured Credit Agreement
Terms
On April 15, 2005, in connection with the Province Business Combination, the Company entered
into a Credit Agreement, as amended and restated, supplemented or otherwise modified from time to
time (the Credit Agreement) with Citicorp North America, Inc. (CITI), as administrative agent
and the lenders party thereto, Bank of America, N.A., CIBC World Markets Corp., SunTrust Bank and
UBS Securities LLC, as co-syndication agents and Citigroup Global Markets Inc., as sole lead
arranger and sole book runner. Effective May 11, 2007, the Company amended its Credit Agreement and
increased its additional tranches available under its term B loans (the Term B Loans) and
revolving loans (the Revolving Loans) by $200.0 million and $50.0 million, respectively.
Additionally, the amendment allows for the issuance of up to $250.0 million in term A loans (the
Term A Loans), which was previously unavailable. Finally, the amendment modified certain existing
non-monetary terms of the Credit Agreement to allow for the flexibility in the issuance of the
31/2% Notes, as discussed further in this note.
The Credit Agreement, as amended, provides for secured Term A Loans up to $250.0 million, Term
B Loans up to $1,450.0 million and Revolving Loans of up to $350.0 million. In addition, the Credit
Agreement provides that the Company may request additional tranches of Term B Loans up to $400.0
million and additional tranches of Revolving Loans up to $100.0 million. The Term A Loans and
Revolving Loans both mature on April 15, 2010. The Term B Loans mature on April 15, 2012 and are
scheduled to be repaid beginning June 30, 2011 in four equal installments totaling $706.4 million.
The Term B Loans are subject to additional mandatory prepayments with a certain percentage of
excess cash flow as specifically defined in the Credit Agreement. The Credit Agreement is
guaranteed on a senior secured basis by the Companys subsidiaries with certain limited exceptions.
As amended, the Credit Agreement provides for letters of credit up to $75.0 million.
Borrowings and Payments
During June 2008, the Company borrowed $10.0 million in the form of Revolving Loans for
general corporate purposes. The $10.0 million borrowing was fully repaid during July 2008. As of
December 31, 2008, the Company had no Revolving Loans outstanding.
During the year ended December 31, 2007, the Company repaid a portion of its outstanding Term
B Loans and all of its outstanding Revolving Loans, primarily with the proceeds from the issuance
of $575.0 million in 31/2% Notes, as further discussed within this note, and
from the proceeds from the sales of St. Josephs and Coastal, as discussed in Note 3. Subsequently,
certain of the syndicate of lenders under the Term B Loans declined a portion of the mandatory
repayment made in connection with the sale of Coastal, and in April 2008, CITI returned to the
Company $0.4 million of the previously repaid Term B Loans.
Letters of Credit and Availability
As of December 31, 2008, the Company had $38.4 million in letters of credit outstanding under
the Revolving Loans that were related to the self-insured retention level of the Companys general
and professional liability insurance and workers compensation programs as security for payment of
claims. Under the terms of the Credit Agreement, Revolving Loans available for borrowing were
$411.6 million as of December 31, 2008, including the $100.0 million available under the additional
tranche. Under the terms of the Credit Agreement, Term A Loans and Term B Loans available for
borrowing were $250.0 million and $400.0 million, respectively, as of December 31, 2008, all of
which is available under the additional tranches.
F-29
Interest Rates
Interest on the outstanding balances of the Term B Loans is payable, at the Companys option,
at CITIs base rate (the alternate base rate or ABR) plus a margin of 0.625% or at an adjusted
London Interbank Offered Rate (Adjusted LIBOR) plus a margin of 1.625%. Interest on the Revolving
Loans is payable at ABR plus a margin for ABR Revolving Loans or Adjusted LIBOR plus a margin for
eurodollar Revolving Loans. The margin on ABR Revolving Loans ranges from 0.25% to 1.25% based on
the total leverage ratio being less than 2.00:1.00 to greater than 4.50:1.00. The margin on the
eurodollar Revolving Loans ranges from 1.25% to 2.25% based on the total leverage ratio being less
than 2.00:1.00 to greater than 4.50:1.00.
As of December 31, 2008, the applicable annual interest rate under the Term B Loans was 3.82%,
which was based on the 90-day Adjusted LIBOR plus the applicable margin. The 90-day Adjusted LIBOR
was 2.19% at December 31, 2008. The weighted-average applicable annual interest rates for the years
ended December 31, 2006, 2007 and 2008 under the Term B Loans were 6.74%, 7.07% and 4.85%,
respectively.
Covenants
The Credit Agreement requires the Company to satisfy certain financial covenants, including a
minimum interest coverage ratio and a maximum total leverage ratio, as set forth in the Credit
Agreement. The minimum interest coverage ratio can be no less than 3.50:1.00 for all periods ending
after December 31, 2005. These calculations are based on the trailing four quarters. The maximum
total leverage ratios cannot exceed 4.25:1.00 for the periods ending on March 31, 2008 through
December 31, 2008; 4.00:1.00 for the periods ending on March 31, 2009 through December 31, 2009;
and 3.75:1.00 for the periods ending thereafter. In addition, on an annualized basis, the Company
is also limited with respect to amounts it may spend on capital expenditures. Such amounts cannot
exceed 10.0% of revenues for all years ending after December 31, 2006.
The financial covenant requirements and ratios are as follows:
|
|
|
|
|
|
|
|
|
|
|
Level at |
|
|
Requirement |
|
December 31, 2008 |
Minimum Interest Coverage Ratio
|
|
≥ 3.50:1.00
|
|
|
5.88 |
|
Maximum Total Leverage Ratio
|
|
≤ 4.25:1.00
|
|
|
3.14 |
|
Capital Expenditure Ratio
|
|
≤ 10.0%
|
|
|
5.8 |
% |
In addition, the Credit Agreement contains customary affirmative and negative covenants, which
among other things, limit the Companys ability to incur additional debt, create liens, pay
dividends, effect transactions with its affiliates, sell assets, pay subordinated debt, merge,
consolidate, enter into acquisitions and effect sale leaseback transactions.
The Companys Credit Agreement does not contain provisions that would accelerate the maturity
date of the loans under the Credit Agreement upon a downgrade in the Companys credit rating.
However, a downgrade in the Companys credit rating could adversely affect its ability to obtain
other capital sources in the future and could increase its cost of borrowings.
31/2% Convertible Senior Subordinated Notes due May 15, 2014
On May 29, 2007, the Company issued $500.0 million of its 31/2% Notes
and on May 31, 2007, the Company issued another $75.0 million pursuant to the underwriters
exercise of their over-allotment option. The net proceeds of approximately $561.7 million were used
to repay a portion of the Companys outstanding borrowings under the Credit Agreement. The
31/2% Notes bear interest at the rate of 31/2% per
year, payable semi-annually on May 15 and November 15.
The 31/2% Notes are convertible prior to March 15, 2014 under the
following circumstances: (1) if the price of the Companys common stock reaches a specified
threshold during specified periods; (2) if the trading price of the 31/2%
Notes is below a specified threshold; or (3) upon the occurrence of specified corporate
transactions or other events. On or after March 15, 2014, holders may convert their
31/2% Notes at any time prior to the close of business
on the scheduled trading day immediately preceding May 15, 2014, regardless of whether any of
the foregoing circumstances has occurred.
F-30
Subject to certain exceptions, the Company will deliver cash and shares of its common stock
upon conversion of each $1,000 principal amount of its 31/2% Notes as
follows: (i) an amount in cash (the principal return) equal to the sum of, for each of the 20
volume-weighted average price trading days during the conversion period, the lesser of the daily
conversion value for such volume-weighted average price trading day and $50; and (ii) a number of
shares in an amount equal to the sum of, for each of the 20 volume-weighted average price trading
days during the conversion period, any excess of the daily conversion value above $50. The
Companys ability to pay the principal return in cash is subject to important limitations imposed
by the Credit Agreement and other credit facilities or indebtedness the Company may incur in the
future. If the Company does not make any payments it is obligated to make under the terms of the
31/2% Notes, holders may declare an event of default.
The initial conversion rate is 19.3095 shares of the Companys common stock per $1,000
principal amount of the 31/2% Notes (subject to certain events). This
represents an initial conversion price of approximately $51.79 per share of the Companys common
stock. In addition, if certain corporate transactions that constitute a change of control occur
prior to maturity, the Company will increase the conversion rate in certain circumstances.
Upon the occurrence of a fundamental change (as specified in the indenture), each holder of
the 31/2% Notes may require the Company to purchase some or all of the
31/2% Notes at a purchase price in cash equal to 100% of the principal amount
of the 31/2% Notes surrendered, plus any accrued and unpaid interest.
The indenture for the 31/2% Notes does not contain any financial
covenants or any restrictions on the payment of dividends, the incurrence of senior or secured debt
or other indebtedness, or the issuance or repurchase of securities by the Company. The indenture
contains no covenants or other provisions to protect holders of the 31/2%
Notes in the event of a highly leveraged transaction or other events that do not constitute a
fundamental change.
31/4% Convertible Senior Subordinated Debentures due August 15, 2025
On August 10, 2005, the Company sold $225.0 million of its 3 1/4% Debentures. The net proceeds
of approximately $218.4 million were used to repay indebtedness and for working capital and general
corporate purposes. The 31/4% Debentures bear interest at the rate of
31/4% per year, payable semi-annually on February 15 and August 15.
The 31/4% Debentures are convertible (subject to certain limitations
imposed by the Credit Agreement) under the following circumstances: (1) if the price of the
Companys common stock reaches a specified threshold during the specified periods; (2) if the
trading price of the 31/4% Debentures is below a specified threshold; (3) if
the 31/4% Debentures have been called for redemption; or (4) if specified
corporate transactions or other specified events occur. Subject to certain exceptions, the Company
will deliver cash and shares of its common stock, as follows: (i) an amount in cash (the principal
return) equal to the lesser of (a) the principal amount of the 31/4%
Debentures surrendered for conversion and (b) the product of the conversion rate and the average
price of the Companys common stock, as set forth in the indenture governing the securities (the
conversion value); and (ii) if the conversion value is greater than the principal return, an
amount in shares of the Companys common stock. The Companys ability to pay the principal return
in cash is subject to important limitations imposed by the Credit Agreement and other indebtedness
the Company may incur in the future. Based on the terms of the Credit Agreement, in certain
circumstances, even if any of the foregoing conditions to conversion have occurred, the
31/4% Debentures will not be convertible, and holders of the
31/4% Debentures will not be able to declare an event of default under the
31/4% Debentures.
The initial conversion rate for the 31/4% Debentures is 16.3345 shares
of the Companys common stock per $1,000 principal amount of 31/4% Debentures
(subject to adjustment in certain events). This is equivalent to a conversion price of $61.22 per
share of the Companys common stock. In addition, if certain corporate transactions that constitute
a change of control occur on or prior to February 20, 2013, the Company will increase the
conversion rate in certain circumstances, unless such transaction constitutes a public acquirer
change of control and the Company elects to modify the conversion rate into the public acquirers
common stock.
F-31
On or after February 20, 2013, the Company may redeem for cash some or all of the
31/4% Debentures at any time at a price equal to 100% of the principal amount
of the 31/4% Debentures to be purchased, plus any accrued and unpaid
interest. Holders may require the Company to purchase for cash some or all of the
31/4% Debentures on February 15, 2013, February 15, 2015 and February 15,
2020 or upon the occurrence of a fundamental change, at 100% of the principal amount of the
31/4% Debentures to be purchased, plus any accrued and unpaid interest.
The indenture for the 31/4% Debentures does not contain any financial
covenants or any restrictions on the payment of dividends, the incurrence of senior or secured debt
or other indebtedness, or the issuance or repurchase of securities by the Company. The indenture
contains no covenants or other provisions to protect holders of the 31/4%
Debentures in the event of a highly leveraged transaction or fundamental change.
Province 71/2% Senior Subordinated Notes
In connection with the Province Business Combination, approximately $193.9 million of the
$200.0 million outstanding principal amount of Provinces 71/2% Senior
Subordinated Notes due 2013 (the Province 71/2% Notes) was purchased and
subsequently retired. The fair value assigned to the Province 71/2% Notes in
the Province purchase price allocation included tender premiums of $19.5 million paid in connection
with the debt retirement.
The supplemental indenture incorporating the amendments to the indenture governing the
Province 71/2% Notes in connection with Provinces consent solicitation with
respect to such Province 71/2% Notes became operative on April 15, 2005 and
is binding upon the holders of any Province 71/2% Notes that were not
tendered pursuant to such tender offer. The remaining $6.1 million outstanding principal amount of
the Province 71/2% Notes bears interest at the rate of
71/2% payable semi-annually on June 1 and December 1. The Company has the
right to redeem all or a portion of the Province 71/2% Notes on or after June
1, 2008, at the current redemption prices, plus accrued and unpaid interest. The Province
71/2% Notes are unsecured and subordinated to the Companys existing and
future senior indebtedness. The supplemental indenture contains no material covenants or
restrictions.
Province 41/4% Convertible Subordinated Notes
In connection with the Province Business Combination, approximately $172.4 million of the
$172.5 million outstanding principal amount of Provinces 41/4% Convertible
Subordinated Notes due 2008 (the Province 4 1/4% Notes) was purchased and subsequently retired. The
fair value assigned to the Province 41/4% Notes in the Province purchase
price allocation included tender premiums of $12.1 million paid in connection with the debt
retirement. During November 2008, the Company repaid all remaining outstanding amounts due under
the Province 41/4% Notes.
Interest Rate Swap
On June 1, 2006, the Company entered into an interest rate swap agreement with Citibank, N.A.
(Citibank) as counterparty. The interest rate swap agreement, as amended, was effective as of
November 30, 2006 and has a maturity date of May 30, 2011. The Company entered into the interest
rate swap agreement to mitigate the floating interest rate risk on a portion of its outstanding
variable rate borrowings. The interest rate swap agreement requires the Company to make quarterly
fixed rate payments to Citibank calculated on a notional amount as set forth in the table below at
an annual fixed rate of 5.585% while Citibank is obligated to make quarterly floating payments to
the Company based on the three-month LIBOR on the same referenced notional amount. Notwithstanding
the terms of the interest rate swap transaction, the Company is ultimately obligated for all
amounts due and payable under its Credit Agreement.
|
|
|
|
|
|
|
Notional Amount |
Date
Range |
|
(In millions) |
November 30, 2006 to November 30, 2007 |
|
$ |
900.0 |
|
November 30, 2007 to November 28, 2008 |
|
|
750.0 |
|
November 28, 2008 to November 30, 2009 |
|
|
600.0 |
|
November 30, 2009 to November 30, 2010 |
|
|
450.0 |
|
November 30, 2010 to May 30, 2011 |
|
|
300.0 |
|
F-32
The Company does not hold or issue derivative financial instruments for trading purposes. The
Company has designated the interest rate swap as a cash flow hedge instrument. The Company assesses
the effectiveness of this cash flow hedge instrument on a quarterly basis. The Company completed an
assessment of the cash flow hedge instrument at December 31, 2006, and determined the hedge to be
highly effective in accordance with SFAS No. 133. The Company completed its quarterly assessments
during the years ended December 31, 2007 and 2008, and determined its cash flow hedge was partially
ineffective. Because the notional amount of the interest rate swap in effect at certain of the
quarterly assessment intervals exceeded the Companys outstanding borrowings under its variable
rate debt Credit Agreement, a portion of the cash flow hedge instrument was determined to be
ineffective. The Company recognized an increase in interest expense of approximately $0.5 million
and $0.6 million related to the ineffective portion of the Companys cash flow hedge during the
years ended December 31, 2007 and 2008, respectively. The interest rate swap agreement exposes the
Company to credit risk in the event of non-performance by Citibank. However, the Company does not
anticipate non-performance by Citibank.
Note 8. Stockholders Equity
Preferred Stock
The Companys Amended and Restated Certificate of Incorporation provides that up to 10,000,000
shares of preferred stock may be issued, of which 90,000 shares have been designated as Series A
Junior Participating Preferred Stock, par value $0.01 per share (Series A Preferred Stock). The
Board of Directors has the authority to issue preferred stock in one or more series and to fix for
each series the voting powers (full, limited or none), and the designations, preferences and
relative, participating, optional or other special rights and qualifications, limitations or
restrictions on the stock and the number of shares constituting any series and the designations of
this series, without any further vote or action by the stockholders. Because the terms of the
preferred stock may be fixed by the Board of Directors without stockholder action, the preferred
stock could be issued quickly with terms calculated to defeat a proposed takeover or to make the
removal of the Companys management more difficult.
Preferred Stock Purchase Rights
Pursuant to the Companys stockholders rights plan, each outstanding share of common stock is
accompanied by one preferred stock purchase right. Each right entitles the registered holder to
purchase from the Company one one-thousandth of a share of Series A Preferred Stock of the Company
at a price of $35 per one one-thousandth of a share, subject to adjustment.
Each share of Series A Preferred Stock will be entitled, when, as and if declared, to a
preferential quarterly dividend payment in an amount equal to the greater of $10 or 1,000 times the
aggregate of all dividends declared per share of common stock. In the event of liquidation,
dissolution or winding up, the holders of Series A Preferred Stock will be entitled to a minimum
preferential liquidation payment equal to $1,000 per share, plus an amount equal to accrued and
unpaid dividends and distributions on the stock, whether or not declared, to the date of such
payment, but will be entitled to an aggregate payment of 1,000 times the payment made per share of
common stock. The rights are not exercisable until the rights distribution date as defined in the
stockholders rights plan. The rights will expire on May 7, 2009, unless the expiration date is
extended or unless the rights are earlier redeemed or exchanged.
The rights have certain anti-takeover effects. The rights will cause substantial dilution to a
person or group that attempts to acquire the Company on terms not determined by the Companys Board
of Directors to be in the best interests of all of the Companys stockholders. The rights should
not interfere with any merger or other business combination approved by the Board of Directors.
F-33
Common Stock
Holders of the Companys common stock are entitled to one vote for each share held of record
on all matters on which stockholders may vote. There are no preemptive, conversion, redemption or
sinking fund provisions applicable to shares of the Companys common stock. In the event of
liquidation, dissolution or winding up, holders of the Companys common stock are entitled to share
ratably in the assets available for distribution, subject to any prior rights of any holders of
preferred stock then outstanding. Delaware law prohibits the Company from paying any dividends
unless it has capital surplus or net profits available for this purpose. In addition, the Credit
Agreement imposes restrictions on the Companys ability to pay dividends.
Repurchases of Common Stock
In November 2007, the Companys Board of Directors authorized the repurchase of up to $150.0
million of outstanding shares of the Companys common stock either in the open market or through
privately negotiated transactions, subject to market conditions, regulatory constraints and other
factors. The Companys stock repurchase program expired on November 26, 2008. The Company
repurchased approximately 1.4 million shares and 3.8 million shares for an aggregate purchase
price, including commissions, of approximately $41.2 million and $103.7 million with a weighted
average purchase price of $30.35 per share and $26.57 per share during the years ended December 31,
2007 and 2008, respectively. As of December 31, 2008, the Company had repurchased in the
aggregate, approximately 5.2 million shares at an aggregate purchase price, including commissions,
of approximately $144.9 million with an average purchase price of $27.56 per share. These shares
have been designated by the Company as treasury stock.
The Company redeems shares from employees upon vesting of the Companys Amended and Restated
1998 Long-Term Incentive Plan (LTIP) and Management Stock Purchase Plan (MSPP) stock awards for
minimum statutory tax withholding purposes. The Company redeemed approximately 0.1 million shares
of certain vested LTIP and MSPP shares for an aggregate price of approximately $2.4 million during
the year ended December 31, 2008. There were no redemptions during the years end December 31, 2006
and 2007 because there were no LTIP or MSPP shares that vested during these years. These shares
have been designated by the Company as treasury stock.
Comprehensive Income (Loss)
Comprehensive income (loss) consists of two components: net income and other comprehensive
income (loss). Other comprehensive income (loss) refers to revenues, expenses, gains and losses
that under SFAS No. 130, Reporting Comprehensive Income, are recorded as an element of
stockholders equity but are excluded from net income.
On June 1, 2006, the Company entered into an interest rate swap agreement, which was effective
November 30, 2006 and which the Company has designated as a cash flow hedge in accordance with SFAS
No. 133. The changes in the fair value of the interest rate swap resulted in comprehensive losses
of $14.7 million, or $9.6 million net of income taxes for
the year ended December 31, 2006; $15.9
million, or $10.2 million net of income taxes for the year ended December 31, 2007; and $13.4
million, or $8.5 million net of income taxes for the year ended December 31, 2008. The Companys
interest rate swap agreement is further described in Note 7.
ESOP Compensation
In 1999, the Company established an ESOP as a defined contribution retirement plan that
covered substantially all of the Companys employees. Upon establishment, the ESOP purchased from
the Company approximately 2.8 million shares of the Companys common stock at its then fair market
value of $11.50 per share. The purchase of the shares was primarily financed by the ESOP issuing a
promissory note to the Company, which the ESOP repaid in annual installments over the term of the
loan. The ESOP funded its repayments to the Company through the Companys contributions to the
ESOP. The term of the loan concluded on December 31, 2008.
F-34
Prior to December 31, 2008, shares of the Companys common stock acquired by the ESOP were
held in a suspense account and were allocated ratably to participant accounts as the loan was
repaid. The loan to the ESOP was recorded as unearned ESOP compensation in the accompanying
consolidated balance sheets through December 31, 2008, upon which date the loan was fully repaid.
Reductions to unearned ESOP compensation were made throughout the term of the loan as shares were
committed to be released to participant accounts at the ESOP shares original cost. Shares were
deemed to be committed to be released ratably during each period as the employees performed
services. As shares were committed to be released, the shares became outstanding for earnings per
share calculations. As of December 31, 2008, all of the approximately 2.8 million shares were
released and accordingly, considered outstanding for purposes of calculating earnings per share.
Through December 31, 2008, the Companys ESOP expense had two components: common stock and
cash. Shares of the Companys common stock were allocated ratably to employee accounts at an
approximate rate of 23,306 shares per month. The ESOP expense amount for the common stock component
was determined using the average market price of the Companys common stock released to
participants in the ESOP. The cash component was determined by the difference between the
Companys required contributions under the plan and the fair value of the Companys common stock
allocated and released to the plan. During the year ended December 31, 2008, the Company utilized
forfeitures in the ESOP to reduce its cash contributions for the year. There were $3.9 million,
$5.1 million and $1.1 million of cash contributions by the Company during the years ended December
31, 2006, 2007 and 2008, respectively. Subsequent to December 31, 2008, the Company will
contribute to its defined contribution retirement plan with cash only.
The Companys ESOP expense was $12.6 million, $13.9 million and $8.7 million for the years
ended December 31, 2006, 2007 and 2008, respectively. The ESOP expense tax deduction attributable
to released shares was fixed at $3.2 million per year during each of the years ended December 31,
2006, 2007 and 2008.
Note 9. Stock-Based Compensation
The Company issues stock options and other stock-based awards (nonvested stock, restricted
stock, and deferred stock units) to key employees and directors under its various plans as
described in more detail within this note. The Company accounts for its stock-based awards in
accordance with the provisions of SFAS No. 123(R). In
accordance with SFAS No. 123(R), the Company recognizes compensation expense based on the estimated
grant date fair value of each stock-based award.
Effective May 13, 2008, upon stockholders approval, the Company amended both its LTIP and
MSPP. The amendments increased the shares available for grant by an additional 2.1 million shares
and approximately 0.1 million shares under the LTIP and MSPP, respectively. Additionally, the
amendment of the LTIP increased the limits on grants of restricted shares, performance shares and
other full-value awards by approximately 0.7 million shares.
Description of Stock-Based Compensation Plans
1998 Long-Term Incentive Plan
The Companys LTIP authorizes
approximately 15.7
million shares of the Companys common stock for issuance as
of December 31, 2008. The LTIP authorizes the grant of stock options, stock appreciation rights and
other stock-based awards to officers and employees of the Company. Options to purchase shares
granted to the Companys employees under this plan were granted with an exercise price equal to the
fair market value of the Companys common stock on the day prior to the grant date. These options
become ratably exercisable beginning one year from the date of grant to three years after the date
of grant. All options granted under this plan expire ten years from the date of grant. The Company
granted stock options to purchase 918,245, 1,056,811 and 1,134,125 shares of the Companys common
stock to certain key employees during the years ended December 31, 2006, 2007 and 2008,
respectively, under this plan with an exercise price equal to the fair market value of the
Companys common stock on the day prior to the grant date.
F-35
The Companys outstanding nonvested stock awards have a cliff-vesting period ranging three to
five years from the grant date and the majority contain no vesting requirements other than the
continued employment of the employee. There are certain nonvested stock awards that require the
vesting to be contingent upon the satisfaction of certain financial goals in addition to the
continued employment of the employee, which is described in more detail within this note. The
Company granted 393,844, 453,796 and 478,872 shares of nonvested stock awards to certain key
employees under the LTIP during the years ended December 31, 2006, 2007 and 2008, respectively.
Vesting of awards granted under the LTIP may be accelerated in the event of disability or
death of a participant or change of control of the Company.
Outside Directors Stock and Incentive Compensation Plan
The Company has an Outside Directors Stock and Incentive Compensation Plan (ODSICP) for
which approximately 0.4 million shares of the Companys common stock have been reserved for issuance. There were no
options granted under this plan during the years ended December 31, 2006, 2007 or 2008. The
outstanding options under this plan become exercisable beginning in part from the date of grant to
three years after the date of grant and expire ten years after grant.
The ODSICP further provides that non-employee directors may elect to receive, in lieu of any
portion of their annual retainer (in multiples of 25%), a deferred stock unit award. A deferred
stock unit represents the right to receive a specified number of shares of the Companys common
stock. The shares are paid, subject to the election of the non-employee director, either two years
following the date of the award or at the end of the directors service on the Board of Directors.
The number of shares of the Companys common stock to be paid under a deferred stock unit award is
equal to the value of the cash retainer that the non-employee director has elected to forego,
divided by the fair market value of the Companys common stock on the date of the award. The
Company recognizes a nominal amount of stock-based compensation expense under this plan. As of
December 31, 2008, there were 9,582 deferred stock units outstanding under the ODSICP.
Pursuant to the ODSICP, the Company granted 24,500, 28,000 and 28,000 restricted stock unit
awards to its non-employee directors during the years ended December 31, 2006, 2007 and 2008,
respectively. These awards are fully vested and are no longer subject to forfeiture. The
non-employee directors receipt of shares of the Companys common stock pursuant to the restricted
stock unit award is deferred until the first business day following the earliest to occur of (i)
the third anniversary of the date of grant, or (ii) the date the outside director ceases to be a
member of the Companys Board of Directors.
ESPP
Prior to July 1, 2007, the Company sponsored an employee stock purchase plan which allowed
employees to purchase shares of the Companys common stock at a discount. There were approximately 0.3 million shares
of the Companys common stock reserved for issuance under this plan. Through July 1, 2007, the
Company issued all remaining shares available under the ESPP and on this date terminated the plan.
The Company amended the plan effective January 1, 2006 to be in compliance with the safe harbor
rules of SFAS No. 123(R). Accordingly, the plan was not compensatory and no expense was recognized
during the years ended December 31, 2006 and 2007. The Company received $2.2 million and $1.3
million for the issuance of common stock under this plan during the years ended December 31, 2006
and 2007, respectively.
Presented below is a summary of activity under the ESPP for the years ended December 31, 2006
and 2007:
|
|
|
|
|
|
|
Shares Available |
|
|
for Issuance |
December 31, 2005 |
|
|
107,977 |
|
Issuances |
|
|
(71,847 |
) |
|
|
|
|
|
December 31, 2006 |
|
|
36,130 |
|
Issuances |
|
|
(36,130 |
) |
|
|
|
|
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
F-36
MSPP
The Company has another employee stock purchase plan, the MSPP, which provides to certain
designated employees an opportunity to purchase restricted shares of the Companys common stock at
a 25% discount through payroll deductions over six-month intervals.
There
were approximately 0.3 million shares of the Companys common stock reserved for issuance under this plan
at December 31, 2008. Such shares are subject to a three-year cliff-vesting period. The Company
recognizes a nominal amount of stock-based compensation expense under this plan as a result of the
relatively small number of participants in the MSPP. The Company received, $0.8 million, $0.3
million and $0.8 million for the issuance of stock under this plan during the years ended December
31, 2006, 2007 and 2008, respectively. As of December 31, 2008, there were 85,290 restricted shares
outstanding under the MSPP.
Stock Options
Valuation
The Company estimated the fair value of stock options granted using the Hull-White II
Valuation Model (HW-II) lattice option valuation model and a single option award approach. The
Company uses the HW-II because it considers characteristics of fair value option pricing, such as
an options contractual term and the probability of exercise before the end of the contractual
term. In addition, the complications surrounding the expected term of an option are material, as
clarified by the Securities and Exchange Commissions (SEC) focus on the matter in Staff
Accounting Bulletin No. 107, Share Based Payment (SAB No. 107). Given the Companys reasonably
large pool of unexercised options, the Company believes a lattice model that specifically addresses
this fact and models a full term of exercises is the most appropriate and reliable means of valuing
its stock options. The Company is amortizing the fair value on a straight-line basis over the
requisite service periods of the awards, which are the vesting periods of three years. The stock
options vest 33.3% on each grant anniversary date over three years of continued employment.
The following table shows the weighted average assumptions the Company used to develop the
fair value estimates under its HW-II option valuation model and the resulting estimates of
weighted-average fair value per share of stock options granted during the years ended December 31,
2006, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
2007 |
|
2008 |
|
|
|
|
Expected volatility |
|
|
32.8 |
% |
|
|
27.2 |
% |
|
|
31.9 |
% |
|
|
|
|
Risk free interest rate (range) |
|
|
4.38% - 5.21 |
% |
|
|
3.34% - 5.21 |
% |
|
|
0.09% - 3.89 |
% |
|
|
|
|
Expected dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average expected term (years) |
|
|
5.4 |
|
|
|
4.7 |
|
|
|
5.3 |
|
|
|
|
|
Fair value per share of stock options granted |
|
$ |
11.15 |
|
|
$ |
10.24 |
|
|
$ |
8.14 |
|
|
|
|
|
Population Stratification
Under SFAS No. 123(R), a company should aggregate individual awards into relatively
homogeneous groups with respect to exercise and post-vesting employment behaviors for the purpose
of refining the expected term assumption, regardless of the valuation technique used to estimate
the fair value. In addition, SAB No. 107 clarifies that a company may generally make a reasonable
fair value estimate with as few as one or two groupings. Prior to January 1, 2008, the Company
stratified its employee population into two groups: (i) Insiders, who were the Section 16 filers
under SEC rules; and (ii) Non-insiders, who were the rest of the employee population. Effective
January 1, 2008, the Company determined that a single employee population group was more
appropriate. The Company derived its two group stratification prior to January 1, 2008 and post
January 1, 2008 single employee grouping based on an analysis of its historical exercise patterns.
F-37
Expected Volatility
Volatility is a measure of the tendency of investment returns to vary around a long-term
average rate. Historical volatility is an appropriate starting point for setting this assumption
under SFAS No. 123(R). According to SFAS No. 123(R), companies should also consider how future
experience may differ from the past. This may require using other factors to adjust historical
volatility, such as implied volatility, peer-group volatility and the range and mean-reversion of
volatility estimates over various historical periods. SFAS No. 123(R) and SAB No. 107 acknowledge
that there is likely to be a range of reasonable estimates for volatility. In addition, SFAS No.
123(R) requires that if a best estimate cannot be made, management should use the mid-point in the
range of reasonable estimates for volatility. The Company estimates the volatility of its common
stock at the date of grant based on both historical volatility and implied volatility from traded
options of the Companys common stock, consistent with SFAS No. 123(R) and SAB No. 107.
Risk-Free Interest Rate
Lattice models require risk-free interest rates for all potential times of exercise obtained
by using a grant-date yield curve. A lattice model would, therefore, require the yield curve for
the entire time period during which employees might exercise their options. The Company bases the
risk-free rate on the implied yield in effect at the time of option grant on United States Treasury
zero-coupon issues with equivalent remaining terms.
Expected Dividends
The Company has never paid any cash dividends on its common stock and does not anticipate
paying any cash dividends in the foreseeable future. Consequently, it uses an expected dividend
yield of zero.
Pre-Vesting Forfeitures
Pre-vesting forfeitures do not affect the fair value calculation, but they affect the expense
calculation. SFAS No. 123(R) requires the Company to estimate pre-vesting forfeitures at the time
of grant and revise those estimates in subsequent periods if actual forfeitures differ from those
estimates. The Company uses historical data to estimate pre-vesting forfeitures and records
share-based compensation expense only for those awards that are expected to vest.
During the year ended December 31, 2007, the Company changed from a static forfeiture rate
methodology to a dynamic forfeiture rate methodology. The dynamic forfeiture rate methodology
incorporates the lapse of time into the resulting expense calculation and results in a forfeiture
rate that diminishes as the granted award approach its vest date. Accordingly, the dynamic
forfeiture rate methodology results in a more consistent stock compensation expense calculation
over the vesting period of the award.
Additionally, during the year ended December 31, 2007, the Company performed an analysis of
its initial pre-vesting forfeiture rate percentage and increased its initial pre-vesting forfeiture
rate ranging from 3.0% to 7.5%, up to an initial pre-vesting forfeiture rate of 12.5%. The increase
in the Companys initial pre-vesting forfeiture rate reflects the recent forfeiture trends
experienced by the Company and expectations of future forfeitures. As previously discussed, as the
Company utilizes the dynamic forfeiture rate methodology, this rate is updated and is reduced
accordingly as time lapses until it ultimately reaches zero on the vesting date, contingent upon
the continued employment of the grantee.
Post-Vesting Cancellations
Post-vesting cancellations include vested options that are cancelled, exercised or expire
unexercised. Lattice models treat post-vesting cancellations and voluntary early exercise behavior
as two separate assumptions. The Company uses historical data to estimate post-vesting
cancellations.
F-38
Expected Term
SFAS No. 123(R) calls for an extinguishment calculation, dependent upon how long a granted
option remains outstanding before it is fully extinguished. While extinguishment may result from
exercise, it can also result from post-vesting cancellation or expiration at the contractual term.
Expected term is an output in lattice models so the Company does not have to determine this amount.
Stock Option Activity
A summary of stock option activity during the year ended December 31, 2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
Weighted |
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
Average |
|
|
Average |
|
|
|
|
|
|
Aggregate |
|
|
Remaining |
|
|
|
Number |
|
|
Exercise |
|
|
Fair |
|
|
Total |
|
|
Intrinsic |
|
|
Contractual |
|
Stock Options |
|
of Shares |
|
|
Price |
|
|
Value |
|
|
Fair Value |
|
|
Value(a) |
|
|
Term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
|
(In millions) |
|
|
(In years) |
|
Outstanding
at December 31, 2007 |
|
|
4,128,563 |
|
|
$ |
30.65 |
|
|
$ |
11.25 |
|
|
$ |
46.5 |
|
|
$ |
17.7 |
|
|
|
5.68 |
|
Exercisable at December 31, 2007 |
|
|
2,915,406 |
|
|
$ |
28.47 |
|
|
$ |
11.20 |
|
|
$ |
32.7 |
|
|
$ |
17.6 |
|
|
|
4.43 |
|
Unvested at December 31, 2007 |
|
|
1,213,157 |
|
|
$ |
35.90 |
|
|
$ |
11.31 |
|
|
$ |
13.8 |
|
|
$ |
0.1 |
|
|
|
8.67 |
|
Granted |
|
|
1,134,125 |
|
|
$ |
26.10 |
|
|
$ |
8.14 |
|
|
$ |
9.2 |
|
|
|
N/A |
|
|
|
N/A |
|
Forfeited (pre-vest cancellation) |
|
|
(127,268 |
) |
|
$ |
30.83 |
|
|
$ |
9.21 |
|
|
$ |
(1.2 |
) |
|
|
N/A |
|
|
|
N/A |
|
Exercised |
|
|
(230,210 |
) |
|
$ |
15.77 |
|
|
$ |
5.61 |
|
|
$ |
(1.3 |
) |
|
$ |
3.9 |
|
|
|
N/A |
|
Expired (post-vest cancellation) |
|
|
(107,650 |
) |
|
$ |
38.18 |
|
|
$ |
14.81 |
|
|
$ |
(1.6 |
) |
|
|
N/A |
|
|
|
N/A |
|
Vested |
|
|
564,277 |
|
|
$ |
36.72 |
|
|
$ |
12.71 |
|
|
$ |
7.2 |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
4,797,560 |
|
|
$ |
30.13 |
|
|
$ |
10.77 |
|
|
$ |
51.6 |
|
|
$ |
7.8 |
|
|
|
5.76 |
|
Exercisable at December 31, 2008 |
|
|
3,141,823 |
|
|
$ |
30.56 |
|
|
$ |
11.76 |
|
|
$ |
37.0 |
|
|
$ |
7.8 |
|
|
|
4.19 |
|
Unvested at December 31, 2008 |
|
|
1,655,737 |
|
|
$ |
29.30 |
|
|
$ |
8.83 |
|
|
$ |
14.6 |
|
|
$ |
|
|
|
|
8.74 |
|
|
|
|
(a) |
|
The aggregate intrinsic value represents the difference between the underlying stocks market
price and the stock options exercise price. |
In March 2007, the Company granted performance-based stock options to certain senior
executives to acquire up to an aggregate of 760,000 shares of the Companys common stock. These
stock options were subject to forfeiture unless certain targeted levels of diluted earnings per
share were achieved for the year ended December 31, 2007. Depending on the level of diluted
earnings per share achieved for the year ended December 31, 2007, the senior executives would
forfeit 0% to 100% of these stock options. For purposes of accounting for these stock options, the
Company assumed a target level of diluted earnings per share that resulted in the grant of 380,000
stock options. Because the required targeted level of diluted earnings per share was not met, the
Company cancelled all of these stock options. As a result, there was no expense recognized for
these performance-based stock options during the year ended December 31, 2007. The stock options
granted and forfeited of 1,056,811 and 570,307, respectively, during the year ended December 31,
2007 included these 380,000 performance-based stock options
The total intrinsic value of stock options exercised during the years ended December 31, 2006,
2007 and 2008 was $0.5 million, $3.1 million and $3.9 million, respectively. The Company received
$0.6 million, $12.7 million, and $3.6 million in cash from stock option exercises for the years
ended December 31, 2006, 2007 and 2008, respectively. The actual tax benefit realized for the tax
deductions from stock option exercises totaled $1.2 million and $1.1 million for the years ended
December 31, 2007 and 2008, respectively. There was a nominal amount of actual tax benefits
realized for the tax deductions from stock option exercises for the year ended December 31, 2006.
As of December 31, 2008, there was $8.4 million of total estimated unrecognized compensation
cost related to stock option compensation arrangements. Total estimated unrecognized compensation
cost will be adjusted for future changes in estimated forfeitures. The Company expects to recognize
that cost over a weighted average period of 1.3 years.
F-39
Other Stock-Based Awards
The fair value of other stock-based awards (nonvested stock and restricted stock units) are
determined based on the closing price of the Companys common stock on the day prior to the grant
date. The Companys other stock-based awards require no payment from employees and directors, and
stock-based compensation expense is recorded equally over the vesting periods ranging from six
months to five years.
A summary of other stock-based award activity under the LTIP, ODSICP and MSPP during the years
ended December 31, 2007 and 2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
Number |
|
|
Average |
|
|
Total |
|
|
Aggregate |
|
Other Stock-Based Awards |
|
of Shares |
|
|
Fair Value |
|
|
Fair Value |
|
|
Intrinsic Value |
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
|
(In millions) |
|
Outstanding at December 31, 2007 |
|
|
1,341,998 |
|
|
$ |
37.17 |
|
|
$ |
49.8 |
|
|
|
37.4 |
|
Granted |
|
|
546,411 |
|
|
|
24.96 |
|
|
|
13.6 |
|
|
|
N/A |
|
Vested and exercised |
|
|
(324,134 |
) |
|
|
42.37 |
|
|
|
(13.7 |
) |
|
|
9.0 |
|
Forfeited (pre-vest cancellation) |
|
|
(102,454 |
) |
|
|
33.72 |
|
|
|
(3.4 |
) |
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2008 |
|
|
1,461,821 |
|
|
$ |
31.68 |
|
|
$ |
46.3 |
|
|
$ |
31.6 |
|
Unvested at December 31, 2008 |
|
|
1,395,320 |
|
|
$ |
31.60 |
|
|
$ |
44.1 |
|
|
$ |
30.5 |
|
During the years ended December 31, 2007 and 2008, the Company granted 240,000 and 247,500
shares, respectively, of nonvested stock awards under the LTIP to certain senior executives. These
nonvested stock awards are included in the above table. In addition to requiring continuing service
of an employee, the vesting of these nonvested stock awards is contingent upon the satisfaction of
certain financial goals, specifically related to the achievement of budgeted annual revenues and
earnings targets within a three-year period. Under the LTIP, if these goals are achieved, the
nonvested stock awards will cliff-vest three years after the grant date. The fair value for each of
these nonvested stock awards was determined based on the closing price of the Companys common
stock on the day prior to the grant date and assumes that the performance goals will be achieved.
If these performance goals are not met, no compensation expense will be recognized and any
previously recognized compensation expense will be reversed.
As of December 31, 2008, there was $16.7 million of total estimated unrecognized compensation
cost related to other stock-based awards granted under the LTIP, ODSICP and MSPP. Total estimated
unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. The
Company expects to recognize that cost over a weighted average period of 1.6 years.
F-40
Summary of Stock-Based Compensation
The following table summarizes the activity under the Companys stock-based compensation plans
for the years ended December 31, 2006, 2007 and 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred Stock |
|
|
|
|
|
|
Stock Options |
|
Other Stock-Based Awards |
|
Units |
|
|
|
|
|
|
Outstanding |
|
Outstanding |
|
Outstanding |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
Weighted |
|
|
|
|
Shares |
|
|
|
|
|
Average |
|
|
|
|
|
Average |
|
|
|
|
Available |
|
Number of |
|
Exercise |
|
Number of |
|
Grant Date |
|
Number of |
|
|
for Grant |
|
Shares |
|
Price |
|
Shares |
|
Price |
|
Shares |
December 31, 2005 |
|
|
4,434,113 |
|
|
|
3,559,674 |
|
|
$ |
29.98 |
|
|
|
874,801 |
|
|
$ |
42.51 |
|
|
|
11,168 |
|
Stock option grants |
|
|
(918,245 |
) |
|
|
918,245 |
|
|
|
33.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards grants |
|
|
(449,523 |
) |
|
|
|
|
|
|
|
|
|
|
449,523 |
|
|
|
31.90 |
|
|
|
|
|
Deferred stock unit grants |
|
|
(6,255 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,255 |
|
Stock option exercises |
|
|
|
|
|
|
(30,327 |
) |
|
|
17.62 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(799 |
) |
Stock option cancellations |
|
|
326,068 |
|
|
|
(326,068 |
) |
|
|
37.68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards cancellations |
|
|
270,820 |
|
|
|
|
|
|
|
|
|
|
|
(270,820 |
) |
|
|
40.23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2006 |
|
|
3,656,998 |
|
|
|
4,121,524 |
|
|
|
30.19 |
|
|
|
1,053,504 |
|
|
|
38.62 |
|
|
|
16,624 |
|
Stock option grants |
|
|
(1,056,811 |
) |
|
|
1,056,811 |
|
|
|
36.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards grants |
|
|
(513,314 |
) |
|
|
|
|
|
|
|
|
|
|
513,314 |
|
|
|
34.98 |
|
|
|
|
|
Deferred stock unit grants |
|
|
(3,979 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,979 |
|
Stock option exercises |
|
|
|
|
|
|
(400,639 |
) |
|
|
30.64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards exercises |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,500 |
) |
|
|
40.60 |
|
|
|
|
|
Deferred stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,784 |
) |
Stock option cancellations |
|
|
649,133 |
|
|
|
(649,133 |
) |
|
|
36.93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards cancellations |
|
|
214,320 |
|
|
|
|
|
|
|
|
|
|
|
(214,320 |
) |
|
|
38.97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
2,946,347 |
|
|
|
4,128,563 |
|
|
|
30.65 |
|
|
|
1,341,998 |
|
|
|
37.17 |
|
|
|
9,819 |
|
Increase in shares available for grant |
|
|
2,175,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option grants |
|
|
(1,134,125 |
) |
|
|
1,134,125 |
|
|
|
26.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards grants |
|
|
(546,411 |
) |
|
|
|
|
|
|
|
|
|
|
546,411 |
|
|
|
24.96 |
|
|
|
|
|
Deferred stock unit grants |
|
|
(1,746 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,746 |
|
Stock option exercises |
|
|
|
|
|
|
(230,210 |
) |
|
|
15.77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards exercises |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(324,134 |
) |
|
|
42.37 |
|
|
|
|
|
Deferred stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,983 |
) |
Stock option cancellations |
|
|
234,918 |
|
|
|
(234,918 |
) |
|
|
34.20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other stock-based awards cancellations |
|
|
102,454 |
|
|
|
|
|
|
|
|
|
|
|
(102,454 |
) |
|
|
33.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2008 |
|
|
3,776,437 |
|
|
|
4,797,560 |
|
|
$ |
30.13 |
|
|
|
1,461,821 |
|
|
$ |
31.68 |
|
|
|
9,582 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes the Companys total stock-based compensation expense as well as
the total recognized tax benefits related thereto for the years ended December 31, 2006, 2007 and
2008 (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Other stock-based awards |
|
$ |
7.4 |
|
|
$ |
11.8 |
|
|
$ |
16.1 |
|
Stock options |
|
|
5.7 |
|
|
|
6.9 |
|
|
|
7.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense |
|
$ |
13.1 |
|
|
$ |
18.7 |
|
|
$ |
23.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax benefits on stock-based compensation expense |
|
$ |
5.2 |
|
|
$ |
7.8 |
|
|
$ |
9.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company did not capitalize any stock-based compensation cost during the years ended
December 31, 2006, 2007 and 2008. As of December 31, 2008, there was $25.1 million of total
estimated unrecognized compensation cost related to all of the Companys stock compensation
arrangements. Total estimated unrecognized compensation cost may be adjusted for future changes in
estimated forfeitures. The Company expects to recognize that cost over a weighted-average period of
1.5 years.
F-41
Note 10. Commitments and Contingencies
Legal Proceedings and General Liability Claims
The Company is, from time to time, subject to claims and suits arising in the ordinary course
of business, including claims for damages for personal injuries, medical malpractice, breach of
contracts, wrongful restriction of or interference with physicians staff privileges and employment
related claims. In certain of these actions, plaintiffs request payment for damages, including
punitive damages that may not be covered by insurance. The Company is currently not a party to any
pending or threatened proceeding, which, in managements opinion, would have a material adverse
effect on the Companys business, financial condition or results of operations.
Physician Commitments
The Company has committed to provide certain financial assistance pursuant to recruiting
agreements with various physicians practicing in the communities it serves. In consideration for a
physician relocating to one of its communities and agreeing to engage in private practice for the
benefit of the respective community, the Company may advance certain amounts of money to a
physician, normally over a period of one year, to assist in establishing the physicians practice.
The Company has committed to advance a maximum amount of approximately $43.5 million at December
31, 2008. The actual amount of such commitments to be subsequently advanced to physicians is
estimated at $22.2 million and often depends upon the financial results of a physicians private
practice during the guarantee period. Generally, amounts advanced under the recruiting agreements
may be forgiven pro rata over a period of 36 to 48 months contingent upon the physician continuing
to practice in the respective community. Pursuant to the Companys standard physician recruiting
agreement, any breach or non-fulfillment by a physician under the physician recruiting agreement
gives the Company the right to recover any payments made to the physician under the agreement. The
Companys physician minimum revenue guarantees are described further in Notes 1 and 4.
Capital Expenditure Commitments
The Company is reconfiguring some of its facilities to accommodate patient services more
effectively and restructuring existing surgical capacity in some of its hospitals to permit
additional patient volume and a greater variety of services. The Company has incurred approximately
$39.7 million in uncompleted projects as of December 31, 2008, which is included as construction in
progress in the Companys accompanying consolidated balance sheet. At December 31, 2008, the
Company had projects under construction with an estimated cost to complete and equip of
approximately $169.8 million. The Company is subject to annual capital expenditure commitments in
connection with several of its facilities.
Development Agreement with the City of Ennis
The Company entered into a development agreement with the City of Ennis, Texas (the Ennis
Development Agreement) during 2005 to construct a new hospital (Ennis New) to replace the
existing Ennis Regional Medical Center (Ennis Old). The Company leased Ennis Old from the City of
Ennis. Under the Ennis Development Agreement, the Company constructed and equipped Ennis New for
approximately $35.0 million, all of which was paid for by the Company. The construction was
completed during July 2007 and the Company moved its operations from Ennis Old to Ennis New.
Pursuant to the terms of the Ennis Development Agreement, the City of Ennis paid $14.7 million of
the construction cost to the Company during August 2007, which the Company recorded as a deferred
income liability and has included in professional and general liability claims and other
liabilities in the Companys accompanying consolidated balance sheets. In addition, the Company, as
lessee, entered into a 40-year lease agreement (the Ennis Lease Agreement) with the City of
Ennis, the lessor. The Company is amortizing the $14.7 million deferred income liability
straight-line over the term of the Ennis Lease Agreement.
As of December 31, 2008, the unamortized deferred income liability was
$13.9 million.
F-42
Acquisitions
The Company has historically acquired businesses with prior operating histories. Acquired
companies may have unknown or contingent liabilities, including liabilities for failure to comply
with healthcare laws and regulations, medical and general professional liabilities, workers
compensation liabilities, previous tax liabilities and unacceptable business practices. Although
the Company institutes policies designed to conform practices to its standards following completion
of acquisitions, there can be no assurance that the Company will not become liable for past
activities that may later be asserted to be improper by private plaintiffs or government agencies.
Although the Company generally seeks to obtain indemnification from prospective sellers covering
such matters, there can be no assurance that any such matter will be covered by indemnification, or
if covered, that such indemnification will be adequate to cover potential losses and fines.
Leases
The Company leases real estate properties, buildings, vehicles and equipment under cancelable
and non-cancelable leases. The leases expire at various times and have various renewal options.
Certain leases that meet the lease capitalization criteria in accordance with SFAS No. 13,
Accounting for Leases, as amended, have been recorded as an asset and liability at the lower of
the net present value of the minimum lease payments at the inception of the lease or the fair value
of the asset at the inception date. Interest rates used in computing the net present value of the
lease payments are based on the Companys incremental borrowing rate at the inception of the lease.
Rental expense of operating leases for the years ended December 31, 2006, 2007 and 2008 was $23.0
million, $25.8 million and $25.6 million, respectively.
Future minimum lease payments at December 31, 2008, for those leases having an initial or
remaining non-cancelable lease term in excess of one year are as follows for the years indicated
(in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating |
|
|
Capital Lease |
|
|
|
|
|
|
Leases |
|
|
Obligations |
|
|
Total |
|
2009 |
|
$ |
13.5 |
|
|
$ |
1.3 |
|
|
$ |
14.8 |
|
2010 |
|
|
8.7 |
|
|
|
1.1 |
|
|
|
9.8 |
|
2011 |
|
|
6.7 |
|
|
|
1.0 |
|
|
|
7.7 |
|
2012 |
|
|
5.0 |
|
|
|
0.9 |
|
|
|
5.9 |
|
2013 |
|
|
3.3 |
|
|
|
0.4 |
|
|
|
3.7 |
|
Thereafter |
|
|
9.3 |
|
|
|
|
|
|
|
9.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
46.5 |
|
|
|
4.7 |
|
|
$ |
51.2 |
|
|
|
|
|
|
|
|
|
|
|
|
Less: interest portion |
|
|
|
|
|
|
(0.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term obligations under capital leases |
|
|
|
|
|
$ |
4.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Matters
See Note 5 for a discussion of the Companys contingent tax matters.
F-43
Note 11. Earnings (Loss) Per Share
The following table sets forth the computation of basic and diluted earnings (loss) per share
for the years ended December 31, 2006, 2007 and 2008 (dollars and shares in millions, except per
share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Numerator for basic and diluted earnings per share income from
continuing operations |
|
$ |
144.2 |
|
|
$ |
127.7 |
|
|
$ |
138.2 |
|
Income (loss) from discontinued operations, net of income taxes |
|
|
1.3 |
|
|
|
(25.7 |
) |
|
|
(23.7 |
) |
Cumulative effect of change in accounting principle |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
146.2 |
|
|
$ |
102.0 |
|
|
$ |
114.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic earnings (loss) per share weighted average shares
outstanding |
|
|
55.6 |
|
|
|
56.2 |
|
|
|
52.5 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Employee stock benefit plans |
|
|
0.7 |
|
|
|
1.0 |
|
|
|
1.0 |
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted earnings (loss) per share weighted average shares |
|
|
56.3 |
|
|
|
57.2 |
|
|
|
53.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
2.59 |
|
|
$ |
2.27 |
|
|
$ |
2.63 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
(0.45 |
) |
|
|
(0.45 |
) |
Cumulative effect of change in accounting principle |
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
2.63 |
|
|
$ |
1.82 |
|
|
$ |
2.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
2.56 |
|
|
$ |
2.23 |
|
|
$ |
2.58 |
|
Discontinued operations |
|
|
0.03 |
|
|
|
(0.44 |
) |
|
|
(0.44 |
) |
Cumulative effect of change in accounting principle |
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
2.60 |
|
|
$ |
1.79 |
|
|
$ |
2.14 |
|
|
|
|
|
|
|
|
|
|
|
The Companys 31/2% Notes and 31/4% Debentures are
included in the calculation of diluted earnings per share whether or not the contingent
requirements have been met for conversion using the treasury stock method if the conversion price
of $51.79 and $61.22, respectively, is less than the average market price of the Companys common
stock for the period. Upon conversion, the par value is settled in cash, and only the conversion
premium is settled in shares of the Companys common stock. The impact of the
31/4% Debentures has been excluded because the effect would have been
anti-dilutive for the years ended December 31, 2006, 2007 and 2008. The impact of the
31/2% Notes has been excluded because the effect would have been
anti-dilutive for the years ended December 31, 2007 and 2008.
Note 12. Financial Impact of Changes in the Companys Executives
On April 26, 2007, Michael J. Culotta resigned from his position of Chief Financial Officer of
the Company. On May 4, 2007, LifePoint CSGP, LLC, a subsidiary of the Company, and Mr. Culotta
entered into an Agreement to Cooperate and General Release (the Release Agreement). Under the
Release Agreement, Mr. Culotta agreed to cooperate with the Company in various matters in which his
knowledge of the business of the Company may be relevant and to assist the Company so as to
facilitate a smooth and seamless transition of the responsibilities held and information learned by
him while employed by the Company. Mr. Culotta agreed that his participation in various employment
plans sponsored by the Company had ceased with his resignation and to release any claims he may
have against the Company. As consideration for entering into the Release Agreement, the Company
agreed to pay Mr. Culotta a total amount of approximately $0.8 million over the course of 18 months
following the date of the Release Agreement. Mr. Culotta also acknowledged certain terms of
existing stock options and rights under Company plans, including the expiration thereof, in
relation to his resignation. Finally, Mr. Culotta agreed to certain confidentiality,
non-competition, non-solicitation and other requirements under the Release Agreement.
F-44
As a result of Mr. Culottas resignation, the Company incurred a net decrease in compensation
expense of approximately $0.7 million, $0.4 million, net of income taxes, or an increase in diluted
earnings per share of $0.01, during the year ended December 31, 2007. This net decrease in
compensation expense consists of approximately $0.8 million recognized in connection with the
Release Agreement, as described above, offset by an approximate $1.5 million reversal of stock
compensation expense resulting from the termination of his unvested stock options and nonvested
stock.
Effective June 26, 2006, Executive Vice President William F. Carpenter III, was named
President and Chief Executive Officer of the Company. Mr. Carpenter replaced Kenneth C. Donahey,
who retired after serving five years as the Companys Chairman, President and Chief Executive
Officer. In addition, on June 25, 2006, Mr. Donahey resigned from the Companys Board of Directors
and Mr. Carpenter was elected by the Companys Board of Directors to fill the vacancy resulting
from Mr. Donaheys resignation. In addition, the Companys Lead Director, Owen G. Shell, Jr., was
elected as the Companys Chairman of the Board as of June 26, 2006.
Effective June 25, 2006, LifePoint CSGP, LLC, a subsidiary of the Company, entered into a
Separation Agreement with Mr. Donahey that terminated the employment agreement between LifePoint
CSGP, LLC and Mr. Donahey (the Employment Agreement). Mr. Donahey received $3.5 million in two
equal installments, on December 27, 2006 and June 27, 2007, together with a payment to cover any
liability for federal excise tax he would have incurred as a result of the receipt of such
payments. The confidentiality provisions of the Employment Agreement remain in effect for 36
months. In accordance with the terms of his pre-existing stock option agreements, Mr. Donahey may
exercise his stock options that were vested at the time of his retirement over a period of three
years after his retirement date. He will receive insurance benefits comparable to those available
to Company executives for a period of two years. The Company and Mr. Donahey also agreed to a
mutual release of claims, except for any indemnity claims to which Mr. Donahey may be entitled and
for breaches of the Separation Agreement. Mr. Donahey agreed not to compete with the Company for a
period of one year in non-urban hospitals, diagnostic/imaging or surgery centers, and the physician
recruitment business, subject to certain limitations, and he agreed not to induce or encourage the
departure of Company employees for a period of one year.
As a result of Mr. Donaheys retirement, the Company incurred additional net compensation
expense of approximately $2.0 million, $1.2 million net of income taxes, or a decrease in diluted
earnings per share of $0.02, for the year ended December 31, 2006. This compensation expense
consists of the $3.5 million in cash payments, as described above, offset by a $1.5 million
reversal of stock compensation expense resulting from the forfeiture of his unvested stock options
and nonvested stock.
F-45
Note 13. Unaudited Quarterly Financial Information
The quarterly interim financial information shown below has been prepared by the Companys
management and is unaudited. It should be read in conjunction with the audited consolidated
financial statements appearing herein (dollars in millions, except per share amounts).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
First |
|
|
Second |
|
|
Third |
|
|
Fourth |
|
Revenues |
|
$ |
645.8 |
|
|
$ |
638.2 |
|
|
$ |
641.0 |
|
|
$ |
643.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
38.9 |
|
|
$ |
25.0 |
|
|
$ |
32.1 |
|
|
$ |
31.7 |
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations |
|
|
(1.1 |
) |
|
|
(3.0 |
) |
|
|
(3.8 |
) |
|
|
(0.7 |
) |
Impairment (charge) adjustment |
|
|
(7.9 |
) |
|
|
(8.5 |
) |
|
|
0.3 |
|
|
|
(0.4 |
) |
Loss on sale of hospitals |
|
|
(0.1 |
) |
|
|
(0.1 |
) |
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations |
|
|
(9.1 |
) |
|
|
(11.6 |
) |
|
|
(3.9 |
) |
|
|
(1.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
29.8 |
|
|
$ |
13.4 |
|
|
$ |
28.2 |
|
|
$ |
30.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.70 |
|
|
$ |
0.44 |
|
|
$ |
0.57 |
|
|
$ |
0.56 |
|
Discontinued operations |
|
|
(0.17 |
) |
|
|
(0.20 |
) |
|
|
(0.07 |
) |
|
|
(0.02 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.53 |
|
|
$ |
0.24 |
|
|
$ |
0.50 |
|
|
$ |
0.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.69 |
|
|
$ |
0.43 |
|
|
$ |
0.56 |
|
|
$ |
0.55 |
|
Discontinued operations |
|
|
(0.16 |
) |
|
|
(0.20 |
) |
|
|
(0.07 |
) |
|
|
(0.02 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.53 |
|
|
$ |
0.23 |
|
|
$ |
0.49 |
|
|
$ |
0.53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
First |
|
|
Second |
|
|
Third |
|
|
Fourth |
|
Revenues |
|
$ |
685.1 |
|
|
$ |
665.7 |
|
|
$ |
675.1 |
|
|
$ |
674.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
41.3 |
|
|
$ |
32.2 |
|
|
$ |
31.5 |
|
|
$ |
33.2 |
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from discontinued operations |
|
|
(1.8 |
) |
|
|
(1.4 |
) |
|
|
(3.3 |
) |
|
|
0.2 |
|
Impairment adjustment (charge) |
|
|
2.3 |
|
|
|
|
|
|
|
(16.8 |
) |
|
|
(2.6 |
) |
Loss on sale of hospitals |
|
|
|
|
|
|
(0.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from discontinued operations |
|
|
0.5 |
|
|
|
(1.7 |
) |
|
|
(20.1 |
) |
|
|
(2.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
41.8 |
|
|
$ |
30.5 |
|
|
$ |
11.4 |
|
|
$ |
30.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.76 |
|
|
$ |
0.62 |
|
|
$ |
0.61 |
|
|
$ |
0.64 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
(0.04 |
) |
|
|
(0.39 |
) |
|
|
(0.05 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.77 |
|
|
$ |
0.58 |
|
|
$ |
0.22 |
|
|
$ |
0.59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.75 |
|
|
$ |
0.60 |
|
|
$ |
0.60 |
|
|
$ |
0.63 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
(0.03 |
) |
|
|
(0.38 |
) |
|
|
(0.05 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.76 |
|
|
$ |
0.57 |
|
|
$ |
0.22 |
|
|
$ |
0.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-46
Note 14. Subsequent Event
Effective February 1, 2009, the Company acquired Rockdale Medical Center, Inc., a 138-bed
facility located in Conyers, Georgia for $80.0 million plus net working capital. In connection
with the Companys agreement to purchase the facility, the Company deposited $5.0 million in an
escrow account and prepaid $1.0 million of the purchase price as of December 31, 2008. The Company
has included the $5.0 million escrow deposit and $1.0 million prepaid purchase price as other
long-term assets in the accompanying consolidated balance sheet as of December 31, 2008.
F-47
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Brentwood, State of Tennessee, on February 20, 2009.
|
|
|
|
|
|
LIFEPOINT HOSPITALS, INC.
|
|
|
By: |
/s/ WILLIAM F. CARPENTER III
|
|
|
|
William F. Carpenter III |
|
|
|
President and Chief Executive Officer |
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant in the capacities and on the date
indicated.
|
|
|
|
|
Name |
|
Title |
|
Date |
|
|
|
|
|
/s/ OWEN G. SHELL, JR.
|
|
Chairman of the Board of Directors
|
|
February 20, 2009 |
Owen G. Shell, Jr. |
|
|
|
|
|
|
|
|
|
/s/ WILLIAM F. CARPENTER III
William F. Carpenter III
|
|
President, Chief Executive
Officer, and Director (Principal
Executive Officer)
|
|
February 20, 2009 |
|
|
|
|
|
/s/ DAVID M. DILL
David M. Dill
|
|
Chief Financial Officer
(Principal Financial Officer)
|
|
February 20, 2009 |
|
|
|
|
|
/s/ MICHAEL S. COGGIN
Michael S. Coggin
|
|
Chief Accounting Officer
(Principal Accounting Officer)
|
|
February 20, 2009 |
|
|
|
|
|
/s/ GREGORY T. BIER
Gregory T. Bier
|
|
Director
|
|
February 20, 2009 |
|
|
|
|
|
/s/ RICHARD H. EVANS
Richard H. Evans
|
|
Director
|
|
February 20, 2009 |
|
|
|
|
|
/s/ DEWITT EZELL, JR
DeWitt Ezell, Jr
|
|
Director
|
|
February 20, 2009 |
|
|
|
|
|
/s/ MICHAEL P. HALEY
Michael P. Haley
|
|
Director
|
|
February 20, 2009 |
|
|
|
|
|
/s/ MARGUERITE W. KONDRACKE
Marguerite W. Kondracke
|
|
Director
|
|
February 20, 2009 |
|
|
|
|
|
/s/ JOHN E. MAUPIN, JR., D.D.S
John E. Maupin, Jr., D.D.S
|
|
Director
|
|
February 20, 2009 |
84
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
3.1 |
|
|
|
|
|
Amended and Restated Certificate of Incorporation (incorporated by reference
from exhibits to the Registration Statement on Form S-8 filed by LifePoint
Hospitals, Inc. on April 19, 2005, File No. 333-124151). |
|
|
|
|
|
|
|
3.2 |
|
|
|
|
|
Second Amended and Restated Bylaws of LifePoint Hospitals, Inc. (incorporated
by reference from exhibits to the LifePoint Hospitals, Inc. Current Report on
Form 8-K dated October 16, 2006, File No. 000-51251). |
|
|
|
|
|
|
|
3.3 |
|
|
|
|
|
Amendment No. 1 to the Second Amended and Restated Bylaws of LifePoint
Hospitals, Inc. (incorporated by reference from exhibits to the LifePoint
Hospitals, Inc. Current Report on Form 8-K dated May 20, 2008, File No.
000-51251). |
|
|
|
|
|
|
|
4.1 |
|
|
|
|
|
Form of Specimen Stock Certificate (incorporated by reference from exhibits to
the Registration Statement on Form S-4, as amended, filed by LifePoint
Hospitals, Inc. on October 25, 2004, File No. 333-119929). |
|
|
|
|
|
|
|
4.2 |
|
|
|
|
|
Form of 3.25% Convertible Senior Subordinated Debenture due 2025 (incorporated
by reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated August 10, 2005, File No. 000-51251). |
|
|
|
|
|
|
|
4.3 |
|
|
|
|
|
Registration Rights Agreement, dated August 10, 2005, between LifePoint
Hospitals, Inc. and Citigroup Global Markets Inc. as Representatives of the
Initial Purchasers (incorporated by reference from exhibits to LifePoint
Hospitals Current Report on Form 8-K dated August 10, 2005, File No.
000-51251). |
|
|
|
|
|
|
|
4.4 |
|
|
|
|
|
Rights Agreement, dated as of April 15, 2005, by and between LifePoint
Hospitals, Inc. and National City Bank, as Rights Agent (incorporated by
reference from exhibits to the Registration Statement on Form S-8 filed by
Historic LifePoint Hospitals, Inc. on April 15, 2005, File No. 333-124093). |
|
|
|
|
|
|
|
4.5 |
|
|
|
|
|
Subordinated Indenture, dated as of May 27, 2003, between Province Healthcare
Company and U.S. Bank Trust National Association, as Trustee (incorporated by
reference from exhibits to Province Healthcare Companys Quarterly Report on
Form 10-Q for the quarter ended June 30, 2003, File No. 001-31320). |
|
|
|
|
|
|
|
4.6 |
|
|
|
|
|
First Supplemental Indenture to Subordinated Indenture, dated as of May 27,
2003, by and among Province Healthcare Company and U.S. Bank National
Association, as Trustee, relating to Province Healthcare Companys
71/2% Senior Subordinated Notes due 2013 (incorporated by
reference from exhibits to Province Healthcare Companys Quarterly Report on
Form 10-Q for the quarter ended June 30, 2003, File No. 001-31320). |
|
|
|
|
|
|
|
4.7 |
|
|
|
|
|
Second Supplemental Indenture to Subordinated Indenture, dated as of April 1,
2005, by and among Province Healthcare Company and U.S. Bank National
Association, as Trustee (incorporated by reference from exhibits to Province
Healthcare Companys Current Report on Form 8-K dated April 1, 2005, File No.
001-31320). |
|
|
|
|
|
|
|
4.8 |
|
|
|
|
|
Indenture, dated as of October 10, 2001, between Province Healthcare Company
and National City Bank, including the forms of Province Healthcare Companys
41/4% Convertible Subordinated Notes due 2008
(incorporated by reference from exhibits to the Registration Statement on Form
S-3, filed by Province Healthcare Company on December 20, 2001, File No.
333-75646). |
|
|
|
|
|
|
|
4.9 |
|
|
|
|
|
First Supplemental Indenture, dated as of April 15, 2005, by and among Province
Healthcare Company, LifePoint Hospitals, Inc. and U.S. Bank National
Association (as successor in interest to National City Bank), as trustee to the
Indenture dated as of October 10, 2001, relating to Province Healthcare
Companys 41/4% Convertible Subordinated Notes due 2008
(incorporated by reference from exhibits to the Historic LifePoint Hospitals,
Inc. Current Report on Form 8-K dated April 15, 2005, File No. 000-29818. |
85
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
4.10 |
|
|
|
|
|
Indenture, dated August 10, 2005, between LifePoint Hospitals, Inc. and
Citibank, N.A., as Trustee (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K dated August 10, 2005, File No.
000-51251). |
|
|
|
|
|
|
|
4.11 |
|
|
|
|
|
Indenture, dated May 29, 2007, by and between LifePoint Hospitals, Inc. as
Issuer and The Bank of New York Trust Company, N.A., as Trustee (incorporated
by reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated May 31, 2007, File No. 000-51251). |
|
|
|
|
|
|
|
10.1 |
|
|
|
|
|
Tax Sharing and Indemnification Agreement, dated May 11, 1999, by and among
Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc. (incorporated
by reference from exhibits to Historic LifePoint Hospitals Quarterly Report on
Form 10-Q for the quarter ended March 31, 1999, File No. 000-29818). |
|
|
|
|
|
|
|
10.2 |
|
|
|
|
|
Benefits and Employment Matters Agreement, dated May 11, 1999 by and among
Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc. (incorporated
by reference from exhibits to Historic LifePoint Hospitals Quarterly Report on
Form 10-Q for the quarter ended March 31, 1999, File No. 000-29818). |
|
|
|
|
|
|
|
10.3 |
|
|
|
|
|
Insurance Allocation and Administration Agreement, dated May 11, 1999, by and
among Columbia/HCA, LifePoint Hospitals, Inc. and Triad Hospitals, Inc.
(incorporated by reference from exhibits to Historic LifePoint Hospitals
Quarterly Report on Form 10-Q for the quarter ended March 31, 1999, File No.
000-29818). |
|
|
|
|
|
|
|
10.4 |
|
|
|
|
|
Computer and Data Processing Services Agreement, dated May 19, 2008, by and
between HCA Information Technology Services, Inc. and LifePoint Hospitals, Inc.
(incorporated by reference from exhibits to the LifePoint Hospitals, Inc.
Current Report on Form 8-K dated May 21, 2008, File No. 000-51251). |
|
|
|
|
|
|
|
10.5 |
|
|
|
|
|
Comprehensive Service Agreement for Diagnostic Imaging and Biomedical Services,
executed on January 7, 2005, between LifePoint Hospital Holdings, Inc. and GE
Healthcare Technologies (incorporated by reference from exhibits to Historic
LifePoint Hospitals Annual Report on Form 10-K for the year ended December 31,
2004, File No. 000-29818). |
|
|
|
|
|
|
|
10.6 |
|
|
|
|
|
Amended and Restated 1998 Long Term Incentive Plan (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated July 7,
2005, File No. 000-51251).* |
|
|
|
|
|
|
|
10.7 |
|
|
|
|
|
First Amendment, dated May 13, 2008, to the LifePoint Hospitals, Inc. Amended
and Restated 1998 Long-Term Incentive Plan (incorporated by reference from
Appendix A to the LifePoint Hospitals, Inc. Proxy Statement filed March 31,
2008, File No. 000-51251).* |
|
|
|
|
|
|
|
10.8 |
|
|
|
|
|
Second Amendment, dated December 10, 2008, to the to the LifePoint Hospitals,
Inc. Amended and Restated 1998 Long-Term Incentive Plan (filed herewith).* |
|
|
|
|
|
|
|
10.9 |
|
|
|
|
|
LifePoint Hospitals, Inc. Executive Performance Incentive Plan (incorporated by
reference from Appendix C to Historic LifePoint Hospitals Proxy Statement
dated April 28, 2004, File No. 000-29818).* |
|
|
|
|
|
|
|
10.10 |
|
|
|
|
|
First Amendment, dated December 10, 2008, to the LifePoint Hospitals, Inc.
Executive Performance Incentive Plan (filed herewith).* |
|
|
|
|
|
|
|
10.11 |
|
|
|
|
|
Form of LifePoint Hospitals, Inc. Nonqualified Stock Option Agreement
(incorporated by reference from exhibits to LifePoint Hospitals Quarterly
Report on Form 10-Q for the quarter ended March 31, 2007, File No. 000-51251).* |
|
|
|
|
|
|
|
10.12 |
|
|
|
|
|
Form of LifePoint Hospitals, Inc. Restricted Stock Award Agreement
(incorporated by reference from exhibits to LifePoint Hospitals Quarterly
Report on Form 10-Q for the quarter ended June 30, 2005, File No. 000-51251).* |
|
|
|
|
|
|
|
10.13 |
|
|
|
|
|
Form of LifePoint Hospitals, Inc. Deferred Restricted Stock Award (incorporated
by reference from exhibits to LifePoint Hospitals Quarterly Report on Form
10-Q for the quarter ended June 30, 2008, File No. 000-51251).* |
86
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
10.14 |
|
|
|
|
|
LifePoint Hospitals, Inc. Employee Stock Purchase Plan (incorporated by
reference from exhibits to Historic LifePoint Hospitals Annual Report on Form
10-K for the year ended December 31, 2001, File No. 000-29818).* |
|
|
|
|
|
|
|
10.15 |
|
|
|
|
|
First Amendment to the LifePoint Hospitals, Inc. Employee Stock Purchase Plan
(incorporated by reference from exhibits to the Registration Statement on Form
S-8 filed by Historic LifePoint Hospitals, Inc. on June 2, 2003, File No.
333-105775).* |
|
|
|
|
|
|
|
10.16 |
|
|
|
|
|
Second Amendment To Employee Stock Purchase Plan (incorporated by reference
from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the
quarter ended March 31, 2006, File No. 000-51251).* |
|
|
|
|
|
|
|
10.17 |
|
|
|
|
|
LifePoint Hospitals, Inc. Change in Control Severance Plan, as amended and
restated December 10, 2008 (incorporated by reference from exhibits to the
LifePoint Hospitals, Inc. Current Report on Form 8-K dated December 10/16,
2008, File No. 000-51251).* |
|
|
|
|
|
|
|
10.18 |
|
|
|
|
|
LifePoint Hospitals, Inc. Management Stock Purchase Plan, as amended and
restated (incorporated by reference from exhibits to Historic LifePoint
Hospitals Annual Report on Form 10-K for the year ended December 31, 2002,
File No. 000-29818).* |
|
|
|
|
|
|
|
10.19 |
|
|
|
|
|
First Amendment, dated May 13, 2008, to the LifePoint Hospitals, Inc.
Management Stock Purchase Plan (incorporated by reference from Appendix B to
the LifePoint Hospitals, Inc. Proxy Statement filed March 31, 2008, File No.
000-51251). * |
|
|
|
|
|
|
|
10.20 |
|
|
|
|
|
Second Amendment, dated December 10, 2008, to the LifePoint Hospitals, Inc.
Management Stock Purchase Plan (filed herewith).* |
|
|
|
|
|
|
|
10.21 |
|
|
|
|
|
Form of Outside Directors Restricted Stock Agreement (incorporated by reference
from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the
quarter ended March 31, 2006, File No. 000-51251).* |
|
|
|
|
|
|
|
10.22 |
|
|
|
|
|
Amended and Restated LifePoint Hospitals, Inc. Outside Directors Stock and
Incentive Compensation Plan, dated May 14, 2008 (incorporated by reference from
exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the quarter
ended June 30, 2008, File No. 000-51251).* |
|
|
|
|
|
|
|
10.25 |
|
|
|
|
|
Credit Agreement, dated as of April 15, 2005, by and among LifePoint Hospitals,
Inc., as borrower, the lenders referred to therein, Citicorp North America,
Inc. as administrative agent, Bank of America, N.A., CIBC World Markets Corp.,
SunTrust Bank, UBS Securities LLC, as co syndication agents and Citigroup
Global Markets, Inc., as sole lead arranger and sole bookrunner (incorporated
by reference from exhibits to Historic LifePoint Hospitals Current Report on
Form 8-K dated April 15, 2005, File No. 000-29818). |
|
|
|
|
|
|
|
10.26 |
|
|
|
|
|
Incremental Facility Amendment dated August 23, 2005, among LifePoint
Hospitals, Inc., as borrower, Citicorp North America, Inc., as administrative
agent and the lenders party thereto (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K dated August 23, 2005, File No.
000-51251). |
|
|
|
|
|
|
|
10.27 |
|
|
|
|
|
Amendment No. 2 to the Credit Agreement, dated October 14, 2005, among
LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc., as
administrative agent and the lenders party thereto (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated October
18, 2005, File No. 000-51251). |
|
|
|
|
|
|
|
10.28 |
|
|
|
|
|
Incremental Facility Amendment No. 3 to the Credit Agreement, dated June 30,
2006 among LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc.
as administrative agent and the lenders party thereto. (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated June 30, 2006, File No. 000-51251). |
|
|
|
|
|
|
|
10.29 |
|
|
|
|
|
Incremental Facility Amendment No. 4 to the Credit Agreement, dated September
8, 2006, among LifePoint Hospitals, Inc. as borrower, Citicorp North America,
Inc. as administrative agent and the lenders party thereto (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated September 12, 2006, File No. 000-51251). |
87
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
10.30 |
|
|
|
|
|
Amendment No. 5 to the Credit Agreement, dated as of May 11, 2007, among
LifePoint Hospitals, Inc. as borrower, Citicorp North America, Inc., as
administrative agent and the lenders party thereto (incorporated by reference
from exhibits to LifePoint Hospitals Current Report on Form 8-K dated May 24,
2007, File No. 000-51251). |
|
|
|
|
|
|
|
10.31 |
|
|
|
|
|
ISDA 2002 Master Agreement, dated as of June 1, 2006, between Citibank, N.A.
and LifePoint Hospitals, Inc. (incorporated by reference from exhibits to
LifePoint Hospitals Current Report on Form 8-K/A dated September 8, 2006, File
No. 000-51251). |
|
|
|
|
|
|
|
10.32 |
|
|
|
|
|
Schedule to the ISDA 2002 Master Agreement (incorporated by reference from
exhibits to LifePoint Hospitals Current Report on Form 8-K/A dated September
8, 2006, File No. 000-51251). |
|
|
|
|
|
|
|
10.33 |
|
|
|
|
|
Confirmation, dated as of June 2, 2006, between LifePoint Hospitals, Inc. and
Citibank, N.A. (incorporated by reference from exhibits to LifePoint Hospitals
Current Report on Form 8-K/A dated September 8, 2006, File No. 000-51251). |
|
|
|
|
|
|
|
10.34 |
|
|
|
|
|
Stock Purchase Agreement, dated July 14, 2005, by HCA Inc. and LifePoint
Hospitals, Inc. (incorporated by reference from exhibits to LifePoint
Hospitals Quarterly Report on Form 10-Q for the quarter ended June 30, 2006,
File No. 000-51251). |
|
|
|
|
|
|
|
10.35 |
|
|
|
|
|
Amendment to the Stock Purchase Agreement, dated June 2, 2006 (incorporated by
reference from exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q
for the quarter ended June 30, 2006, File No. 000-51251). |
|
|
|
|
|
|
|
10.36 |
|
|
|
|
|
Repurchase Agreement, dated June 30, 2006, by and between HCA Inc. and
LifePoint Hospitals, Inc. (incorporated by reference from exhibits to LifePoint
Hospitals Quarterly Report on Form 10-Q for the quarter ended June 30, 2006,
File No. 000-51251). |
|
|
|
|
|
|
|
10.37 |
|
|
|
|
|
Executive Severance and Restrictive Covenant Agreement, dated December 11,
2008, by and between LifePoint CSGP, LLC and William F. Carpenter III
(filed herewith).* |
|
|
|
|
|
|
|
10.38 |
|
|
|
|
|
Agreement to Cooperate and General Release, entered into on May 4, 2007, by and
between LifePoint Hospitals, CSGP, LLC and Michael J. Culotta (incorporated by
reference from exhibits to LifePoint Hospitals Current Report on Form 8-K
dated May 10, 2007, File No. 000-51251).* |
|
|
|
|
|
|
|
10.39 |
|
|
|
|
|
Retirement Agreement and General Release, dated August 21, 2008, by and between
LifePoint CSGP, LLC and William M. Gracey . (incorporated by reference from
exhibits to LifePoint Hospitals Quarterly Report on Form 10-Q for the quarter
ended September 30, 2008, File No. 000-51251).* |
|
|
|
|
|
|
|
10.40 |
|
|
|
|
|
Form of Indemnification Agreement (incorporated by reference from exhibits to
the LifePoint Hospitals, Inc. Current Report on Form 8-K dated August 29, 2008,
File No. 000-51251). |
|
|
|
|
|
|
|
10.41 |
|
|
|
|
|
Recoupment Policy Relating to Unearned Incentive Compensation of Executive
Officers (incorporated by reference from exhibits to the LifePoint Hospitals,
Inc. Current Report on Form 8-K dated May 20, 2008, File No. 000-51251). |
|
|
|
|
|
|
|
12.1 |
|
|
|
|
|
Ratio of Earnings to Fixed Charges |
|
|
|
|
|
|
|
21.1 |
|
|
|
|
|
List of Subsidiaries |
|
|
|
|
|
|
|
23.1 |
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm |
|
|
|
|
|
|
|
31.1 |
|
|
|
|
|
Certification of the Chief Executive Officer of LifePoint Hospitals, Inc.
pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
|
|
31.2 |
|
|
|
|
|
Certification of the Chief Financial Officer of LifePoint Hospitals, Inc.
pursuant to Section 302 of the Sarbanes Oxley Act of 2002 |
|
|
|
|
|
|
|
32.1 |
|
|
|
|
|
Certification of the Chief Executive Officer of LifePoint Hospitals, Inc.
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
88
|
|
|
|
|
|
|
Exhibit |
|
|
|
|
Number |
|
|
|
Description of Exhibits |
32.2 |
|
|
|
|
|
Certification of the Chief Financial Officer of LifePoint Hospitals, Inc.
pursuant to Section 906 of the Sarbanes Oxley Act of 2002 |
* Management Compensation Plan or Arrangement
89